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### **Cancer stem cells in hepatocellular carcinoma: An immunohistochemical study with clinicopathological correlation** {#Sec3}

*Smita Mary Matthai,* ***Banumathi Ramakrishna***

Department of Pathology, Christian Medical College, Vellore 632 004, India

*Background and Aims*: Cancer stem cells (CSC) may be responsible for tumor recurrence and resistance to chemotherapy in hepatocellular carcinomas (HCC). This study evaluated the associations between histological parameters and liver CSCs (LCSC) in HCC, and compared CSC in HCC associated with and without hepatitis B virus (HBV) infection.

*Methods*: Seventy-nine tumors (49 surgical resections from 46 patients, and 30 from autopsy) were reviewed. Immunohistochemical staining for the LCSC marker EpCAM, liver progenitor cell (LPC) marker CK19 and NCAM were performed and were correlated with histological features of tumor behavior.

*Results*: Thirty-three tumors (41.8 %) showed positive staining for EpCAM. CK19 and NCAM expression were seen in 26 (32.9 %) and 4 (5.1 %) tumors respectively. The expression of EpCAM and CK19 correlated significantly with each other (*p*\<0.001). EpCAM expression was significantly associated with features indicating aggressive tumor behavior, including younger age of onset, higher serum AFP levels, tumor cell dedifferentiation, increased mitotic activity, and vascular invasiveness. There was no significant difference in expression of EpCAM, CK19 and NCAM between HBV positive and negative HCC.

*Conclusion*: The LCSC marker EpCAM was expressed in less than half of HCC, was independent of HBV etiology, and was strongly associated with clinical and histological features of aggressive tumor behavior. Positive staining for CK19 suggests a possible LPC origin of the EpCAM positive HCCs.

**A-2** {#Sec4}
-------

### **Relationship of cytokines, oxidative stress and gastrointestinal motility with bacterial overgrowth in ulcerative colitis patients** {#Sec5}

***S V Rana*** *, S Sharma, S K Sinha, K K Prasad, A Malik, J Kaur, R K Morya*

Department of Super Specialty of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Ulcerative colitis (UC) is idiopathic, chronic and relapsing inflammatory bowel disease. Factors which initiate and perpetuate UC are not well understood. It is still unclear if any relationship exists between cytokines, oxidative stress, gastrointestinal (GI) motility, small intestinal bacterial overgrowth (SIBO) in UC patients. Therefore, the present study was planned to examine the relationship between these factors among UC patients.

*Methods*: Total 120 UC patients and 125 age and sex matched controls with no GI symptoms were enrolled. Levels of plasma IL-6, IL-8, TNF-α and IL-10 were measured in all subjects by using ELISA. Lipid-peroxidation (LPO) and reduced glutathione (GSH) were measured by standard methods. Orocecal transit time (OCTT) and SIBO were measured by lactulose and glucose hydrogen breath tests respectively.

*Results*: Out of 120 UC patients, 74 were males with mean±SD of age 45.6±17.5 years. Plasma levels of IL-6, IL-8, TNF-α and IL-10 in UC patients were significantly higher (*p*\<0.01) as compared to controls. LPO in UC patients was significantly increased (*p*\<0.01) while reduced glutathione (GSH) was significantly decreased (*p*\<0.01) as compared to controls. OCTT and SIBO were significantly higher in UC patients as compared to controls. It was also observed that there was significant correlation between SIBO with IL-6, IL-8, TNF-α, IL-10, LPO and GSH. Although correlation with GSH was inversely proportional to SIBO.

*Conclusion*: This study indicates that increase in cytokines and decrease in anti-oxidants in UC patients would have resulted in oxidative stress causing delayed GI motility leading to SIBO.

A-3 {#Sec6}
---

### Colorectal cancers in Indian patients with ulcerative colitis {#Sec7}

***Devendra Desai*** *, Abhijit Deshmukh, Philip Abraham, Anand Joshi, Sudeep Shah, Tarun Gupta, Ramesh Deshpande, Varun Khandagale, Siji George*

Divisions of Gastroenterolgy, Surgery, and Pathology, P D Hinduja Hospital, Veer Savarkar Marg, Mahim, Mumbai 400 016, India

*Background*: Data from India suggest that colorectal cancer (CRC) occurs in 0.94 % to 1.8 % of patients with ulcerative colitis (UC). We report our data on CRC in UC.

*Methods*: Data on 430 patients (248 males \[57.7 %\]; mean age 44 \[SD 14.6\] years; median duration of disease 6 (Interquartile range 7) years with UC were available for analysis from the inflammatory bowel disease database maintained since 2005. Thirty-eight (8.8 %) patients had proctitis, 95 (22.1 %) procto-sigmoiditis, 131 (30.5 %) left-sided colitis, 159 (37 %) pancolitis and extent was unknown in 7 patients. Patients with histologically confirmed CRC within the segment with colitis were compared with those without CRC, to determine risk factors for the development of CRC.

*Results*: Twelve patients (2.8 %) developed CRC. The incidence density was 3.556/1000 patient-years of disease (PYD) overall--2.995/1000 in the first 10 years, 3.338/1000 PYD at 10 to 20 years, and 7.030 /1000 PYD at \>20 years. On univariate analysis age, gender, duration of disease, extent of colitis, smoking, duration of 5-aminosalicylic acid therapy, family history of inflammatory bowel disease, medication compliance and disease control were considered for analysis. Extensive colitis (disease proximal to splenic flexure) (*p*=0.01), longer duration of disease (*p*=0.00001) and poor control of disease (*p*=0.007) were associated with development of CRC. On multivariate analysis, duration of disease (*p*=0.0099) and extent of colitis (*p*=0.0273) were significant factors for development of malignancy.

*Conclusion*: In this study, colorectal cancer occurred in 2.8 % of patients with ulcerative colitis. The risk increased with extent and duration of disease.

A-4 {#Sec8}
---

### Microsatellite instability and promoter hypermethylation in colorectal cancer in India {#Sec9}

***V V Ravi Kanth*** *, Sandeep Balsingh, M Sasikala, G V Rao, R Pradeep, Steffie Avanthi, D Nageshwar Reddy*

Asian Healthcare Foundation and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Background and Objectives*: The incidence of colorectal cancer (CRC) is increasing in India. Genomic instability is the hallmark of cancer and microsatellite instability (MSI) is an important factor in tumor development. MSI is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. It is important to identify MSI clinically as they have a better prognosis and differ with response to chemotherapy. Limited data is available on the incidence of MSI in Indian CRCs. The objectives of this study were to identify the extent of MSI in Indian CRC patients below 50 years and determine promoter methylation status of hMLH1 and hMSH2 in relation to MSI.

*Methods*: Ninety-one individuals with CRC were recruited (Bethesda guidelines); patient characteristics were noted down. Colorectal tumors were tested for MSI by NCI recommended Bethesda panel using labeled primers and the fragments were separated and analyzed on Beckman Sequencer. Promoter methylation status was determined by restriction enzyme digestion and PCR.

*Results*: MSI-High was detected in 13.2 % (12/91), MSI-low in 35.2 % (32/91) and the rest were Microsatellite stable (MSS) 51.6 % (47/91). Majority (8/12) of the MSI-H tumors were associated with rectum (site of the tumor, were moderately or poorly differentiated (12/12) and the tumor type was adenocarcinoma (10/12). Promoter hypermethylation was significantly associated with instability, both MSI-H and MSI-L.

*Conclusions*: In the present study, MSI, both high and low was associated with 48.4 % of CRC patients below fifty years of age.

A-5 {#Sec10}
---

### HCV viremia levels are determinant of serum IFN-α expression via TRAF6 interaction with MAVS and TRIF {#Sec11}

***Phani Kumar Gumma*** *, Soumya Jyoti Chowdhury, Vijay Kumar Karra, Rajesh Ruttala, Premashis Kar*

Department of Medicine, Maulana Azad Medical College, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, India

Infection with the hepatitis C virus (HCV) leads to chronic hepatitis C (CHC) in 50 % to 80 % of individuals. The recognition of HCV by immune system, triggers pathways leading to type-I interferon production, and induce an antiviral state. HCV associated with hepatocellular carcinoma (HCC) and B cell lymphoma. HCV infection causes a 5 to 10 fold increase in mutation frequency in Ig heavy chain, BCL-6, p53, and β-catenin genes of in vitro HCV-infected B cell lines and HCV-associated peripheral blood mononuclear cells, lymphomas, and HCCs, but not in lymphomas of non-viral origin or HBV-associated HCC. HCV induces a mutator phenotype and may transform cells by a hit-and-run mechanism in the host. Gene sequences codes for TRAF6-binding motifs in TRIF 250--PEEMSW--255 and in MAVS, 153--PGENSE--158 and 455--PEENEY--460 were analyzed for mutations by direct sequencing, and IFN-β levels from 63 patients of CHC and 38 healthy individuals. We made an effort to confirm these protein interactions by co-immuno precipitation of TRAF6 with MAVS and TRIF isolated from biopsy of 47 chronic hepatitis C patients and 12 autopsy liver tissue and Western blotting. Alignment sequences code for MAVS and TRIF motifs which interacts with TRAF6 revealed they were highly conserved. MAVS and TRIF interact with TRAF6 in CHC patients. Thus there is no association of sequence variations with these protein interactions in CHC patients. HCV viremia \<1.4 × 105 IU/mL was associated with TRAF6 interaction with MAVS and TRIF proteins which causes increase in IFN-β levels in CHC patients.

A-6 {#Sec12}
---

### Complete hepatitis B virus genome analysis in patients of hepatocellular carcinoma and asymptomatic carriers from Northern, Sothern and North East India {#Sec13}

***Manash Pratim Sarma*** *, Giasuddin Ahmed, Subhash Medhi, Premashis Kar*

Department of Medicine, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, India, and Department of Biotechnology, Gauhati University, Assam

*Materials and Method*: Seventy-five HBV related HCC cases and 15 HBV related asymptomatic carriers were included in the study. HBV DNA was amplified by six sets of walking primers. PCR amplicons were sequenced commercially, submitted to [http://www.ncbi.nlm.nih.gov](http://www.ncbi.nlm.nih.gov/), translated into amino acid and aligned using BioEdit v7.0.9.

*Result*: A total of 60, 15, 23 and 1 mutations were observed in the PC/C, X, P and S genes respectively. Mutations like 10I→L was significantly associated in HCC cases from NEI \[(*p*=0.01; OR=5. 63) VS SI\] and \[(*p*\<0.01; OR=16.63) VS NI\]. Mutations like 41S→T (*p*\< 0.001; OR= 19.01), 92 V→G (*p*\< 0.001; OR= 19.01), 96N→T (*p*\< 0.001; OR= 19.01) and 164Q→P (*p*=0.0279; OR= 3.085) were found significantly associated with HCC cases from NI \[VS SI\].Widely reported 28 W→stop mutation was found in few HCC cases. 132→stop \[(*p*= 0.004486; OR= 5.479 VS SI) and \[(*p*= 0.004486; OR= 5.479) VS NEI\] was a novel finding. Mutations like 267I→N and 268D→T were exclusively found in HCC cases from NEI while 270S→F was confined to NI. Reported drug mutants like 80L→I, 236N→T, 169I→T and 181A→V) were also observed.

*Conclusion*: PC/C region of the HBV genome is most prone to mutation followed by P, X and S genes. The highest variation in the entire HBV genome was observed in HCC cases from North India while the genome was comparatively conserved in asymptomatic HBV carriers. Noval mutations in surface (132 stop), polymerase (frameshift mutation at codon 178), core (10 I→L, 41 S→T, 92 V→G, 96 N→T and 164 Q→P) and X (33 P→S) gene needs molecular and cellular studies to be used as a novel kit for the diagnosis and prognosis of HCC. Association of exclusive mutants in HCC cases from NEI needs close attention for developing region based HBV related HCC management in India.

Young Investigator Award Session {#Sec14}
================================
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### Single stage laparoscopic common bile duct exploration and cholecystectomy versus two stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with concomitant gallbladder stones and common bile duct stones {#Sec16}

***Karthik Rajan*** *, Virinder Kumar Bansal, Mahesh C Misra, Ragini Kilambi, Subodh Kumar, Asuri Krishna, Atin Kumar, Chandrakant S Pandav, Rajeshwari Subramaniam, M K Arora, Pramod Kumar Garg*

Departments of Surgery, Radiodiagnosis, Preventive and Social Medicine, Anesthesiology, and Gastroenterology, All India Institute of Medical Sciences, New Delhi 110 029, India

*Background*: Management of gallbladder stones with common bile duct (CBD) stones is debatable with two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy being the currently preferred method.

*Objective*: To compare the success and cost-effectiveness of single stage vs. two-stage management of patients with concomitant gallbladder and CBD stones.

*Methods*: Consecutive patients with concomitant gallbladder and CBD stones were randomized to either single-stage laparoscopic CBD exploration and cholecystectomy (Group I) or to two-stage procedure ie. ERCP for CBD stones extraction followed by laparoscopic cholecystectomy (Group II). Success was defined as complete clearance of CBD and cholecystectomy by the intended modality.

*Results*: From February 2009 to October 2012, 168 patients were randomized--84 to single-stage procedure (Group I) and 84 to two-stage procedure (Group II). Both the groups were matched with regard to patients' demographic and clinical parameters. The success rates of laparoscopic CBD exploration and ERCP for clearance of CBD were similar (91.7 % vs. 88.1 %). Overall success rate was also similar (88.1 % vs. 79.8 %; *p*=0.20). The mean operative time was significantly higher in Group I (135.7±36.6 vs. 72.4±27.6 minutes; *p*=\<0.001) but the overall hospital stay was significantly shorter (4.6±2.4 vs. 5.3±6.2 days; *p*=0.03). The cost of treatment was lower in Group I (INR 21258 vs. 27328; *p*=0.001). There was no significant difference in complications between the 2 groups.

*Conclusions*: Single-stage and two-stage management for uncomplicated concomitant gallbladder and CBD stones had similar success and complications but the single-stage strategy was better in terms of shorter hospital stay and cost effectiveness.

B-2 {#Sec17}
---

### Whole genome expression profile to identify genes involved in pathogenesis of celiac disease {#Sec18}

***Asha Mishra***, *Rajesh Pandey, Abhisek Agnihotri, Anurag Mehta, Mitali Mukerji, Govind K Makharia*

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, and Institute of Genomics and Integrative Biology, New Delhi, India

*Background*: Celiac disease (CeD) is a multifactorial disorder involving genetic and environmental factors with multiple genes expected to be involved. We studied whole genome expression profile in duodenal mucosa of patients with CeD using microarray.

*Patients and Methods*: Mucosal biopsies from duodenum were obtained and total RNA was extracted using RNeasy Kit (Qiagen) from 12 HLA-DQ2 positive CeD patients (villous abnormality Marsh grade 3b and 3c) and 12 controls. 500 ng of total RNA was used for whole genome expression profiling using Illumina HT-12.v4 Bead Chips. Data was analyzed using Illumina Genomic Studio, with ±13 (p50 % of differentially expressed genes in metabolic processes. This included upregulated genes involved in lipid metabolism REP; and downregulated drug metabolizing genes (CYP4A11, CYP4F11 and CYP3A4), and steroid hormones synthesis (ABCA7). It also included other important processes which may regulate metabolism like transport, localization, response to stimulus and homeostatic processes. RNA expression of CYP-3A4 was confirmed by qPCR and it was downregulated by mean factor of 0.189 (0.036-1.083) in CeD compared with control (*p*=0.001).

*Conclusion*: The gene expression analysis shows differential expression of a number of genes in CeD. An underexpression of CYP3A4 in CeD has been validated earlier by us. Cyp3A4 has a potential for being used as a biomarker of villous atrophy.

B-3 {#Sec19}
---

### Association of polymorphisms of human leukocyte antigen-DQA1 and DQB1 alleles with outcome of HBV infection from North India {#Sec20}

***Vijay Kumar Karra*** *, P K Gumma, R Ruttala, S J Chowdhury, S K Polipalli, Anita Chakravarti, P Kar*

PCR-Hepatitis Laboratory, Departments of Medicine, and Medical Microbiology, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, Delhi 110 002, India

*Aim*: To assess the contribution of the HLA class II DQA1 and DQB1 gene polymorphisms for susceptibility or resistance to acute hepatitis B, chronic hepatitis B, and development of HBV related liver cirrhosis and HCC.

*Materials and Methods*: HLA-DQA1 and -DQB1 alleles in 134 acute hepatitis B, 48 chronic hepatitis B, 84 liver cirrhosis, 14 HCC patients and 280 healthy controls were analyzed by using the polymerase chain reaction/sequence specific primer (PCR/SSP) technique from New Delhi.

*Results*: Our data suggest that allele frequency of DQA1\*0101/0104 (2.2 % vs. 30.0 %), DQA1\*0102/3 (42.53 % vs. 57.1 %), DQA1\*0501 (23.88 % vs. 57.1 %), DQA1\*0601 (17.9 % vs. 35.0 %), DQB1\*0302/3 (17.9 % vs. 71.7 %), DQB1\*0303 (2.2 % vs. 15.2 %), DQA1\*0601 (4.1 % vs. 35.0 %), DQB1\*0302/3 (37.5 % vs. 71.7 %), DQA1\*0101/0104 (14.2 % vs. 30.0 %), DQA1\*0101/2/4 (25.0 % vs. 49.2 %), DQA1\*0102/3 (57.1 % vs. 40.4 %), DQA1\*0103 (22.6 % vs. 44.2 %), DQA1\*0501 (33.3 % vs. 57. 1%), DQA1\*0601 (3.5 % vs. 35.0 %), DQB1\*0302/3 (38.0 % vs. 71.7 %), DQA1\*0102/3 (21.4 % vs. 57.1 %), DQA1\*0103 (7.1 % vs. 44.2 %), DQA1\*0501 (14.2 % vs. 57.1 %), DQA1\*0601 (0.0 % vs. 35.0 %), DQB1\*0302/3 (71.7 % vs. 21.4 %), were markedly lower in HBV related acute, chronic, cirrhosis and HCC than in the control group there was a significant correlation between them, which strongly suggest a protective effect against HBV infection. Allele frequency of DQA1\*0101/2/4 (76.11 % vs. 49.2 %), DQA1\*0103 (78.3 % vs. 44.2 %), DQB1\*0501 (6.7 % vs. 1.7 %), DQB1\*0402 (29.1 % vs. 1.0 %), DQB1\*0601 (45.8 % vs. 24.2 %), DQB1\*0402 (35.7 % vs. 1.0 %) were markedly higher in HBV related acute, chronic and cirrhosis than in the control group there was a significant correlation between them. which strongly suggest a susceptible effect against HBV infection.

*Conclusion*: DQA1\*0101/0104, DQA1\*0101/2/4, DQA1\*0102/3, DQA1\*0103, DQA1\*0501, DQA1\*0601, DQB1\*0302/3, DQB1\*0303 are closely related with resistance to HBV infection, DQA1\*0101/2/4, DQA1\*0103, DQB1\*0501, DQB1\*0402, DQB1\*0601 closely related with susceptibility to HBV infection. These findings suggest that host HLA class II gene is an important factor determining the outcome of HBV infection.

B-4 {#Sec21}
---

### Alteration of tight junction proteins (Zo-1, Claudin 2, 3 and 4, Occludin and JAM) in patients with celiac disease and Crohn\'s disease {#Sec22}

*Pooja Goswami,* ***Prasenjit Das*** *, Anil K Verma, Shyam Prakash, T K Das, T C Nag, Vineet Ahuja, Siddhartha Datta Gupta, Govind K Makharia*

All India Institute of Medical Sciences, New Delhi 110 029, India

*Background*: Tight junctions (TJ) maintain the integrity of intercellular pathway and are regulated by transmembrane and cytoplasmic proteins. Abnormalities of TJ have been implicated in pathogenesis of both celiac (CeD) and Crohn's disease (CD). Since the mechanisms of abnormalities in intestinal permeability are different in CeD and CD; we planned to study if there was a difference in expression of key TJ proteins at baseline and at six months after treatment.

*Patients and Methods*: Endoscopic mucosal biopsies from treatment naÃ¯ve patients with CeD (*n*=24), active CD (*n*=28), 15 control subjects and duodenal biopsies after 6 months of treatment were subjected to histological examination (Modified Marsh grade), immune-histochemical analysis of key TJ proteins \[transmembrane proteins (claudin-2, 3, 4, occludin and JAM) and cytoplasmic protein (ZO-1)\]. The expression patterns of the TJ proteins were validated using western blot analysis. Ultrastructural image morphometry was performed to study correlation between TJ protein expression and ultrastructural changes.

*Results*: There was a significant overexpression of claudin-2 (pore forming protein), occludin (cell polarity) and underexpression of ZO-1 (cytoplasmic anchoring protein), claudin-3 and 4 (pore sealing proteins) at baseline biopsies of CeD and CD. Ultrastructurally there was loss of pentalaminar structures and dilatation of TJs at baseline. Normalization of some of these key pore modulating and structural TJ proteins were seen 6 months after treatment. Ultrastructurally there was reduction in TJ diameter.

*Conclusions*: Overexpression of pore forming and underexpression of pore sealing and cytoplasmic anchoring proteins lead to loss of TJ integrity. These changes are however not disease specific.

B-5 {#Sec23}
---

### Molecular characterization of full length HCV genotype 3a reveals additional hypervariable region with potential epitopic region analyzed by an in-silico approach {#Sec24}

***Manish Chandra Choudhary*** *, Vidhya Natarajan, Shvetank S Sharma, Priyanka Pandey, Garima Mishra, Banishree Saha, Tarandeep Singh, Rachana Tripathi, Munpally Shesheer Kumar, Syed N Kazim, Ekta Gupta, Shiv K Sarin*

Department Research, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India, Department of Medicine, University of Massachusetts Medical School, Worcester, USA, London School of Hygiene and Tropical Medicine, London University, and Centre for Interdisciplinary Research in Basic Sciences, Jamia Milia University, New Delhi 110 025, India

*Background*: Hepatitis C virus (HCV) causes persistent infection due to its ability to undergo rapid mutations, thus evading host's immune surveillance mechanism. Much of research to understand escape mechanism has been directed against identifying potential epitopes with some success in various genotypes, however, there is paucity of data for HCV genotype 3a (GT3a).

*Objective*: To clone, sequence and characterize full-length HCV from plasma of patients with GT3a infection.

*Study design*: Molecular characterization of five patients with HCV GT3a infection was performed by assessing its genomic variability with other genotypes and subtypes, by measuring Shannon entropy, analyzing extent of positive selection and performing physico-chemical analysis.

*Results*: Genetic analysis by Shannon entropy measurement revealed two novel hypervariable regions (HVR) within the envelope protein E2 of HCV GT3a, named as HVR496 and HVR576 with a variable 5-8 amino-acid insertion site and a putative N-glycosylation site. Phylogenetic analysis revealed these sequences formed a distinct clade and was of earliest evolving representatives of the HCV GT3a. Evolutionary analysis of E2 region encompassing most of HVR region ie. HVR1, HVR496, and HVR576 showed that positively selected sites were largely restricted to these HVR regions. Physico-chemical and antigenicity prediction analysis were in concordance with entropy analysis data confirming these regions as novel hypervariable regions. Further, B- and T-cell epitope prediction using in-silico tools revealed potential immunogenic regions.

*Conclusions*: The newly identified HVRs may be employed as markers while assessing viral genetic diversity in infected individuals to better define the course of treatment and may act as vaccine targets for HCV GT3a.

B-6 {#Sec25}
---

### Ultra deep high-throughput sequencing of intestinal microflora in celiac disease and first-degree relatives and effect of gluten-free diet on them {#Sec26}

***Sudarshan A Shetty*** *, Dhiraj P Dhotre, Khushbo Bhatia, Anil K Verma, Asha Mishra, Vineet Ahuja, Govind K Makharia, Yogesh S Shouche*

National Centre for Cell Sciences, All India Institute of Medical Sciences, New Delhi 110 029, India

*Background*: Gut microflora has been implicated in pathogenesis of celiac disease (CeD). We aimed to investigate the duodenal microflora in patients with CeD (both before and after gluten-free diet, \[GFD\]), first-degree relatives (FDR) and controls.

*Patients and Methods*: The small intestinal microflora in duodenal biopsies of patients with CeD both before and six months after GFD, first degree relatives and controls was analyzed using ultra deep high-throughput amplicon sequencing of V3 region of 16S rRNA gene using Illumina HiSeq2000 sequencer.

*Results*: The observed species of bacteria in controls, FDR and CeD patients before and after GFD at an even sequencing depth were approximately 1470, 1311, 1209 and 1586, respectively. Shannon and Chao1 rarefaction measure suggested near complete sampling of bacterial species present. Treatment naÃ¯ve CeD patients had a higher abundance of pathogenic bacteria. GFD led to reduction in colonization of pathogenic bacteria and increase in abundance of beneficial microflora. The distribution pattern of microbial flora in first-degree relatives, both at phylum and family level, were different from that in CeD patients. The principal component analysis demonstrated a near similarity in duodenal microflora of first-degree relatives and controls.

*Conclusion*: The present study is the first study that elucidates the duodenal microflora in controls, First-degree relatives and CeD patients (before and after GFD). GFD in CeD patients shifted the bacterial community composition towards a healthy gut microflora and comparable to that of FDR and controls. There was difference in duodenal microflora of CeD patients and first-degree relatives.

Presidential Posters {#Sec800}
====================

PP-1 {#Sec700}
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### A study of SPINK 1 mutation and clinical correlates in idiopathic recurrent acute pancreatitis {#Sec701}

***Shiran Shetty,*** *J Krishnaveni, LVenkatakrishnan, Ramalingam*

Department of Gastroenterology, P S G Institute of Medical Sciences, 1674, Peelamedu, Coimbatore 641 004 India

Recurrent acute pancreatitis and chronic pancreatitis are labeled as idiopathic when no identifiable factors are found. The identifications of genetic mutations associated with pancreatitis have provided opportunities for identifying patients at risk for idiopathic pancreatitis.

*Aim*: To study of clinical profile and prevalence of SPINK 1 mutation in idiopathic recurrent acute and chronic pancreatitis.

*Design*: Prospective observational study of patients with idiopathic recurrent and chronic pancreatitis in a tertiary care hospital from November 2010 to 31st December 2011.

*Results*: Fifty patients were included out which 17 patients were idiopathic recurrent acute pancreatitis and 33 were chronic. Out of 17 patients with RAP mean age was 22.29±9.7 years, duration of illness was 28.23±10.34 months, 82 % were male, 94 % had BMI \>18.5 kg/m2 41.17 % had SPINK1 mutation. Out of 33 patients with chronic pancreatitis mean age was 31.75±13.07 year, duration of illness was 31.33±19.89 months, mean fasting sugar was 112.57 mg/dL, 67 % were male, 93.94 % had pain 87.8 % had ductal dilatation on CT, 36.36 % were SPINK 1 positive.

*Conclusion*: SPINK1 mutation patients have more frequent episodes of pancreatitis and parenchymal calcification on CT. The clinical profile of idiopathic chronic pancreatitis is different from what has been reported in the past.

PP-2 {#Sec702}
----

### Amebic liver abscess: Diagnostic and therapeutic appraisal {#Sec703}

***Jayanta Kumar Ghosh,*** *Sundeep Kumar Goyal, Manas Kumar Behera, V B Abhilash, Sunit Kumar Shukla, Vinod Kumar Dixit, A K Jain*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Aims and Objectives*: i) Clinical profile and diagnosis of uncomplicated right lobe amebic liver abscess (ALA) by ultrasonography and serologic methods, ii) To define prognostic markers such as non-resolution of ALA, morbidity and mortality, and iii) Compare the efficacy of metronidazole treatment alone vs. aspiration and metronidazole combined treatment by radiologic and serologic methods.

*Materials and Methods*: Total 160 consecutive patients with right lobe ALA were divided into 4 groups: ALA patients treated with 1) metronidazole only \[(a) \< 5 cm and (b) 5 cm)\] and 2) metronidazole and aspiration \[(a) \<5 cm and (b) 5 cm)\]. Ultrasonography was done to assess the size of ALA, and E. histolytica Gal/GalNAc lectin detection in serum by Techlab II Elisa kit was done with some modifications on day 1 and 14.

*Results*: Ninety percent of the patients were male and alcoholic. Diabetes was common in females. Abscess cavity size \>5 cm, continued alcohol abuse, uncontrolled diabetes were factors with significantly increased morbidity and mortality. Techlab II Elisa in serum was a useful method for antigen detection in ALA patients. Patients who underwent aspiration plus metronidazole had shown significantly better outcome in terms of clinical symptoms, biochemical markers, radiological and serologic improvement.

*Conclusion*: In this prospective, quasi-randomized, double-blinded study the role of aspiration plus metronidazole was re-established. The 2009 Cochrane's review found no evidence to support or refute aspiration of the abscess cavity plus metronidazole vs. metronidazole alone in uncomplicated amebic liver abscess.

PP-3 {#Sec704}
----

### Expression profile of Toll like receptor-7 and TH1/TH2 dependent cytokines in acute viral hepatitis cases from Assam: A pilot study {#Sec705}

***Priyanka Kashyap***, *Manab Deka, Sujoy Bose, Manashree Sharma, Raj Kumari Deblakshmi, Sangit Dutta, Subhash Medhi*

Departments of Biological Science, Biotechnology, and Medicine, Gauhati University, Guwahati 14, Assam,

*Introduction*: Toll-like receptors (TLRs) are innate sensors that recognize microbial and endogenous ligands, initiating host defense response of which TLR-7 recognizes viral single-stranded RNA.

*Aim*: To study the TLR7 expression in acute viral hepatitis cases along with the expression profile of Th1/Th2 dependant cytokines in patients from Assam.

*Methodology*: Subjects enrolled included acute cases of hepatitis A virus (HAV) *n*=10, hepatitis E virus (HEV) *n*=10 along with healthy controls n=10 collected from Gauhati Medical College. Expression of TLR7 was done by Real Time-PCR, using Î²-actin as internal control. Expression profile of Th1/Th2 cytokines was assessed by flow cytometry.

*Result*: Expression of TLR7 was increased in case of HEV (fold increase 4.01±2.77) than HAV (fold increase 3.23±0.91) compared to healthy controls and correlation analysis was statistically non significant (*p*=0.464) in the fold change.Th1/Th2 cytokine expression revealed that IL-6 expression was highest in HAV \[31.51 (pg/mL)±70.25\] as well as HEV \[15.16±18.64\] which was statistically non significant (*p*=0.4861) among the two acute case groups. In HAV IL-4 \[0.09±0.23\], and in HEV IL-10 \[3.95±8.61\] was least expressed in comparison to healthy controls where only cytokines TNF-Î± \[3.2\] and IL-6 \[0.12\] were expressed.

*Conclusion*: Our study may indicate that TLR7 signaling plays an important role in acute viral hepatitis and possible interaction between TLR7, pathogenesis and disease progression of acute viral hepatitis. IL-6 upregulation in both acute HAV and HEV may play an important role in the disease progression of acute viral hepatitis.
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### Predictive value of serum actin-free Gc-globulin for complications and outcome in acute liver failure {#Sec707}

***Avishek Bagchi***, *Suresh Kumar, P C Ray, P Kar*

Department of Medicine, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, Delhi 110 002, India

*Introduction*: Serum concentration of the actin free fraction of Gc-globulin is postulated to represent a good prognostic indicator in acute liver failure (ALF) patients. This prospective study was designed to evaluate whether early changes in actin free Gc- globulin levels were associated with complications and outcomes and to identify factors associated with persistent low actin free Gc-globulin levels in ALF.

*Methods*: Thirty-two consecutive ALF patients admitted from October 2011 to December 2012 were followed up until death or complete recovery. All had serum actin free Gc-globulin estimation at admission and at day three or expiry. Logistic regression analysis was performed to identify independent predictors of mortality. A receiver operating characteristic curve analysis was also done.

*Results*: Nonsurvivors had significantly lower median actin free Gc-globulin levels than survivors. A receiver operating characteristic curve analysis showed that serum actin free Gc-globulin level of 124 mg/L would predict mortality with 92 % sensitivity and 71.4 % specificity. Patients with lower serum actin free Gc-globulin levels at admission and with decreasing trends in serum actin free Gc-globulin levels were found to have 100 % mortality and also developed more complications. Logistic regression analysis showed that serum actin free Gc-globulin, total leukocyte count and serum creatinine at admission were independent predictors of mortality. Incorporating these variables, a score predicting mortality risk at admission was derived.

*Conclusion*: Serum actin free Gc-globulin level at presentation is predictive of outcome and can be used for risk stratification. Its persistent low level predicts mortality and is correlated with various complications.
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### Multilocus genotyping and subgenotyping of Cryptosporidium species infecting humans from India {#Sec709}

***Pooja Yadav***, *Bijay R Mirdha, Govind K Makharia, Shinjini Bhatnagar*

Departments of Microbiology, Gastroenterology and Human Nutrition and Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India

*Background*: *Cryptosporidium hominis* and *Cryptosporidium parvum* are two commonest cause of human cryptosporidiosis. Very few studies from the sub-continent have analyzed the clinical and socio-demographic features with that of species, genotypes and sub-genotypes of the species. Hence, the objective of the study was to examine cryptosporidiosis and their association with clinico-epidemiological variables.

*Patients and Methods*: Three consecutive stool samples were collected from 600 patients \[immunocompetent (*n*=300) and immunocompromized (*n*=300)\] with diarrhea. Besides, microscopic examination, extracted DNA from stool samples were subjected to PCR-RFLP assays at small subunit ribosomal (SSUrRNA), *Cryptosporidium* oocyst wall protein (COWP), thrombospondin-related adhesive protein of *Cryptosporidium* (TRAP-C1) and *Cryptosporidium* glycoprotein (Cpgp40/15) loci.

*Results*: *Cryptosporidium* species was detected microscopically in 82 (14 %, 82/600) \[immunocompetent (*n*=18) and immunocompromized (*n*=64)\] patients. Sensitivities of PCR assays using SSUrRNA, COWP, TRAP-C1 and Cpgp40/15 genes were 92 % (77/82+2) (2 additional positives by PCR), 68 % (54/80), 43 % (34/80) and 95 % (70/74), respectively. Seventy percent of the isolates were *C. hominis* and rest 30 % were *C. parvum* \[monkey and bovine genotypes\]. Sub-genotyping using Cpgp40/15 gene could detect seven different sub-genotypes \[Ia(19 %), Ib(13 %), Id(19 %), Ie(38 %), If(4 %), IIc(2 %), IId(4 %)\] in 52 *C. hominis* isolates, and only three sub-genotypes \[IIa(72 %), IIb(11 %), IId(17 %)\] in 18 *C. parvum* isolates. Infections with *Cryptosporidium* were common in children below 5 years of age than older children (*p* value \<0.001) and most of them were infected with Ie, Ia and Id subgenotypes.

*Conclusion*: Zoonotic transmissions have an important role in human cryptosporidiosis, and multilocus genotyping tool is best suited for dissecting anthroponotic and zoonotic transmissions in a community.
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### Titres of anti-tissue transglutaminase antibody correlate well with severity of villous abnormality in celiac disease {#Sec711}

*Prashant Singh, Lalit Kurray,* ***Abhishek Agnihotri,*** *Prasenjit Das, Anil Kumar Verma,Vishnubhatla Sreenivas, Siddharth Dattagupta, Govind K Makharia*

All India Institute of Medical Sciences, New Delhi 110 029, India

*Background and Aim*: ESPGHAN 2012 guidelines for diagnosing celiac disease (CeD) suggest that biopsy could be avoided in some patients with high anti-tissue transglutaminase (tTG) antibody (ab) titre. We reviewed our CeD database to study if anti-tTG ab titres correlate with severity of villous abnormalities in Asian population and to find out a cutoff value of anti-tTG ab fold rise which could best predict CeD.

*Methods*: We reviewed a cohort of 366 anti-tTG ab positive individuals in whom duodenal biopsies were performed. Anti-tTG ab results were expressed in terms of fold-rise by calculating ratio of observed values with cut-off value. CeD was diagnosed in presence of positive serology, villous atrophy (\>Marsh grade 2) and unequivocal response to gluten-free diet.

*Results*: The mean anti-tTG fold-rise in groups with Marsh grade-2 was 2.6 (±2.5), grade 3a was 4.0 (±3.9), 3b was 5.7 (±5.1) and 3c was 11.8 (±8.0). The positive likelihood ratio for diagnosing CeD was 15.4 and 27.4 at 12 and 14 fold-rise of anti-tTG titre, respectively. The positve predictive value of diagnosis of CeD was 100 % when anti-tTG antibody titre was 14 folds higher over the cutoff value. Fifty-seven (43.9 %) individuals with anti-tTG titre rise \<2 folds also had CeD.

*Conclusions*: As severity of villous abnormality increases, titre of anti-tTG also rises. Presence of villous atrophy can be predicted at very high anti-tTG titre. Contrary to emerging belief, mucosal biopsies should be performed even if anti-tTG antibody titre is less than 2 times, because many patients with CeD have low titres.
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### RS2230201 polymorphism may dictate complement C3 levels and response to treatment in chronic hepatitis patients {#Sec713}

***Soumya Jyoti Chowdhury,*** *Phani Kumar Gumma, Vijay Kumar Karra, Premashis Kar*

Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, Delhi 110 002, India

*Background*: The basis of response of chronic hepatitis C (CHC) patients to treatment is still unclear and there may be many other factors which influence treatment outcome other than the existing ones. The serum concentration of C3 closely reflects the total complement activity and Individuals affected by C3 deficiency suffer from recurrent pyogenic infections. This study aims to find out if there is any relation between levels of C3 in serum and its functional SNPs with response to treatment.

*Methods*: The study included 132 CHC patients and 81 healthy controls, genotyped for 3 known functional SNP's, out of which 48 patients obtained conventional IFN+ribavirin.

*Results*: C3 Level of the healthy group was significantly higher (88.5±19 mg/dL) when compared to CHC group (56±18 mg/dL; *p*\<0.001). Thirty-three out of 36 responders were CC genotype carriers whereas 9 out of 12 non-responders were non-CC genotype of rs2230201. The 'C' allele of rs2230201 was found to be associated with increased serum C3 levels when compared to other genotypes in healthy group whereas CT genotype was associated with lowered serum C3 in CHC group. A serum C3 value of \<53 mg/dL was predictive of SVR with sensitivity 63.89 % and specificity 66.67 %.

*Conclusion*: Our study indicates that rs2230201 'C' allele is associated with increasing of serum C3 levels when compared to "T" allele which may confer advantage in attaining SVR when present in homozygous condition. Our study indicates that patients with serum C3 value \<53 mg/dL and non-CC genotypes may not respond to treatment.
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### Prevalence of cirrhotic cardiomyopathy and its correlation with S.BNP levels {#Sec715}

***Neha Kapoor,*** *Suresh Kumar, Vimal Mehta, Sanjay Tyagi, P Kar*

Department of Medicine, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, India

*Introduction*: Decompensate liver cirrhosis is characterized by a peripheral vasodilation with a low-resistance hyperdynamic circulation. The sustained increase of cardiac work load associated with such a condition may result in an inconstant and often subclinical series of heart abnormalities, constituting a new clinical entity known as cirrhotic cardiomyopathy. Diastoilc dysfunction has been described in cirrhosis.

*Methods*: Tissue doppler echocardiography is a newer sensitive technique to detect diastolic dysfunction. We used this newer technique and also did conventional 2D and doppler echocardiography in cirrhotic patients. Additionally, QTc interval, BNP, Tropinin T levels were measured. Ultrasound abdomen, UGI endoscopy, doppler SPA, MELD score and CTP was done.

*Result*: In our study 30 cirrhotic patients were compared with 30 controls. The results in 30 cirrhotic patients (mean age 44.7±14.8 yr, M:F:28:2) etiology:alcoholic-12, nonalcoholic-18, Child score (A-0, B-11, C-19), MELD Score 14.7±6.4. Tissue doppler echocardiography showed mean early diastolic velocity of 11.6±2.6 vs. 19.8±6 cm/sec (*p*)
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### Manometric evaluation in patients with reflux symptoms but normal upper gastrointestinal endoscopy {#Sec29}

***Mayank Jain*** *, Sandip Ware, Amit Bundiwal, Shohini Sircar, Ajay Jain*

Choithram Hospital and Research Centre, Manik Bagh Road, Indore 452 014, India

*Aim*: To study the manometric findings in all patients with reflux symptoms of more than six months duration and a normal upper gastrointestinal endoscopy.

*Materials and Methods*: This retrospective study was done at Choithram Hospital and Research Centre, Indore. Records of all patients with reflux symptoms of \>6 months duration and a documented normal OGD at our centre were analyzed. The study period was from October 2011 to March 2013. High resolution manomtery was done in left lateral position using 16 channel water perfusion system. Basal LES pressures were recorded for 1 minute. Peristalsis was recorded for ten swallows of 5 mL water each. Age and sex distribution, basal and nadir LES pressures and esophageal peristaltic pattern were analyzed.

*Results*: A total of forty-five patients formed the study group. The mean age was 46.1 years and male to female ratio was 34:11. Sixteen (35.5 %) patients had a normal manometric study. The major abnormalities detected included hypotensive lower esophageal sphincter (21), nonspecific dysmotility (11), absent peristalsis in lower 2/3 of esophagus (1) and diffuse esophageal spasm (3).

*Conclusion*: Only a third of patients with normal OGD scopy and long standing reflux symptoms have normal manometric findings. Hypotensive lower esophageal sphincter and nonspecific dysmotility are the major manometric abnormalities.
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### The characters of lower esophageal sphincter function and esophageal motility in patients with reflux disease {#Sec31}

***Mayank Jain***

Choithram Hospital and Research Centre, Manik Bagh Road, Indore 452 014, India

*Background*: Reflux esophagitis (RE) and nonerosive reflux disease (NERD) are subtypes of gastroesophageal reflux disease (GERD). Lower esophageal sphincter (LES) function and esophageal motility play an important role in antireflux in patients with GERD.

*Aim*: To study the characters of esophageal motility and LES function in patients with RE and NERD.

*Materials and Methods*: The study was done at Choithram Hospital and Research Centre. All patients who underwent esophageal manometry for reflux symptoms between April 2012 to March 2013 formed the study group. They were divided into two groups based on the upper gastrointestinal endoscopy reports-reflux esophagitis and NERD. High resolution manomtery was done in left lateral position using 16 channel water perfusion system. Basal LES pressures were recorded for 1 minute. Peristalsis was recorded for ten swallows of 5 mL water each. Age and sex distribution, basal and nadir LES pressures and esophageal peristaltic pattern were analyzed in the two groups. Unpaired *t* test was applied.

*Results*: A total of 46 patients (31-RE and 15-NERD) formed the study group. The age and sex distribution in the two groups was similar. The basal LES pressures were significantly lower (*p*=0.003) in the RE group. The peristaltic pattern showed normal peristalsis in eleven and nonspecific dysmotility in 4/15 patients with NERD. In patients with reflux esophagitis, normal peristalsis (18/31), nonspecific dysmotility (7/31), hypertensive peristalsis (2/31), absent peristalsis in lower 2/3 of esophagus (3/31) and hypotensive peristalsis (1/31) were noted.

*Conclusion*: Patients with RE have significantly lower LES pressures and show abnormal peristaltic patterns compared to patients with NERD.
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### Methylene blue chromoendoscopy for early diagnosis of Barrett's metaplasia, dysplasia and early esophageal adenocarcinoma: A pilot study {#Sec34}

***S Mukundan*** *, K Muthukumaran, G Ramkumar, R Balamu Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College and Hospital, Chennai 600 010, India

*Introduction*: Chronic GERD predisposes to Barrett's metaplasia, dysplasia and adenocarcinoma. Early detection of these lesions is important for making treatment decisions and surveillance stratergies.

*Aim*: To evaluate and compare the effectiveness of methylene blue chromoendoscopy directed biopsies in the early diagnosis of Barrett's metaplasia, Dysplasia and early esophageal adenocarcinoma in high risk population compared to routine random biopsy.

*Materials and Methods*: This is an ongoing prospective study in Department of Digestive Health and Diseases, Government Peripheral Hospital, Annanagar, Chennai from April 2013. Patients with chronic GERD were included in the study based on certain inclusion criteria. Each patient underwent routine whitelight and 0.5 % methylene blue chromoendoscopy with biopsy as per protocol. They were assessed based on staining pattern, number of biopsies required and histology.

*Results*: So far 12 patients (9 male and 3 female) were included in the study. Six patients had chronic GERD (3 had nocturnal symptoms), 4 had heartburn and 2 had noncardiac chestpain. Uniform dark blue staining was seen in 5 patients and patchy staining in 7 patients. None of the patients had Barett's metaplasia or dysplasia on routine biopsy. After chromoendoscopy directed biopsy, 2 patients had evidence of classical Barretts on histology, 3 had gastric metaplasia, 1 had esophagitis and none had dysplasia.

*Conclusion*: With the available data Methylene blue chromoendoscopy and targeted biopsy in comparison to whitelight endoscopy and random biopsy, improved the identification and diagnosis of Barett's metaplasia and impacted treatment strategies.
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### Prevalence and associations of gastroesophageal reflux disease: A community study in South India {#Sec36}

***Sudipta Dhar Chowdhury*** *, Gemlyn George, Kartik Ramakrishna, S Pugazendhi, Balamurugan Ramadoss, John Mechenro, B S Ramakrishna*

Department of Gastrointestinal Sciences, Christian Medical College, Vellore 632 004, India

*Background and Aim*: There exist scarce community-based data on prevalence of gastroesophageal reflux disease (GERD) in India. This study was conducted to determine the prevalence of symptoms of GERD and to identify potential associations with the disease.

*Method*: A community-based survey of adults (aged 18-65 years) was done through proportionate sampling in urban and rural areas of Vellore District, Tamil Nadu, India. The participants were questioned about symptoms of heart burn and sour or acid reflux in the last 12 months and frequency and severity of symptoms noted. We also evaluated associations of GERD with place of residence (urban or rural), age, gender, diabetes mellitus, socioeconomic status, body mass index (BMI), central obesity, blood pressure, tobacco and alcohol use. Odds ratios (OR) with 95 % confidence intervals were derived from logistic regression models.

*Results*: Six thousand six hundred and thirty-nine adults were interviewed, of whom 905 (13.6 %) had reflux symptoms. Amongst the subjects with reflux symptoms 24.2 % (219) had symptoms every day. 19.1 % (173) were on daily medications for GERD. GERD symptoms were positively associated with urban dwelling (OR=2.2, 95 % CI: 1.9 -2.6 for urban), higher age (OR=1.3, 95 % CI: 1.1 -1.5 for age \>40), higher BMI (OR=1.3, 95 % CI: 1.1-1.5 for BMI 25), central obesity (OR=1.5, 95 % CI: 1.2-1.8) and alcohol use (OR=1.5, 95 % CI: 1.1-2.04). There was no significant association with gender, diabetes mellitus, blood pressure, socioeconomic status, or tobacco use.

*Conclusion*: The prevalence of GERD symptoms in this representative south Indian community was 13.6 %. Urban dwelling, age \>40 years, BMI \> 25 kg/m2, central obesity and alcohol use were associated with GERD.
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### Endoscopic stenting for leaks following surgical esophageal procedures: A case series {#Sec38}

***Mohd. Juned Khan*** *, P S Rajan, P Karthikeyan, Amol Shinde, C Palanivelu*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Background/Aims*: Leak after esophageal anastomosis or perforation has high morbidity and mortality especially due to sepsis, mediastinitis and malnutrition. Management of this is a therapeutic challenge. This study reviews our experience treating postoperative esophageal leaks with the esophageal stent.

*Methods*: Between 2007 and 2012, 11 patients with intrathoracic anastomotic leak after esophagectomy (*n*=8), perforation following hellers cardiomyotomy (*n*=3) were treated with endoscopic placement of a removable covered SEMS. The clinical details of these patients were analyzed and recovery pattern studied.

*Result*: Eleven patients had stents placed for leak occlusion after esophagectomy (*n*=8), or myotomy (*n*=3). The mean interval between surgical intervention and stent placement was 7 days. Occlusion of the leak occurred in all 11 patients as documented by gastrograffin study on 2nd day following stenting. One patient had stent migration partially which was replaced with another lengthy stent and required feeding jejunostomy also temporarily. None of the other patients had Stent migration or any stent related complications. Eleven stents were removed without residual leak at mean duration of 75±33 days. One patient had a stricture after stent removal that required endoscopic dilatation.

*Conclusion*: The esophageal stent is an effective method for occluding a postoperative esophageal leak. It effectively eliminates mediastinal and peritoneal contamination, promotes enteral nutrition and is easily removable. These stents are an effective alternative to traditional esophageal diversion and subsequent reconstruction in patients with a persistent esophageal leak.
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### Combined thoracoscopic-endoscopic approach for leaks after esophageal surgery {#Sec40}

***Mohd. Juned Khan*** *, P S Rajan, P Karthikeyan, Amol Shinde, C Palanivelu*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Background/Aims*: Esophageal surgery, especially esophageal resections are associated with high morbidity. Intrathoracic leaks, at esophagogastric anastomosis can lead to mediastinitis and sepsis. Early detection and appropriate measures to drain intrathoracic collection and preventing continuing leak into mediastinum should be the aim. Rarely leaks can also occur after Heller's cardiomyotomy. Here we report 3 cases where we used combined thorocoscopy and endoscopic approach to successfully manage intrathoracic leak.

*Methods*: Of the three patients, two had undergone minimally invasive thoraco-laparoscopic Ivor-Lewis esophagectomy for adenocarcinoma of lower esophagus. Both the leaks were detected on postoperative day 4 when patient developed features of mediastinitis and collection. The third patient had undergone laparoscopic Heller's cardiomyotomy. The leak was detected on postoperative day three. In all three patients the approach to drain the pleural collection was right thoracoscopic with patient in prone position. Thorough drainage and lavage of the mediastinum and right pleural cavity was done. In one case a small segment of the gastric conduit which was discolored at the anastomotic line was excised and re-suturing done. This was followed by placement of self expanding removable PTFE coated metallic stent endoscopically.

*Result*: All patients improved dramatically in the postoperative period. There was no leak in the postoperative period as documented by gastrograffin study. They were able to tolerate orally from post procedure day five. The stents were removed 3 months following the procedure.

*Conclusion*: Combined thoraco-endoscopic approach can be life saving.
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### Role of high resolution manometry in determining response to pneumatic dilation in achalasia cardia in a tertiary referral center {#Sec42}

***K Srinivas*** *, M Ramanna, M Umadevi, P Shravan Kumar*

Department of Gastroenterology, Gandhi Medical College and Hospital, Hyderabad 500 029, India

*Background*: Achalasia cardia is the commonest cause of motor dysphagia.

*Aim*: To study the role of high resolution manometry (HRM) in determining the effect of pneumatic dilation in achalasia in a tertiary referral centre in south India.

*Materials and Methods*: We have retrospectively reviewed 20 cases of achalasia cardia over a 3-year period from 2010 to 2013.

*Results*: Males were more often affected than females in a ratio of 1.5:1. Mean age of presentation is 38 years. Two male pediatric cases are below the age of 10 years. When symptoms were analyzed, dysphagia for solids and liquids was found in 90 %, chest pain in 40 %, regurgitation in 30 %. Barium swallow X-ray studies of the esophagus were diagnostic. Fifteen patients underwent HRM and the ratio of type1 to 2 to 3 is 6:8:1. Long-term follow up of 15 patients over a 3-year period revealed excellent response of 95 % at 1 year, 80 % at 3 years. One male child underwent second dilation after 8 months. The 2 pediatric cases and the one with type 3 achalasia had recurrence of symptoms after 2 years and were referred for surgery.

*Conclusions*: The response to pneumatic dilation was more effective for type 1 and 2 , but not for type 3 and pediatric achalasia cardia.
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### Esophageal variceal stent for uncontrolled post endoscopic variceal ligation ulcer bleed {#Sec44}

*B S Ravindra, Naveen Ganjoo,* ***Eranna B Maanthagonda*** *, Kiran Shinde*

Medical Gastroenterology, B G S Global Hospital, Kengeri, Bengaluru 560 060, India

Sixty-eight-years-male, a case of hepatitis B cirrhosis (Child B) with diabetes, presented with acute massive hemetemesis. No history of alcoholism, smoking, hepatic encephalopathy, SBP, HRS. Past history, had undergone endoscopic variceal ligation. Mucosal pallor noted. Systemic examination: NAD.

*Investigations*: Hemoglobin-7.6 %, RBS-279, PT INR-1.2, LFT-s.bilirubin-0.7, total proteins-5.6, serum albumin-2, SGOT-55, SGPT-24, alp-43, GGT-37. Ultrasound abdomen showed liver cirrhosis, spleenomegaly, mild ascites. Ascitic fluid examination-no evidence of SBP. Upper gastrointestinal endoscopy showed esophageal varices with post-endoscopic variceal ligation ulcer. Management: endoscopic glue injection was attempted but patient continued to bleed, due to unavailability of TIPS, esophageal variceal stent (DANIS STENT). Followed by the procedure patient was hemodynamically stable and bleeding stopped. After 7 days stent was removed. No bleeding was observed. Later he underwent TIPS and is symptom free since then.
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### Predictors of Barrett's esophagus in patients presenting to a tertiary care centre: A case control study {#Sec46}

***Yamuna R Pillai*** *, H Abhilash, Anil P John, Devang Tank, E H Rooby, N Premaletha, K R Vinayakumar*

Department of Medical Gastroenterology, Government Medical College, Thiruvananthapuram 695 011, India

*Background*: Barrett's esophagus is the most important surrogate marker for the development of esophageal adenocarcinoma. This study was aimed to identify the predictors of Barrett's esophagus in patients presenting for upper gastrointestinal (GI) endoscopy for any indication.

*Methods*: A case control study conducted in patients undergoing upper GI endoscopy in Medical Gastroenterology Department from January to June 2013. Patients with Barrett's (cases) were compared to those without Barrett's (controls). Baseline characteristics including demographic information, body mass index, history of smoking, use of aspirin/ NSAIDs, endoscopic details of endoscopically suspected esophageal metaplasia (ESEM) presence of hiatus hernia were noted. Biopsies were taken from ESEM to assess for intestinal/gastric metaplasia and subjected to histology, doubtful cases confirmed by PAS and Alcian blue staining. Data analyzed using SPSS version 16.0.

*Results*: Barrett's was present in 7.8 % of the 590 study subjects. On univariate analysis BMI\>24.5 (*p*-002), hiatus hernia (*p*-0.034) and nocturnal symptoms (*p*-0.00) were found to be predictive of Barrett's.

*Conclusions*: High BMI, hiatus hernia and nocturnal symptoms were found to be predictors of Barrett's esophagus.
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### Two years follow up in patients who underwent dilation for esophageal strictures {#Sec48}

***C Vaishnavi Priyaa*** *, S Jeevan Kumar, P Ganesh, R Balamurali, K Muthukumaran, G Ramkumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Poonamallee High Road, Kilpauk, Chennai 600 010, India and Dr M G R Medical University, 69, Anna Salai, Guindy, Chennai 600 032, India

*Objectives*: To compare the frequency of dilation among various esophageal strictures over 2 years, in patients who underwent Savary-Gilliard bougie dilation.

*Materials and Methods*: A cross sectional study was, done in 63 patients, with esophageal strictures who underwent dilation session, between March 2011 and June 2011 at Kilpauk Medical College. The frequency of repeat dilation in them, over a period of 2 years follow up, were analyzed based on, etiology of strictures.

*Results*: Among 63 patients dilated, postradiotherapy strictures were more (23 cases=36 %). Among corrosive strictures, two patients underwent dilation 10 times, and two patients underwent dilation five times, three patients dilated twice. Among postradiotherapy strictures 2 patients underwent dilation seven times, and 3 patients underwent dilatation 5 times.

*Conclusion*: In our centre, postradiation strictures constituted maximum number of cases dilated. Corrosive stricture group, closely followed by postradiation, had maximum number sessions of dilation. Corrosive stricture needed frequent dilations, at shorter intervals than postradiation.
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### Achalasia is associated with eNOS4a4a, iNOS22GA and nNOS29 TT genotypes: A case-control study {#Sec50}

***Rajan Singh*** *, Uday C Ghoshal, Asha Misra, Balraj Mittal*

Departments of Gastroenterology and Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226 014, India

*Background*: Achalasia, a common esophageal motor disorder, is associated with incomplete lower esophageal sphincter (LES) relaxation and esophageal aperistalsis resulting from degeneration of ganglion cells in the myenteric plexus. Nitric oxide (NO), produced by NO synthase (NOS), plays an important role in peristalsis and LES relaxation. We aimed to study the role of NOS gene isoforms (eNOS, iNOS and nNOS) polymorphisms in patients with achalasia as compared to healthy subjects (HS).

*Methods*: Consecutive patients with achalasia (diagnosed using high resolution manometry) and HS were genotyped for 27 bp eNOS variable number of tandem repeats (VNTR), iNOS22 G/A (rs1060826), nNOS C/T (rs2682826) polymorphisms by PCR and PCR-restriction fragment length polymorphism (RFLP), respectively.

*Results*: Among 183 patients (118 \[64.5 %\] male, age 39.5±13-y) with achalasia and 366 HS (254 \[69.4 %\] male, age 40.8±11-y), eNOS4a4a genotype of 27bp VNTR was commoner among patients compared to HS (20 \[10.9 %\] vs. 13 \[3.6 %\], *p*=0.000, OR 3.72, 95 % CI 1.8-7.7). Patients with achalasia more often had iNOS22GA genotypes than HS (95 \[51.9 %\] vs. 93 \[25.4 %\], *p*=0.000, OR 3.0, 95 % CI 2.1-4.4). Frequency of genotypes GA+AA was frequent among patents compared to HS (97\[53 %\] vs. 107 \[29.2 %\], *p*=0.000, OR 2.7, 95 % CI 1.8-3.9). Also, nNOS29TT variant genotype in rs2682826 was commoner among patients compared to HS (14 \[7.7 %\] vs. 6 \[1.6 %\], *p*=0.000, OR 5.91, 95 % CI 2.2-15.8).

*Conclusion*: Achalasia is associated with eNOS4a4a, iNOS22GA and nNOS29TT genotypes, respectively. This association may explain the importance of polymorphisms of eNOS, iNOS and nNOS genes for development of achalasia.
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### Ingestion of carbonated drink decreases lower esophageal sphincter pressure and increases transient lower esophageal sphincter relaxations in patients with gastroesophageal reflux {#Sec52}

*Shobna Bhatia,* ***Akash Shukla*** *, Megha Meshram, Prashant Dhore, Gaurav Sharma*

Department of Gastroenterology, Seth G S Medical College and K E M Hospital, Mumbai 400 012, India

*Introduction*: Transient lower esophageal sphincter relaxations (tLESr) and diminished baseline lower esophageal sphincter pressure (LESP) are postulated mechanisms of gastroesophageal reflux (GER). Ingestion of carbonated drink increases tLESr and lowers LESP in healthy subjects; we assessed the effects of carbonated drink on these in GER patients.

*Methods*: Eleven patients (mean age 33.3 \[10.9\] y; 10 men) with GER, diagnosed by symptoms and endoscopy, underwent high resolution manometry for 120 minutes each at baseline, and after ingestion of 200 mL of chilled potable water, and 200 mL of chilled Coke (Coca-Cola, India) on different days. The sequence of drinks was decided by computer-generated random numbers. A physician who was blinded to sequence of drinks did the analysis (Trace 1.2, Hebbard, Australia). No patient was receiving PPI or prokinetics at the time of study. The institutional ethics committee permission was obtained, and all patients consented to the study.

*Results*: tLESr were more frequent after carbonated beverage (3 \[0-43\]) as compared to water (1 \[0-19\]; *p*=0.03, OR 9.3 \[1.7-17.9\]). LESP was lower after ingestion of carbonated beverage (13.9 \[7.5\] mmHg) as compared to baseline (24.2 \[10.9\]), or after water ingestion (18.6 \[8.3\] mmHg, *p*=0.000). Median tLESr duration was longer after carbonated beverage (8.5 \[0-26\] sec) as compared to that after water (5.7 \[0-11\] sec, *p*=0.000, OR 9.12 \[6.3-11.9\]). Gastric pressure was similar in the three parts of the study.

*Conclusions* Ingestion of carbonated beverage is associated with lowering of LESP, increase in number and duration of tLESr.
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### Per-oral endoscopic myotomy (POEM) for achalasia cardia - Results from a single centre {#Sec56}

***Amol Bapaye*** *, Nachiket Dubale, Rajendra Pujari, Suhas Date*

Department of Digestive Diseases and Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Erandawne, Pune 411 004, India

*Background and Aim*: Treatment for achalasia cardia includes endoscopic balloon dilatation or surgical/laparoscopic Heller's myotomy. Peroral endoscopic myotomy (POEM) is an upcoming modality. This study reports preliminary results of POEM in a single center study.

*Materials and Methods*: Patients with confirmed achalasia on EGD and high-resolution manometry (HRM) undergoing POEM included. Preoperative work up: OGD, HRM and barium swallow. Associated comorbidities and previous treatments for achalasia noted. Procedure under general anesthesia. *Equipment*: Standard endoscope, ESD cap, hybrid knife, CO2 insufflation. Hemoclips for closure. Procedure time, technical success and immediate complications noted. Clinical success determined by reduction in dysphagia score. Postprocedure reflux noted. Postprocedure OGD and HRM repeated at 4 weeks.

*Results*: N: 8, achalasia type: I -- 2, II -- 6, III -- 0. Mean pre-op LES pressures (mmHg): 40.6 (26-59). Significant comorbidities: 3/8. Previous therapy: Heller's--0, Botox--1 and Dilatation--2. Mean symptom duration (months): 70.25 (4-180).

Technical success -- 100 %. Mean procedure duration (minutes): 187.5 (60-330). Intra-op complications: Nil. Technical difficulties: 2/8. Mean follow up LES pressure (mmHg): 10.8 (5-16).

Clinical success -- dysphagia relief -- 8/8 (100 %). Postop reflux -- 2/8 (25 %) -- PPI therapy. Follow up (mean) -- 6 months.

*Conclusions*: POEM is safe and effective treatment for achalasia cardia. It is effective in previously treated patients and is safe in comorbid patients. GERD occurred in 25 % but was easily managed with PPI. Prospective randomized studies with larger sample size are warranted.
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### Eosinophilic esophagitis: An evaluation of it\'s importance in a tropical region {#Sec58}

*P Murali Krishna,* ***Sailesh Atmakuri*** *, L R S Girinath*

Andhra Medical College, Jagadamba Junction, Visakhapatnam Part, Andhra Pradesh 530 002, India

*Background*: Esophagitis is a inflammatory condition characterized by eosinophilic infiltration of the esophagus. Eosinophilic esophagitis is emerging cause for dysphagia in western society.

*Aim*: The purpose of this study was to reevaluate the incidence of eosinophilic esophagitis in patients suffering from dysphagia and to assert it\'s importance as a distinct clinical entity.

*Methods*: Over 100 patients suffering from dysphagia were sought out from the Southern states of India. Biopsy and failure to respond to PPI were selected. Further screening of patients by rejecting patients with histories of NSAID intake, corrosive injuries, malignancy, comorbid conditions or any systemic disease. The age of the patients ranged between 12 and 75 years.

*Conclusion*: Since the incidence of eosinophilic esophagitis is lower in the tropics than temperate climates-despite the higher level of allergens in the former-we might also consider research into the etiology of this entity confirming whether or not it truly is an immunological condition.
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### Study of mucosal healing after high dose PPI in acute corrosive injury esophagus {#Sec60}

***N A Rajesh*** *, Kani Sheik Mohammed, Ratnakar Kini, K Prem Kumar, T Pughazhendi, Mohd. Ali*

Madras Medical College, Chennai 600 003, and Rajiv Gandhi Government General Hospital (RGGGH), Park Town, Chennai 600 003, India

There is no standard treatment protocol for acute corrosive injury of esophagus and most patients are treated with proton pump inhibitors. However clinical studies evaluating efficacy of PPIs in caustic injury are lacking. Ours is a ongoing prospective study evaluating efficacy of high dose proton pump inhibitor in causing mucosal healing in acute corrosive injury of esophagus. Study began during June 2013, have enrolled 15 patients so far. Adult patients presenting to the hospital within 12 hours of consumption of corrosive agent were included in the study. Upper gastrointestinal endoscopy was done within 24 hrs of presentation and injury graded according to Zargar classification. All patients were treated high dose proton pump inhibitors from day 1 of admission. Patients with 1, 2a, 2b, 3a were scheduled for repeat endoscopy after 72 hours which was limited to assessment of esophageal injury. Of the 15 patients studied 6 patients had grade 1, 4 patients had grade 2a, 4 patients had grade 2b, 1 patient had grade 3a esophageal injury during initial OGD. Second endoscopy by the same observer showed improvement in mucosal healing by 1 or 2 grades in 13 out of 15 patients. No adverse events related to endoscopy were observed. Our study which is still in its preliminary stages have already shown promising results with respect to usefulness of proton pump inhibitors in causing mucosal healing in acute corrosive injury.
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### Endoscopic evaluation of dysphagia in North coastal Andhra Pradesh {#Sec62}

***T Ravishankar*** *, L R S Girinadh, P Murali Krishna*

Andhra Medical College, Jagadamba Junction, Visakhapatnam Part, Andhra Pradesh 530 002, India

*Background*: Dysphagia is one of the most alarming among all upper gastrointestinal symptoms. The clinical profile of dysphagia varies with race and geographic regions.

*Aim*: To identify the etiology and clinical profile of dysphagia in patients of North coastal Andhra Pradesh.

*Methods*: All the subjects attending Gastroenterology OPD are evaluated clinically and subjected to UGIE as a primary indication if the presenting complaint is dysphagia. The study period is between January 2011 and May 2013. Upper gastrointestinal (GI) endoscopy is done with Olympus GIE 150 video gastroscope with white light. The data was analyzed to see the prevalence of various etiological factors causing dysphagia.

*Results*: Total no of 1,016 subjects came with dysphagia as the primary symptom. Dysphagia accounted for 8.3 % of total (12,202) endoscopies. Male:female ratio is 1.17:1. Most common benign cause being post cricoid web (18.5 %). The order of frequency of esophageal malignancy (30.9 %) in upper, middle and lower third is 19.7 %, 5.2 % and 6.0 % respectively. Post cricoid carcinoma accounts for significant percentage (7.8 %) of cases of dysphagia. No finding in endoscopy is found in 14.8 % of subjects. Twenty-four hour pH manometry and impedance may be important in the evaluation of these cases.

*Conclusions*: Dysphagia accounts for 8.3 % of the total upper GI endoscopies. Esophageal malignancy especially upper one third accounts for majority causes of dysphagia. Significant number of patients doesn't have findings on endoscopy which cannot explain the cause for dysphagia. Further evaluation with pH manometry and impedance studies are useful in endoscopically normal dysphagic cases.
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### Otorhinolaryngological manifestations of laryngopharyngeal reflux disease and gastroesophageal reflux disease {#Sec64}

***Sundeep Goyal*** *, V K Dixit, A K Jain, R K Jain, J Ghosh, S Roy*

Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Background*: Recent evidences suggest that gastroesophageal reflux (GER) causes laryngeal symptoms and lead to wide acknowledgement of laryngopharyngeal reflux (LPR). We aimed to study: (1) Various otorhinolaryngeal manifestation of LPR and GER, (2) Association between different risk factors and laryngoscopic findings in LPR.

*Method*: Laryngologic evaluation with indirect laryngoscopy, otoscopy, anterior and posterior rhinoscopy and gastroenterologic evaluation with esophagogastroduodenoscopy (UGIE) were performed in 50 patients.

*Result*: Mean age of the patients was 34.8±10.4 years. Females were more affected as compared to males (56 % vs. 44 %). Ten percent patients were obese and 24 % were overweight. The frequency of various symptoms were lump in throat (88 %), cough (68 %), excessive throat mucus (60 %), dysphagia (18 %), nasal discharge (10 %) and earache in 10 %. History of addiction (tobacco, alcohol) was present in 50 % cases. Heartburn was present in 28 % cases. On laryngoscopy changes found were hyperemia (96 %), ventricular obliteration (74 %), vocal fold edema (74 %), posterior commissure hypertrophy (68 %), and vocal cord granuloma (18 %). Erosive esophagitis was present only in 10 % cases. Fourteen percent had hiatus hernia. Mean reflux symptom index (RSI) was 20.34±5.8 and mean reflux finding score (RFS) was 10.5±2.1. Association between addiction and high RSI and RFS score was not significant but spicy food consumption habit had significant association with high RSI and RFS value.

*Conclusion*: Thus, LPR has variety of presentations. High clinical suspicion along with consultation with an otolaryngologist, who can evaluate for laryngeal findings, is necessary to accurately diagnose LPRD.
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### Genotyping of virulent genes of ***Helicobacter pylori*** from Guwahati, Assam {#Sec67}

***Shweta Mahant***, *Rajashree Das, Sangitanjan Dutta, Valentina Gehlot, Asish Kumar Mukhopadhyay, Kunal Das*

Amity Institute of Biotechnology, Amity University, Noida 201 303, Gauhati Medical College, Bhangagarh Guwahati, 781 034, Assam, National Institute of Cholera and Enteric Diseases, Kolkata, Max Super Speciality Hospital, Patparganj, New Delhi 110 092, India

*Background and Objective*: *Helicobacter pylori* is a gram-negative, spiral, microaerophilic bacterium 1. Its infection is very common affecting approximately 80 % to 90 % of Indian population 2. The cagA gene ie. (cytotoxin-associated gene) is considered to be a marker for the presence of a pathogenicity island (cag PAI), and individuals infected with cagA-positive *H. pylori* strains have a higher risk of developing peptic ulcers and gastric cancer 4. The vacA gene encodes a vacuolating toxin excreted by *H. pylori* present in all strains and having two variable parts 5 the s-region (signal) and the m region (middle).

*Materials and Methods:* Sixty-five gastric biopsies were collected from the patients suffering from various gastroduodenal diseases in Guwahati, Assam. Out of 65 biopsies *H. pylori* was successfully isolated from 10 gastric biopsies. The genomic DNA was isolated by C-TAB method from the isolated strains. For the rest of the 55 biopsies from which we failed to isolated *H. pylori*, genomic DNA was isolated directly from the biopsies by using mammalian DNA isolation kit (Himedia). Urease PCR was positive in 30 genomic DNA indicating the presence of *H. pylori* DNA. Multiplex PCR was done for the strains which were urease positive. All the *H. pylori* strains were cagA, vacA, positive.

*Results*: The average age of the 30 patients included in the study was 38.06 yr. and the M:F ratio was 1:0.5. All the strains were cagA and vac A s1m1 positive (100 %) as shown in Table 1. Among all the cagA positive strains 28 were cag type A (93.3 %) and 2 were cag type B (6.66 %), IceA1 (33 %), IceA2 (33 %) and (33 %) with both IceA1 and IceA2 negative.

*Discussion*: All the *H. pylori* strains isolated from Guwahati were cagA and vacA positive. This is similar to the strains isolated from China and Japan 7, 8. This is in sharp contrast to the strains isolated from North India where the incidence of cagA positive strains is less than 50 % (our unpublished Data). The high rate of cagA positive strains may be related to incidence of ulcer leading to gastric cancer 9.
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### Prevalence of ***H. pylori*** infection in patients with portal hypertensive gastropathy {#Sec69}

*Mona Dhakal,* ***O P Dhakal***

Sikkim-Manipal Institute of Medical Sciences (SMIMS) and Central Referral Hospital (CRH), 5th Mile Tadong, Gangtok, Sikkim 737 102, India

Portal hypertensive gastropathy refers to changes in the mucosa of the stomach in patients with portal hypertension; by far the most common cause of this is cirrhosis of the liver. These changes in the mucosa include friability of the mucosa and the presence of ectatic blood vessels at the surface. On endoscopy evaluation of the stomach, this condition shows a characteristic mosaic or snake-skin appearance of the mucosa.

*Aim of Study*: To see the prevalence of *H. pylori* infection in patient with portal gastropathy.

*Method*: One hundred cases of liver cirrhosis having portal gastropathy were taken and during routine endoscopy procedure, antral biopsy was taken and rapid urease test was performed.

*Result*: Twenty cases were positive for RUT, 80 cases were negative for RUT, out of 20 positive cases 18 had duodenal ulcer and 2 cases had antral lesions.

*Conclusion*: It was seen that majority patient tested negative for *H. pylori* infection in portal gastropathic mucosa, but those who had associated peptic ulcer disease, *H. pylori* positivity was seen higher in them.
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### Molecular characterization of ***Helicobacter pylori***: A pilot study {#Sec71}

***V Anand***, *D Babu Vinish, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health Diseases, Government Peripheral Hospital and Kilpauk Medical College, Anna Nagar, Chennai 600 010, India

*Aim*: To determine virulence of *Helicobacter pylori* in our center among cases of PUD and dyspepsia.

*Materials and Methods*: This is an ongoing cross sectional study in Department of Digestive Health and Diseases, Government Peripheral Hospital, Annanagar, Chennai from April 2013. Patients with active peptic ulcer disease, confirmed history of peptic ulcer. Gastric MALT-lymphoma, following endoscopic resection of early gastric cancer, uninvestigated dyspepsia were included. Functional dyspepsia, GERD, persons using NSAIDs, current or recent use of medications such as antibiotics, bismuth-containing compounds, or acid inhibitors, especially PPIs were excluded. *Helicobacter pylori* testing by rapid urease test and histological examination by antral biopsy done using gastroscopy. All patients were subjected for molecular characterization by PCR targeting glmm on *H. pylori* glmm positive specimen were analyzed for presence of cag and vac genes by PCR.

*Results*: So far 29 patients were included out of which 20 were positive for rapid urease test, *H. pylori* was identified histopathologically in 3 patients, OGD revealed normal study in 9, clean based duodenal ulcer in 2, Type 1 gastritis (Taiwanese classification) in 4, Type 2 in 6, Type 3 in 8, molecular characterization by PCR targeting glmm positive for 6 patients, both cag and vac positivity is seen in 5 and only Vac positivity is seen in 1.

*Conclusion*: *H. pylori* positive individuals were positive for both Cag and Vac indicating high degree of virulence of strains circulating in this region.
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### Prevalence of cagA in ***Helicobacter pylori*** infection and its relationship with peptic ulcer disease {#Sec73}

***Amit Bhasin***, *R Selvi, Mayank S Pansheriya, S Shanmuganathan, Shanthi Vijayaraghavan*

Sri Ramachandra Medical College, Porur, Chennai 600 116, India

*Background and Aims*: The cagA gene is one of the major virulence determinants of *Helicobactor pylori* and associated with increased risk for gastric ulcers or cancer development. The aim of this study was to determine prevalence of *H. pylori* cagA and its correlation with associated chronic gastritis and ulcer disease.

*Methods*: DNA was isolated from gastric biopsies of *H. pylori* positive cases by phenol chloroform method. Quantity and quality check was done by agar gel elctrophoresis and nanodrop and polymerase chain reaction (PCR). PCR pdt subjected to DNA sequencing and cagA status was determined. The prevalence of cagA based on ulcer was also compared.

*Results*: *H. pylori* was detected in 13/40 (32 %) dyspeptic patients. The positivity rate of cagA gene was 38 % (5/13) of *H. pylori* positive cases. Four (4/13) had gastric (prepyloric) ulcer. The prevalence of cagA strains in ulcer patients (75 %) was significantly greater than in non-ulcer patients (7 %). Of the patients infected with cagA strain, almost equal numbers had nonulcer dyspepsia (2/5) or peptic ulceration (3/5). Chronic inflammation was more severe in cagA+than in cagA- group. However one patient infected with cagA- strains had antral intestinal metaplasia compared with none in cagA+group. An antral predominant gastritis was present in majority of cagA-patients (5/8). Caga+ patients had corporal/diffuse gastritis.

*Conclusion*: *H. pylori* strains of cagA is an indication of severity of gastric mucosal damage and presence of peptic ulcer.
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### In vitro drug resistance pattern in the treatment of ***Helicobacter pylori*** {#Sec75}

***Hardik S Shah***, *Sumitra Mitra, Mehul Panchal, Anjali Shetty, Devendra C Desai, Philip Abraham*

Division of Gastroenterology, Departments of Medicine, Laboratory Medicine, and Microbiology, P D Hinduja National Hospital and Medical Research Centre, Mumbai 400 016, India

*Introduction*: Antibiotic resistance is a key factor in the failure of eradication therapy for *Helicobacter pylori* and is a growing problem worldwide.

*Aim*: To determine using Epsilometer test (E-test) the prevalence of resistance to commonly used antibiotics for treatment of *Helicobacter pylori* and to check if this correlates with clinical response.

*Patients and Methods*: A prospective study done in a tertiary-care centre from September 2012 to April 2013. All patients who underwent upper GI endoscopy for dyspepsia and gave written consent to participate in the study were included. Those on antibiotics or proton-pump inhibitor therapy in the previous four weeks were excluded. *Helicobacter pylori* infection was screened for by the rapid urease test (RUT) on biopsies from the gastric antrum and body. Specimens testing positive were processed for culture and subsequent antibiotic susceptibility test against amoxicillin (AMX), clarithromycin (CLA), levofloxacin (LEV), tetracycline (TET) and metronidazole (MTZ), using the E-test as per BSAC 2012 guidelines.

*Results*: Of the 61 RUT-positive biopsy specimens, 44 were cultured successfully (72.1 % success). In vitro resistance rates were: metronidazole (100 %), amoxicillin (84.1 %), clarithromycin (81.8 %), tetracycline (11.4 %) and levofloxacin (6.8 %). Fifteen of these 44 patients (34.1 %) were tested by the urea breath test for *Helicobacter pylori* eradication 4 weeks after 10 days' sequential therapy. Successful eradication was achieved in 14 of the 15 patients (93.3 %).

*Conclusion*: In vitro testing of *Helicobacter pylori* for antibiotic resistance showed a high resistance rate to commonly used agents; however, most of the followed up patients had successful eradication with sequential therapy.
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### Assessment of survivin and STAT3 as biomarkers of gastric cancer progression {#Sec77}

***Kailash Mishra***, *Arvind Pandey, Satyendra Chandra Tripathi, Sutapa Mahata, Shirish Shukla, Kanchan Vishnoi, Sri Prakash Misra, Vatsala Misra, Manisha Dwivedi, Alok C Bharti, Kapil Sharma, Ravikant Kumar*

Departments of Gastroenterology, and Pathology, Moti Lal Nehru Medical College, Allahabad 221 001, Division of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICMR), Noida, and Center for Biotechnology, University of Allahabad, Allahabad

*Aim*: To analyze expression and localization pattern of survivin with STAT3/active pSTAT3(Y705) during progression of gastric cancer and *H. pylori* infection.

*Methods*: We examined 156 (61 normal, 30 pre-cancer and 65 adenocarcinoma) clinicopathologically-confirmed gastric endoscopic biopsies for *H. pylori* infection by cagA and ureC PCR. The expression and localization pattern of survivin and STAT3/pSTAT3 was studied by western blotting and immunohistochemistry.

*Results*: Survivin was highly expressed in diffuse and intestinal type of gastric adenocarcinoma in both cytoplasm and nucleus. The intestinal metaplastic and dysplastic tissues showed moderate cytoplasmic expression of survivin with low nuclear involvement. A high STAT3 and pSTAT3 immuno-positivity was invariably detected in nucleus and cytoplasm of majority of adenocarcinoma lesions irrespective of their types. Intestinal metaplasia lesions showed moderate expression of STAT3 diffusely located in cytoplasm while in dysplasia lesions, moderate expression equally localized to nucleus and cytoplasm was observed. The ureC significantly correlated with nuclear survivin in adenocarcinoma lesions. On the contrary, cagA positivity was correlated with cytoplasmic survivin and STAT3 in pre-cancer lesions. Survivin positivity was found strongly associated with STAT3 and pSTAT3 positivity irrespective of subcellular localization of these proteins. The AUCs obtained in normal vs. adenocarcinoma was 0.949 and 0.900 (*p*\<0.001) for cytoplasmic survivin and STAT3, respectively. The nuclear survivin, STAT3 and pSTAT3 showed AUC values of 0.822, 0.800 and 0.809 (*p*\<0.001) respectively.

*Conclusion*: The differentially localized survivin and STAT3 could be the potential biomarkers in pre-cancer and adenocarcinoma cases of stomach that correlate with progression of gastric cancer.
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### Carcinogenic ***H. pylori*** infection in gastric pre-cancer and cancer lesions and its association with habits of tobacco and alcohol abuse {#Sec79}

***Kailash Mishra***, *Arvind Pandey, Satyendra Chandra Tripathi, Sutapa Mahata, Shirish Shukla, Kanchan Vishnoi, Sri Prakash Misra, Vatsala Misra, Manisha Dwivedi, Alok C Bharti, Kapil Sharma, Ravikant Kumar*

Departments of Gastroenterology, and Pathology, Moti Lal Nehru Medical College, Allahabad 221 001, Division of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICMR), Noida, and Center for Biotechnology, University of Allahabad, Allahabad

*Background*: India has comparatively low incidence rate of gastric carcinoma relative to the highly prevalent *H. pylori* infection. Data relevant to *H. pylori* infection during gastric carcinogenesis in Indian scenario is currently lacking.

*Aims*: 1) To study the prevalence of carcinogenic *H. pylori* infection in gastric pre-cancer and cancer lesions. 2) To study association of *H. pylori* infection with habits of tobacco and alcohol abuse.

*Materials and Methods*: We examined prevalence of *H. pylori* infection in DNA derived from 156 endoscopic gastric biopsies of pre-cancer (intestinal metaplasia, *n*=15 and dysplasia, *n*=15), cancer (diffuse adenocarcinoma, *n*=44 and intestinal adenocarcinoma, *n*=21) and symptomatic but histopathologically normal control (*n*=61) by a generic ureC PCR or cagA-specific PCR that specifically identifies carcinogenic *H. pylori* strain.

*Results*: *H. pylori* infection was present in \~61 % symptomatic histopathologically normal individuals, however only 34 % of among these groups were harboring cagA+*H. pylori* strains. Interestingly, similar proportion of *H. pylori* infection and cagA positivity was observed in gastric cancer group. On the contrary, *H. pylori* infection in general (90 %), or cagA positive *H. pylori* infection (73 %) in particular, was significantly high in gastric pre-cancer lesions. *H. pylori* infection showed association with habit of tobacco chewing, whereas no association was seen with tobacco smoking or alcohol abuse in any of the patient groups.

*Conclusion*: There was high incidence of *H. pylori* infection and carcinogenic cagA positive strain in pre-cancerous lesions that may be associated with the habit of tobacco chewing.

STH-8 {#Sec80}
-----

### Comparison of capsulated versus non-capsulated ^14^C-urea breath test for the detection of ***Helicobacter pylori*** infection: A scintigraphy study {#Sec81}

*Chander M Pathak*, ***Balwinder Kaur***, *Deepak K Bhasin, Bhagwant R Mittal, Sarika Sharma, Krishan L Khanduja, Lalit Aggarwal, Surinder S Rana*

Departments of Biophysics, Gastroenterology, and Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, and Department of Surgery, Lady Harding Medical College, New Delhi 110 067, India

^14^C-urea breath test (^14^C-UBT) is considered as gold standard for detection of active gastric *H. pylori* infection. However, till date no comparative study using capsulated and non-capsulated ^14^C-UBT protocols has been conducted in same subjects in identical conditions. We have monitored the gastric fate of capsule containing ^14^C-urea with real time display and compared sensitivities of these protocols at different time points of breath collection. Non-capsulated ^14^C-UBT was performed using 74 kBq of ^14^C-urea in 100 dyspeptic patients by collecting breath samples at 10, 15 and 20 min. Thereafter, within 2 days a gelatin capsule containing ^14^C-urea along with 6.0 MBq of 99mTc-diethylene triamine penta-acetic acid was administered to each patient for real time display of capsule movement and its fate in gastrointestinal tract by gamma camera. Simultaneously, breath samples were collected for ^14^CO2 measurement during image aquisition. Employing non-capsulated ^14^C-UBT, 74 out of 100 dyspeptic patients were found to be *H. pylori* positive. Discordant ^14^C-UBT results were obtained in 4/74 (5.4 %) cases using these two protocols. By employing capsulated and non-capsulated ^14^C-UBT protocols, sensitivities of ^14^C-UBT were found to be 90.5 % vs. 98.6 % at 10 and 91.8 % vs. 97.2 % at 15 min respectively; while these were 94.6 vs. 100, 90.7 vs. 98.6 and 83.7 vs. 93.2 % considering any one, two or all three positive values respectively. In conclusion, incomplete/non-resolution of ^14^C-urea capsule in stomach during the phase of breath collections appears to decrease sensitivity of capsulated ^14^C-UBT as compared to non-capsulated protocol for detection of *H. pylori* infection.
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### Gastric cancer in Indian population is associated with Pro (IL-8-251T/A) and anti-inflammatory (IL-10 -819/592 C/T) gene polymorphisms and serum levels of these cytokines particularly in ***H. pylori*** infected subjects {#Sec83}

***Sushil Kumar***, *R D Mittal, Samir Mohindra, Niraj Kumari, Uday C Ghoshal*

Departments of Gastroenterology, Urology and Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: IL-8-251T/A and IL-10 (-1082G/A and -819/592 C/T) polymorphisms may influence gastritis, gastric atrophy, intestinal metaplasia (IM) and gastric cancer (GC) following *H. pylori* infection altering their expression.

*Methods*: Genotyping of these genes was performed (ASO-PCR) in 180 each patients with GC and functional dyspepsia (FD) and 250 healthy subjects (HS). Serum IgG-antibody against *H. pylori* was tested in all subjects and IL-8 and IL-10 were measured in 60 subjects in each group ELISA.

*Results*: IL-8 AA and IL-10-819 TT (-592 AA) genotypes were commoner among GC than HS (43/180\[23.9 %\] vs. 35/250\[14.0 %\]; OR 1.9 \[1.09-3.3\], *p*=0.022 and 35/180\[19.4 %\] vs. 30/250\[12.0 %\]; OR 2.03 \[1.12-3.7\], *p*=0.02) but comparable with FD (35/180\[19.4 %\], and 35/180\[19.4 %\]). IL-8 AA and Il-10 -819 T allele carriers were also commoner in *H. pylori*-infected GC than HS (28/101\[27.7 %\] vs. 22/168\[13.1 %\]; OR 2.8 \[1.38-5.71\], *p*=0.004 and 18/101\[17.8 %\] vs. 21/168\[12.5 %\]; OR 1.7 \[1.01-2.96\], *p*=0.046, respectively). IL-10-1082 G/A genotype and IL-10 haplotypes (ACC, GCC, ATA and GTA) were comparable in all groups. IL-8 and IL-10 level was higher among patients with GC and FD than HS (57.64 \[6.44-319.46\] vs. 54.35 \[4.24-318.96\] vs. 26.33 \[4.67-304.54\] pg/mL respectively for IL-8; *p*\<0.001 for GC vs. HS and 15.47 \[1.01-270.87\] vs. 12.28 \[0.96-64.88\] vs. 3.79 \[1.24-56.65\] for IL-10; *p*=0.024). However, IL-10 level was lower among *H. pylori*-infected than non-infected subjects (3.79 \[8.34 \[1.24-54.43\] vs. 12.28 \[0.96-64.87\], *p*=0.012).

*Conclusions*: IL-8-251AA and IL-10 -819TT gene polymorphisms and their serum levels is associated with GC. These cytokines may play role in *H. pylori*-associated gastric carcinogenesis in India.
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### Association of Interleukin 10 (1082G/A) polymorphism in gastritis, gastric ulcer and gastric carcinoma {#Sec85}

***Jitendra Kumar Choudhary***, *Neha Singh, Smita Verma, Manish Kumar Tripathi, Neha Gupta, Arrtrika Ranjan, Ashok Kumar Jain, Vinod Kumar Dixit*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Background*: Interleukin 10 (IL-10) is an important anti-inflammatory and immunosuppressive cytokine, plays role in initiation of the B-cell mediated immune response. It inhibits the pro-inflammatory cytokines by inhibition of T-helper1(Th1) lymphocytes and stimulation of B lymphocyte and Th2 lymphocytes. Single nucleotide polymorphism (SNP) in IL-10 promoter region has been reported to be associated with gastric cancer. *Helicobacter pylori* infection is considered to be a principal cause of chronic gastritis, peptic ulcer and gastric adenocarcinoma.

*Aim*: To analyze the association of IL 10 1082 G/A polymorphism with gastritis, gastric ulcer and gastric carcinoma.

*Methods*: A prospective study was performed on patients with antral gastritis, peptic ulcer, and gastric carcinoma, diagnosed on endoscopy and histopathology. All the patients were subjected to antral biopsy for ultra rapid urease test (URUT), DNA isolation and histopathology. Polymerase chain reaction for *H. pylori* specific 16SrDNA, and IL 10 -1082 G/C SNP genotyping was done.

*Results*: There were total of 102 patients (M/F-73/29) with mean age 47.77±17.77. Fifty-four patients (52.94 %) were positive for URUT. *H. pylori* infection was confirmed by 16SrDNA amplification. The distribution frequencies of IL10-1082 A/G in gastric cancer genotype AA (55.55 %) was high followed by genotype GG (18.51 %) and AG (25.92.5 %). In gastritis distribution of genotype GG (37.21 %) and AA (34.88 %) was slightly high than AG (27.91 %) and in gastric ulcer genotype AA, GG and AG was (37.5 %), (37.21 %) and (31.25 %) respectively.

*Conclusion*: Genotype AA was highly associated with gastric carcinoma than other genotype, whereas in gastritis and gastric ulcer distribution of all genotype were almost similar.
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### Effect of ***H. pylori*** density by histopathology on efficacy of eradication treatment and complications related to ***H. pylori*** {#Sec87}

***Dharmesh K Shah***, *Samit S Jain, Piyush O Somani, Ashok R Mohite, Q Q Contractor, Pravin M Rathi*

Department of Gastroenterology, B Y L Nair Charitable Hospital and T N Medical College, Mumbai Central, Mumbai 400 008, India

*Introduction*: *Helicobacter pylori* infection causes chronic gastritis and is a major risk factor for duodenal and gastric ulceration, gastric adenocarcinoma, and primary gastric lymphoma. Increased gastric bacterial density may lead to increased levels of inflammation and epithelial injury.

*Aims and Objectives*: To study the effect of *H. pylori* density on 1) Histological changes in stomach. 2) Efficacy of standard triple drug anti-*H. pylori* eradication treatment. 3) Complication related to *H. pylori*.

*Materials and Methods*: Patients with the symptoms of dyspepsia not responding to proton pump inhibitor or having alarm symptoms were subjected to upper GI endoscopy and biopsy. All the patients whose biopsies showed *H. pylori* were enrolled in the study. All the biopsy specimens were studied in detail by pathologist and reported according to Sydney classification. All the patients were given standard 14 day triple drugs therapy for *H. pylori* eradication. *H. pylori* eradication was confirmed by urea breath test after six weeks of completion of treatment.

*Results*: Out of 250 patients screened 120 patients were enrolled in the study. Success rate of *H. pylori* triple drug therapy was 80 %. Changes of chronic gastritis were seen in 81.7 %, while rest of the patients had acute inflammation. Rate of eradication was significantly lower among the patients with higher *H. pylori* density (*p*\<0.05). Among all the complications related to *H. pyori*; duodenal ulcers, reflux esophagitis and antral erosions were higher among the patients with higher *H. pylori* density (*p*\<0.05).

*Conclusion*: *H. pylori* density by histopathology correlates with the complication related to *H. pylori,* ie. duodenal ulcer, reflux esophagitis and antral erosions. It also correlates with the success of the standard triple drug eradication treatment.
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### Interleukin 10 polymorphism at position 819C/T and 592 A/C and its association with gastroduodenal disease {#Sec89}

***Jitendra Kumar Choudhary***, *Neha Singh, Smita Verma, Manish Kumar Tripathi, Neha Gupta, Ashok Kumar, Ashok Kumar Jain, Vinod Kumar Dixit*

Department of Gastroenterology, Institute of Medical Sciences, School of Biotechnology, and Faculty of Science, Banaras Hindu University,Varanasi 221 005, India

*Background*: Interleukin 10 (IL-10) is a pleiotropic cytokine with important immune regulatory and immune stimulatory function. It can act as an anti-inflammatory cytokine and can enhance B-cell proliferation, differentiation and immunoglobulin production. It has been confirmed that IL 10 single nucleotide polymorphism (SNP) are correlated with the expression of mucosal IL 10 in patients with *Helicobacter pylori* infection.

*Aim*: To evaluate association of IL-10 819 C/T and 592A/C polymorphism in gastroduodenal disease.

*Methods*: A prospective study was performed on patients with antral gastritis, peptic ulcer, and gastric carcinoma, diagnosed on endoscopy and histopathology. All the patients were subjected to antral biopsy for ultra rapid urease test (URUT), DNA isolation and histopathology. Isolated DNA were subjected to polymerase chain reaction for *H. pylori* specific 16SrDNA, and IL10 -819 C/T and -592A/C gene characterization. Polymorphism at -819 C/T and -592A/C are in linkage disequilibrium with each other.

*Results*: There were total of 102 patients (M/F-73/29) with mean age 47.77±17.77. Fifty-four patients (52.94 %) were positive for URUT. *H. pylori* infection was confirmed by 16SrDNA amplification. The distribution frequencies of IL10-819 C/T and 592 C/A in gastritis genotype CT/CA (48.84 %) was high followed by genotype CC/CC (30.23 %) and TT/AA (20.93 %) respectively for -819 C/T and 592 C/A. In gastric ulcer distribution of genotype CC/CC (46.88 %) was higher than TT/AA (34.37 %), CT/CA (18.75 %). In gastric ulcer genotype TT/AA, CT/CA and CC/CC was (44.44 %), (37.04 %) and (18.52 %) respectively.

*Conclusion*: Genotype CT/CA, CC/CC, TT/AA more associated with gastritis, gastric ulcer and gastric carcinoma respectively in -819 C/T and 592 C/A.
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### Diagnostic value of upper gastrointestinal endoscopy prior to cholecystectomy {#Sec91}

***Samit S Jain***, *Deepa Peswani, Dharmesh K Shah, Piyush O Somani, Qais Q Contractor, Pravin M Rathi*

Department of Gastroenterology, B Y L Nair Hospital and T N Medical College, Mumbai Central, Mumbai 400 008, India

*Introduction*: Upper abdominal symptoms may wrongly be attributed to gallstones and many patients continue to have symptoms after cholecystectomy. Undiagnosed peptic ulcer or gastritis may be the cause of persistent symptoms after cholecystectomy.

*Aims*: 1) To assess the value of preoperative OGD in patients undergoing cholecystectomy. 2) To assess whether surgery can be avoided for atypical pain in patients having positive findings on OGD.

*Methods*: This prospective observational study was conducted in a tertiary hospital over a period of one year, May 2011- April 2012. Patients with abdominal pain with sonographically documented gallstones were subjected to OGD and under consideration for elective cholecystectomy were studied, managed and followed up over a period of 6 weeks. OGD performed in all patients 3 days before surgery.

*Results*: Of 60 patients, 37 (38.33 %) presented with typical pain and rest 23 (61.67 %) with atypical pain. OGD was abnormal in 22 patients (36.67 %), \[14 (23.33 %) had antral gastritis, 3 (5.00 %) pangastritis and duodenal ulcer each, 1 (1.67 %) each had Barrett's esophagus and gastric ulcer\]. *H. pylori* were seen in 26 patients on histopathology. Twenty-one patients (91.3 %) and one patient (2.7 %) had positive findings on OGD in atypical and typical pain groups (*p*\<0.005). *H. pylori* positive gastritis patients were given *H. pylori* kit and others were given pantoprazole. Out of 22 patients with positive findings on OGD, 19 patients (86 %) were symptoms free with the management after 6 weeks and cholecystectomy was avoided in those.

*Conclusions*: OGD prior to cholecystectomy is valuable in patients with gallstone disease for detection of upper GI pathology responsible for symptoms.
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### Association between pepsinogen (PG-II) 100 bp insertion/deletion gene polymorphism and precancerous gastric lesion (intestinal metaplasia) {#Sec93}

***Sushil Kumar***, *Niraj Kumari, Samir Mohindra, Rama D Mittal, Uday C Ghoshal*

Departments of Gastroenterology, Pathology, and Urology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Pepsinogen (PG)-II gene polymorphism and PG-I/PG-II ratio is an effective biomarker for terminal differentiation of gastric mucosa into intestinal metaplasia (IM) and gastric cancer.

*Methods*: Genotyping of PG-II 100 bp insertion/deletion polymorphism was performed in age and gender matched patients with GC (*n*=192), functional dyspepsia (FD, *n*=180) and healthy subjects (HS, *n*=240). Serum PG-I and PG-II were measured in 145 patients in each group and 60 HS using ELISA.

*Results*: Five alleles were amplified by PCR: allele 1 (510 bp), allele 2 (480 bp), allele 3 (450 bp), allele 4 (400 bp) and allele 5 (310 bp). Allele 5 was less frequent among patients with GC and FD than HS (124/384 \[32.3 %\] vs. 147/360 \[40.8 %\], 212/480 \[44.2 %\], respectively; GC vs. FD; OR 0.69 \[95 % CI 0.51-0.94\], *p*=0.015 and GC vs. HC; OR 0.61 \[95 % CI 0.45-0.81\], *p*=0.0003) but allele 2 was more common among patients with GC than FD and HS (106/384 \[27.6 %\] vs. 70/360 \[19.4\], 87/480 \[18.1 %\]; OR 1.58 \[95 % CI 1.1-2.26\], *p*=0.008; OR 1.72 \[95 % CI 1.23-2.41\], *p*=0.007, respectively). PG-I, PG-II and PG-I/PG-II ratio was comparable among all subjects. Patients with IM more often had allele 5 (65/160 \[40.6 %\] vs. 169/554 \[30.5 %\]; OR 1.56 \[95 % CI1.07-2.28\], *p*=0.001 and higher levels of PG-II (mean±S.D; 24.4±14.4 vs. 18.1 μg/l, *p*=0.046) whereas PG-I/PG-II was lower (5.9±9.3 vs. 8.4±11.4, *p*=0.038) than those without.

*Conclusions*: Pepsinogen (PG-II) 100 bp insertion/deletion polymorphism is associated with GC. Moreover, allele 5 (shorter allele) and low PG-I/PG-II ratio are associated with IM, a precursor of GC.
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### A randomized clinical trial to evaluate the safety and efficacy of UNIM-701 compound in the treatment of duodenal ulcer and eradication of ***Helicobacter pylori*** {#Sec95}

***M A Raheem Rafeeq***, *M A Shareef, Avinash Bardia, Sandeep Kumar Vishwakarma, Md. Aejaz Habeeb, Aleem A Khan*

Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Hyderabad 500 058, and Central Research Institute of Unani Medicine, Erragadda, Hyderabad 500 038, India

The gastric pathogen *Helicobacter pylori*, has been a major cause of peptic ulcer disease and is an early risk factor for gastric carcinoma. It is the second most common chronic bacterial infection in humans. Eradication of *Helicobacter pylori* is an important event in overcoming gastric diseases. Many regimens are currently available but none of them could achieve 100 % success in eradication. Therefore the present study was designed to evaluate the efficacy of herbal medicine (UNIM-701). A clinical trial was conducted to evaluate the efficacy of herbal medicine in duodenal ulcer. Eighty-five cases of duodenal ulcer were assessed for the clinical trial (56 males and 29 females) with endoscopically proven duodenal ulcer were subjected to trial (UNIM-701 divided in 2 doses) for a period of eight weeks. *H. pylori* infection was assessed by diagnostic tests, rapid urease, direct smear, and histological exam. Clinical assessment was done every week and repeat endoscopy was performed at the end of the therapy. Seventy-five patients completed the trial and 10 patients dropped out. *H. pylori* became negative in 56 out of the 75 patients who completed trial according to the protocol. Twenty-eight patients were cured and 39 patients relieved symptomatically whereas 8 patients had no response to the therapy. The drug was well tolerated and there was no complaint of any side effects. These results demonstrate that our compound UNIM-701 exhibits bactericidal activity against *H. pylori*. This may have potential as new and safe agents for treatment of duodenal gastric diseases.
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### Prevelance of ***Helicobacter pylori*** infection in first degree relatives of carcinoma stomach patients {#Sec97}

***Babu Vinish***, *Jayakumar Jaikrishnan, Balamurali, Muthukumaran, Ramkumar, A Murali, P Ganesh, S Jeevan Kumar*

Department of Digestive and Health Diseases, Kilpauk Medical College and Hospital, Chennai 600 010, India

*Aim*: To assess the prevalence of *Helicobacter pylori* infection and premalignant histological changes in the stomach of first degree relatives of gastric carcinoma patients.

*Materials and Methods*: This prospective case control study was carried out in a tertiary center for gastrointestinal diseases. A total of 100 persons were recruited with 50 in the study and control group respectively. All patients underwent upper GI endoscopy and multiple biopsies were taken from the stomach. One tissue specimen was used for the rapid urease test, the others were histopathological analysis.

*Results*: The gender distribution was study 31 males and 19 females in the study group and 30 males and 20 females in the control group. The rapid urease test was positive in 39 persons in the study group (*p*=0.032\*) and in 29 controls histology for *Helicobacter pylori* was positive in 34 persons in the study group (*p*=0.067) and in 25 persons in the control group. There was concordance with histology and urease test in 34 of 39 (87 %) in the study group and 25 of 29 persons (86 %) in the control group. All patients who demonstrated *Helicobacter pylori* histologically were positive for the rapid urease test. Premalignant changes were seen in 4 persons, all from study group (*p*= 0.268).

*Conclusion*: Prevalence of *Helicobacter pylori* is higher in first degree relatives of patients with gastric carcinoma than that seen in than in the general population. Premalignant changes (atrophic gastritis) were seen only in study group and who were positive for *Helicobacter pylori*.

Stomach (Non─*H pylori*) {#Sec98}
========================

STNH-1 {#Sec99}
------

### Frequency of HER2 positive gastric cancer and its clinicopathological correlation: A pilot study from south India {#Sec100}

***P Thirumal*** *, Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

*Background and Aim*: Gastric cancer show varying clinical behavior and response to chemotherapy, determined by its biological aberrations and molecular vulnerabilities. Overexpression of human epidermal growth factor receptor (HER2, also known neu, ERBB2) is associated with poor prognosis, aggressive disease and poor response to chemotherapy. Trastuzumab, a monoclonal antibody against HER2 in combination with chemotherapy is becoming the standard of care in HER2 positive gastric cancer. Frequency of HER2 positivity has been reported to be 4.4 % to 28 % in different geographic zones. We aim to study the frequency of HER2 positive gastric and esophagogastric junction (OGjn) cancer in south India and its correlation with clinical and pathological staging.

*Methods*: Study cohort was gastric and esophagogastric junction adenocarcinoma patients evaluated in Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai from July 2013. HER2 overexpression in cancer was studied using immunohistochemistry (IHC) with score of 3+considered positive for HER2.

*Results*: So far we had 20 patients. HER2 was positive (3+) in 9 patients (45 %). There is no difference in HER2 positivity or negativity in relation to age, gender and risk factors. All gastric cancer were located in antrum (66 %) or body (34 %) with 3 cases being diffuse type and the rest being intestinal type. We didn't have OGjn cancer so far. HER2 positivity was stastically significant in clinical stage IV (78 % vs. 45 %) cancer and in diffuse type of gastric cancer (all 3 cases).

*Conclusion*: With the available preliminary data, frequency of HER2 overexpression was relatively more (45 %) in south India, with significant positive correlation with advanced stage and diffuse type gastric cancer.
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### Xanthelasmas of UGI tract {#Sec102}

***Sandeep Patil***, *B Ravi Shankar*

Yashoda Hospitals, Behind Hari Hara Kala Bhavan, S P Road, Secunderabad 500 003, India

Gastric xanthelasmas are macroscopically well demarcated yellow or yellowish-white plaques and microscopically composed of agglomerated foamy cells in lamina propria of stomach. Foamy cells in xanthelasma are positive for CD 68 and uniformly negative with PAS staining. Out of 6,959 subjects who underwent UGI endoscopy, 38 (0.5 %) were found to have UGI xanthelasma. A predominance of men over women (2.2:1) was noted. Age of patients ranged between 21-85 yrs (mean 53 yrs). Single lesion was found in 20 (53 %) patients and multiple in 18 (47 %). The most common location of xanthelasmas was the stomach (64 %), followed by the esophagus (18 %) and duodenum (18 %). Xanthelasmas were associated with other lesions. Eight (21 %) patients had gastric erosions, 2 (5.3 %) had esophagitis, 2 (5.3 %) had gastric antral vascular ectasia (GAVE), 1 (2.6 %) had esophageal candidiasis, 1 (2.6 %) had gastric polyp, 1 (2.6 %) had duodenal ulcer, while the remainder had normal gastric mucosa (60.6 %). Gastric xanthelasmas are most frequently found in the antrum (47 %). The cause of gastric xanthelasma is unknown, but chronic gastritis may be the most probable etiologic factor. Biopsy is practiced as a preferable method rather than other methods of follow up.
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### An observational study on duodenal eosinophilia in functional dyspepsia {#Sec104}

***Anish Philip***, *Vinu Joseph, M Mukunda, D Krishnadas, R Sobhana Devi*

Department of Gastroenterology, Government Medical College, Kottayam 686 008, India

*Background*: Many uncontrolled studies have shown that significant increase in duodenal eosinophil count occur in functional dyspepsia.

*Aim*: To study the prevalence of significant duodenal eosinophilia in functional dyspepsia.

*Methods*: The study included functional dyspepsia patients diagnosed by Rome III consensus criteria attending our outpatient clinic over a period of 6 months. Mucosal biopsies were taken from gastric antrum, D1 and D2 by OGDscopy. Gastroduodenal eosinophil counts and presence of *Helicobacter pylori* after special staining were assessed by pathologist. Eosinophils were quantied by counting their number per 5 high-power fields (HPF) at antrum, D1 and D2 and presence of *H. pylori* was noted.

*Results*: Total number of cases studied was 84. The mean age was 42.64 years (range 19-78 years). Male patients were 40 (47.62 %). Twenty-three patients (27.3 %) had *H. pylori* in antral biopsy. No subjects had intestinal parasites or celiac disease in biopsy. Mean eosinophil count was 8.1 per 5 HPF in D1 and 11.8 per 5 HPF in D2. Based on median values of eosinophil count in the previous study by Talley et al. cut-off values for eosinophil count in D1 were 22 and in D2 was taken as 21. Six (7.1 %) and fourteen (16.6 %) patients had eosinophil count above the cut-off values in D1 and D2 respectively. No significant association between gastric *H. pylori* infection and eosinophilia in D1 (*p*=0.54) and D2 (*p*=0.34).

*Conclusions*: There was no significant increase in duodenal eosinophilia in patients with functional dyspepsia in this study.
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### Whitish lesions in the stomach and their histopathological correlation {#Sec106}

***B Vinoth***, *Thomas Alexander, George Kurian, Renu G Boy Varghese, Anita Ramdas, Manjiri Dilip Phansalkar, G Nidhya*

Departments of Gastroenterology, and Pathology, Pondicherry Institute of Medical Sciences, Ganapathichettikulam, Pondicherry 605 014, India

*Aim*: To evaluate the incidence and endoscopic characteristics of small (\<10 mm) white lesions of the stomach at white light endoscopy and to correlate them with histopathological findings.

*Methods*: In this retrospective study, all endoscopic records between May 2009 and June 2013, were analyzed to detect the incidence of such whitish lesions. The endoscopic characteristics were independently analyzed from the saved pictorial data, by two Gastroenterologists who were blinded to the endoscopy and histopathology reports. Similarly the histopathology slides were reviewed by three pathologists, who were blinded to the endoscopy and histopathology reports.

*Results*: The incidence of small, whitish lesions in our study was 1.68 % (52 out of 3,091 UGI scopies). The antrum was the most common site (79 %) followed by the body of the stomach (19 %). On histopathology majority of the lesions showed foamy macrophages indicative of xanthelasmas (43 %), followed by foveolar hyperplasia (33 %), intestinal metaplasia (28 %) and atrophy (24 %). Endoscopically, the presence of well defined margins correlated with the diagnosis of xanthelasma.

*Conclusion*: Though small whitish lesions of the stomach are rather uncommon they should not be ignored because 41 % of such lesions showed intestinal metaplasia or gastric atrophy, which are considered as premalignant conditions of the stomach. A prospective study is required to confirm our observations and characterize additional endoscopic features.
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### FRG1a potential angiogenesis regulator and its expression in gastric cancer {#Sec108}

***Ankit Tiwaria***, *S P Singh, Manjusha Dixit*

School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar 751 005, Department of Gastroenterology, S C B Medical College, Cuttack 753 007, and Kalinga Gastroenterology Foundation, Cuttack, India

*Background and Aim*: FSHD region gene 1 (FRG1), which is located at chromosome 4q35 is a candidate gene for Facioscapulohumeral muscular dystrophy (FSHD). Fifty percent to seventy percent of the FSHD patients are associated with retinal vasculopathy. However, a recent study in Xenopus laevis has proposed FRG1 to be an angiogenesis regulator altering the expression of vascular marker dab2. DAB2 is a conserved protein and a candidate tumor suppressor which is down regulated in various cancers. The aim of our study is to understand expression levels of FRG1 and DAB2 in gastric cancer.

*Materials and Methods*: We obtained gastric biopsy from 11 gastric cancer patients and 11 controls from Digestive Disease Centre, Cuttack, Odisha. Consent was taken from each of the participant recruited for the study as per the protocol approved by the Institutional Human Ethics Committee. RNA was extracted from the collected biopsy and expression of FRG1 and DAB2 were analyzed by quantitative real time PCR.

*Results*: Expression levels of FRG1 was found to be higher in patients compared to controls, with an average fold change of 1.99, but was not statistically significant (*p* =0.077). In case of DAB2 the expression levels were not much altered with an average fold change 0.92 but this too was not statistically significant (*p*=0.86).

*Conclusion*: This ongoing study has demonstrated that FRG1 is up regulated, but DAB2 expression level does not change in gastric cancer, as observed in other cancers. FRG1 may be a potential oncogene associated with angiogenesis.
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### A study to assess the risk factors for exacerbation of symptoms of functional dyspepsia {#Sec110}

***George Sarin Zacharia***, *Varghese Thomas*

Department of Gastroenterology, Government Medical College Campus, Kozhikode 673 008, India

*Aims*: To identify the role of dietary and psychological factors in exacerbation of symptoms in functional dyspepsia (FD).

*Methods*: One hundred and nineteen consecutive patients with FD who satisfied the Rome III criteria were enrolled in this cross sectional study. Patients were evaluated to rule out organic causes. A detailed history regarding symptoms, dietary habits and food materials associated with worsening of symptoms was obtained. Patients were asked to fill up a questionnaire containing the Presumptive Stressful Life Events Scale (PSLES), Perceived Stress Scale (PSS) and Hospital Anxiety and Depression Scale (HADS).

*Results*: Mean age of cohort was 35.5±11.04 years with male:female ratio of 47:72. Mean total duration of symptoms was 44.2 months. The most predominant symptoms were epigastric burning sensation (57.1 %), epigastic pain (21 %) and postprandial fullness (12.6 %). Ninety-one (76.4 %) reported worsening with spicy food. Worsening was noted with brown chickpeas (*n*=29; 24.4 %), dal (*n*=26; 21.8 %), long beans (*n*=23; 19.3 %), green gram (*n*=16; 13.4 %), cassava (*n*=17; 14.2 %), and potatoes (*n*=17; 14.2 %). Oil fried food items were associated with worsening of symptoms in 20 (16.7 %). Ninety-two (77.3 %) had improvement with reduction of spices in diet. Mean PSLES and PSS scores were 258.38±146.21 and 19±7.35 respectively. Severe and moderate stress was reported by 63 % and 31.9 % respectively. HADS scores were abnormal for anxiety (*n*=54; 45.4 %) and depression (*n*=21; 17.6 %). Mean HADS A and D scores were 9.36±4.30 and 7.03±3.88 respectively.

*Conclusion*: Spicy food, pulses and tubers were found to be associated with worsening of symptoms in patients with FD. High levels of anxiety, depression and stress were identified in patients with FD.
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### Cholecystokinin receptor-A gene polymorphism is protective against development of functional dyspepsia {#Sec112}

***Rajan Singh***, *Balraj Mittal, Uday C Ghoshal*

Departments of Gastroenterology, and Genetics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Functional dyspepsia (FD) is characterized by epigastric pain, burning, early satiety and postprandial fullness in absence of organic or metabolic causes. Cholecystokinin receptor-A (CCK-AR) is known to modulate satiety signal and delay gastric emptying, which are associated with FD. CCK-AR (rs1800857, T/C) polymorphism is associated with a defective splicing of the primary transcript of CCK-AR mRNA, which may result in the lower expression of the CCK-AR. Therefore, we evaluated the role of genetic polymorphism of CCK-AR gene (rs1800857, T/C) in FD.

*Methods*: Two hundred and thirty-seven consecutive patients with FD (Rome III) and 250 healthy controls (HC) were genotyped for CCK-AR gene polymorphism (PCR-RFLP). Patients with FD were sub-classified into epigastric pain syndrome (EPS), postprandial distress syndrome (PDS) and EPS-PDS overlap.

*Results*: Patients with FD \[173 (73 %) male, age 38±12-y\] were comparable with HC \[195 (78 %) male, age 37±12-y\] with respect to age and gender. 26/237 (11 %) had EPS, 55 (23.2 %) PDS and 156 (65.8 %) EPS-PDS overlap. Among 237 patients with FD, CC (variant) genotype of CCK-AR (rs1800857) was infrequent among patients than HC \[19 (8 %) vs. 46 (18.4 %) *p*=0.001, odds ratio (OR) =0.36, 95 % confidence interval (CI) =0.19-0.66\]. However, genotypes distribution was comparable among patients with different subtypes of FD (*p*=0.44).

*Conclusion*: CC genotype of CCK-AR polymorphism is protective for FD. EPS-PDS overlap was common among patients with FD.
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### Clinicopathological profile of gastrointestinal stromal tumor {#Sec114}

***A B Totagi***, *P Piramanayagam, R Gaadhe, S Deshmukh, V Vyas, P Borasadia, A Dalal, V Sheshadri, N Murugan, H Hariharan, S A Parameswaran, U Dhus, U Srinivas, A T Mohan, K R Palaniswamy*

Medical Gastroenterology, Apollo Hospitals, Greams Road, Chennai 600 006, India

*Background*: Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract. Data pertaining to clinical profile of GIST in India is scarce.

*Method*: Consecutive patients of GIST were retrospectively reviewed over past 2 yrs and the clinicopathological features, treatments, and outcomes were recorded.

*Results*: There were 23 patients (16 males and 7 females), with a median age of 50 years. All patients were symptomatic and abdominal pain (48 %) was the most common symptom followed by, anorexia (39 %) and melena (34 %). The different sites of GIST were stomach (12), small intestine (7), colon (2), extragastrointestinal stromal tumor (E-GIST) (2). The tumor diameter on imaging varied from 1 to 24 cm. Seventeen percent of patients presented with metastasis. Most common histology was spindle cell morphology followed by mixed spindle cell and epithelioid morphology. Thirty-nine percent patients showed high risk for aggressive behavior (National Institute of Health GIST workshop 2001 criteria). Liver was the most common site of metastasis. Histologically negative margin of surgical specimen noted in 96 % of patients. Recurrence was seen in two patients.

*Conclusion*: Common site for GIST was stomach followed by small intestine. Thirty-nine percent patients showed high risk for aggressive behavior of tumor.
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### Endoscopic full thickness resection of a large gastric GIST with a serious unexpected complication during tumor delivery {#Sec116}

***Nachiket Dubale*** *, Amol Bapaye*

Department of Digestive Diseases and Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Erandawne, Pune 411 004, India

*The abstract matter was not received at the time of sending to press, despite reminders to corresponding author.*
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### Expression of E-cadherin, VEGF, MMP-1, MMP-2 and MMP-3 in gastric carcinoma {#Sec118}

***Arun Sebastin***, *Puneet, Gopeshwar Narayan, Mohan Kumar, A K Khanna, V K Dixit*

Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Introduction*: Gastric carcinoma is one of the common malignancy of GI tract. Various etiological factors are implicated for its pathogenesis including genetic cause. E-cadherin, VEGF and MMPs expression may be helpful in better understanding of the disease and its potential therapeutic implication.

*Material and Method*: It is a prospective study performed in 73 biopsy samples from gastric carcinoma (*n*=73) which were collected following surgery/endoscopy. Twenty-seven controls were taken for comparison. Expression of E-cadherin, VEGF, MMP-1, MMP-2 and MMP-3 was done through RT-PCR.

*Results*: Most of the patients were between age group of 40-60 year (56.2 %). Forty were male and 33 females. Most patients had BMI\<18.5 (57.5 %). On tumor histology, 48 (65.8 %) were intestinal type whereas 25 diffuse. E--cadherin was under expressed in 38.4 % cases of gastric carcinoma (*p*=0.01). However, no correlation of E-cadherin was noted with site of growth, serosal invasion, lymph node or liver metastases. The underexpression of E-cadherin was more pronounced in advance gastric cancer (stage III+IV) (*p*=0.13). VEGF expression was upregulated in 7 (9.6 %) while unchanged in 66 (90.4 %) patients of gastric cancer (*p*=0.76). MMP-1 and MMP-9 expression were not statically significant in gastric cancer. Although MMP-2 was upregulated in 21 (28.8 %) cases. E-cadherin, VEGF and MMPs has showed no significant expression in relation to histological grade, differentiation, lymphatic, vascular invasion and muscle invasion.

*Conclusion*: E-cadherin is underexpressed in 38.4 % cases of gastric cancer. However, VEGF and MMPs showed no significant change in expression.
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### Argonized tumor bleed: A case report {#Sec120}

***K Raja Yogesh***, *Ratnakar Kini, Kani Sheik, K Prem Kumar, T Pugazhendhi, Mohamed Ali*

Department of Medical Gastroenterology, Madras Medical College, Chennai 600 003, India

*Introduction*: Malignant gastroduodenal obstruction is considered a preterminal event. SEMS is an effective mode of palliative treatment for such patients. Its complications include re-obstruction (10 %), stent migration (10 %), persistent pain (5 %), perforation (4 %), pancreatitis (4 %) and bleeding 5 %. Here, we report a case of tumor bleed following SEMS which was successfully managed endoscopically using argon plasma coagulation.

*Case Report*: 38/M, a case of in-operable antropyloric growth who had underwent palliative pyloroduodenal uncovered SEMS placement 2 months back for GOO, presented with history of seven days of melena, abdominal pain and exertional dyspnea. Patient did not have any features of stent obstruction at current presentation. On examination patient was pale and abdomen revealed a hard immobile mass in the epigastrium. Lab investigation was unremarkable except for anemia. The possibilities considered were tumor bleed, SEMS related bleed or bleeding secondary to a cause unrelated to the tumor. Endoscopy revealed multiple areas of diffuse bleed from the tumor surface seen through the uncovered SEMS. The bleed was managed effectively by endotherapy using argon plasma coagulation.

*Discussion*: Bleeding is a known complication with SEMS. Most bleed are diffuse and superficial. Endotherapeutic modalities which cause superficial noncontact coagulation such as APC, Nd-YAG laser are ideally suited. Cases not controlled by endoscopy might require angiographic embolization.
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### Buried bumper syndrome: An uncommon complication of percutaneous endoscopic gastrostomy {#Sec122}

***M Shujaath Asif***, *Ratnakar Kini, Kani Sheik, K Prem Kumar, T Pugazhendhi, Mohamed Ali*

Department of Medical Gastroenterology,

*Introduction*: Percutaneous endoscopic gastrostomy (PEG) is considered a safe procedure and simple method of providing long-term enteral nutrition to patients unable to swallow but with a functioning gastrointestinal tract. One of the major complication encountered is buried bumper syndrome (BBS). BBS is the external migration of the internal bumper from the gastric lumen becoming lodged in the gastric wall or anywhere along the gastrostomy tract. The reported incidence of BBS ranges from 1.6 % to 21.8 %. Here, we illustrate the following case report from our instituition which was managed conservatively initially and replacement PEG tube later.

*Case Report*: A 48-year-old female patient diagnosed to have carcinoma esophagus arrived at our department with severe odynophagia and dysphagia. Endoscopy showed severe mucositis and edema. Of note patient had received chemotherapy and radiotherapy. She underwent PEG, as patient required further chemotherapy and anticipated to develop similar problems in future. Two months later, she presented with fever, pain abdomen, swelling and thick, white discharge at PEG site. Abdominal exam revealed localized tenderness, erythema and induration at PEG site. Labs were unremarkable. Underwent endoscopy, which showed internal bumper buried in PEG tract with lots of pus flowing from the tract. BBS was diagnosed and PEG tube was removed externally. Pain controlled, local wound care given. Foley's catheter was placed externally in track to maintain patency. Replacement PEG tube was placed later.

*Discussion*: BBS is a preventable complication and, in light of its significant morbidity and healthcare associated costs, deserves thorough prevention efforts.
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### Signet ring cell carcinoma of stomach - Unchanged incidence over the years {#Sec124}

***B Vinoth***, *Thomas Alexander, George Kurian, Renu G Boy Varghese, Anita Ramdas, Manjiri Dilip Phansalkar*

Departments of Gastroenterology, and Pathology,

*Background*: Signet ring cell carcinoma (SRCC) of stomach is a specific histological type of gastric carcinoma and they differ from classical adenocarcinomas in prognosis according to few studies. Data from India is very limited with regard to its incidence and hence we did a retrospective study to find out the incidence and endoscopic characteristics of this type of cancers.

*Methods*: In this retrospective study records of all carcinoma stomach patients diagnosed by endoscopic biopsy between May 2009 and June 2013 were analyzed to find out the incidence and endoscopic characteristics of signet ring cell carcinoma of stomach.

*Results*: The total number of stomach cancers diagnosed was 50 out of 3,091 gastroscopies done (1.62 %) and the incidence of signet ring cell carcinoma was 40 % (20 out of 50). The average age of onset is earlier (50 yrs vs. 60 yrs) and male to female ratio is equal (1:1 vs. 4:1) in SRCC when compared to adenocarcinomas. Most common site involved in SRCC of stomach is antrum (75 %), followed by body (65 %) and fundus (35 %). Two patients (10 %) had bilateral ovarian tumors suggestive of Krukenberg's tumor.

*Conclusion*: The incidence of signet ring cell carcinoma of stomach from our study was 40 % which correlates with the previous studies. Making a preoperative histological diagnosis of this type is extremely important since they differ in prognosis from classical adenocarcinomas.
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### A rare cause of PUO {#Sec127}

***Ashutosh Chaturvedi*** *, Lokesh Jain, Kunal Kothari, Ganesh Narain Saxena*

Mahatma Gandhi Medical College and Hospital, Sitapura, Tonk Road, Jaipur 302 022, India

A 29-year-old male presented with complaints of fever, pain abdomen, anorexia and weight loss of 45 days duration. Physical examination was unremarkable. Investigations revealed Hb 12.5 mg/dL, TLC 11900, ESR 65, b.sugar 88 mg/dL, Bil.0.9, SGOT 45, SGPT 35, alkaline phosphatase 111, Cr.0.9. X-ray chest and USG abdomen was within normal limits. UGI endoscopy showed a 1.5 cm sized smooth surfaced submucosal lesion in D1. On biopsy of the lesion, pus came out. CECT abdomen showed peri-portal matted lymph nodes with central necrosis of variable size compressing first part of duodenum which shows thickened wall, small wedge shaped lesion in segment lll of liver, pancreatic cyst and minimal ascites. Duodenal biopsy showed dense infiltration by acute and chronic inflammatory cells in the lamina propria with granuloma formation. Mauntoux test was 18 mm. HIV was negative. He was started on ATT four drug regime. Fever responded in 3 days and he regained appetite and gained weight. On follow up endoscopy after 2 months the duodenal lesion disappeared and lymph nodes decreased in size on CECT abdomen. Stomach and duodenal tuberculosis each constitute around 1 percent of cases of abdomen tuberculosis. Most patients (73 %) had symptoms of duodenal obstruction. In a majority of these cases obstruction was due to extrinsic compression by tuberculous lymph nodes, rather than by intrinsic duodenal lesion. Gastroduodenal tuberculosis should be kept in mind as a cause of PUO.
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### Etiology and epidemiological profile of chronic diarrhea at a tertiary care center {#Sec129}

*Lokesh Jain,* ***Prakhar Garg*** *, Aakash Rajender, Shashank Choudhary, Saahil Nohria*

Mahatma Gandhi Medical College and Hospital, Sitapura, Tonk Road, Jaipur 302 022, India

*Aim*: To study etiology and epidemiological profile of chronic diarrhea at a tertiary care hospital.

*Methods*: Patients of chronic diarrhea admitted between period of 15 October 2012 to 30 June 2013 were studied for epidemiology and clinical profile and analyzed.

*Results*: Fifty patients of chronic diarrhea were admitted. Mean age was 18±5 years, M:F 1.8:1, mean duration of presentation was 87±17 days. Associated symptoms and signs included, anemia in 36 (72 %) patients, pain abdomen in 22 (44 %) patients, edema feet in 15 (30 %) patients, oily stools in 7 (14 %) patients, carpopedal spasm in 4 ( 8 %) patients, rachiticickettic rosary in 2 (4 %) patients, bleeding per rectum in 14 (28 %) patients, joint pains in 2 (4 %) patients, weight loss in 42 (84 %) patients and tremors in 2 (4 %) patients. Fourteen (28 %) patients were diagnosed as celiac sprue, 7 (14 %) patients as tropical sprue, 7 (14 %) patients as chronic calcific pancreatitis, 7 (14 %) patients as ulcerative colitis, 6 (12 %) patients as ileocecal TB, 4 (8 %) as AIDS related, 2 (4 %) patients as giardiasis, 2 (4 %) patients as hyperthyroidism and 1 (2 %) patient was diagnosed as primary amyloidosis.

*Conclusion*: Celiac sprue remains the commonest cause of chronic diarrhea followed by tropical sprue, chronic pancreatitis, ulcerative colitis and intestinal tuberculosis.
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### Superior mesenteric artery syndrome: A case report of one of the rarest gastrointestinal disorders known to medical science {#Sec131}

***Amit R Gupta*** *, Vandana S Dube, S V Kanitkar, S Balwantkar*

Department of General Surgery, B J Medical College and Sassoon Hospital, Pune 411 001, India

Superior mesenteric artery (SMA) syndrome is an uncommon but well recognized clinical entity characterized by compression of the third or transverse portion of the duodenum between the aorta and the superior mesenteric artery. This results in chronic intermittent, acute complete or partial duodenal obstruction. Some studies report the incidence of superior mesenteric artery syndrome to be 0.1 % to 0.3 %. Approximately 0.013 % to 0.78 % of barium upper GI studies evaluating for superior mesenteric artery syndrome support the diagnosis. As the syndrome involves a lack of essential fat, four of every five afflicted are underweight, often to the point of sickliness and emaciation. Females are impacted twice as often as males, with 75 % of cases occurring between the ages of 10 and 30. Common comorbid conditions include hyperchlorhydria (noted in 50 % of cases), peptic ulcer disease (25 % to 45 %), pancreatitis and scoliosis. SMA syndrome is estimated to have a mortality rate of 1 in 3. Delay in the diagnosis of SMA syndrome can result in fatal catabolysis (advanced malnutrition), dehydration, oliguria, electrolyte abnormalities, hypokalemia, acute gastric rupture or intestinal perforation (from prolonged mesenteric ischemia), gastrectasia, spontaneous upper gastrointestinal bleeding, hypovolemic shock, aspiration pneumonia, or sudden cardiovascular collapse (from increased velocity of blood flow in the SMA due to the reduced mesenteric angle). Here is a case report of how a 17-year-old male, who was diagnosed as a case of SMA syndrome, was managed conservatively and surgically when conservative management failed.
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### A rare case of management of ischemic jejunal stricture due to superior mesenteric artery and celiac artery stenosis {#Sec133}

***S Sathiamoorthy*** *, T S Rameshkumar, H Azimudin, M G Manoj, Manimaran, Chitra, Murali, Malarvizhi, M S Revathy, A R Venkateswaran*

Department of Medical Gastroenterology, Stanley Medical College, Old Jail Road, Chennai 600 001, India

*Background*: Small bowel strictures associated with mesenteric vessel thrombosis are an uncommon entity. Here we report an interesting case of ischemic jejunal stricture presenting as subacute intestinal obstruction due to superior mesenteric and celiac artery stenosis and its subsequent management.

*Case Report*: A 45-year-old man, engineer, nonsmoker, nonalcoholic, with no comorbidies admitted with history of abdominal pain, vomiting, abdominal distension intermiteently for 1 month duration with significant weight loss, anorexia, constipation and ball rolling movements. Similar complaints 3 months ago managed conservatively with NBM, Ryle's tube and I/V fluids. No history of fever, surgery, ATT. On examination: upper abdominal distension with visible intestinal peristalsis seen. Blood investigations normal. OGD scopy: dilated stomach, D1 and D2 with bile stasis-proximal small bowel obstruction. Barium meal study: most likely stricture at proximal jejunal loop at L3 vertebra level right side. CECT abdomen:superior mesenteric artery (SMA) thrombosis with proximal jejunal stricture. Sixteen slice CT abdominal angiogram: complete thrombosis of proximal and mid SMA, jejunal and ileal arteries which arises from the left side of the SMA are thrombosed, focal concentric narrowing of proximal celiac trunk with post stenotic dilatation. Prothrombotic and autoimmune work:negative. Cardiology evaluation normal. Vascular surgery opinion obtained. Patient was initially managed conservatively for intestinal obstruction. With the help of interventional radiologist celiac angioplasty done and was started on s/c LMWH, aspirin, clopidogrel, atorvastatin. Patient improved symptomatically. Planned for mesentric revascularization procedure before planning for surgical intervention of involved segment (stricturoplasty/resection).

*Conclusion*: A greater awareness of the association between mesenteric thrombosis and intestinal strictures would reduce the delay in diagnosis and subsequent treatment.

Careful CT scan interpretation may be of benefit but in this light, the barium small bowel follow-through and CT angiography are the investigation of choice.
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### Small intestinal bacterial overgrowth and oro-cecal transit time in irrritable bowel syndrome patients {#Sec135}

***Laxmikant Desai*** *, Ebby George Simon, Sudipta Dhar Chowdhury, Balakrishnan Siddhartha Ramakrishna*

Christian Medical College, Vellore 632 004, India

*Aim*: To study the prevalence of small intestinal bacterial overgrowth (SIBO) and to determine oro-cecal transit time (OCTT) in patients with irritable bowel syndrome (IBS).

*Materials and Methods*: Consecutive patients aged \>18 years with IBS as per Rome II criteria who attended Gastroenterology, OPD of Christian Medical College, Vellore; between August 2012 and July 2013 were included. Patients who had taken antibiotics within last 4 weeks, on lactulose within 1 week or had any other cause for SIBO were excluded. Patients underwent glucose and lactulose HBT on 2 consecutive days as per standard protocol using Bedfont Hydrogen Breath Analyser, UK. GHBT was used to study SIBO and LHBT was used to calculate OCTT.

*Results*: One hundred and twenty-one patients were enrolled, of which 102 underwent both tests (17 did not complete tests). Mean age was 40.5 (±10.9) yrs and 70 (68.63 %) were males. IBS-diarrhea predominant (IBS-D) was diagnosed in 45 (44.1 %), IBS-constipation predominant (IBS-C) in 13 (12.8 %) and IBS-mixed (IBS-M) in 44 (43.1 %). GHBT was positive in 7 (6.8 %) -3 (6.6 %) in IBS-D, 1 (7.6 %) in IBS-C and 3 (6.8 %) in IBS-M. OCTT could not be calculated in 16 patients, OCTT was 115.1 (±24.1) min in all subjects together, 114 (±26.8) min in IBS-D, 125(±31.5) min in IBS-C, 114 (±20.4) min in IBS-M. ANOVA test (*p*=0.421) did not show any difference in OCTT between subgroups.

*Conclusions*: Prevalence of SIBO in IBS patients was 6.8 %. OCTT was 115.1 (±24.1) min. There was no statistical difference between OCTT in different subgroups of IBS.
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### Role of capsule endoscopy in obscure occult gastrointestinal bleed {#Sec137}

***Vikas Pandey*** *, Nilesh Pandav, Sandeep Patil, Meghraj Ingle, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To investigate the efficacy of capsule endoscopy in diagnosing causes of obscure occult gastrointestinal (GI) bleed.

*Method*: All patients with obscure occult GI bleed visiting our Gastroenterology Department were subjected to either barium follow through or CT enteroclysis to rule out obvious stricture. All patients were subjected to capsule endoscopy (OMOM, China) after a full bowel preparation (Polyetheylene glycol, 138 grams). Follow up of patients were done as per OPD consultation or telephonic conversation. The findings of capsule endoscopy were categorized as a) Obvious/definitive b) Equivocal c) Negative.

*Results*: Thirty-four patients (males 24, females 10, median age) were studied. The total yield of capsule endoscopy with definitive lesions was in 22/34 (65 %) of patients. In descending order a) AV malformations (AVM)-8/34 (23.53 %) b) Crohn's disease 5/34 (14.7 %) c) NSAID enteropathy 3/34 (8.8 %) d) Small bowel ulcers 2/34 (5.9 %) e) Jejunal and ileal polyps 1/34 (2.94 %) f) Intestinal lymphangectasias 2/34 (2.94 %) g) Ileal hemangiomas 1/34 (2.94 %). Equivocal findings 6/34 (17.65 %). Negative study was seen in 6/34 (17.65 %). Complications in the form of capsule retention in distal ileum was noted in 2/34 (5.88 %). Endoscopic insertion of capsule was performed in 1/34 (2.94 %). Among 6 with equivocal result 3 had intermittent history of short duration of NSAID ingestion.

*Conclusion*: In our study AVM was the commonest findings with few having overlapping history of NSAID ingestion. Crohn's, NSAID enteropathy, small bowel ulcers are other common etiologies. Thus capsule endoscopy is an important tool in diagnosis of obscure occult GI bleed.
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### The prevalence of celiac disease in patients with irritable bowel syndrome {#Sec139}

***Nilesh Pandav*** *, Vikas Pandey, Kaivan Shah, Mukesh Nasa, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aims*: Celiac disease (CD) shares many clinical features with irritable bowel syndrome (IBS). Many patients with celiac disease are mistakenly considered as IBS. This study aimed to investigate the prevalence of CD among those that fulfill the Rome III criteria for IBS.

*Methods*: Patients fulfilling the Rome III criteria for IBS were prospectively enrolled in the study. Anti-tissue transglutaminase (IgA anti-tTG) serology was checked to initially recognize possible CD cases. Patients with detectable antibody levels underwent endoscopic duodenal biopsy to confirm a diagnosis of celiac disease.

*Results*: Two hundred patients (127 males, mean age 35.27 years, range 19-60 years) fulfilling the Rome III criteria for IBS were prospectively enrolled in the study. Out of 200 patients 110 were IBS-C, 81were IBS-D and 9 were IBS-M. Four patients tested positive for IgA anti-tTG antibodies, and duodenal biopsies confirmed the diagnosis in all of them. All four patients had IBS-D. All four patients were put on gluten-free diet, two patients who are following up are symptomatically better. Thus, in this study population patients who fulfill Rome III criteria for IBS, 2 % actually had celiac disease. No patient with IBS-C had positive IgA anti-tTG as compared to IBS-D (*p*\<0.05).

*Conclusion*: These findings emphasize the need to rule out celiac disease in patients with diarrhea predominant IBS. Larger studies in our population are required to confirm this association.
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### Role of routine small intestinal biopsy in patients with chronic small bowel diarrhea and its endoscopic correlation {#Sec141}

***Pathik Parikh*** *, Kaivan Shah, Vikas Pandey, Milind Patil, Anjali Amrapurkar, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To evaluate the role of small intestinal biopsy in patients with chronic diarrhea and to establish endoscopic correlation with histological findings.

*Methods*: Consecutive patients scheduled for upper endoscopy for evaluation of chronic (\>4 weeks) diarrhea were enrolled. Patients with chronic pancreatitis were excluded. At least 4 duodenal biopsies were taken for histological evaluation.

*Results*: A total of 863 biopsies from 215 patients (126 males, 89 females, Mean age - 35 years, range- 5 to 75 years) was evaluated. Endoscopy showed normal mucosa (57.2 %), reduced folds (16.2 %), nodularity (14.4 %), scalloping (7.4 %), thickened folds (2.7 %) and erythema (1.3 %). Microscopic damage was observed in 164 of 215 patients (76.2 %). Lymphoplasmacytic infiltration, increased intra epithelial lymphocytes (\>25/100 epithelial cells), partial villous atrophy, total villious atrophy and Brunner's gland hyperplasia were histologically confirmed in 76 %, 7.4 %, 5.1 %, 2.3 % and 0.9 % of 215 patients respectively. Of 123 with normal appearing mucosa, 100 had abnormal histological findings. Negative predictive value of normal looking intestinal mucosa was only 23.9 %. Table 1 shows the correlation of endoscopic and histological findings of small intestinal mucosa. Diagnosis confirmed were celiac disease in 3.02 %, giardiasis, eosinophilic gastroenteritis, Crohn's disease and neuroendocrine tumor in 0.46 % each. 4.6 % were treated as tropical enteropathy after exclusion of all other causes.

*Conclusion*: Normal macroscopic mucosa on endoscopy has very low negative predictive value and it should not restrict us from taking small intestinal biopsies in patients of chronic diarrhea.
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### Diagnostic and therapeutic impact of double-balloon enteroscopy in patients with suspected small bowel disease undiagnosed after both upper and lower endoscopies {#Sec143}

***J Chandran*** *, A P Chettupuzha, P Augustine, M J Chooracken, J V Francis, R J Mukkada, A Koshy*

Digestive Diseases Centre, Lakeshore Hospital and Research Centre, Kochi 682 304, India

*Background*: Double-balloon enteroscopy (DBE) permits visualization and intervention for lesions in the small bowel.

*Aim*: To determine the diagnostic yield and therapeutic impact of DBE.

*Materials and Methods*: Ninety-two consecutive patients with suspected small bowel disease, undiagnosed after upper and lower GI endoscopy from August 2011 to July 2013, were studied.

*Result*: Patients were 46+19 years, (M+SD), male:female, 55:37.

*Indications*: Obscure gastrointestinal bleed (OGIB, 44), abdominal pain (20), suspicion of Crohn's on CT (16), diarrhea (8) and polyp surveillance (4). A new diagnosis was obtained in 63/92 (68 %) patients. In patients with chronic small bowel diarrhea, 7/8, 87 % had Crohn's not suspected on other tests, changing the treatment plan. In OGIB (*n*=44), the cause was identified in 31 patients (70 %). In 19/31 (61 %) a new diagnosis was found. Endoscopic therapy was required in 25/92, 27 %. Success of endoscopic therapy was 100 %; hemostasis in 15/15 (100 %) patients with angioectasia and 2 with anastomotic ulcer bleed; and polypectomy in 8 patients with intestinal polyp. The 43 biopsies revealed Crohn's disease in 26 (60 %), lymphomas in 4 (9 %), NSAID enteropathy and neuroendocrine tumor in 2 each (4 %); GIST, vasculitis, eosinophilic gastroenteritis and tuberculosis in 1 each (2 %) and Peutz-Jeghers syndrome in 3 (7 %). Only one complication developed: ulcerative pharyngitis requiring hospitalization for 3 days.

*Conclusion*: DBE had 68 % diagnostic yield and 100 % therapeutic success in the 27 % who required endoscopic therapy.
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### Prevalence of microscopic colitis and celiac disease in patients with irritable bowel syndrome {#Sec145}

***Anish Philip***, *Vinu Joseph, M Mukunda, D Krishnadas, R Sobhana Devi*

Department of Gastroenterology, Government Medical College, Medical College Campus Road, Gandhinagar, Aarppookkara, Kottayam 686 008, India

*Background*: Irritable bowel syndrome (IBS) is a chronic condition with limited therapeutic options. Celiac disease (CD) and microscopic colitis (MC) can present with IBS-like symptoms and their diagnosis can offer a chance of cure, for patients labeled as IBS.

*Aim*: To investigate the prevalence of celiac disease or microscopic colitis among patients with IBS.

*Methods*: We included patients with IBS, satisfying the Rome III consensus criteria, attending outpatient clinic during a 6 month period. MC was investigated by performing total colonoscopy with multiple biopsies from mucosa from proximal colon. CD was investigated by doing an upper GI endo OGDscopy with D2 biopsy and with IgA transglutaminase antibodies in patients with positive biopsy.

*Results*: Total number of patients with IBS included was 58. Mean age was 40.51 years (range 18-70 years). Male patients were 40 (68.9 %). The CD was identified in 3 patients (5.17 %). The Marsh types in each of the three cases were 3b, 3b, 3c respectively. MC was identified in 15 patients (17.24 %). The histological type was collagenous colitis in 1 patient and lymphocytic colitis in 14 patients. Eosinophilic colitis was identified in colonic mucosal biopsy in 2 patients satisfying the Rome III IBS criteria. One of the patients with celiac disease also had lymphocytic colitis.

*Conclusion*: Microscopic colitis and celiac disease frequently meet the diagnostic criteria for IBS. So, diagnostic work up for both diseases should be under taken, in every patient with persistent symptoms of IBS.
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### Prevalence of small intestinal bacterial overgrowth in patients with irritable bowel syndrome using lactulose hydrogen breath test {#Sec147}

***Anish Philip*** *, Vinu Joseph, M Mukunda, D Krishnadas, R Sobhana Devi*

Department of Gastroenterology, Government Medical College, Medical College Campus Road, Gandhinagar, Aarppookkara, Kottayam 686 008, India

*Introduction*: Irritable bowel syndrome (IBS) is a common functional disorder and its pathophysiology is poorly understood. Various studies have pointed out that there can be considerable overlap of symptoms between IBS and small intestinal bacterial overgrowth (SIBO).

*Aim*: To study prevalence of SIBO in our population of patients with IBS using lactulose hydrogen breath test (LHBT).

*Methods*: Patients with IBS satisfying Rome III criteria attending our outpatient clinic over a period of 6 months and an equal number of controls, without any gastrointestinal symptoms were selected. Both groups were evaluated for SIBO using LHBT. After ingestion of 10 g of lactulose, an increase in breath hydrogen concentration, more than 20 ppm above basal value, before a second peak of rise in breath hydrogen after 90 minutes, was diagnostic of SIBO.

*Results*: One hundred and twenty patients with IBS and 120 healthy controls were included. Fifty-six patients had diarrheal type and 64 patients had mixed type IBS. The mean age of cases (43.1±24.4 years) was similar to controls (45.9±24.6 years) (*p*=0.86). Male patients were predominant in IBS group; 87 males (72 %), compared to control group; 48 males (40 %) (*p*=0.001). IBS patients had a higher proportion of LHBT positivity with 9 patients (7.8 %) compared to 2 patients (1.6 %) in control group. But there was no statistical significant difference in LHBT positivity between the two groups (*p*= 0.06).

*Conclusion*: There is no significant difference in the prevalence of SIBO in patients with IBS compared to control population.
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### Reduced HD-5 gene expression in inflammatory bowel disease {#Sec149}

***J Asha Latha*** *, G Prasad, Rupa Banerjee, M Sasikala, D Nageshwar Reddy*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Defensins are antimicrobial peptides secreted by paneth cells which are the key effectors of innate mucosal defense. Human Defensin-5(HD-5) is a paneth cell specific defensin expressed at the base of small intestine. Reduced expression of HD-5 could compromise mucosal host defenses and predispose to intestinal mucosal inflammation in inflammatory bowel disease (IBD). A decrease of the paneth cell±-defensins can alter the intestinal microbiome allowing mucosal invasion and triggering inflammation.

*Objective*: To evaluate the expression status of HD-5 mRNA in IBD patients in comparison to non-IBD healthy controls.

*Methods*: Biopsies from the terminal ileum were obtained from 24 patients with confirmed IBD (WHO criteria) and 27 non-IBD healthy controls. RNA was extracted and amplified through generation of cDNA. PCR amplification was done for candidate gene (HD-5). Amplicons were resolved through agarose gel electrophoresis and semi-quantified by densitometry.

*Result*: The gene expression of HD-5 was found to be decreased significantly (*p*=0.03) in IBD patients (0.24) as compared to non-IBD controls (0.32).

*Conclusion*: There is a reduced expression of HD-5 in the terminal ileum in Crohn\'s disease (CD). This could account for IBD associated alteration in the microbiome. This could pave the way for a molecular alternative to restore gut barrier function.
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### Etiological profile of post solid organ transplant patients presenting with diarrhea {#Sec151}

***Viral Vyas*** *, K R Palaniswamy, A T Mohan, Usha Srinivasan, Sarojini Permeswaran, Ubal Dhus, M Hariharan, N Murugan, P Piramanayagam, V Seshadri, Ravindra Gaadhe, Sharad Deshmukh, Anand Totagi, Pravin Borsadia, Ankit Dalal*

Department of Gastroenterolog, Apollo Hospital, 21, Greams Lane, Off. Greams Road, Chennai 600 006, India

*Introduction*: Diarrhea is frequently encountered in post transplant period. Severe diarrhea can lead to weight loss, fluctuating immunosuppressive drug levels and can threaten graft survival. There is limited literature from India regarding etiological spectrum of post-solid organ transplant diarrhea.

*Materials and Methods*: Prospective observational study. All post solid organ transplant patients developing diarrhea (defined as 3 loose or liquid bowel movements per day) irrespective of the time from transplant and the immunosuppressive protocol were included. Patient with chronic diarrheal disease existing before transplant and with severe comorbid conditions were excluded. Investigations done were stool examination including for ova and cyst, stool for clostridium difficile toxin, CMV PCR, gastroduodenoscopy and colonoscopy.

*Results*: Out of 35 (26 male) patients, 31 (88.57 %) had undergone renal transplant while 4 (11.4 %) had undergone liver transplant. Small bowel type of diarrhea was seen in 28/35 (80 %), while large bowel type was seen in 7 (20 %). Diarrhea - 2 weeks was seen in 21/35 (60 %), while \<2 weeks seen in 14/35 (40 %). For diarrhea \>2 weeks, common etiologies were protozoal infection 10 /21 (47.61 %), drug toxicity in 5/21 (23.8 %), CMV infection 5/21 (23.8 %); no etiology was found in one. In diarrhea \<2 weeks, 9/14 (64.3 %) had self limiting enteritis; specific cause was found in two (1-CMV, 1-V.cholera). Bilioma was identified in 2 (14.3 %) post liver transplant patients.

*Conclusion*: In patients with \<2 weeks diarrhea, self limiting enteritis is most common, while in those with diarrhea ≥2 weeks, protozoal infections, drugs and CMV were common etiologies.
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### Chronic diarrhea among immunocompetent patients due to intestinal cryptosporidiosis {#Sec155}

***D Banerjee*** *, A K Handa, R Shrivasta, N Hazra, S Sen, K Kapila*

Departments of Gastroenterology, and Microbiology, Command Hospital (SC), Armed Forces Medical College, Pune 411 040, India

*Introduction*: Intestinal protozoa are increasingly being studied because of their association with sporadic cases of acute and chronic diarrhea in immunocompromised as well as immunocompetent patients. Various community outbreaks due to contamination of water and/or food with these protozoa have further highlighted their importance in public health.

*Methods*: Over three years, consecutive patients of chronic diarrhea were evaluated for protozoan infection. All immunocompromised patients were excluded. Freshly collected stool samples were analyzed for presence of oocysts of Cryptosporidium by modified ZN stain and smears were graded as described by Mathan et al.

*Results*: One hundred and thirty-two samples from 110 immunocompetent patients with chronic diarrhea were analyzed, including 22 post treatment samples from 19 patients after three days of Nitazoxanide therapy. Out of the 110 patients, 32 were tested positive (prevalence 29 %). Mean age group was 35 yrs (Range 20-62 years), 21 of these patients had dual deficiency anemia.

*Discussion*: Our study revealed a prevalence of 29 %, which is higher than that reported in various other studies from India. Grading of smears can be used to access response to therapy.

*Conclusion*: In addition to common enteropathogenic organisms, Cryptosporidium is indicated as a key causative agent of diarrhea in humans. In many cases, it can cause persistent recalcitrant diarrhea requiring preventive and therapeutic measures. An aware clinician must consider Cryptosoridial infection in the differential diagnosis of chronic diarrhea in immunocompetent patient also.
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### Prevalence of autoimmune markers in patients of celiac disease {#Sec157}

***Jahangeer Basha*** *, Pradeep Siddappa, Vishal Bodh, Sanjay Kumar Bhadada, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, and Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Introduction*: Recent data suggests that there is an increased prevalence of autoimmune marker positivity among patients of celiac disease with increasing age. However data regarding such prevalence is lacking from India.

*Aim*: To evaluate the prevalence of various autoimmune markers among patients of adult celiac disease (CD).

*Methods*: Thirty consecutive patients (53.3 % females, mean age 22.15 years) of adult CD (age \>12 years) presenting to Gastroenterology Clinic over a period of 6 months were included. The diagnosis of CD was based on modified ESPGHAN criteria. All patients underwent complete clinical assessment and investigated for autoimmune markers including ANA, AMA, LKM, SMA and PCA, thyroid profile and blood sugar profile.

*Results*: Of 30 patients, 4 (13.33 %) patients (2 males, 2 females) were found to have auto antibody positivity, with ANA positivity in 2 and SMA positivity in 2 patients. Three out of 4 patients had atypical clinical presentation and short stature. On investigation, all 4 patients had anemia, 3 of them had transaminitis (AST/ALT levels \>1.5 times), high tTG titers (\>100 IU/L) and subtotal villous atrophy on histopathology. One patient had hypothyroidism also none of them had type 1 diabetes mellitus. However, in the remaining patients 26 patients, 2 had hypothyroidism and 4 had type 1 diabetes mellitus.

*Conclusion*: This preliminary data suggests that there is increased incidence of autoantibodies in CD.
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### Anemia in celiac disease is multifactorial in etiology {#Sec159}

***Jahangeer Basha*** *, Sreekanth Appasani, Pradeep Siddappa, Vishal Bodh, Subhash Chander Varma, Neelam Varma, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Internal Medicine, and Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Aims*: To prospectively evaluate the etiological profile of anemia in patients with adult celiac disease (CD).

*Materials and Methods*: One hundred and three consecutive patients (54.4 % females, mean age 26.15±11.1 years) of adult CD (age \>12 years) diagnosed on basis of modified ESPGHAN criteria were evaluated. All patients underwent complete clinical assessment and were investigated for hematological parameters including complete hemogram, iron profile, vitamin B~**12**~ and folate levels. Anemia was defined as hemoglobin \<0.001).

*Conclusion*: Anemia in CD is multifactorial in etiology. In addition to iron deficiency; deficiencies of vitamin B~**12**~, folate and anemia of chronic disease have significant role in the pathogenesis.
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### A rare case of intraabdominal cocoon {#Sec161}

*Sandip Vare, Amit Bundiwal,* ***Mayank Jain*** *, Ajay K Jain, Shohini Sircar, Anup Gupta, Chandrashekhar Chamania*

Departments of Gastroenterology, Radiology, and General Surgery, Choithram Hospital and Research Centre, Manikbagh Road, Indore 452 017, India

*Introduction*: Intraabdominal cocoon or encapsulating peritoneal sclerosis (EPS) is a rare and life threatening condition of small bowel obstruction, characterized by a complete or partial encasement of the small bowel by a fibrocollagenic cocoon-like sac.

*Case Report*: 30-years-old male patient, chronic alcoholic presented with history of upper abdominal pain and distention for 8 months, non-projectile bilious vomiting for last 2 months, weight loss of 15 kgs over 2 months and constipation and borborygmi for last one month. He was admitted at private hospital 2 weeks prior to his current admission. He was treated conservatively on the lines of intestinal obstruction and improved with treatment. Soon after starting orally he had recurrence of similar symptoms and hence referred to our centre. There was 6 cm x 4 cm lump in the right half of abdomen 3 cm below right costal margin, firm in consistency, rounded, non-mobile, not moving with the respiration, free from skin, nontender with normal temperature. Carnet's sign was negative. On percussion it was tympanic. Complete blood counts, serum creatinine and electrolytes were normal. Computed tomography study of the abdomen showed multiple peritoneal bands and thickened mesentery enveloping the small bowel loops and jejunum and forming multiple sacs with dilated stomach, duodenum and proximal jejunum, small bowel cocooning. The patient was subjected to laparotomy and adhesiolysis. Histopathological examination of the sac showed fibrous tissue with patchy lymphocytic infiltrate. Granulation tissue is also seen. No evidence of granuloma or malignancy was noted.
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### Fructose malabsorption is uncommon among patients with irritable bowel syndrome in India: A case control study {#Sec163}

***Atul Sharma*** *, Deepakshi Srivastava, Abhai Verma, Asha Misra, Vivek A Saraswat, Uday C Ghoshal*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Introduction*: In previous studies, 38 % to 75 % patients with functional bowel disorders have been reported to have fructose malabsorption (FM), though there is no study on this issue from India. Hence, we studied the frequency of FM among patients with IBS and healthy controls from India.

*Methods*: Eighty-five patients with IBS (diagnosed using Rome III criteria) and 27 healthy controls were evaluated for FM by hydrogen breath test (FHBT) using 25 g fructose dissolved in 250 mL water. Breath hydrogen was estimated at baseline and every 15 minutes thereafter for 3 hours. Persistent rise in breath hydrogen 20 ppm above basal was considered diagnostic of FM.

*Result*: Patients (median age 37 y \[range 21-66\], 63/85 \[74 %\] male) and controls (31 y \[23-56\], 17/27 \[63 %\] male) were comparable in age (*p*=0.105) and gender (*p*=0.264). 12/85 (14.1 %) patients with IBS had FM compared to 1/27 (3.7 %) controls (OR 4.3, 95 % CI 0.5-34.5; *p*=0.173).

*Conclusion*: Fourteen percent of patients with IBS in this study had FM, which was not higher than the frequency among healthy controls.
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### Quantitative alterations in the selected fecal bacteria in patients with irritable bowel syndrome and healthy controls by real time PCR {#Sec165}

***Ratnakar Shukla*** *, Ujjala Ghoshal, Vikas Agarwal, Tapan N Dhole, Uday C Ghoshal*

Departments of Microbiology, Immunology, and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Alterations in the gut microbiota, such as reduction in population of beneficial bacteria like Lactobacillus and Bifidobacterium and increase in pathogens such as Pseudomonas aeruginosa may play a role in pathogenesis of irritable bowel syndrome (IBS). Therefore, we aimed to study fecal Lactobacillus, Bifidobacterium and Pseudomonas in patients with IBS and healthy controls (HC) using quantitative real time polymerase chain reaction (qPCR).

*Methods*: Three consecutive stool samples were collected from 40 patients with IBS (Rome III criteria) and 30 HC. DNA was extracted from stool samples and quantified. Genomic DNA from Lactobacillus acidophilus ATCC 4356, Bifidobacterium breve ATCC 15700 and Pseudomonas aeruginosa ATCC 27853 was used as positive controls. Quantitative determination of each bacterium was performed by qPCR.

*Results*: Patients with IBS (*n*=40) were comparable in age and gender (33-y \[17-68\], 32/40 male \[80 %\]) with HC (*n*=30; 35-y \[21-69\], 22/30 male \[73 %\]). Pseudomonas aeruginosa was more frequently detected in patients than HC \[39/40 (97.5%) vs. 10/30 (33.3%), *p*\<0.001\]. Copy number of Pseudomonas aeruginosa \[Log103.85 (0.00-4.23) vs. Log100.00 (0.00-3.86)\] was higher in patients than HC (*p*\<0.001). Copy number of Lactobacillus \[Log104.07, IQR (3.50-4.65) vs. Log104.18 (2.76-5.28)\] and Bifidobacterium spp. \[Log10 5.64 (4.96-6.24) vs. Log105.03 (3.19-5.83)\] was higher in HC than patients with IBS (*p*\<0.001).

*Conclusion*: Patients with IBS had pathogenic bacteria like Pseudomonas aeruginosa more often in their feces and in higher number. Number of beneficial bacteria was lower in feces of IBS patients than HC. Hence, we suggest that dysbiosis may play a role in IBS.
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### Small bowel adenocarcinomas: A single center experience {#Sec169}

***Siva Sankar Reddy Gangireddy*** *, Shaesta Mehta, Prachi S Patil*

Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Parel, Mumbai 400 012, India

*Introduction and Aims*: Small bowel adenocarcinomas are rare tumors which are treated like colorectal cancers and are considered to have a poorer prognosis. We planned an audit of the small bowel adenocarcinomas seen at the Tata Memorial Hospital from 2008-2013.

*Methods*: A retrospective chart review was done. Charts of 27 consecutive patients with small bowel adenocarcinomas (non-periampullary) were evaluated to assess the presentation, treatment, nutritional status, and outcomes.

*Results*: The mean age was 45 years (range 17-82 years). There were 18 males and 9 females. The common presenting symptoms were vomiting in 7 (36 %), abdominal pain in 5 (26 %) and both vomiting and pain in 7 (36 %). Fourteen (70 %) patients presented with intestinal obstruction. The mean duration of symptoms was 56 days. The tumors originated in the jejunum in 19 (70 %), the ileum in 3 (11 %) and the distal duodenum in 2 (7 %) patients. The tumors were well differentiated in 2 (7 %), moderately differentiated in 14 (51 %), poorly differentiated in 6 (22 %) patients. Metastatic disease was seen in 4 patients (16 %). The mean hemoglobin was 12.3 g/dL and the mean albumin was 4.0 g/dL. Eleven (57 %) patients were moderately malnourished and 7 (36 %) patients were severely malnourished. Eighteen patients (66 %) underwent surgery-resection anastomosis in 16 and palliative bypass in 2 patients. Eleven of these patients received adjuvant chemotherapy.

*Conclusions*: Small bowel adenocarcinomas are rare tumors. Most patients present with obstructive symptoms and moderate to severe malnutrition. More than 80 % patients have non-metastatic disease and can be cured by surgery.
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### Outcome of incidentally detected asymptomatic terminal ileal ulcers {#Sec171}

***D Viswanath Reddy*** *,* *Sudipta Dhar Choudhury, Ebby George Simon, A J Joseph*

Department of Gastrointestinal Sciences, Christian Medical College, Vellore 632 004, India

*Background*: Incidentally detected terminal ileal ulcers on colonoscopy of is seen occasionally and there is scarce literature on the approach to the management of them.

*Aim*: To know the histology and clinical outcome of patients who have been incidentally detected to have terminal ileal ulcers on colonoscopy.

*Design*: Prospective and retrospective cohort study in a tertiary care centre in south India.

*Methods*: Patients with incidentally detected asymptomatic terminal ileal ulcers on colonoscopy from January 2011 to September 2013 were recruited and their clinical profile and ulcer histology reviewed. The patients with lesions in other part of colon or have a clinical picture or diagnosis of inflammatory bowel disease or with history of chronic NSAIDS intake have been excluded. These patients were followed up and their clinical picture, repeat colonoscopy and histology was reassessed.

*Results*: One hundred and thirty-five patients with incidentally detected terminal ileal ulcers on colonoscopy were included in the study. These patients had mild to moderate chronic ileitis on histology. Of these, 15 patients had repeat colonoscopy which showed reduction in size of ulcer in 10 patients and disappearance of the ulcers in 5 patients. The follow up histology also showed reduction in severity of inflammation in them. Another 15 patients who had a clinical follow up without colonoscopy were doing well.

*Limitation*: Small number of patients had repeat colonoscopy and duration of follow up was short (less than 2 years).

*Conclusions*: The incidentally detected terminal ileal ulcers are usually self-resolving and may not need treatment or surveillance colonoscopy.

SI-24 {#Sec172}
-----

### All patients with celiac disease do not have anemia {#Sec173}

*Prashant Singh, Shubhangi Arora,* ***Govind K Makharia***

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India

*Introduction*: Most patients with celiac disease (CeD) have anemia and diagnosis of CeD is seldom considered in presence of normal hemoglobin levels. However, over past few years, we have observed a few CeD patients having normal hemoglobin. Therefore, we reviewed our database of CeD to find the proportion of CeD patients with and without anemia and looked for any differences in their clinical, laboratory, serological and histological characteristics.

*Patients and Methods*: In this retrospective analysis, we reviewed the case records of 338 patients with CeD. The diagnosis of CeD was made as per European Society of Pediatric Gastroenterology, Hepatology and Nutrition guidelines. Anemia was diagnosed using World Health Organization cutoffs.

*Results*: Fifty (14.8 %) patients with CeD had normal hemoglobin levels at the time of diagnosis. When compared with CeD patients without anemia, CeD patients with anemia had significantly longer median duration of symptoms \[48 months (18-120) vs. 24 months (8-60); *p*=.004\], higher proportion having abnormal d-xylose tests (75.6 % vs. 53.6 %, *p*=.01), lower mean albumin levels (4.19g/dL (±0.86) vs. 4.66g/dL (±0.91), *p*\<0.001), higher median tissue transglutaminase level rise (7.3 (2.6-14.7) vs. 3.6 (1.7-10), *p*=.0161) and higher proportion of Marsh 3c lesions (60.8 % vs. 32 %, *p*=0.0002).

*Conclusion*: CeD patients with anemia have more severe disease than those without anemia. It is therefore important to diagnose these patients at earlier stage of the disease even when the classical feature such as anemia is not clinically evident.
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### A case report of metastatic duodenal melanoma with unknown primary {#Sec176}

***P Shanija*** *, Rathnakar Kini, Kani Sheik, Prem Kumar Pugazhendhi, Mohamed Ali*

Department of Medical Gastroenterology, Madras Medical College Hospital, Chennai 600 003, India

Small intestine is commonest site of metastasis of malignant melanoma. This is a case report of duodenal melanoma with locoregional and distant metastasis without skin lesion.

A 42-year-old male patient presented to Medical Gastroenterology, OPD with history of melena and weight loss for 3 months. Clinical examination finding was only pallor; otherwise normal.

*Investigations and Hospital Course*: Blood investigation showed anemia. Upper GI endoscopy revealed two nodular lesion with central umbilication with blackish pigmentation in the second part of duodenum. HPE suggestive of malignant melanoma of duodenum with IHC marker HMB-45 and focal S-100 positivity. Colonoscopy was normal.

On further evaluation there was no skin lesion; external genitalia --normal. Eye fundus examination showed bilateral papilledema. CECT chest and abdomen showed bilateral lung, liver, kidney and lytic bone metastasis; nodal deposit in mediastinum and mesentery. CT brain revealed metastasis. Treated with IV steroid for the control of raised ICT. As the patient having skeletal metastasis, palliative radiotherapy given followed by chemotherapy.

*Conclusion:* Malignant melanoma is the most common tumor metastatic to the gastrointestinal tract. Before making the diagnosis of malignant melanoma of the small bowel, other primary melanomas have to be excluded and there should be no distant metastasis. This patient has no evidence of primary melanoma, there is distant metastasis, so diagnosed as metastatic duodenal melanoma with unknown primary.
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### IBS patients produced more H2 with wheat than rice intake compared to healthy subjects though bloating was unrelated to H2 production {#Sec178}

*Uday C Ghoshal, Anshika Agarwal,* ***Ankit Shukla*** *, Geetanjali Singh, Deepakshi Srivastava, Asha Misra*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Rice may be better tolerated than wheat in patients with irritable bowel syndrome (IBS). We hypothesized that intolerance to wheat among patients with IBS is related to increased hydrogen production by fermentation of malabsorbed starch by colonic bacteria.

*Method*: Initially, 9 healthy subjects (HS) underwent hydrogen breath tests (every 15-min for 4 hours) after 100 g rice and 100 g wheat on two consecutive days; since there was no difference in hydrogen production, the same tests were repeated for 6 hours on 8 other HS. Subsequently, 6-h tests were performed on 10 patients with IBS (Rome III criteria), and postprandial bloating and pain were scored using standard severity scales over the recording time.

*Results*: Levels of breath hydrogen were comparable after wheat and rice on 9 HS \[26 y (21-28), 5 male\] initially tested for 4 h (Fig. 1C). On the other 8 healthy subjects \[(25 y (24-29), 4 male\], levels of breath hydrogen were comparable after wheat and rice over 6 h recording period (Fig. 1A). In contrast, wheat produced more hydrogen than rice in 10 patients with IBS \[age 32 y (24-54), 6 male\] and the difference started at 315 minutes after ingestion (Fig. 1B). Wheat ingestion led to more bloating than rice and it started 15 min after ingestion (Fig. 1D). However, there was no difference in pain score with wheat and rice ingestion (Fig. 1E).

*Conclusion*: IBS patients produced more hydrogen in breath after ingestion of wheat than rice in contrast to HS.
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### Hyperesonophilic syndrome with secondary eosinophilic gastroenteritis: A case report and review {#Sec180}

*S Arulprakash, T Arun, Tirou Kannane,* ***Vikas Devendra Kohli*** *, George M Chandy*

MIOT Advanced Center for GI and Liver Diseases, MIOT International, MIOT Hospitals, 4/112, Mount Poonamalle Road, Manapakkam, Chennai 600 089, India

Hypereosinophilic syndrome (HES) is defined as persistent eosinophilia (\>1.5---109/L for more than six consecutive months) with evidence of eosinophil-induced organ damage, where other causes of hypereosinophilia have been excluded. Eosinophilic gastroenteritis has a chronic relapsing course, characterized by intense eosinophilic infiltrate in one or multiple segments of the intestine (esophagus to rectum) with varying depth of infiltration (mucosal, muscular and serosal) and unpredictability in presenting symptoms. HES is one of the causes for secondary eosinophilic gastroenteritis. We report a 51-years-old lady with recurrent episodes of abdominal pain, eosinophilic ascites and loose stools from 2008 till 2013 associated with peripheral eosiniphilia (TC-21,960 mm^**3**^, eosinophils-44.8 %). After detailed serological and radiological work up autoimmune, allergic, bacterial, viral, tubercular, parasitic and malignant causes were ruled out. Duodenal biopsy showed significant eosinophilic infiltrates. Ascitic fluid analysis was suggestive of high protein eosinophilic ascites. Diffuse small bowel wall thickening and ascites were found on abdominal CT. Diagnostic laproscopy and full thickness ileal biopsy revealed a heavy infiltrate of eosinophils in the submucosa, muscularis propria and serosa confirming the diagnosis of eosinophilic gastroenteritis. Bone marrow biopsy showed 40 % mature eosinophils, eosinophilic myelocytes and metamyelocytes. cytogenetics and molecular studies (JAK 2, PDGFR alfa and beta, Fibroblast growth factor and FISH for BCR-ABL) were negative. She was treated with diethylcarbamazine and albendazole for 4 weeks. She responded well. If her symptoms recur the plan is to start her on steroids. This represents a rare case of hyperesonophilic syndrome with secondary eosinophilic gastroenteritis.
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### Prevalence of Campylobacters in and around Chandigarh and their antibiotic resistance profile by molecular methods {#Sec184}

***Chetana Vaishnavi*** *, Meenakshi Singh, B R Thapa*

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Campylobacter is an important cause of bacterial gastroenteritis with *C. jejuni* and *C. coli* being commonly associated. In the present investigation the prevalence of Campylobacters in and around Chandigarh and their antibiotic resistance profile was done.

*Methods*: Stool samples from 1,145 diarrheal patients and 102 healthy subjects from hospital and community were cultured microaerophilically on Campylobacter media for 48 h. The suspected colonies were identified by Gram stain, biochemical and serologic investigations. Molecular confirmation was done using specific primers to unique regions of 16SrRNA, *C. jejuni* (hipO), *C. coli* (aspK), *C. lari* (glyA) and *C. upsaliensis* (lpxA) genes. Identification of specific genes to look for resistance to nalidixic acid, ciprofloxacin, tetracycline and streptomycin was also done.

*Results*: Campylobacters were isolated from 30 (2.6 %) diarrheal samples but none from healthy subjects. The most frequent serogroups were Group S:27, Group B:2, Group Z5:52 and Group V:32 in descending order. Of the 30 positive patient samples for Campylobacter species, 27 were *C. jejuni* and 3 were *C. coli*. DNA amplification revealed *C. jejuni* in 78.9 %, *C. coli* in 1.8 % and co-infection of *C. coli* and *C. jejuni* in 19.3 % of the cultures but no *C. lari* or *C. upsaliensis*. Antibiotic resistance was 40.0 % for nalidixic acid, 23.3 % for ciprofloxacin, 50 % for tetracycline and 20 % for streptomycin.

*Conclusion*: *C. jejuni* species is most commonly isolated among the Campylobacter diarrheas. High degree of resistance was seen for nalidixic acid and tetracycline and moderate degree of resistance were seen for ciprofloxacin and streptomycin.
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### Phenotypic and genotypic investigation of Clostridium difficile isolates obtained from patients reporting to a tertiary care hospital {#Sec186}

*Meenakshi Singh, Chetana Vaishnavi,* ***Prashant Kapoor*** *, Rakesh Kochhar*

Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Clostridium difficile produces two major enterotoxins, Toxins A and B which are responsible for nosocomial diarrhea in patients who receive antibiotics and other medications. The disease can lead to life threatening manifestations like pseudomembranous colitis and toxic megacolon. A phenotypic and genotypic investigation of C. difficile isolates obtained from patients reporting to a tertiary care hospital was done.

*Methods*: Fecal samples from 356 patients suspected to have C. difficile infection were incubated overnight anaerobically in Robertson's cooked meat media. From this culture was done directly and after alcohol-shock on Columbia blood agar and incubated for 48 h. Suspected colonies of C. difficile were identified biochemically and also by amplifying species-specific triose phosphate isomerase (TPI) gene. Isolates found to be positive for C. difficile by both phenotypic and genotypic methods were further processed for identification of toxins A and B. Toxigenic status of C. difficile was identified both by ELISA and by PCR.

*Results*: Phenotypically and genotypically 29 (8.1 %) C. difficile isolates were obtained. C. difficile toxins A/B were detected by ELISA in 12/29 (41.4 %) of the total isolates. PCR for tcdA and/or tcdB genes were identified in 16 (55 %) of the isolates. Two (12.5 %) of the toxigenic isolates were positive for tcdA alone whereas 5 (31.2 %) of the toxigenic isolates elaborated tcdB gene alone.

*Conclusion*: PCR is a better tool than ELISA to identify toxigenic C. difficile producing either one toxin or both toxins. Toxigenic C. difficile is prevalent along with non-toxigenic ones in patients reporting to hospital.
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### Spectrum of colonic polyps: Our centre experience {#Sec188}

***S Mukundan*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesan, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Poonamallee High Road, Kilpauk, Chennai 600 003, India

*Introduction*: Colonic polyps though rarely symptomatic are important because of their silent potential to become malignant. This is a prospective study of all patients who underwent colonoscopy from June 2011- June 2013 in the Department of Digestive Health and Diseases, Anna Nagar, Kilpauk Medical College, Chennai.

*Aims*: The study aims to present the incidence of colonic polyps detected during colonoscopy and analyze the morphology and histopathology with possible prognostic implications.

*Methodology*: All the patients who were found to have polyps at the time of colonoscopy during the study period were included.

*Observations*: A total of 97 patients were found to have colonic polyps out of the total 1,447 colonoscopies. The number of polyps per patient ranged from 1 to numerous. The commonest presentation of patients was abdominal pain with altered bowel habits in elderly population and bleeding per rectum in the younger population. The presentation showed a higher incidence in the 5th, 6th and 7th decades and was more common in males. The highest incidence of polyps was in the rectum (26 %) and sigmoid (19 %). Majority of the polyps were less than 1 cm in diameter. The polyps were removed for histopathological examination which showed adenomas (58 %) as the commonest type followed by hyperplastic polyps (31 %).

*Conclusion*: Colonic polyps have higher incidence in the 5th, 6th and 7th decades. The commonest location is the distal colon with adenoma being the commonest histological type and removal of the polyp is indicated all cases.
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### Clinical and endoscopic correlation of disease activity in ulcerative colitis {#Sec190}

***V Anand*** *, R Poppy Rejoice, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Poonamallee High Road, Kilpauk, Chennai 600 003, India

*Aim*: To evaluate clinical and endoscopic correlation of disease activity in ulcerative colitis.

*Materials and Methods*: A cohort study of ulcerative colitis patients identified by clinical, laboratory, colonoscopic examination and histological parameters in the age group of 18 to 80 years during the period of April 2012-February 2013 is included. Baseline clinical severity, laboratory parameters and endoscopic grading were recorded and treated under 3 groups as follows, group-I: sulfasalazine, group-II sulfasalazine+oral prednisone, group-III azathioprine+prednisone. These patients were in follow up and assesed for clinical response and endoscopic follow up at 3 and 6 months.

*Results*: Out of 101 patients 48 were excluded. The 53 patients were included. Age group- 16 to 64 years. Nocturnal diarrhea, fever had a positive correlation with severe disease. 36,14,03 patients were treated under group I, II and III respectively. All had clinical remission in this study. Endoscopically no mucosal healing was observed in 80.5 % and 70.5 % at 3 and 6 months in group I. In group II only 42.9 % had an endoscopic response. In group III endoscopically complete response was seen in 33 %.

*Conclusion*: Mucosal healing as assessed by endoscopy is a useful tool for evaluating and guiding response to therapy in IBD, however, endoscopic mucosal healing has no correlation with disease activity.
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### A study on rifaximin therapy for patients with IBS-diarrhea {#Sec192}

***A Santhi Selvi*** *, G Ramkumar, G Muthukumaran, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Poonamallee High Road, Kilpauk, Chennai 600 003, India

*Aim*: To determine whether the nonabsorbable antibiotic rifaximin is effective than placebo in reducing symptoms in patients with IBS-diarrhea.

*Study*: *Prospective Place*: Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai. Period: July 2012-December 2012.

*Methodology*: Forty-nine participants satisfying ROME-III criteria for IBS were included. Twenty participants received placebo and 29 received 400 mg rifaximin TDS for 14 days. Two rifaximin recipients lost follow up. Patients were reviewed on 1st and 2nd week, then 4 weeks and 10 weeks after completing therapy.

*Results*: Total cases - 47. Males -- 21 (44.68 %). Females -- 26 (55.31 %). Age - 20 to 50 years. *Rifaximin group*: \[13(48.14 %) patients reported abd pain relief, 20 (74.07 %)-reduced stool frequency, 19 (70.37 %)- improved stool consistency, 19 (70.37 %) - relief of bloating\] after 2weeks. *Placebo group*: \[12 (60 %) had abd pain relief, 13 (65 %) -reduced stool frequency, 11 (55 %) - improved stool consistency, 11 (55 %) -improvement in bloating\] after 2 weeks. Ten weeks after completing rifaximin \[9 (33.33 %)- had abd pain recurrence, 11 (40.74 %) -increased stool frequency, 9 (33.33 %) - loose stools and 8 (29.62 %)- bloating\]. Ten weeks after completing placebo \[7(35 %)- abd pain recurrence, 5 (25 %) -increased stool frequency, 6 (30 %)-loose stools and 9 (45 %)-bloating\] with placebo.

*Conclusion*: Rifaximin provided adequate relief of IBS symptoms (stool consistency, frequency and bloat) than placebo. But abdominal pain relief was better with placebo than rifaximin. Recurrence of symptoms was reported after discontinuing rifaximin. Rifaximin was well tolerated, without undue adverse effect.
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### Prevalence of TPMT gene polymorphisms in inflammatory bowel disease patients {#Sec194}

***Sandeep Patil*** *, B Ravi Shankar*

Yashoda Hospitals, Behind Hari Hara, Kala Bhavan, S P Road, Secunderabad 500 003, India

*Background*: Thiopurine drugs-Azathioprine and 6-mercaptopurine (6-MP) are well-established in the treatment of moderate to severe inflammatory bowel disease (IBD). Their efficacy has been shown in placebo-controlled trials for maintenance of remission in both Crohn\'s disease and ulcerative colitis and for induction of remission in Crohn\'s disease. TPMT genotyping seems to play a role in the prediction of early drug toxicity in patients who have not been previously exposed to AZA or MP and in determining standard starting dose. The present study is carried to determine the prevalence of TPMT gene polymorphisms in inflammatory bowel disease patients.

*Material and Methods*: Twenty-one patients with inflammatory bowel disease referred to Yashoda Hospital were subjected to blood sampling to determine the concentration of thiopurine methyltransferase (TPMT) enzyme in RBC and TPMT genotyping using PCR technique.

*Results*: Among 21 IBD patients included in the study, 9 patients were diagnosed with ulcerative colitis, 9 patients with Crohn\'s disease and in 7 patients diagnosis was unknown. Mean age of patients included in the study was 45.5 years. Concentration of TPMT ranged between 11.8 to 58.1 U/mL. 90.5 % of patients had the TPMT\*1/\*1 (Homozygous wild-type) genotype, 9.5 % of patients had the TPMT\*1/\*3C (Heterozygote-type) genotype.

*Conclusion*: Homozygous wild-type (TPMT\*1/\*1) genotype was found to have high (90.5 %) prevalence compared to Heterozygote-type (TPMT\*1/\*3C) genotype (9.5 %).
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### Vesicointestinal fistulae: A short series {#Sec196}

***Sandeep Patil*** *, B Ravi Shankar*

Yashoda Hospitals, Behind Hari Hara, Kala Bhavan, S P Road, Secunderabad 500 003, India

Vesicointestinal fistula disease is a rare entity and usually manifests as urinary tract infection (UTI) pneumaturia or faecaluria. The commonest cause in the western world is diverticulitis; diverticular disease is uncommon in Asian countries. We present six cases of urinary bladder fistulae with varied etiology. ie. Crohn's disease (CD), radiation and malignancy. S. no age gender diagnosis location of fistula treatment outcome 1 55 F CD rectovesical infliximab survied 2 82 M carcinoma rectum rectovesical RT; surgery survied 3 31 F CD ileovesical infliximab; surgery survived 4 58 F carcinoma cervix colo-vesical untreated No follow up 5 45 M carcinoma rectum rectovesical surgery; chemotherapy survived 6 36 F carcinoma rectovesical conservative no follow up.

*Conclusions*: Most cases of vesicointestinal fistulae are due to malignancy or Crohn\'s disease. Main therapeutic option is surgery. Infliximab may be useful in CD presenting with vesicointestinal fistulae. The patients are likely to have a complicated course.
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### Attenuation of toxicity and increase in chemotherapeutic potential of 5-Fluorouracil with fish oil as an adjuvant in experimental colon carcinogenesis {#Sec198}

***Isha Rani*** *, Navneet Agnihotri*

Department of Biochemistry, Panjab University, Sector 14, Chandigarh 160 014, India

Fish oil (FO) rich in n-3 PUFAs (polyunsaturated fatty acids) has been reported to improve the efficacy and attenuate the toxicities of chemotherapeutic drugs. Therefore, the current study is designed to evaluate the role of FO as adjuvant with 5-FU, standard treatment for colorectal cancer in an experimental model. DMH/DSS treated Balb/c mice were kept for 20 weeks for the development of colon cancer and further subdivided based on the treatment with 5-FU and/or FO. After treatment, the efficacy of the drug was analyzed through gross and histopathological examination of colon, serum sialic acid levels, CK19 expression and cell cycle in isolated colonocytes. Toxicity profile was evaluated by the structural and functional alteration in liver, kidney, spleen and hematological parameters. The decrease in body weight and survival rate in carcinogen treated and 5-FU treated group was attenuated by FO. There was a major decrease in tumor volume and count in colon of 5-FU+FO+DMH. A decline ie. serum sialic acid and CK19 expression as tumor biomarkers was observed in 5-FU+FO+DMH group. 5-FU mediated S phase arrest in cell cycle was potentiated with FO. On administration of FO and 5-FU, there was a decrease in the toxicity as depicted by liver and renal function tests as well as hematological parameters. In addition, reduced inflammation, necrosis and fibrosis was observed in liver, kidney and spleen on histopathological examination. The results suggests that administration of 5-FU with FO as adjuvant may attenuate the drug toxicity and increase its efficacy against colon cancer.
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### Upregulation of apoptotic pathways in chemopreventive action of different ratios of fish oil and corn oil in experimental colon carcinogenesis {#Sec200}

*Gayatri Sharma, Isha Rani, Archana Bhatnagar,* ***Navneet Agnihotri***

Department of Biochemistry, Panjab University, Sector 14, Chandigarh 160 014, India

Apoptosis plays an important role in prevention of colon cancer. Therefore, the present study was designed to understand mechanism of apoptosis in the chemopreventive action of Fish oil (FO) with respect to corn oil (CO) in colon cancer. The animals were given FO+CO(1:1) and FO+CO(2.5:1) containing diet and N, N-dimethylhydrazine dihydrochloride (DMH)/EDTA (once weekly) for a period of 4 weeks. The groups were labelled as control (EDTA) and DMH treated depending on the treatment regimen. Animals were sacrificed either 48 hrs (initiation phase) or 16 weeks (post initiation phase) later. The extrinsic apoptotic pathway was delineated by Fas, FasL estimation and intrinsic by Bax, Bcl-2 and cyto c expression. Caspase-3 activity and mitochondrial membrane potential (MMP) was also measured. FO and CO in different ratios led to an increase in Fas expression in both phases and an increase in FasL expression in FO+CO(2.5:1)+DMH group as compared to DMH treatment. In FO+CO(1:1)+DMH and FO+CO(2.5:1)+DMH groups, Bax was increased in postinitiation phase only in comparison to DMH treatment. An increase in Bcl-2 expression initially followed by a decrease in FO+CO(1:1)+DMH and FO+CO(2.5:1)+DMH groups was observed. Cyto c expression was increased in FO+CO(2.5:1)+ DMH and FO+CO(1:1)+DMH as compared to DMH treatment. FO+CO(2.5:1)+DMH administration increased caspase-3 in both phases as compared to FO+CO(1:1)+DMH and DMH animals. In both phases, there was an increase in MMP levels in FO+CO(1:1)+DMH and FO+CO(2.5:1)+DMH in comparison to DMH group. The chemopreventive action of FO may involve activation of both intrinsic and extrinsic apoptotic pathway in experimental colon carcinogenesis.
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### DNA copy number variations and their significance in the diagnosis of ulcerative colitis associated and sporadic colorectal neoplasia {#Sec202}

***B M Shivakumar*** *, Lakshmi Rao, Vasudevan Geetha, B V Tantry, Hema Kini, Rajesh Dharamsi, Kapaettu Satyamoorthy, C Ganesh Pai*

Departments of Gastroenterology and Hepatology, and Pathology, Kasturba Medical College, Manipal University, Manipal, and School of Life Sciences, Manipal University, Manipal 576 104, India

*Introduction*: Colorectal cancer (CRC) incidence and mortality can be reduced by the detection and removal of early-stage, treatable neoplasia. There is currently lack of established markers to detect early neoplastic changes. The aim of this study was to determine copy number variations (CNVs) in genes within CNVs as potential markers for the detection of neoplasia in both ulcerative colitis-associated (UC-CRN) and sporadic colorectal neoplasia (S-CRN).

*Materials and Methods*: We employed array comparative genome hybridization (aCGH) to identify copy number aberrations in tissue samples of UC nonprogressor, progressor and S-CRC. Microarray study was followed by validation of a panel of markers by using Taqman based real time PCR method along with the microsatellite instability (MSI) status in a subset of samples. Immunohistochemistry analyses were also performed in a subset samples.

*Results*: Integrated analysis showed 10 overlapping regions between UC-Progressor and S-CRC, majorly in 8q and 12p regions, comprising of C-MYC and CCND2 respectively. A panel of 6 genes with or without MSI was successful in detecting neoplasia in S-CRC with overall accuracy of 54 % and 58 % respectively in comparison to 29 % in UC high risk samples. The IHC study showed that p53 and CCND1 were significantly overexpressed in an increasing pattern from high risk pre-neoplastic to neoplastic stages. EGFR and AMACR expressions were observed only in neoplastic conditions of UC-HR samples.

*Conclusion*: Study identifies genomic aberrations in the form of CNVs present in UC-CRN and S-CRN and may help identify genes driving carcinogenesis and further understanding of disease pathogenesis.
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### Spectrum of inflammatory bowel disease in central India {#Sec204}

*Mohd Talha Noor,* ***Satyarth Choudhary*** *, Bhagwan Singh Thakur, Neeraj Jain, Sunil Jain*

Department of Gastroenterology, Sri Aurobindo Institute of Medical Sciences, Indore 543 111, India

*Background*: Inflammatory bowel disease is an important cause of morbidity and mortality. In this study we describe the spectrum of inflammatory bowel disease from a tertiary care centre in central India.

*Methods*: Between June 2011 and June 2013, clinical profile of 51 patients with inflammatory bowel disease attending the outpatient and emergency departments of our hospital was analyzed. Evaluation of these patients included history taking, clinical examination, hemogram, liver function tests, stool examination and colonoscopy. Patients of Crohn's disease were classified according to montreal classification.

*Results*: Out of 51 patients, 34 were diagnosed as ulcerative colitis and 17 as Crohn's disease. Among 34 patients (mean age 40.2±10.4 years) of ulcerative colitis 10 (29.4 %) had pancolitis, 9 (26.5 %) left sided colitis, 12 (35.3 %) proctosigmoiditis and 3 (8.8 %) had proctitis. Four (11.8 %) had extraintestinal manifestations (peripheral arthropathy 3, ankylosing spondylitis 1, episcleritis 1). All of these patients were managed medically. Among 17 patients (mean age 37.5±13.8 years) of Crohns disease, 7 (41.2 %) had non-stricturing, non-penetrating disease (B1), 8 (47.1 %) had stricturing disease (B2) and 2(11.8 %) had penetrating disease (B3). Perianal involvement was present in 3 (17.6 %). Two (11.8 %) had small bowel involvement (L1), 9 (52.9 %) had colonic involvement (L2) and 6 (35.3 %) had involvement of both small and large bowel (L3). Three (17.6 %) had extraintestinal manifestations (pyoderma gangrenosum 1, sacroiliitis 1, peripheral arthropathy 1). Majority of these patients were managed medically, only two required surgery.

*Conclusion*: Both ulcerative colitis and Crohn's disease are quite common in central India. Most of these patients can be managed medically.
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### Risk factors for exacerbation of symptoms of irritable bowel syndrome {#Sec206}

***P Sivaprasad*** *, Varghese Thomas*

Department of Gastroenterology, Calicut Medical College, Kozhikode 673 008, India

*Objectives*: Irritable bowel syndrome (IBS) is a chronic disorder lasting for many years, but very often patients present with exacerbation of symptoms. We analyzed the role of various psychological and dietary factors in the exacerbation of IBS.

*Methods*: One hundred consecutive patients with IBS who satisfied the Rome III criteria were enrolled in this cross sectional study. Patients were evaluated to rule out organic causes. Detailed dietary history and a questionnaire containing the Presumptive Stressful Life events Scale (PSLES) and the Hospital Anxiety and Depression Scale (HADS) was answered.

*Results*: Mean age of the cohort was 30.74 (SD 9.31). The male:female ratio was 68:32. 62 % patients had IBS-D, 28 % had IBS-M and 10 % had IBS-C. Mean stool frequency of IBS-D patients was 4.5/day vs. 1.9/week for IBS-C. Mean PSLES score of the patients was 262.21(SD 143.86.) indicating high level of stress. Moderate to high scores for anxiety and depression were documented. Higher scores of PSLES, HADS-A and HADS-D were associated with increased stool frequency. However statistical significance was achieved only for HADS-A scores (*p*=0.05). Mean PSLES and HADS-D scores were significantly higher for patients with psychiatric illness (*p*=0.007 and 0.027 respectively). Majority of subjects (96 %) consumed a spicy diet and 67 (69.8 %) subjects reported subjective symptomatic improvement after reducing the spices in their diet.

*Conclusion*: High levels of stress, anxiety and depression were noted in patients suffering from IBS. Majority of patients noted relief of symptoms on reduction of spices in their diet.
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### Colonoscopic band ligation for internal hemorrhoids. A tertiary care experience {#Sec208}

***L V Lokesh*** *, Umesh Jalihal, B S Satyaprakash, B Avinash*

Department of Gastroenterology, New B E L Road, M S Ramaiah Nagar, MSRIT Post, Mathikere, Bangalore 560 054, India

*Introduction*: Rubber band ligation (BL) is the most widely used technique for treatment of symptomatic internal hemorrhoids (IH) that are refractory to conservative treatment. The aim of this study is to assess the efficacy of colonoscopic BL as therapy for symptomatic IH.

*Methodology*: Patients seen at our center with symptomatic IH who underwent BL from January 2006 to December 2011 were included in this prospective study. The clinical and colonoscopic details were entered in uniform structured data forms.

*Results*: Two hundred and eighteen consecutive patients with symptomatic IH were enrolled in the study. The presentation was rectal bleed in 150 (69 %) and prolapse in remaining 68 (31 %) patients. All the patients were treated with same operator. The severity of the IH was classified by using Goligher grading system. The mean age was 48.3+15 years with age range of 22-85 years. The mean follow up was 3 months (range 1 month -36 months). In 209 patients (96 %) there was at least 1 grade reduction in hemorrhoids as well the symptoms were controlled. Two patients required surgery and another 7 patients required repeat session of banding. After banding session 32 (15 %) patients had perianal pain and 13 (6 %) had mild bleeding. Twenty-four patients (11 %) had chronic liver disease (Child B-C).

*Conclusions*: Colonoscopic BL is a safe, effective and outpatient therapeutic procedure for symptomatic internal hemorrhoids. More so the BL is helpful in patients of coagulopathy associated with chronic liver disease.
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### Cigarette smoke and benzo(±)pyrene-induced changes in colon cancer cells: Role of phospholipase A2 {#Sec210}

***S K Sharma*** *, S K Yadav, G Kaushik, C M Pathak, S V Rana, K L Khanduja*

Departments of Biophysics, and Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Cigarette smoke which contains as Benzo(±)pyrene the major carcinogen is responsible for colon cancer. PLA2s have been implicated in diverse pathological conditions, including inflammation, tissue repair and cancer. The different PLA2s, identifïed to date, can be classifïed into three groups: secreted PLA2 (sPLA2), calcium-independent PLA2 (iPLA2) and calcium-dependent cytosolic PLA2 (cPLA2).

*Aim*: To evaluate the role of PLA2 isoforms in cigarette smoke and benzo(a)pyrene-induced molecular changes in colon cancer cells.

*Materials and Methods*: The effects of different concentrations of cigarette smoke and benzo(±)pyrene at different time interval were assessed on two lineages of colon cancer cells (HCT-15 and HT-29). The effect of cigarette smoke and benzo(±)pyrene on cell viability, reactive oxygen species, cell membrane integrity, cell apoptosis and proliferation was assessed by MTT, DCFHDA, DHE, DHR123, FDA, AnnexinV-PI, and CYQUANT kit respectively. We screened both cell lines for different PLA2 isoforms expression by using RT-PCR.

*Results*: The cell viability, cell membrane integrity and proliferation, deteriorated with time and increase in cigarette smoke and benzo(±)pyrene concentration which may be due to increased ROS production and apoptosis. Both the cell lines expressed all the PLA2 isoforms except IIA, IIE, V, and VII. Expression of IB and IVA were increased with higher concentration of benzo(±)pyrene in HT-29 and HCT-15 cells respectively whereas increase in IID were cell specifïc.

*Conclusion*: It seems that at least IID form of PLA2 and ROS is responsible for inflammatory reaction induced by cigarette smoke and benzo(a)pyrene in the colon cancer cells.
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### Risk factors for relapse of ulcerative colitis: A case control study {#Sec212}

***Jino Thomas*** *, Varghese Thomas*

Department of Gastroenterology, Calicut Medical College, Kozhikode 673 008, India

*Introduction*: Ulcerative colitis (UC) characteristically has a chronic relapsing course. There are several factors which precipitate relapse.

*Objective*: To assess the role of various risk actors in precipitating relapse in UC.

*Methods*: Forty-two consecutive patients with a relapse of UC were recruited. A detailed clinical and laboratory evaluation including stool examination for parasites, stool culture, sigmoidoscopy and immunohistochemistry for cytomegalovirus on rectal biopsy specimens were done. Severity assessment was done as per Truelove and Witts criteria and Mayo severity index. Perceived stress score (PSS) over previous one month was calculated for all using a validated questionnaire. Age and sex matched patients with UC in remission were studied as controls.

*Results*: There were 42 study subjects (39 severe and 3 moderate UC; mean age 44.2±15.1 years, males: 29) and 30 control patients (mean age 42.1±15.4 years, males 19). Noncompliance to treatment was present in 12 (28.6%; *p*=0.001), inadequate drug dosage in 7 (16.7 %; *p*=0.018) stool culture for pathogenic bacteria in 3 (7.1 %). Entameba trophozoites were seen in stool in 2, history of recent NSAID intake in 4, antibiotic intake in 4 and intake of indigenous drugs in 4 patients. One patient had CMV infection and 2 had stopped smoking recently. Perceived stress score was 17.6 in study group and 14.9 in controls (*p*=0.003).

*Conclusion*: Noncompliance to treatment, inadequate drug dosage and high PSS are associated with significantly increased risk for relapse of UC.
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### Customized removable fully covered SEMS for ano-rectal stricture {#Sec214}

*B S Ravindra, Naveen Ganjoo,* ***Kiran Dhananjay Shinde*** *, Eranna B Maanthagonda*

Medical Gastroenterology Department, B G S Global Hospital, \#67, Uttarahalli Road, Kengeri, Bangalore 560 060, India

A 31-years-male, a case of rectosigmoid adenocarcinoma, post LAR presented with rectal obstruction secondary to recurrent and refractory rectal stricture at 3-4 cms from anal verge. This patient due to obstructive symptoms and vomiting underwent multiple CRE (controlled radial expansion) balloon dilatations, followed by which patient underwent laparoscopic assisted transanal excision of anastomotic stricture with diversion ileostomy. Obstructive symptoms persisted even after ileostomy closure. Customized fully covered 8 cm stent placement was done. The stent was in situ for 7 days after which it was removed in view of pain and occasional bleeding. The patient was comfortable and had no obstructive symptoms. The stricture site was patent on fexible sigmoidoscopy. Follow up done after 2 months, patient was symptom-free.

LI-17 {#Sec215}
-----

### APC and β-catenin mutations and expression analysis in sporadic colorectal tumors: A mutational "hotspot" for tumorigenesis {#Sec216}

***Mumtaz Anwar***, *Neha Nanda, Rakesh Kochhar, Shabeer Ahmad, Alka Bhatia, Rajinder Singh, Kim Vaiphei, Safrun Mahmood*

Departments of Gastroenterology, General Surgery, Histopathology, and Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: The incidence of colorectal cancer (CRC) is increasing rapidly in Asian countries during the past few decades, but no comprehensive analysis has been done to find out the exact cause of this disease. In the present study we investigated the frequencies of mutations and expression analysis of APC and β-catenin in tumor, adjoining and distant normal mucosa and correlated these alterations with patients clinicopathological parameters.

*Methods*: PCR-SSCP (Single Strand Conformation Polymorphism) analysis followed by DNA sequencing was used to detect mutations in MCR of Exon 15 of APC and Exon 3 of β-catenin. The concentration of APC and β-catenin mRNA in tumor, adjoining and distant normal mucosa specimens (35 each) was determined by real-time quantitative RT-PCR. The ratio of APC and β-catenin cDNA copies/β-actin cDNA copies was used to represent the mRNA expression level in different tissues. Immunohistochemistry was used to detect the protein expression pattern of APC and β-catenin.

*Results*: The frequencies of mutations in MCR of exon 15 of APC and exon 3 of β-catenin in 35 tumor tissue samples were 45.0 % and 20.0 % respectively. Furthermore, the overall mRNA expression of APC gene was down-regulated and that of β-catenin gene was up-regulated in tumor tissue samples by 16 fold and 22.5 fold respectively as compared to distant normal mucosa. In addition to this, β-catenin mRNA levels in tumors with lymph node metastasis positive cases were significantly increased as compared to tumors without lymph node metastasis. The protein expression of APC was decreased and that of β-catenin was increased in tumor tissue samples as compared to normal and adjoining mucosa. There was no association between the mutations and expression pattern of APC and β-catenin (*p*\>0.05). Moreover, these results highly correlate with the patients clinicopathological factors.

*Conclusions*: In this study, it was found that the alterations in APC and β-catenin are different than those found in Westerns, which suggests that these genetic alterations might have independent influence on CRC development and there are multiple alternative genetic pathways to CRC in our patients.
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### Role of QuantiFERON GOLD TB in differentiating gastrointestinal tuberculosis from Crohn's disease {#Sec218}

***K R Pradeep*** *, Harshad Joshi, Nilesh N Toke, Rony Thomas, Charles Panackel, Sunil K Mathai*

Department of Gastroenterology and Hepatology, Medical Trust Hospital, M G Road, Kochi 682 016, India

*Objective*: The clinical, endoscopic, and histological features of Crohn's disease (CD) and intestinal tuberculosis mimic each other so much that it becomes difficult to differentiate between them. The aim of our study was to assess the sensitivity and specificity of QuantiFERON- GOLD TB (QGTB) test in differentiating the two diseases.

*Methods*: We prospectively included 44 patients with ileo-colonic ulcers and 10 normal subjects as controls. Demographic, clinical, laboratory, endoscopic and histological features were noted. All patients were evaluated with a QGTB. Patients were diagnosed as either tuberculosis or CD based on clinical, endoscopic and histologic criteria. Patients were followed up and a repeat colonoscopy was performed at the end of 3 months; diagnosis was revised if the patient did not demonstrate mucosal healing or an improvement when compared to the previous colonoscopy.

*Results*: Twenty-nine of the 54 patients (54 %) were male, and the mean age was 39.4 years (Range 10-81 years). A final diagnosis of CD was made in 26 patients (52 %), tuberculosis in 18 patients (36 %). QGTB test was positive in 20 patients, of which 16 patients had a final diagnosis of tuberculosis and 4 patients had CD. Two patients who had a final diagnosis of tuberculosis had a negative QGTB test. All 10 control subjects had a negative test. The sensitivity of the test was 88.9 % and specificity was 85 %. Positive predictive value was 80 %, negative predictive value was 91.7 %.

*Conclusion*: The QGTB test is both sensitive and specific for differentiating gastrointestinal tuberculosis from Crohn's disease.
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### Alterations of MMP-9 and Caspase-3 expression in colonic tumors induced by 1,2-dimethylhydrazine (DMH) in rats {#Sec220}

***Neha Nanda*** *, Mumtaz Anwar, D K Dhawan, Safrun Mahmood*

Departments of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, and Department of Biophysics, Panjab University, Sector 14, Chandigarh 160 014, India

*Rationale*: 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in rats has many similarities with human sporadic colorectal cancer and is a reliable model to explore molecular mechanism involved in progression of colorectal cancer from adenoma to carcinoma sequence.

*Objective*: To study the expression of various proteins involved in tumorigenesis pathway of DMH induced rat model.

*Methods*: Two groups of chow-diet-fed, male Sprague Dawley rats, aged 10 weeks (*n*=12/group) were fed a normal diet and injected subcutaneously for two time durations of 10 and 20 weeks DMH at a dose of 30 mg/kg body weight/week or with Ethylene diamine tetra-acetic acid (EDTA) saline. Macroscopic and microscopic analyses were performed for confirmation of adenoma and carcinoma. Protein expression of MMP-9 and Caspase-3 were analyzed by immunohistochemistry studies.

*Results*: Gross examination of 10 weeks DMH treated colon showed polypoid lesions. And multiple tumors were formed after 20 weeks DMH treatment. Histopathological studies confirmed the colon carcinogenesis from adenoma carcinoma sequence by type of tumor, degree of differentiation and invasion of tumors. Immunohistochemistry studies showed the increase expression of MMP-9 and reduced expression of Caspase-3 in colonic tissues of DMH induced rat model as compared to controls.

*Conclusion*: The observed data strongly implicates that DMH induced colon carcinogenesis altered the apoptotic machinery by modulating the expression of various proteins involved in this pathway.
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### Relationship between MGMT gene promoter hypermethylation and tumor profile in sporadic colorectal cancer in Indian population {#Sec222}

***Rupal Sinha*** *, Showket Hussain, R Suresh Kumar, Kapil Kumar, Pankaj Pande, Shivendra Singh, Dinesh Chandra Doval, Seemi Farhat Basir, Mausumi Bharadwaj*

Rajiv Gandhi Cancer Institute and Research Centre, Institutional Area, Rohini, New Delhi 110 085, Institute of Cytology and Preventive Oncology (ICMR). Plot No. 1-7, Sector-39, Noida 201 301, and Jamia Millia Islamia, Jamia Nagar, New Delhi 110 025, India

*Background and Objective*: Colorectal cancer (CRC) is a heterogeneous disease with complex etiology including alterations of epigenetic information. The study was conducted to analyze the relationship between epigenetic modification in MGMT gene and tumor profile in sporadic CRC in Indian population.

*Materials and Methods*: Altogether 124 consecutive surgically resected fresh tissue specimens (62 tumor tissues and adjacent normal control regions each) of primary sporadic CRC were included. Bisulphite modification and methylation specific PCR was done for studying MGMT gene.

*Results*: Methylated MGMT gene was observed in 47 % and 13 % cases of CRC in the tumor and adjacent control regions, respectively. Higher number of cases with methylated MGMT gene were tumor stage 3 (52 %) and moderately differentiated grade (66 %). Tumor stage, metastasis and lymphatic invasion were found to be significantly correlated with the presence of methylated MGMT gene (*p*-values 0.018, 0.044 and 0.048, respectively).

*Conclusion*: Presence of epigenetic modification in MGMT gene suggests its possible role in the causation and development of sporadic CRC in the Indian population. Prospective studies with larger sample size are however required in this direction.
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### CMV in ulcerative colitis: Pathogen or an innocent bystander? {#Sec224}

***Sumit Bhatia*** *, C Ganesh Pai, Ganesh Bhat, Deepak Suvarna*

Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal 576 104, India

*Background*: Cytomegalovirus infection is considered to worsen disease severity and outcomes in patients with ulcerative colitis but this is controversial.

*Methods*: Consecutive patients with flare of ulcerative colitis from January 2011 - May 2013 had colonoscopy and colonic biopsies performed for histopathology.

*Results*: Nine patients (7 male, 2 female) with active ulcerative colitis were found to have CMV infection on histopathology. Their median age was 38 years (range: 20-58 yrs). At presentation 4 patients had severe, 4 had moderate and 1 patient had mild disease. Four patients were on azathioprine maintenance and 5 patients on mesalamine treatment at the time of diagnosis. All 9 patients received corticosteroids for their flare pending histopathology reports. Azathioprine was withheld only in 1 patient due to persistent symptoms and in rest of the patients immunosuppressants were continued. Treatment outcomes: Six patients achieved complete remission with standard treatment. Two received Ganciclovir treatment in view of persistent symptoms-1 patient achieved complete remission, 1 had partial remission. One patient on standard treatment was lost to follow up. Follow up: One patient on antiviral underwent colectomy 3 months later due to relapse. Colectomy specimen was negative for CMV. Second patient died 3 months later due to progressive neuropathy. Six patients on regular follow up, range (9-28 months) did not have any adverse outcomes.

*Conclusion*: CMV infection in patients with active colitis may not adversely impact disease outcomes when left untreated. Colonic CMV reactivation may be predominantly a bystander, rather than the factor leading to disease flares.
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### Early atherosclerosis in ulcerative colitis: A cross-sectional case-control study {#Sec226}

***Samit S Jain*** *, Dharmesh K Shah, Pravir M Gambhire, Piyush O Somani, Qais Q Contractor, Pravin M Rathi*

Department of Gastroenterology, B Y L Nair Hospital and T N Medical College, Mumbai Central, Mumbai 400 008, India

*Introduction*: Ulcerative colitis (UC) being the chronic inflammatory bowel disease, the potential impact of chronic inflammation on atherosclerosis in these patients may be relevant. Recent studies reported that inflammation, carotid intima media thickness (CIMT), homocysteine, and insulin resistance (IR) are associated with atherosclerosis. Hyperhomocysteinemia, inflammation, and IR play a role in the development and progression of coronary artery disease. CIMT are valuable in the diagnosis of subclinical early atherosclerosis.

*Objectives*: 1\] To study the extent of subclinical atherosclerosis in UC patients by measuring CIMT 2\] To study the correlation between CIMT, serum homocystiene level and homeostasis model assessment of insulin resistance (HOMA-IR) in UC.

*Methods*: We studied 60 UC patients and 60 healthy controls (matched for age, sex, BMI and other major risk factors for atherosclerosis). Patients aged \>45 years, history of cardiovascular disease and known risk factors for atherosclerosis were excluded from the study. CIMT was measured for all participants using B-mode duplex imaging study. All subjects would be investigated for fasting blood glucose, lipid profile, insulin levels (HOMA IR), ESR, serum vitamin B~12~ level and homocysteine levels.

*Results*: CIMT was significantly higher (*p*\<0.05) in UC patients (0.68±0.07 mm) compared with controls (0.52±0.04 mm). Other parameters are shown in Table 1. Pearson correlation coefficient showed significant correlations (*p*\<0.05) between CIMT and age, duration of UC, HOMA-IR, and homocysteine level. Multiple regression analysis showed only homosysteine levels as significant predictor of CIMT and only age and duration of UC as significant predictor of HOMA-IR.

**Table 1** Ulcerative colitis patients(*n*=60)Controls(*n*=60)*p*-valueESR (mm/h)41.06±15.7615.14±4.54\<0.05CIMT (mm)0.68±0.070.52±0.04\<0.05Fasting insulin (IU/mL)12.67±4.246.98±0.77\<0.05FBS (mg/dL)94.17±6.6390.42±7.040.06HOMA-IR2.94±0.991.36±0.20\<0.05Homocysteine (mmol/L)21.26±5.8711.85±2.11\<0.05Vitamin B~12~ (pg/L)369.86±331.26415.70±296.740.06

*Conclusions*: Evidence of subclinical atherosclerosis in UC, as demonstrated by greater CIMT compared with healthy subjects. Age, duration of UC, HOMA-IR, and homocysteine levels were the most important factors associated with increased CIMT.
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### IL 6 polymorphism in patients of ulcerative colitis and irritable bowel syndrome {#Sec228}

***Manish Kumar Tripathi*** *, P Kaushik, S C Lamtha, J K Choudhary, A Ranjan, V K Dixit, A K Jain*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Background*: Pathogenesis of ulcerative colitis (UC) involves both environmental and genetic factors. Activation of macrophages and T lymphocyte; proinflammatory cytokine, chemokines and adhesion molecule expression and an inability to adequately down-regulate immune activation is often noted in UC. Interleukin 6 regulates inflammation and various physiological processes and its polymorphism may be risk factor for UC.

*Aim*: The aim of the present study is to examine pro inflammatory cytokine gene Interleukin 6 (IL6) polymorphism in patients with UC, irritable bowel syndrome (IBS) and healthy controls (HC).

*Methods*: Age and sex matched 36 patients with ulcerative colitis, 38 with IBS and 16 healthy controls were enrolled in the study. Blood samples were obtained after informed consent. DNA isolation was done from peripheral blood leukocytes in all subjects by phenol-chloroform method. PCR for IL 6 (-174) was done by double set of primers and result was analyzed by electrophoresis on 2 % agarose gel.

*Results*: Two-third of UC subjects, 68 % with IBS and 75 % of HC were high producer GG genotype. Twenty-seven percent of UC, 26.3 % IBS subjects and 12.5 % of HC genotype were intermediate producer GC. Low producers CC genotype was found to be 5.5 % in UC, 5.3 % in IBS and 12.5 % in HC.

*Conclusion*: This study could not substantiate association of ulcerative colitis with GG genotype polymorphic form of pro-inflammatory cytokine IL6 in our region.
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### Endoscopic significance of bowel wall thickening on abdominal computed tomography scan (CT scan) of patients with no prior history of gastrointestinal disease- An observational study {#Sec230}

***K S Sijil*** *, Devang Tank, A B Suthanu, N Premaletha, K R V Kumar*

Department of Medical Gastroenterology, Government Medical College, Thiruvananthapuram 695 011, India

*Background*: Computed tomography scan is used as a diagnostic modality in many abdominal situations. Bowel wall thickening is a common finding in patients with no prior history of gastroenterological disease. The significance of this nonspecific incidental finding is not clear. Wall thickening in the lower GI tract is a real challenge as there is concern for neoplasia and inflammatory bowel disease.

*Aim*: To study the significance of bowel wall thickening in the CT scan by comparing it with colonoscopic findings within 1 month of CT scan.

*Methods*: All patients with CT abdomen finding of thickened bowel wall who underwent colonoscopy were included in this study. Colonoscopic findings were noticed and biopsy taken whenever necessary. Patients with known history of gastrointestinal disease were excluded.

*Results*: Sixty-five patients were included in this study. Abdominal pain was the indication for CT in majority (*n*=48, 73.85 %). Thirty-nine had abnormal colonoscopy findings with a positive predictive value of 60 %. Twenty-nine patients (74.36 %) with abnormal colonoscopy findings required further intervention. The results of colonoscopy were colorectal malignancy in 9 patients (13.85 %), ileocecal tuberculosis in 5 (7.69 %), inflammatory bowel disease in 8 patients (12.31 %), polyps in 7 patients (10.77 %), nonspecific in 8 (12.30 %) and diverticular disease in 2 (3.07 %).

*Conclusion*: Bowel wall thickening on computed tomography (CT) scan has high predictive value for abnormal colonoscopic findings. It warrants colonoscopic evaluation in all patients bowel wall thickening in CT scan.
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### Genetic polymorphism in DNA repair genes and their contribution to ulcerative colitis {#Sec232}

***Avinash Bardia*** *, Santosh K Tiwari, Sivaram Gunisetty, Sandeep K Vishwakarma, Pratibha Nallari, Md. Aejaz Habeeb, Aleem A Khan*

Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, Hyderabad 500 058, India

Ulcerative colitis (UC) is an inflammatory destructive disease of the large intestine characterized by motility and secretion disorders. The inter-individual variation is partly due to the genetic polymorphisms in genes involved in DNA repair genes mechanisms which may modulate the functions of the encoded proteins. Genetic polymorphisms in XPD, XRCC3 and hMSH2 genes have been reported to increase the susceptibility of various cancers; however their precise role in UC still remains elusive. The present study was designed to examine the polymorphisms in XPD, XRCC3, hMSH2 and investigate the level of NO and MDA in the risk of UC. Blood samples from 384 unrelated subjects (171- UC, 213- healthy controls) were collected. Genomic DNA was isolated and genotyped for XPD Lys751Gln, XRCC3 Thr241Met and hMSH2 Gln322Asp using PCR and RFLP. No and MDA levels in serum were also measured. The frequency of genotype Lys/Gln at codon 751 of XPD gene did not show significant difference in UC than the controls (95 % CI 0.98-2.23, *p*=0.06). The genotypic frequency of XRCC3 Thr/Met at 241 codon and hMSH2 Gln/Asp at 322 codon showed statistically significant among UC subjects than the controls (95 % CI 1.15-2.65, *p*=0.008) (95 % CI 1.15-2.62, *p*=0.009) respectively. Polymorphism in XRCC3/XPD and XRCC3/hMSH2 together considerably increased the risk of UC (95 % CI 1.31-3.29, *p*=0.001) (95 % CI 1.24-3.15, *p*=0.004). High level of NO and MDA were seen in UC subjects than the controls (*p*=0.01). Polymorphisms in XRCC3 and hMSH2 significantly increased the risk of UC in our population not in XPD polymorphisms.
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### Influence of genetic polymorphisms in X-ray repair cross-complementing group-1 and apurinic/apyrimidinic endonuclease-1 on apoptosis and ulcerative colitis {#Sec234}

***Avinash Bardia***, *Santosh K Tiwari, Sivaram Gunisetty, Sandeep K Vishwakarma, Pratibha Nallari, Aleem A Khan, Md Aejaz Habeeb*

Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, Hyderabad 500 058, and Department of Genetics, Osmania University, Hyderabad 500 00, India

Ulcerative colitis is one of the two major manifestations of inflammatory bowel disease. Base excision repair (BER) is an important DNA repair mechanism which every cell utilizes to repair the damaged DNA. X-ray cross-complementing group 1 (XRCC1) and apurinic/apyrimidinic endonuclease 1 (APE1) are two vital DNA repair proteins that play definitive roles in BER pathway. Genetic polymorphisms in these genes have been reported to increase the susceptibility of various cancers; however their precise role in apoptosis and etiology of ulcerative colitis still remains elusive. Therefore the present study was designed to examine the polymorphisms in XRCC1 and APE1 and investigate their role on the rate of apoptosis and ulcerative colitis risk. Blood samples from 384 unrelated subjects (171- UC, 213- healthy controls) were collected. Genomic DNA was isolated and genotyped for XRCC1 Arg399Gln and APE1 Glu148Asp. Apoptosis and intracellular ROS levels in peripheral blood mononuclear cells were measured using Annexin-V and H2DCFDA assay respectively. The frequency of genotype Arg/Gln at codon 399 of XRCC1 and APE1 Asp/Glu at 148 codon gene was statistically significantly in patients with UC than the controls. High rate of apoptosis coupled with elevated ROS levels were seen in UC subjects than the controls (*p*=0.01). Increased percentage of necrotic and late apoptotic cells were observed among UC subjects with XRCC1 Arg399Gln and those with both XRCC1 Arg399Gln and APE1 Asp148Glu. Polymorphisms in XRCC1 Arg399Gln and APE1 Asp148Glu significantly increased the apoptotic rates and risk of ulcerative colitis in our population.
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### A rare case of non-Hodgkin lymphoma in inflammatory bowel disease patient on immunosuppressive therapy: Case report {#Sec236}

***S Kavitha***, *S Rathanarkini, Mohamed Kani sheik, K Premkumar, T Pugazhendhi, Mohamed Ali*

Department of Medical Gastroenterology, Madras Medical College, Chennai 600 003, and Government Rajiv Gandhi Government General Hospital (RGGGH), Park Town, Chennai 600 003, India

The association between ulcerative colitis and lymphoma is rare. We report the case of a 22-year-old female who presented a clinical picture and radiological and colonoscopic findings suggesting the diagnosis of idiopathic ulcerative colitis. Patient presented after three years with increased symptoms. When proceeded with investigation found colonic mucosa studded with multiple polypoidal lesions from sigmoid colon upto cecum. Histopathological and immunohistochemical studies of tissue specimens obtained at biopsy led to the diagnosis of non-Hodgkin\'s B-cell rich lymphoma throughout the colon. Possible relations between ulcerative colitis and gastrointestinal lymphoma are discussed.
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### Clinical characteristics, disease course and outcome of patients hospitalized with severe ulcerative colitis {#Sec238}

***Mayank Agrawal*** *, Sanjay Banerjee, G K Dhali, Sumit Sanyal, Rajib Sarkar*

School of Digestive and Liver Disease, S S K M Hospital, Kolkata 700 020, India

*Background*: Around 30 % of severe ulcerative colitis fail to respond to intravenous steroids, rescue therapy or colectomy is required in these. Result of colectomy become poor as medical therapy is prolonged so there is need for parameters to predict nonresponse early.

*Material and Methods*: Demographic, clinical and laboratory parameters were collected on day 1, 3 and 5 after admission of 22 consecutive patients (23 episodes) and prospectively recorded. Each episode was treated with intravenous hydrocortisone, fluid administration and electrolyte management. The data of patients who failed to respond or developed complications requiring emergency surgery or died within 5 days of hospitalization, were compared with the data of those who responded during this period using student t test for nominal variable and chi-square test for ordinal variables.

*Results*: Medical treatment failed in 9 of the 23 episodes, all 9 underwent colectomy, 1 of the patient died after colectomy. Female sex, higher lichtiger score on day 1, 2, 3, 4, 5 and a lesser decline in lichtiger score from baseline over day 2, 3, 4 and 5, higher CRP on day 3 and 5 and lesser fall in CRP from day 1 to day 5 and low serum albumin on day 1, 3 and 5 was associated with failure of medical therapy on univariate analysis.

*Conclusion*: It may be possible to predict the failure of medical treatment in exacerbations of UC using a scoring system based on clinical parameters and simple laboratory tests.
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### Effect of argon plasma coagulation in the treatment of symptomatic chronic radiation proctitis {#Sec240}

***Sultania Surender***

School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, 244, A J C Bose Road, Kolkatta 700 020, India

*Background*: Argon plasma coagulation (APC) has increasingly became treatment of choice for bleeding in chronic radiation proctitis (CRP). Worldwide studies showed radiotherapy for carcinoma prostate as the main cause of CRP. In India carcinoma cervix is the predominant cause. This is the first Indian study to evaluate role of argon plasma coagulation in CRP.

*Objective*: To evaluate - 1. The efficacy of APC on rectal bleeding and other symptoms in CRP. 2. Short and long-term complication of APC. 3. Correlation between success of therapy and colonoscopic severity or rectal bleeding score (RBS).

*Design*: Prospective study Setting: Tertiary care hospital.

*Methods*: APC (max 4) treatment sessions given in CRP patients with rectal bleeding score -2, at the interval of 1 month till RBS remained -2. Therapeutic success is RBS -1. Follow up done for 6 months. Colonoscopic severity grading was also done.

*Results*: Forty-two female patients (mean age 51.88 yrs) with carcinoma cervix (37) and carcinoma endometrium (5) patients were studied. Thirty-four (80 %) patients had therapeutic success out of which 50 % had complete cessation of bleeding. Therapeutic success rate was 100 %, 94 %, 63 % in mild (7), moderate (16), severe (19) colonoscopic severity patients respectively. In RBS 2 (13 %), 3 (22 %), 4 (7 %) success rate was 92 %, 87 %, 57 % respectively. Rectal ulcer developed in 7 (17 %) patients. One patient had recurrence of symptoms after 3 months of follow up.

*Conclusion*: APC is excellent treatment modality in mild and moderate CRP but less effective in severe CRP.
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### Preprobiotics vs. rifaximin in the treatment of IBS-D {#Sec242}

***Pravir Gambhire*** *, Samit Jain, Piyush Somani, Q Contractor, Pravin Rathi*

Department of Gastroenterology, T N Medical College and B Y L Nair Hospital, Mumbai Central, Mumbai 400 008, India

*Background*: IBS is a chronic condition with no known cure. Clinically important benefits might be achieved in patients with preprobiotics particularly in those with diarrhea-predominant symptoms in light of alterations in commensal enteric bacterial species in this subset. There is also accumulating evidence pointing towards the benefit of a short course of rifaximin in the global improvement of patients with IBS-D.

*Aims and Objectives*: To assess the efficacy of preprobiotics vs. rifaximin for patients with IBS-D.

*Materials and Methods*: It was a comparative parallel randomized study. Male/female patients between 18 to 65 yrs, with a diagnosis of IBS as per Rome III criteria, were included, the patients in the preprobiotic arm were given perprobiotics for 14 days while those in the rifaximin arm got Tab 400 mg TID for 14 days. The patients were interviewed at baseline and weekly for 4 weeks; the parameters to scale the symptoms included likert scale, subjective global assesement score and irritable bowel syndrome score.

*Stastical Analysis*: Qualitative data was represented in form of frequency and percentage. Association between qualitative variables was be assesed by chi-square test. Before --after comparison of qualitative data within each group was be done using McNemar Test. Quantitaive data was be represented using mean±SD and median and IQR (Interquartile range).

*Results*: Significant improvements in global symptoms of IBS (*p*\<0.05) and bloating (*p*\<0.05) throughout the 4-week follow up in the rifaximin group, although differences in relief of diarrhea, and generalized ill feeling between the two groups were not significant.

*Conclusions*: Short course of rifaximin was better than the preprobiotics in the IBS-D subset.
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### Invalidity of ROME III criteria in diagnosing Indian patients with irritable bowel syndrome {#Sec245}

***Gautam Ray***

B R Singh Hospital, Sealdah, Kolkata 700 014, India

*Background*: Though Rome III criteria is used to diagnose IBS in West, the same is not validated in India where normal bowel habit is quite different.

*Methods*: A questionnaire in English (and in local vernacular) containing questions of ROME III criteria was administered to 100 patients consulting for symptoms of IBS who had normal colonoscopy (39), sigmoidoscopy (61) and negative stool OBT. All had normal hemoglobin, ESR, blood sugar and thyroid status.

*Results*: Age 41.62+16.2 years, Male:Female: 60:40, 100 % resident of the area for at least 8 years \[88 % lifetime\]. Symptom duration 8.53+3.2 \[2-18\] years, constipation 14, diarrhea 63, alternate constipation and diarrhea 0, feeling of incomplete evacuation 93. Average stool frequency/day 2.2 \[1-5\] and per week 16.6 \[7-27\]. Stool type--not well formed 80, watery 5, combination 15 and type 4 \[22\], 5 \[60\], 6 \[18\] on Bristol Stool Scale. Symptoms were abdominal pain 23/discomfort 54, bloat 21, mucus in stool 94 \[all \>25 % time\], visible distension in none, more frequent/looser stool with pain onset 65/72, relief with stool passage 53, passing stool after meals 67, straining at stool in none, pain at least 3 days/month and 3 months/year 75, milk intolerance leading to stoppage of taking milk 96. Thirty-seven felt they had no diarrhea and 11 felt constipated with incomplete evacuation even when passing 3 stools/day.

*Conclusion*: Rome III criteria is invalid in Indian patients. Patients' feeling of incomplete evacuation and mucus in stool are important as also associated milk intolerance.
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### An evaluation of the symptom of constipation in Indian patients {#Sec247}

***Gautam Ray***

B R Singh Hospital, Sealdah, Kolkata 700 014, India

*Background*: Normal bowel habit of Indians is quite different from the West and hence the definition of constipation but this has not been appropriately studied.

*Methods*: Seventy consecutive patients complaining of subjective feeling of constipation (1) either presenting to OPD (consulters) or (2) during evaluation of other diseases (non- consulters) were evaluated by clinical, biochemical and colonoscopic examination.

*Results*: Mean age 63.9+13.45 (46-84) years, 49 (70 %) were above 60 years of age. Male:female: 55:15, consulters 48 (male 45 \[81.8 %\], females 3 \[20 %\], *p*\<.05). Forty-two (60 %) had feeling of incomplete evacuation but passed 1-2 motions/day. Fifteen (21.4 %) had 4-6 motions/week and only 13 (18.6 %) had less than 3 motions/week (the western definition of constipation). On Bristol Stool Scale, stool forms were 11 type 1 (15.7 %), 10 type 2 (14.3 %), 14 type 3 (20 %), 35 type 4 (50 %). On colonoscopy, only 3 (4.3 %), all non-consulters, had colon cancer and all had other symptoms as well. Others had atonic dilated colon 7 (10 %), diverticulosis 5 (7.2 %) or were normal (78.5 %). Comordities were diabetes mellitus 30 (42.9 %), hypothyroism 10 (14.3 %), hypertension mandating intake of calcium channel blockers and beta blocker drugs 45 (64.3 %), organic brain disease 14 (20 %).

*Conclusions*: A feeling of incomplete bowel evacuation is interpreted as constipation in India, most have benign neuromuscular etiology due to drug intake or comorbid illness. Most consulters are elderly males. The definition of constipation needs to be coined by large scale populaton studies.
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### Clinical and investigative assessment of chronic constipation {#Sec249}

*Rajiv Baijal*, ***Praveen Kumar***, *Nimish Shah, Sandeep Kulkarni, Soham Doshi, Deepak Gupta, Deepak Amarapurkar*

Jagjivan Ram Railway Hospital, Maratha Mandir Marg, Behind Maratha Mandir Cinema, Mumbai Central, Mumbai 400 008, India

*Introduction*: Constipation may be primary or secondary. Pathophysiologic subtypes of primary constipation are dyssynergic defecation (DD), slow (STC) and normal transit constipation (NTC). Clinical subtypes are functional constipation (FC) and constipation predominant IBS (C-IBS).

*Aims*:1) To study the clinical profile, categorize and compare various subtypes of primary constipation. 2) To assess success of biofeedback therapy (BFT) in DD.

*Material and Methods*: Consecutive constipation patients (April 2011-December 2012) were evaluated. Patients \<18 years and secondary constipation were excluded. 'FC' and 'C-IBS' were classified by Rome-3 module. Patients underwent FBS, calcium, TFT, stool examination, colonoscopy, anorectal manometry (ARM) with balloon expulsion test and colon transit study (CTS). Patients with DD were given BFT.

*Results*: Out of 128 patients 23 %, 58 % and 19 % had secondary constipation, FC and C-IBS respectively. Ninety-nine patients had primary constipation. Mean age-53.50 (18--86) years, (77 % males). Forty-six, 15 and 40 had NTC, STC, DD respectively. 34/40 had paradoxical anal contraction and 6/40 had impaired rectal propulsion. 'FC' and 'C-IBS', were clinically and pathophysiologically similar except for abdominal pain. Patients with DD were more likely to have history of finger evacuation, straining, incomplete evacuation, sensation of anorectal obstruction than no DD (*p*\<0.001). Sixty-nine percent patients with STC had ≤3 stools/week compared to 37 % with NTC. 30/40 patients with DD underwent BFT but 20 completed ≥4 sessions. Seventy percent with ≥4 sessions had improved CSBM with increase in anal relaxation time.

*Conclusion*: NTC is most common subtype of primary constipation. Symptom profile can predict pathophysiologic subtype but investigations (ARM and CTS) are needed to confirm them. DD showed good response to BFT.
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### Prevalence of hyponatremia in treatment naiÃ¯ve patients with cirrhosis and ascites {#Sec252}

***Mayank Jain***

Choithram Hospital and Research Centre, Manikbagh Road, Indore 452 014, India

*Background*: Serum sodium is a simple, readily available and objective marker of disease severity in cirrhosis. Several studies have shown that hyponatremia is a strong predictor of early mortality. Moreover, the accuracy of MELD - Na has been shown to be slightly superior to that of MELD in candidates for transplantation. The present study was done to determine the prevalence of hyponatremia (serum sodium\<130 meq/L) in treatment naïve patients of cirrhosis and ascites during their first hospital admission

*Methods*: This is a prospective and observational study. It enrolled 125 consecutive treatment naïve patients of cirrhosis and ascites who were admitted for the first time at Jagjivanram Hospital, Mumbai and Choithram Hospital and Research Centre, Indore between May 2008 to March 2013. A detailed history regarding use of diuretics, antibiotics, albumin, intravenous fluids, previous episodes of ascites and therapeutic paracentesis was taken. Diagnosis of cirrhosis and ascites was confirmed by clinical, radiological, endoscopic and laboratory investigations. Serum sodium levels were sent within two hours of admission. The data collected was analyzed to determine prevalence of hyponatremia.

*Results*: The mean age of patients was 54.92 years (23-78 years). The majority of patients were males (80 %). The etiological factors for cirrhosis were alcohol (86, 68.8 %), HCV (17, 13.6 %), HBV (8, 6.4 %), cryptogenic (9, 7.2 %) and others (5, 4 %). Thirty-four patients had serum sodium levels of \<130 meq/L. Majority of these patients (29, 85.3 %) had serum sodium levels between 120-129 meq/L while two patients had serum sodium levels below 110 meq/L. Three patients had serum sodium levels between 111 to 119 meq/L. The mean MELD score was 20.94 (range 7-39). Twenty-four patients had MELD score of more than 15 while only one patient had a score of \<9.

*Conclusions*: The prevalence of hyponatremia in treatment naïve patients with cirrhosis and ascites during first hospital admission is 20.7 %. It is more common in patients with MELD score of \>15 suggesting the presence of advanced liver disease.
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### Utility of serum pro-BNP as a marker of cardiac dysfunction in liver cirrhosis {#Sec254}

***B Varun Rao*** *, K Panduranga Rao, B Ramesh Kumar, K Venugopal Reddy*

*Background*: Unrecognized cardiac dysfunction is a cause for increased mortality in the peri trans-plant period (arrhythmias and overt heart failure) and after TIPS (pulmonary edema).

*Aim*: 1) To find the prevalence of cardiac dysfunction in patients with cirrhosis. 2) To study utility of serum pro-BNP as a marker of cardiac dysfunction in patients with liver cirrhosis.

*Methods*: Total of 85 patients with cirrhosis were included in the study after satisfying the inclusion and exclusion criteria between September 2011 to September 2013. All of them underwent evaluation for presence of cardiac dysfunction by 2D-Echo (systolic/diastolic dysfunction) and ECG (QT Prolongation). Serum pro-BNP was measured in all the patients. Patients were divided into two groups group A - those with cardiac dysfunction, group B - those without cardiac dysfunction. Clinical and biochemical indices in both the groups were compared.

*Results*: Out of 85 patients Child A-18, Child B-39, Child C-28. A total of 38 (44.7 %) patients had cardiac dysfunction. Prevalance of cardiac dysfunction was more in Child C 21/28 (75 %) compared to Child B 15/39 (38.46 %) and Child A 2/18 (11.11 %). Out of 85 patients corrected QT interval was prolonged in 30/85 (35.29). QT prolongation was more common in Child C (46.42 %) compared to Child B (35.89 %) and Child A (16.66 %). QT was prolonged in 21/38 (55.26 %) patients with diastolic dysfunction. Serum pro BNP was elevated in 33/38 (86.84 %) patients with cardiac dysfunction. Mean serum pro-BNP levels are higher in Child C compared to Child A, B. The levels also correlate with MELD score.

*Conclusions*: Prevalence of cardiac dysfunction in patients with liver cirrhosis is 44.7 %. Pro-BNP is elevated in majority of the patients with cardiac dysfunction (86.84 %). Higher mean levels of pro-BNP are seen in Child C as compared to Child A, B. The levels also correlate with MELD score.
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### A study of portal hypertensive polyps {#Sec256}

***V Anand*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai 600 010, India

*Background and Aim of Study*: To estimate the prevalence of portal hypertensive polyps in patients with portal hypertension due to any etiology.

*Patients and Methods*: This is a prospective observational study of patients with portal hypertensive polyps. All patients in age group of 18 to 80 years who had portal hypertension diagnosed by clinical, laboratory and imaging criteria who went upper GI scopy from the period of May 2012 to April 2013 were included in the study. Diagnosis of portal hypertensive polyps was confirmed histologically. Patients with proton pump inhibitor use, gastric varices, *H. pylori* gastritis, history of inherited polyposis syndromes, patients who refused consent were excluded.

*Results*: A total of 3,621 upper GI endoscopies were done of which 428 patients had portal hypertension. Polyps were noted in 9 patients (2.1 %), out of 428 patients 366 had chornic liver disease and 62 had extrahepatic portal hypertention. Out of them 1 was excluded due to rapid urease test positivity. Histopathological examination showed four had extensive vascular proliferation and glandular hyperplasia (portal hypertensive polyp) two had hyperplastic polyp and other two had neuroendocrine tumor. Endoscopic appearances of polyps varied considerably, with sizes ranging from 5 mm to 15 mm. Polyps were sessile or pedunculated, singular or multiple, found in the antrum, body of the stomach. There is no specific endoscopic features to identify portal hypertensive polyps.

*Conclusion*: Portal hypertensive polyps are rare. There is no specific endoscopic features. Biopsy is necessary for diagnosis. Long-term studies are needed to characterize their significance.
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### Budd-Chiari syndrome in abdominal tuberculosis-causative or coincidental: A rare case report {#Sec258}

***S Sathiamoorthy*** *, T S Rameshkumar, H Azimudin, M G Manoj, Manimaran, Chitra, Murali, Malarvizhi, M S Revathy, A R Venkateswaran*

Department of Medical Gastroenterology, Government Stanley Medical College, Chennai 600 001, India

*Background*: Tuberculosis (TB) as a cause of Budd-Chiari syndrome (BCS) has less been documented in literature. Here we report a rare case of BCS in abdominal TB.

*Case Report*: A 21-year-young female, admitted with history of abdominal distension, abdominal pain of 3 months duration. Evaluated elsewhere, diagnosed as cryptogenic cirrhosis refered for liver transplant registration to our center. Patient was reevaluated. Past history of antituberculous treatment (ATT) for well documented tuberculous ascites in 2009 for 6 months following which patient improved symptomatically. Her physical examination was normal except prominent back veins, moderate ascites and spleenomegaly. Her LFT was normal. Ascites fluid analysis: low SAAG, high protein. ADA normal. Cytology negative for malignant cells. USG abdomen with portal vein doppler:coarse, irregular liver with caudate lobe hypertropy. Right, middle and left hepatic vein occluded with comma shaped collaterals, spleenomegaly with ascites. OGD Scopy: grade 3 to 2 esophageal varices with PHG. Underwent EVL. CECT abdomen: irregular liver with caudate lobe hypertrophy, hepatic veins could not be visualized, spleenomegaly with ascites, ileocecal thickening with pulled up contracted cecum. Prothrombotic work up normal. Colonoscopy: passed up to cecum, ileum not intubated. Ulceroproliferative lesion in semilunar fold biopsy done. HPE report-chronic inflammatory pathology.

*Conclusion*: Development of BCS in the background of abdominal tuberculosis is less reported.This case is reported due to rare occurance.
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### Prevalence of cirrhotic cardiomyopathy: Our centre experience {#Sec260}

***P Thirumal*** *, Muthukumaran, G Ramkumar, R Balamural, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Disease, Kilpauk Medical College, Chennai 600 010, India

*Aim*: To study the frequency of cirrhotic cardiomyopathy in liver cirrhosis patients and its correlation with severity of liver disease.

*Method*: This is a case series study conducted in Department of Digestive Health and Disease, a tertiary care centre in Chennai over the period from July 2012 to March 2013. First, resting ECG was done in all enrolled cirrhotic patients. QTc values were calculated and value \>0.44 sec were considered as prolonged. Systolic dysfunction was assessed by reduced ejection fraction (value \<55 %). Diastolic dysfunction assessed by reduced E/A ratio (value \<1 was present in 20 (30 %) cases, prolong QT interval (\>0.44 sec) in 16 (22.8 %) and ejection fraction (EF) \<0.55 was in 11 (15.7 %) patients. Cirrhotic cardiomyopathy was present in 25 (35.7 %) cases and frequency correlates directly with severity of liver disease. There was no significant difference in frequency of CCM among alcoholics and nonalcoholics.

*Conclusion*: We observed that cirrhotic cardiomyopathy was present in 25 percent of our cirrhotic patients and significantly more in Child C. Presence of this clinical entity may have major impact on prognosis in these patients.
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### Acute kidney injury at admission and its response to terlipressin as a predictor of mortality in patients with acute-on-chronic liver failure {#Sec262}

***Ankur Jindal*** *, Manoj Kumar, Shiv Kumar Sarin*

Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India

*Background*: Unlike decompensated cirrhotics, the prevalence, associated complications, mortality and treatment outcomes for acute kidney injury (AKI) in acute-on-chronic liver failure (ACLF) are less well defined.

*Methods*: Consecutive acute-on-chronic liver failure patients with AKI \[serum creatinine \>1.5 mg/dL\] at admission were compared with controls for short-term (7 day) and long-term (1, 3 month) mortality and development of HE, SBP and acute variceal bleed (AVB). Patients were further compared based on severity of AKI (mild AKI; S.cr 1.5-3 mg/dL; severe AKI; S.cr \> 3 mg/dL).

*Results*: Of 267 ACLF patients, 55 (22.8 %) had AKI at admission. Patients with AKI at admission had higher short and long-term mortality (7 day, 1 and 3 month) and more often developed HE \[54.1 % vs. 30.6 %; *p*=0.001\] and SBP \[9.1 % vs. 5.9 %; *p*=0.022\]. However, severity of AKI neither predicted survival nor development of complications. Presence of AKI (Odd's ratio, OR: 3.121) and serum bilirubin (OR: 9.136) were independent baseline predictors of survival. Terlipressin was used in 28 of 55 patients with AKI who were volume non-responders; 11/28 (35.28 %) showed response (S. Cr \<1.5 mg/dL) after a median of 4 days and had lower mortality compared to non-responders (10 % vs. 44.3 %, *p*=0.05). There was no difference in terlipressin response rates in mild vs. severe AKI.

*Conclusion*: Almost one fourth of the ACLF patients have AKI at admission and presence of AKI, but not its severity, predicts the development of complications and high mortality. Terlipressin is effective in reversing AKI in \~35 % of patients within a week and results in improved survival.
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### Noninvasive assessment of portal hypertension: A retrospective study in a tertiary care hospital {#Sec264}

***Sanket Shah*** *, Amandeep, M M Prabhu, Naresh*

Medicine Department, Kasturba Hospital, Manipal 576 104, India

It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices that carry a high risk of bleeding and may benefit from prophylactic measures. This approach leads to unnecessary UGIE in those without large esophageal varices. This prospective study was conducted for 130 patients in a tertiary care hospital to evaluate noninvasive predictors of large varices (LV). Specificity and sensitivities were assessed for the each measure.
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### Clinical and etiological profile of patients with decompensated chronic liver disease at a tertiary care centre {#Sec266}

***Jatin Patel*** *, Prasad Bhate, Dhaval Gupta, Meghraj Ingle, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To study the clinical and etiological profile of patients with decompensated chronic liver disease.

*Methods*: Patients with decompensated liver disease admitted in our hospital between May 2011 and May 2013 were included in study. After detailed history and examination all patients underwent routine blood investigations (hemogram, liver function tests, renal function tests, prothrombin time), ascitic fluid investigations, autoimmune markers, viral markers, s.ceruloplasmin, ultrasonography with doppler and esophagogastroduodenoscopy.

*Results*: Age group of the patients included is 4 to 80 years with mean age of 44.89 years. There were 382 male (80.76 %) and 91 female (19.23 %) patients with M:F ratio of 4.2:1. Most common symptom at presentation is abdominal distension in 71 % patients followed by pedal edema in 47.99 %, abdominal pain in 41.86 %, jaundice in 39.75 %, malena in 37.84 %, hematemesis in 31.5 %, encephalopathy in 21.99 % and decreased urine output in 6.55 % patients. Most common etiology of decompensated liver disease was alcoholic liver disease in 56.23 % patients followed by hepatitis B in 19.66 %, cryptogenic in 12 %, autoimmune hepatitis in 3.8 %, hepatitis C in 2.75 %, Budd-Chiari syndrome in 2.54 % and others in 2.96 % patients. Twenty-two percent patients belonged to CTP class B and 77.8 % patients in CTP class C.

*Conclusion*: Alcoholic liver disease followed by hepatitis B were the leading causes of decompensated liver disease and ascites was the most common symptom and majority patients belonged to CTP-C.
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### Incidence of portal vein thrombosis in decompensated chronic liver disease {#Sec268}

***Prasad Bhate*** *, Jatin Patel, Dhaval Gupta, Meghraj Ingle, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To study the incidence of portal vein thrombosis in decompensated chronic liver disease (CLD).

*Methods*: Patients of decompensated CLD admitted in our hospital between July 2012 to June 2013 were included in study. Patients with hepatocellular carcinoma were excluded. All patients are investigated by routine blood investigations like hemogram, blood urea, s.creatinine, s.bil, AST, ALT and USG abdomen with portosplenic Doppler.

*Results*: Out of 193 patients included in study 27 (13.99 %) (22 males) patients showed evidence of portal vein thrombosis on Doppler. Mean age of patients with portal vein thrombosis was 48 years. Most common symptom was abdominal distension in 18 (66.67 %) abdominal pain in 16 (59.26 %), malena in 12 (44.45 %), pedal edema in 12 (44.45 %), jaundice in 7 (25.93 %) and hematemesis in 7 (25.93 %) patients. Liver was palpable in 11 (40.74 %) patients while palpable spleen was present in 14 (51.85 %) patients. Most common etiology of chronic liver disease associated with portal vein thrombosis was alcoholic liver disease in 13 (48.15 %) patients, hepatitis B in 6 (22.23 %), cryptogenic liver disease in 5 (18.52 %), nonalcoholic steatohepatitis in 1 (3.7 %) and hepatitis C in 1 (3.7 %) patient. Ascites was present in 23 (85.18 %), upper GI bleed in 6 (22.23 %), spontaneous bacterial peritonitis in 4 (14.81 %), hepatic encephalopathy in 3 (11.11 %) and hepatorenal syndrome in 2 (7.4 %) patients. Three patients were in CTP-B and 24 (88.89 %) were in CTP-C.

*Conclusion*: Portal vein thrombosis was found in almost 14 % of all our decompensated CLD patients. It could represent an important cause of decompensation especially in CTP C patients and should be actively sought for in patients with decompensation.
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### Incidence of post EVL ulcer bleed after endoscopic variceal banding and its correlation with CTP score {#Sec270}

***B Sajeeth Manikanda Prabu*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Disease, Kilpauk Medical College, Chennai 600 010, India

*Aim*: To study the incidence of ulcer bleeding after endoscopic variceal ligation and its correlation with Child-Pugh score.

*Materials and Methods*: One hundred and ten cirrhotic patients with esophageal varices who required endoscopic variceal ligation to prevent bleeding or rebleeding in our centre were included in the study. The incidence of post EVL ulcer bleeding were noted and correlated with their Child-Pugh scoring.

*Results*: The incidence of rebleeding after EVL was 7.85 % (14 patients). Of 110 patients the etiological cause for cirrhosis was ethanol in 82 patients (74 %), hepatitis B related in 15 patients (13.63 %), EHPVO related in 8 patients (7.27 %) and others (4.54 %). Of 14 patients who had rebleeding 11 (78.57 %) had rebleeding secondary to varcies and 3 (21.42 %) had post EVL ulcer bleed. One patient with EVL ulcer bleed died inspite of active resuscitation. Among 14 patients who had rebleeding (either hematemesis or malena), 10 (71.4 9 %) patients belonged to Child-Pugh class C and 5 (28.57 %) patients to Class B. All 3 patients with post EVL ulcer bleed belonged to Child-Class C.

*Conclusion*: This study demonstrated that the prevalence of ulcer bleed after EVL is uncommon and ulcer bleed is more likely to occur in patients who are in Child-Class C.
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### Incidence of spontaneous bacterial peritonitis in decompensated cirrhotic patients and its correlation with clinical and laboratory parameters {#Sec272}

***B Sajeeth Manikanda Prabu*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Gastroenterology, Kilpauk Medical College, Chennai 600 010, India

A*im*: 1. To study the incidence of spontaneous bacterial peritonitis (SBP) in DCLD patients. 2. To correlate with clinical, lab parameters and scoring system.

*Materials and Methods*: One hundred decompensated cirrhotic patients with suspected SBP, admitted to our hospital over a period of one year were included in our study after excluding other causes. They were assessed based on history, examination, investigations including ascitic fluid analysis and followed up for one month.

*Results*: Among 100 patients, 29 patients had SBP. Among 29 patients, 7 had culture proven SBP and 22 had culture negative neutrocytic ascities (CNNA). The common presentation were worsening of abdominal distension - 29 patients (100 %), Hepatic encephalopathy - 13 patients (44.82 %), fever and abdominal pain 11 patients (37.93 %) and UGI bleed 6 patients (20.69 %). All SBP patients had ascitic fluid albumin 25, 18 (62.06 %) and 8 (27.58 %) patients with score between 16 -24 and \<15 respectively. Five (62.50 %) patients died during follow up, of which 4 had classic SBP and 1 with CNNA. Among those 5 patients, 2 developed HRS, 1 had UGI bleed and 1 had hepatic encephalopathy.

*Conclusion*: 1. Cirrhotic patient with SBP can have atypical presenting symptoms. Hence high degree of suspicion is required to rule out SBP and manage appropriately. 2. Cirrhotic patients with low ascitic albumin and with high CTP and MELD score are more prone to develop SBP. 3. Mortality increases with associated complications.
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### AKI in patients with acute on chronic liver failure is different from patients with cirrhosis {#Sec274}

***Rakhi Maiwall***, *S Kumar, S Lata, Bhaskar Thakur, C Vashishtha, M K Sharma, H Garg, S Taneja, S K Sarin*

Departments of Hepatology, and Nephrology, Institute of Liver and Biliary Sciences, D 1, Vasant Kunj, New Delhi 110 070, and Departments of Hematology, and Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India

*Background and Aims*: The current definitions for AKI (AKIN criteria) and HRS have been derived from patients with cirrhosis with paucity of data on AKI in acute on chronic liver failure (ACLF). We investigated the prevalence, natural history and outcome of AKI and Type 1 HRS in patients with ACLF (*n*=534) and compared it with a cohort of hospitalized patients with cirrhosis (*n*=2,083).

*Methods*: Serial creatinine up to day 30 was recorded for all patients.

*Results*: AKI was more common in ACLF (50.5 % vs. 32.3 %; *p*\<0.0001) and associated with increased risk of mortality (59.9 % vs. 41.3 %; *p*\<0.0001) as compared to CLD. Presence of ACLF (vs. CLD) was associated with a six-fold increased risk of AKI (*p*\<0.0001, OR 6.4 95 % CI 4.9-8.3) on multivariate analysis. There was no significant difference seen in the AKIN stage at baseline (Stage 1 : 61 % vs. 69 %; Stage 2: 29.5 % vs. 23.5 %; Stage 3 : 9.9 % vs. 8.5 %), decrease in serum creatinine at 48 hours (67.3 % vs. 65.3 %), however, progression to AKIN stage 3 (23.5 % vs. 12.6 %) was significantly more common in ACLF (*p*\<0.0001). Prevalence of Type 1 HRS (28.7 % vs. 29.2 %) was similar, however response to terlipressin (15.5 % vs. 50.1 %), mortality (67.9 % vs. 45.9 %; *p*=0.001) and progression to ATN and need of RRT (53.8 % vs. 20.4 %; *p*\<0.0001) was higher for patients with ACLF and type 1 HRS.

*Conclusion*: The prevalence, natural history and mortality of AKI in ACLF is distinctly different from patients with CLD. Patients with ACLF and type 1 HRS have the highest risk of mortality.
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### Clinical and etiological profile of acute febrile illness in cirrhosis {#Sec276}

***P Laksmana Chandra*** *, P Shravan Kumar, M Umadevi, M Ramanna*

Department of Gastroenterology, Gandhi Hospital, Secunderabad 500 025, India

*Aim*: Acute febrile illness is common in cirrhotic patients. The aim of this study was to identify the clinical profile and etiological factors presenting as acute febrile illness in cirrhotic patients.

*Methods*: All cirrhotic patients admitted as inpatients between January 2013 and December 2013 with a history of fever of less than seven days duration. Detailed history, clinical examination and investigations- complete blood picture, complete urine analysis, liver function test, ascitic fluid analysis, serum ammonia, smear for MP, blood culture sensitivity, chest X-ray, ultrasound abdomen were done. The data collected were analyzed.

*Results*: Out of 78 patients male-to-female ratio was males 66 (85 %) females 12 (15 %) ratio male/female 5.5:1. The mean age at presentation was 44 years (24-64 years). The other clinical features associated with fever include abdominal pain 48 (62 %), jaundice 15 (19 %), swelling of lower limb 12 (15 %), vomiting 12 (15 %) altered sensorium 8 (10 %), cough 8 (10 %), burning micturition 6 (8 %). The etiological factors were: spontaneous bacterial peritonitis 40 (51 %), lower limb cellulitis 12 (15 %), lower respiratory tract infection 8 (10 %), viral fever 8 (10 %), urinary tract infection 6 (8 %), acute cholecystitis 2 (2.5 %), and malaria 2 (2.5 %). Hepatic encephalopathy was associated in 8 cases of spontaneous bacterial peritonitis.

*Conclusion*: Spontaneous bacterial peritonitis is the most common cause of acute febrile illness in cirrhosis though multiple other causes have been identified in this study.
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### The association between the serum sodium level and the severity of complications in liver cirrhosis {#Sec278}

***S Sukumaran*** *, A R Akilandeswari, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai 600 010, India

*Introduction*: Cirrhotic patients with ascites have low survival rate of 23 % and 7 % in 5 and 10 years respectively. In patients with hyponatremia and ascites the risk of pretransplant death within 180 days may exceed 40 %. Hyponatremia is independent predictor of mortality in cirrhotic patients and associated with increased rate of various complications.

*Aim*: To find the prevalence of hyponatremia in cirrhosis and study the association between the serum sodium level and severity of complications in liver cirrhosis.

*Materials and Methods*: Study included 50 consecutive patients with liver cirrhosis admitted in our institution from July 2012 to February 2013. Patients with complications due to cirrhosis such as ascites, hepatic encephalopathy, hepatic hydrothorax, spontaneous bacterial peritonitis were included. Patients with hepatocellular carcinoma, diuretics intake currently or within one month and intrinsic renal disease, heart disease were excluded. Enrolled patients were subjected to clinical and laboratory investigations.

*Results*: Hyponatremia (\<130 meq/L) was found in 27 patients (54 %). Patients with hyponatremia had severe ascites (grade 2 and 3 in 6 and 8 patients respectively *p*-0.005) and increased frequency of hepatic encephalopathy (12 patients 44 %) than other complications which did not increase significantly. Hyponatremia is more common in patients with CTP score B (18 patients- 36 %) and C (26 patients-52 %).

*Conclusion*: The prevalence of hyponatremia in cirrhotics is found to be in more than half of the patients and they are more prone for severe ascites and hepatic encephalopathy than other complications. Hyponatremia is found more commonly in those patients with CTP score B and C.
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### Predictors of mortality in alcoholic hepatitis and to compare the MELD score with the Maddrey\`s DF (mDF) score as a predictor of short-term mortality {#Sec280}

***K Srinivas***, *M Ramanna, M Umadevi, P Shravan Kumar*

Department of Gastroenterology, Gandhi Medical College, Hyderabad 500 025, India

*Background*: Alcoholic hepatitis (AH) is associated with bad prognosis. So it is important to know the predictors of mortality and to manage the patient accordingly.

*Aim*: To assess prognostic factors for patients with alcoholic hepatitis and to compare MELD score with mDF score as a predictor of short-term mortality.

*Methods*: Fifty patients with diagnosis of AH were included. Demographic, laboratory data, complications and 30 day mortality were registered. A comparison was performed between survivors and non-survivors.

*Results:* Mean alcohol consumption is about 120.96±59.35 gm/day. mDF (96.81 vs. 56.75, *p*\<0.0001) and MELD score (33.27 vs. 21.82, *p*\<0.0001 ) was higher in patients who died than those who survived respectively. The performance characterisitcs of MELD score (AUC--0.89) is similar to that of mDF score (AUC-0.85). No differences between groups were recorded regarding albumin, age and Glasgow scale. Increased levels of creatinine (2.18 vs. 1.13, *p*\<0.0001), bilurubin (20.27 vs. 12.60, *p*\<0.0001) and INR (2.32 vs. 1.78, *p*\<0.0025) are related with higher risk of death.

*Conclusion*: Increased levels of creatinine, bilurubin, INR, mDF and MELD score are the significant risk factors associated with mortality. Both MELD and mDF scores are equally good predictors of short-term mortality in patients with alcoholic hepatitis.
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### Factors predisposing to bleeding from esophageal ulcers occurring after endoscopic variceal band ligation {#Sec282}

***Roji Ray***, *Varghese Thomas*

Department of Gastroenterology, Government Medical College, Kozhikode 673 008, India

*Background*: Bleeding in the post endotherapy period from post endoscopic variceal band ligation (EVL) ulcers has been described and sometimes it can be life threatening.

*Aims*: To assess the risk factors and outcome of bleeding from esophageal ulcers occurring after EVL.

*Methods*: Consecutive patients with cirrhosis who had undergone EVL for esophageal varices were studied. Clinical, hematological and biochemical parameters as well as Child and MELD scores were compared between those with and without post EVL ulcer bleed which occurred within four weeks of performing EVL.

*Results*: One hundred and fifty-one patients were enrolled in the study. One hundred and twenty-nine (85.4 %) were males and the most common etiology of cirrhosis was alcohol (*n*=104; 68.9 %). Twelve (7.95 %) patients developed post EVL bleed of which 10 (83.3 %) had bleed from post EVL ulcers. The mean duration to ulcer bleed was 14.1 days (SD 2.64) after EVL. Mean platelet count and INR were 0.85 lakhs/mm3 (SD 0.14) and 2.07 (SD 1.17) in those with ulcer bleed compared to 1.37 lakhs/mm3 (SD 0.31) and 1.25 (SD 0.14) respectively in those without bleed (*p*=\<0.001). The mean MELD score was 16.5 (SD 7.35) in those who bled compared to 9.5 (SD 1.63) in those without ulcer bleed (*p*=\<0.001). Post EVL ulcer bleed was associated with hemodynamic disturbance in four patients. One patient expired due to post EVL bleed.

*Conclusion*: 6.6 % of cirrhotic patients who had undergone EVL developed bleeding from post EVL esophageal ulcers. Twenty-five percent of these patients had hemodynamic instability. A low platelet count, prolonged INR, and higher MELD scores were associated with the risk of bleeding from post EVL esophageal ulcers.
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### Incidence and prognosis of functional renal failure in cirrhotic patients {#Sec284}

***M Tarakeshwari*** *, K Muthukumaran, G Ram Kumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Government Peripheral Hospital, Kilpauk Medical College, Chennai 600 010, India

*Aim*: To assess the incidence of functional renal failure in cirrhosis and investigate the prognostic factors.

*Materials and Methods*: An observational study of cirrhotic patients admitted in our hospital between July 2012-June 2013 was carried out. Patients diagnosed with cirrhosis and presenting with elevated renal parameters were included in the study. Cirrhotic patients with underlying structural renal disease were excluded from the study. Patients with functional renal failure were categorized in three subgroups as pre renal failure (group 1), renal failure with infection (group 2) and hepatorenal syndrome (group 3). Clinical characters of these patients were analyzed for precipitating factors. They were treated according to the standard protocol, evaluated for clinical, biochemical and radiological parameters and followed up for survival rates and prognostic factors during hospital stay.

*Results*: Out of the 210 patients 86 (40.95 %) developed functional renal failure. Highest incidence was in the 5th decade (79 %). The most frequent was prerenal failure 63 (73.25 %) followed by renal failue with infection 15 (17.44 %), and hepatorenal syndrome 8 (9.30 %). Upper gastrointestinal bleed and acute gastroenteritis with an incidence of 39.6 % and 31 % respectively were the most frequent precipitants of functional renal failure. The incidence of functional renal failure in Child class A, B, C were 56 %, 36 % and 8 % respectively. Among cirrhotics with Child class C the incidence of hepatorenal syndrome was 61.5 %.

*Conclusion*: Approximately 41 % of patients with cirrhosis developed functional renal failure. Higher CTP score was associated with increased risk of occurrence of hepatorenal syndrome. Most of the patients with functional renal failure recovered with treatment except those with hepatorenal syndrome.
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### Outcome of extrahepatic portal venous obstruction with or without endoscopic and/or surgical treatment {#Sec286}

***Nisar A Shah*** *, S A Zargar, O J Shah, I Rabani, G Javed, G N Yatu, B A Khan, A H Shah, A Sadaf, G M Gulzar, S S Jaswinder, M A Khan*

Departments of Gastroenterology, Surgical Gastroenterology, and Radiodiagnosis, Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Kashmir 190 011, India

*Background*: Extrahepatic portal venous obstruction is an important cause of portal hypertension in children and adults world over, and a major cause in Asian and African population.

*Objective*: To look into the clinical presentation, lab parameters, etiological factors, radiological features, morbidity and mortality in patients of EHPVO on different treatment modalities.

*Design*: Retrospective cum prospective

*Methods*: Extensive demographic lab data, radiological data, anthropometric assessment, endoscopic and interventional data, surgical data from consecutive patients diagnosed and registered since 1982 and those registered prospectively from August 2007 to January 2010 with the Departments of Gastroenterology and Surgical Gastroenterology was revived. Data on the diagnostic work up, etiological profile, endoscopic follow up, complications and their management was also noted. Consecutive patients on pharmacotherapy, EST/EVL alone and patients who had undergone devascularization or shunt were assessed for their outcome.

*Results*: A total of 240 patients, 125 males and 145 children with mean follow up of 9.3±7.7 years were registered. Main presenting symptoms were upper GI bleed, symptomatic splenomegaly, growth retardation, hypersplenism, jaundice, cholangitis and non specific pain abdomen. Thirty-three percent of children had relevant past history especially umbilical and abdominal sepsis. 7.5 % of children had congenital anomalies. Transabdominal ultrasound was initial important informative investigation. CECT, ERCP, MRCP were also found informative supplementary investigations. Eighty-two percent of patients had esophageal varicies, 16 % had gastric varicies and 7.5 % had PHGP. Thirty-four percent had growth retardation. Recurrent GI bleeds and biliopathy were important complications followed by hypersplenism, growth retardation and decompensated liver disease. Previously described classification of biliopathy was found in-adequate and un-informative, a new classification designed to address the severity of biliopathy was used. Surgery was found better treatment modality, especially shunt procedure; however an optimal treatment modality needs to be discovered.

*Limitations*: A retrospective cum prospective study, complete etiological profile not available.

*Conclusion*: EHPVO is an important cause of portal hypertension in both children and adults and an important cause of morbidity. GI bleed and symptomatic splenomegaly are most common presenting symptoms. Esophago gastric varices are important cause of morbidity. Biliopathy, growth retardation and hypersplenism need early surgical intervention. Surgery is a better treatment modality.
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### Insulin resistance in euglycemic chronic liver disease {#Sec288}

***Amitava Goswami*** *, Narendra Bhargava, Sunil Dadhich, Ganaraj Kulamarva*

Dr. Sampurnanand Medical College, Shastri Nagar, Residency Road, Jodhpur 342 001, India

*Introduction*: Chronic liver disease is associated with insulin resistence and IR progressively increases with the advancement of liver disease. So identification of IR can identify the risk for development of hepatogenous DM. Hence a prospective observational study was conducted.

*Aim*: 1. IR in CLD of varied etiology 2. IR assessment in different stages of CLD 3. Pancreatic beta cell insulin secretions in relation with stages of CLD.

*Inclusion Criteria*: 1. Euglycemic cirrhotic patients, diagnosis of cirrhosis were based on histopathological evidence or clinical grounds, impaired liver function tests and ultrasonographic features consistent with cirrhosis. 2. HCC exclusion criteria: 1. Known Type 2 DM or FBS \>126 mg/dL.

*Methods*: Insulin resistance was assessed by the homeostasis model assessment method for the evaluation of insulin resistance. QUICKI an alternative surrogate marker of IR HOMA-beta a parameter for insulin secretion ability of pancreatic beta-cells.

*Results*: IR in euglycemic CLD was seen in 68.5 %. IR in varied etiology was seen in the order HCV (100 %), AIH (100 %), HCC (80 %), ALD (72 %) and HBV (32 %). HOMA -IR value was significantly raised in CTP score \>9 (*p*-value 0.0007) and MELD score \>15 (*p*-value 0.02). HOMA beta was raised in CTP score \>9 (*p*-value 0.006) and MELD score \>15 (*p*-value 0.00001).

*Conclusion*: Insulin resistance is a common manifestation in chronic liver disease of varied etiology and with advancement of liver disease, the pancreatic beta-cell insulin secretion increases which results in development of hepatogenous diabetes.
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### Variceal patterns in male and female portal hypertensives {#Sec292}

***C Vaishnavi Priyaa*** *, S Jeevan Kumar, P Ganesh, R Balamurali, K Muthukumaran, G Ramkumar*

Department of Digestive Health and Diseases, Government Kilpauk Medical College, Chennai 600 010, and Dr M G R Medical University, 69, Anna Salai, Guindy, Chennai 600 032, India

*Objectives*: To compare the pattern of varices between male and female portal hypertensives of various etiologies.

*Methods and Materials*: A prospective analysis of variceal patterns was made in Kilpauk Medical College, in 190 patients who underwent OGD from July 2012 to July 2013 in both male and female portal hypertensives of various etiologies. Among, total 190 patients analyzed, M/F=130/60. Types of varices, with grading were compared.

*Results*: Among, 190 patients, including 130 males and 60 females, females had more fundal varices, 8/60 (13 %), whereas in males fundal varices were 6/130 (5 %). GOV 1 (gastroesophageal varices) was seen 2 females (2/60=3 %) and GOVII was seen in 1 female (1/60=1.6 %) females. Two males had GOV II (2/130=1.5 %). IGV 1 (isolated gastric varices) was seen in four female cases (4/60=6.6 %) and 5 male cases (5/130=4 %). Esophageal varices grade IV was seen in 6 (10 %) cases of females, and 8 male patients (6 %). Grade III esophageal varies were seen in 22 cases of females (37 %) and 39 males (30 %), Grade II esophageal varies was found in 74 males (57 % ) and 28 females (47 %), Grade I esophageal varices were found in 65 males (50 %) and 19 females (32 %).

*Conclusion*: In our centre, female portal hypertensives had more prevalence of fundal varices. More GOV, and esophageal varices Grade IV, and Grade III were seen in females than males. Grade II and grade I esophageal varices, were found more in males.
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### The prevalence of cirrhotic cardiomyopathy in liver cirrhosis and its correlation with pro-BNP level, QTc, and severity of cirrhosis {#Sec294}

***Kailash Mishra*** *, Sri Prakash Misra, Manisha Dwivedi, Kapil Sharma, Ravikant Kumar*

Department of Gastroenterology, Moti Lal Nehru Medical College, University of Allahabad, Allahabad 211 001, India

*Aim*: To determine the frequency of cirrhotic cardiomyopathy and its correlation with the spectrum of disease severity, Pro-BNP levels and QTc.

*Methodology*: This study was conducted in Department of Gastroenterology, M L N Medical College, Allahabad and included consecutive cases of cirrhosis of liver of either sex above 14 years of age. Resting ECG was done in all the patients. QTc values were calculated. QTc interval of \>0.44 sec was considered as prolonged. Systolic dysfunction was assessed by ejection fraction (\< 1 in 29 (82.86 %) cases, mean QTc was 0.47±0.07 second, ejection fraction (EF) 44 sec, ejection fraction \<55 % and E/A ratio \<1.

*Conclusion*: Cirrhotic cardiomyopathy is highly prevalent in cirrhosis and positively correlated with degree of liver dysfunction.
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### Occurence of failure of empirical treatment of spontanous bacterial peritonits and role of other antibiotic in failure {#Sec296}

***Devang Chandrakant Tank*** *, Yamuna Pillai, K S Sijil, S Sreejaya, N Premalatha, K R Vinayakumar*

Department of Medical Gastroenterology, Government Medical College, Thiruvananthapuram 695 011, India

*Background*: Spontaneous bacterial peritonitis (SBP) is a common infection in patients with cirrhosis. In the era of increasing use of antibiotics the ascitic fluid culture is negative hence difficult to treat patients with failure of empirical regime.

*Aim*: To know occurrence of failure of cefotaxime treatment in patients with SBP and explore role of other antibiotics in cefotaxime failure.

*Material and Method*: It was retrospective observational study conducted between July 2012 to July 2013 at Department of Gastroenterology, Government Medical College, Thiruvananthapuram. Data collected in cirrhotic patients with SBP with special regard to previous use of norfloxacillin. Data also collected for hospital acquired SBP. Total 285 patients with SBP were enrolled in the study. All patients with diagnosis of SBP were given standard treatment. More than 25 % reduction in the ANC level after 48 hours of antibiotic was considered as response and in nonresponding patients antibiotics were changed appropriately.

*Results*: Total 285 patients treated empirically with cefotaxime of which 177 (62.1 %) responded. Remaining 108 patients, 95 patients responded to piperacillin+tazobactum. One hundred and forty-five patients were on norfloxacillin prophylaxis for SBP of which 81 (57.9 %) did not respond to cefotaxime (*p*\<0.05). Patients responding to piperacillin+tazobactum, 75 were on norfloxacillin prophylaxis. Total 56 patients were having hospital acquired SBP.

*Conclusion*: Cefotaxime failure occurred in 37.9 %. Patients who are on norfloxacillin are more likely to fail on cefotaxime. Piperacillin+tazobactum is useful in cefotaxime failure cases and patients who develops SBP on norfloxacillin.
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### Renal resistive index and renal function before and after terlipressin therapy in patients with hepatorenal syndrome {#Sec298}

***Asif Iqbal*** *, Jayanta Kumar Ghosh, Amitnandan Dhar Dwivedi, Vinod Kumar Dixit, Kamlakar Tripathi*

Departments of Internal Medicine, Gastroenterology, and Radiodiagnosis, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Aim*: To evaluate effects of terlipressin on renal hemodynamics, with the help of resistive index (RI) of renal arteries in patients of hepatorenal syndrome (HRS).

*Materials and Methods*: Total 40 patients (20 as study group and 20 as control group) of HRS admitted in Internal Medicine ward from the period of January 2012 to June 2013 were evaluated prospectively. Terlipressin 1 mg 6 hourly intravenously was administered to patients in the study group for 48 hours and radiological evaluation was done by recalculating the RI in the interlobar arteries and evaluating effect of terlipressin on resistive index.

*Results*: No significant change in cortical thickness of kidney in both groups was observed elaborating the fact that this parameter is indicative of chronic disease process and not altered by short-term terlipressin therapy (ie. 48 hours). There was significant decrease in RI of interlobar renal arteries in study group after terlipressin therapy, indicating the fact that terlipressin causes significant reduction in renal vasoconstriction as reflected by decrease in resistive indices of interlobar renal arteries.

*Conclusion*: Terlipressin significantly decreased the elevated RI in patients with HRS and its role in HRS was re-established by this study.
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### Factors affecting the outcome of Type 1 HRS in a tertiary care centre in South Kerala {#Sec300}

***E H Rooby*** *, P V Mashhood, George Peter, Sreejaya, N Premalatha, K R Vinayakumar*

Department of Medical Gastroenterology, Government Medical College, Thiruvananthapuram 695 011, India

*Background*: Hepatorenal syndrome type1 (HRS1) is a rapidly progressive but potentially reversible form of renal failure occurring in cirrhosis.

*Objective*: To find the outcome of terlipressin plus albumin therapy (TAT) in HRS1 and predictors of outcome, survival at 1 and 6 months.

*Material and Methods*: Consecutive patients with HRS1 from June 2011 to January 2013 included in this observational study.

*Inclusion Criteria*: Adults with HRS1 defined by IAC. *Exclusion Criteria*: Obstructive or parenchymal renal dysfunction, C V disease.

*Method*: Patients treated with terlipressin 1 mg IV 6 hourly and IV albumin 1 gm/kg on day1 followed by 20-40 gm/day. Dose of terlipressin increased to a maximum of 2 mg/4--6 h if there is no reduction in s.creatinine of minimum 25 % of baseline at day 3. TAT maintained until creatinine \<1.5 or develops complication/death. Primary outcome: reversal of HRS or death. Secondary: recurrence, side effects, transplant free survival at 30 and 180 days.

*Results*: Of 32 patients 29 taken TAT. All were males. Mean age 51.9. Main precipitating factors: SBP, alcoholic hepatitis and cellulitis. 58.2 % recovered. Twelve not responded (7 died, 5 withdrawn). 78.9 % at 1 month and 15.7 % at 6 months survived. Four lost follow up. HRS recurred in 4. Baseline serum creatinine was predictive of response to treatment (2.9+/-0.4 vs. 4.0+/-1.2), *p*-value 0.015. MELD score showed a significant difference for 6 months survival 20.5+/-3.7 vs. 30.4+/- 6.9 (*p* 0.015).

*Conclusion*: Baseline s.creatinine significantly correlates with HRS treatment response. MELD score showed significant correlation with 6 months survival.
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### Metformin reduces hepatic resistance and portal pressure in CCl4 and BDL cirrhotic rats {#Sec302}

***Dinesh Tripathi***, *Eva Erice, Jordi Gracia-Sancho, Hector Garcia-Calder, Juan Carlos Garcia-Pagn, Jaime Bosch, Shiv K Sarin*

Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India and Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clinic-IDIBAPS and CIBERehd, University of Barcelona, Spain

*Background*: Increased hepatic vascular resistance is primary factor in development of portal hypertension. We evaluated the effects of metformin on hepatic and systemic hemodynamics and underlying mechanisms in cirrhotic rats and its possible interaction with propranolol.

*Methods*: CCl4-cirrhotic rats received metformin (300 mg/kg) or its vehicle (*n*=12/group) once daily for 1 week, before measuring hemodynamic parameters (MAP, portal pressure-PP, portal blood flow-PBF, hepatic vascular resistance-HVR), and molecular/cellular potential mechanisms. PP and MAP response to acute propranolol (5 mg/kg IV) was assessed (*n*=10/group). Effects of metformin±propranolol on PP and MAP were further evaluated in BDL-cirrhotic rats (*n*=8/group).

*Results*: Metformin-treated CCl4 cirrhotic rats had lower PP (10.2±0.8 vs. 13.9±0.8 mmHg;-27 %; *p*

*The abstract matter was not received in full at the time of sending to press, despite reminders to corresponding author.*
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### Development of a new prognostic model to predict mortality in hospitalized patients with cirrhosis {#Sec304}

***Rakhi Maiwall*** *, S Kumar, S K Sarin*

Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India Department of Hematology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India

*Background and Aim*: The current MELD score which is validated for prediction of 3-month mortality in cirrhotics is devoid of most of the factors which significantly impact mortality in these patients. Also, it has not been validated to predict mortality at 1 and 6 months. Hence, we aimed to develop a prognostic model in which we evaluated the role of different prognostic variables for prediction of short term mortality at 1, 3 and 6 months for inpatients with cirrhosis.

*Methods:* In a prospective cohort study of 2,083 inpatients with cirrhosis, a multivariate prognostic model was built using Cox Proportion Hazard Regression and was validated and calibrated using internal bootstrapping method by Frank E Harrell.

*Results:* Patients with CLD (1,631 males, with mean age 49.4 (±15.6) years were followed for 12 (0-1269) days of which 338 (16.2 %) died. Age, presence of sepsis, HE, MELD, serum sodium (Na) and potassium (K) were significant on multivariate analysis and considered for model building. A significant increase in mortality was seen with increasing MELD (HR 3.87) and age (HR 1.29), decreasing sodium (HR 0.87), both increasing and decreasing potassium (HR 1.63), presence of sepsis (HR 3.05) and HE (HR 3.12). The model performed better than MELD score in prediction of liver related death.

*Conclusion*: The proposed model predicts liver related death at 1, 3 and 6 months with an accuracy better than the MELD score by combining novel prognostic factors in cirrhotics.
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### Combination therapy using granulocyte colony stimulating factor and recombinant erythropoietin (rEPO) improves transplant free survival in patients of decompensated liver cirrhosis {#Sec307}

***Chandan Kumar Kedarisetty*** *, Ankit Bhardwaj, Chhagan Bihari, Archana Rastogi, Paul David, Nirupama Trehanapati, Shiv Kumar Sarin*

Departments of Hepatology, Research^,^ and Pathology, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi 110 070, India

*Background*: Decompensated cirrhosis is the end of spectrum of chronic liver disease with a median survival of \<2 years. The only effective treatment is liver transplantation. We had recently shown that use of granulocyte colony stimulating factor (GCSF) enhanced survival in acute-on-chronic liver failure patients (Gastroenterology 2012). EPO has been shown to improve liver regeneration in post-hepatectomy and fulminant liver failure rat models.

*Aim:* The present study was to study whether the use of GCSF and Darbopeitin alpha (DPO) could lead to improved survival and liver regeneration in decompensated cirrhotics.

*Patients and Methods*: Consecutive patients with decompensated cirrhosis were enrolled after approval by IRB, to receive 5 μg/kg GCSF on day 1, 2, 3, 4, 5 and then every third day (total 12) and a weekly dose 40 IU DPO for 1 month (Group A, *n*=29) or matched placebo (Group B, *n*=26). Standard of care continued in both groups. Transjugular liver biopsy (TJLB) and hepatic venous pressure gradient (HVPG) were done at baseline and in a proportion of patients at 1 month. Follow up was done on days 2, 4, 7, 14, 28 and then at month 3, 6, 9, and 12.

*Results*: The two groups were well matched in baseline characteristics. The most common etiology was alcohol, followed by cryptogenic and viral hepatitis. There was significant improvement in CTP scores from 10.9±1.2 at baseline to 9.67±1.8 at 1 month, 9.1±1.7 at 3 months and 8.8±1.4 at 6 months follow up (*p*\<0.005) in Group A. Significant reduction seen in albumin requirement in Group A from baseline to one month (*p*- 0.045). There was reduction in need for large volume paracentesis in Group A. Baseline alpha fetoprotein levels were similar in both groups. At 1 month, it was 6.6±3.6 ng/mL in Group A and 4.7±2.7 in Group B (*p*- 0.018). No change in HVPG seen from baseline to 1 month (*p*-0.26). Transplant free survival at 12 months was 68.9 % in Group A and 46.2 % in Group B (*p*-0.049) (Fig. 1) and at 6 months was 82.7 % in Group A and 50 % in Group B (*p*-0.009). Actuarial probability of survival at 6 months and 12 months was significant in Group A and not in Group B. Immunohistochemistry in repeat TJLB of 1 patient in Group A showed an increase in proportion of CD 34+cells, CD 133+cells, Ki-67 and proliferating cell nuclear antigen (PCNA) suggestive of liver regeneration (Fig. 2). No adverse events were noted.

*Conclusions*: This is the first RCT (NCT01384565) showing clinical benefit and a transplant free survival by using a combination of G-CSF and EPO in patients with decompensated cirrhosis.
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### Reduction in liver stiffness at one month is a predictor of survival in acute-on-chronic liver failure {#Sec309}

***Chandan Kumar Kedarisetty***, *Ankit Bhardwaj, Hitendra Garg, Shiv Kumar Sarin*

Departments of Hepatology, and Research, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi 110 070, India

*Background and Aims*: Acute-on-chronic liver failure (ACLF) is a distinct syndrome with high mortality. As there is an element of acute hepatic injury and inflammation, there is a potential of reversibility and a need for identifying non-invasive prognostic markers. We hypothesized and investigated whether regression of acute hepatic insult and inflammation is reflected in the reduction in liver stiffness and improved survival.

*Patients and Methods*: Fifty-three consecutive patients of ACLF were enrolled into the prospective observational study. All patients had baseline liver stiffness measurement (LSM) measured by Fibroscan (Echosens, France) and hepatic venous pressure gradient (HVPG) measurement and received the standard of care. The primary end-point was survival at one month.

*Results*: The mean age was 45.5±11.3 years. The most common etiology for acute insult was alcohol (35 %), acute hepatitis E (35 %) followed by reactivation of hepatitis B (13 %) while the etiology for underlying chronic liver disease was alcohol (33 %), cryptogenic (27 %) and hepatitis C. The baseline CTP score was 10.6±1.1 and MELD score was 20.8±7.1. The baseline LSM was 55.9±19.5 kPa. Mean reduction in LSM from baseline to one month (LSM) was 23.2±13.1 KPa (*p*-0.000), CTP score was 1.79±1.36 (*p*-0.111); MELD score was 8.47±7.4 (*p*-0.004). Mean HVPG at baseline was 15.04±5.21 mmHg and at one month was 16.89±5.76 (*p*-0.126). Mean baseline total bilirubin was 19.9±9.4 mg/dL and mean baseline INR was 1.9±0.58. Bbilirubin at one month was 9.08±7.4 (*p*-0.000) and INR was 0.598±0.44 (*p*-0.000). At one month, there were 48/55 survivors (87.3 %) and 7/55 nonsurvivors (12.7 %). There was a significant correlation between LSM and survival at one month. The threshold of fall in LSM from baseline to 1 month to predict survival was 13.25 kPa with a sensitivity of 89 % and specificity of 71 % (AUROC 0.79; 95 % CI: 0.584-1.005; *p*-0.016) (Fig. 1). No correlation was seen between survival and bilirubin (*p*-0.259), ΔINR (*p*-0.403), CTP (*p*-0.505), MELD (*p*- 0.899).

*Conclusions*: There is a significant reduction in the liver stiffness on improvement of the inflammation due to regression of acute hepatic insult in ACLF. Reduction of 13.25 kPa is the appropriate cut-off for the reduction in liver stiffness from baseline to one month to predict survival.
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### A prospective, double-blind, randomized placebo-controlled trial of carvedilol for early primary prophylaxis of esophageal varices in cirrhosis {#Sec311}

*Ankit Bhardwaj, Chitranshu Vashishtha, K N Chandan, Rakhi Maiwall, Manoj Kumar Sharma,* ***Shiv Kumar Sarin***

Departments of Hepatology and Research, Institute of Liver and Biliary Sciences, D-1, Vasant Kunj, New Delhi 110 070, India

*Background and Aims*: Gastroesophageal variceal (GEV) hemorrhage is a major complication of portal hypertension resulting from cirrhosis of the liver. The risk of bleeding from small (≤5 mm) varices is 7 % at 2 years. Median rate of progression to larger varices is 5 % to 23 % per year. Carvedilol, a non-cardio selective vasodilating beta-blocker, has been claimed to be as effective in preventing variceal bleeding as EVL. We compared the efficacy and safety of carvedilol against placebo in the prevention of growth of small to large varices.

*Methods*: One hundred and seventy-five consecutive patients with cirrhosis and portal hypertension with small esophageal varices (\<5 mm in size and no red color signs) were prospectively enrolled from November 2010 to December 2012. Eight-eight patients received carvedilol (Group A) and 87 patients received matched placebo (Group B). Upper gastrointestinal endoscopy was done at baseline, 6 months and 12 months. Fibroscan and HVPG were done at baseline and at 1 year of follow up. The primary endpoint of the study was prevention of development of large (\>5 mm) varices. The secondary endpoints were adverse events and mortality in both groups.

*Results*: Sixty-three patients in Group A and 69 patients in Group B completed 1 year follow up. The mean CTP and MELD in the carvedilol arm was 7.31±2.1 and 13.65±5.4 while in the placebo arm was 7.48±2.2 and 14.2±5.28 respectively. The mean carvedilol dose was 11.923±2.05 mg/day and target heart rate achieved in Group A was 58±3 beats per minute. Baseline HVPG in Group A and B were 15.3±3.9 and 16.06±5.7 respectively. After 1 year of treatment, there was no statistical difference in reduction of HVPG in the two groups (*p*-0.224). There was no correlation between change in HVPG and fibro scan in carvedilol and placebo group after the period of 1 year (*p*=0.415 vs. *p*=0.799). Twelve (19 %) patients in Group A and 14 (20.1 %) in Group B developed large esophageal varices (*p*=ns). The actuarial probability of prevention of development of large esophageal varices at 30 month was also not different between the groups (*p*-0.218). The kappa index for assessment of variceal size was \<5 %. There were no difference in adverse events reported (7.9 % in Group A vs. 1.4 % in Group B, *p*=0.109). No patient bled from varices in either group.

*Conclusion*: This is the first RCT (NCT01196507) showing that while carvedilol was well tolerated, it was not effective in preventing growth of small to large esophageal varices. The drug was also not effective in achieving significant reduction in HVPG in this group of patients at 12 months.
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### Exercise induced maximal heart rate and risk of variceal bleeding in patients with cirrhosis: A prospective observational study {#Sec313}

***Anil Jangir*** *, S K Mahiuddin Ahammed, Kausik Das, G K Dhali, Abhijit Chowdhury*

Departments of Medical Gastroenterology and Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research, Kolkata 700 020, India

*Background*: Variceal hemorrhage, most direct consequence of portal hypertension, cause substantial morbidity and mortality. Exercise induced changes in hemodynamic parameters are expected to influence the portal pressure and hence the risk of variceal bleeding.

*Aims and Objectives*: To study, prospectively, the relationship between exercise induced maximal heart rate and risk of variceal bleeding in patients with cirrhosis.

*Materials and Methods*: Consecutive patients of cirrhosis with portal HTN were prospectively enrolled attending our OPD. Group A comprised of non-bleeder patients with either large esophageal varices (CTP class A or B) or with small esophageal varices (CTP class B only). Group B comprised of patients with variceal bleed within 4 weeks of attending OPD. Group A patients were put on propranolol with heart rate monitoring and Group B patients were given propranolol along with EBL to cause obliteration of varices. All patients underwent TMT (treadmill test) to look for maximal HR achieved at 9.3 METS which is equivalent to moderate exercise. Endpoint was variceal bleed in group A and recurrence of varices in Group B.

*Results*: Out of 40 patients, 35 belonged to group A and 5 to group B. Mean (±SD) age was 43.82 (±9.78) years in group A and 48 (±7.87) years in group B. Etiology of cirrhosis was -- 12 patients each due to HBV and ethanol related, 10 cryptogenic, 5 HCV related and one NASH related. Twenty-three out of 40 (57.5 %) patients required 160 mg daily dose of propranolol to achieve desired HR. Mean (±SD) HR at rest was 62.95±8.04 per minute (min HR 46, max HR 84). Mean (±SD) HR at 9.3 METS was 103.8±13.07 per minute (min HR 81, max HR 141). There were only 2 endpoint events in group A. Demographic, clinical and exercise characteristics of these two patients were similar to rest of the study population. There was no endpoint event in group B. Only 3/40 patients reported adverse events to propranolol and none required withdrawal.

*Conclusion*: In early cirrhosis with portal HTN, propranolol is an effective agent for both primary and secondary prophylaxis with minimal adverse effects. Greater number of patients are required to correlate moderate exercise induced maximal HR to risk of variceal bleeding.
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### Design of immune therapy for treating chronic hepatitis B on the basis of accumulated evidences in the benches and bedsides over last three decades {#Sec316}

***Mamun Al-Mahtab*** *, Fazle Akbar, Helal Uddin, Salimur Rahman, Julio Cesar Aguilar Rubido, Gerardo Enrique Guillen Nieto, Yoichi Hiasa*

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Department of Medical Sciences, Toshiba General Hospital, Tokyo, Japan, Clinical Research Organization, Dhaka, Bangladesh, and Center for Genetic Engineering and Bio

*Introduction*: Distorted immunity in CHB and in animal models of chronic HBV infection and inadequate immune restoration by antiviral drugs has opened the scope of immunetherapy for CHB with immune-modulators. However, ongoing regimens of immunetherapy were not effective during last 3 decades. It appears that non-HBV antigen-specific agents (cytokines, interleukins, growth factors etc.) will not be effective for CHB. Clinical trials show that these are either ineffective or adequate amounts could not be used due to safety concerns. HBsAg-based prophylactic vaccines for therapeutic purposes also could not stand the test of time and was unable to show therapeutic effect in combination with antiviral drugs or with cell-based or DNA-based therapy.

*Methods*: Studies in HBV transgenic mice revealed that HBcAg should be an integral part of any therapeutic vaccine, because HBcAg-specific cellular immunity down regulates HBV replication and protects liver. A phase I/II clinical trial was accomplished in 18 CHB patients and the long-term safety profile and efficacy led to a phase III clinical trial with this vaccine in 151 patients, in which 75 patients received the vaccine and 76 patients received pegylated-interferon once weekly for 48 weeks.

*Results*: HBsAg/HBcAg-vaccine is safer therapeutic approach and efficacy is comparable to or better than pegylated-interferon. Opportunities remain to attain results by altering dose, duration and route of administration. Combination of HBsAg/HBcAg-vaccine with antiviral or other immune modulators remain an additional option.

*Conclusion*: Success of therapeutic vaccine in CHB would unveil new fields of immune therapeutic approaches against cancer, autoimmunity, allergies and transplantation.
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### Impact of entecavir versus lamivudine on hepatic covalently closed-circular DNA and total hepatic HBV DNA in nucleoside-naive HBeAg positive chronic hepatitis B patients {#Sec318}

*Scott Bowden, Stephen Locarnini, Ting-Tsung Chang, You-Chen Chao, Kwang-hyub Han, Robert G Gish, Robert de Man, Cyril Llamoso, Hong Tang*

Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria; National Cheng Kung University Medical College, Tainan, Taiwan; Tri-Service General Hospital, Taipei, Taiwan; Severance Hospital, Seoul, Korea, Republic of; and University of

*Background*: Hepatic cccDNA and chromosomal HBV integration, together with liver inflammation resulting from the immunological reaction to the infection, are believed to contribute to HCC development. Limited data are available on the effect of nucleos(t)ide analogues on hepatic cccDNA and total HBV DNA levels. These results describe the effect of entecavir (ETV) on hepatic cccDNA and total HBV DNA levels compared with lamivudine (LVD) in biopsies from patients enrolled in the phase III study ETV-022.

*Methods*: Patients with evaluable hepatic cccDNA and total hepatic HBV DNA pairs (ie. both baseline and week 48 measurements from biopsies) were included. Differences (ETV vs. LVD) in mean log10 changes in hepatic cccDNA and total hepatic HBV DNA were estimated using linear regression adjusted for baseline levels. Total hepatic HBV DNA was extracted from frozen liver samples using the Epicenter Masterpure kit. Hepatic cccDNA and total hepatic HBV DNA were quantified by real-time PCR (Roche Light Cycler), and copy numbers per human genome equivalent (HGEq) were determined by normalizing samples to the cellular beta-globin gene (limit of detection for both hepatic cccDNA and total hepatic HBV DNA: 0.002 copies/HGEq).

*Results*: Overall, 305 patients had evaluable pairs (ETV: 159; LVD: 146). Baseline demographics and disease characteristics were comparable between the two arms. Compared with LVD, ETV demonstrated significantly greater reductions of hepatic cccDNA and total hepatic DNA levels at week 48 from baseline.

*Conclusion*: At Week 48, treatment with ETV is superior to LVD in reducing hepatic cccDNA and total hepatic HBV DNA from baseline.
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### Over-expression of microRNA-30a inhibits HBx-induced autophagosome formation in hepatic cells {#Sec320}

***Satendra Kumar*** *, Sweta Khanal, Aashirwad Shahi, Parul Gupta, Preeti Damania, Senthil Kumar Venugopal*

South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi 110 021, India

*Background*: One of the ways that HBV survives and replicates in the host cells is by inducing autophagy. Previous reports have shown that miRNA-30a inhibits autophagosome formation in cancer cells. Hence, we hypothesized that over-expression of miRNA-30a could inhibit HBV-induced autohphagosome formation in HCC.

*Methods*: microRNA-30a was over-expressed in Hep G2 cells and Hep G2.2.1.5 cells. After 72 hours, total RNA was isolated and real time PCR was performed. Western blots were performed for beclin-1, caspase-3 and β-actin. Hep G2 cells were transfected with pSG5-HBx plasmid and its effect on miRNA-30a and beclin-1 was determined.

*Results*: Over-expression of miRNA-30a resulted in a 20-fold increase (*n*=3; *p*\<0.001) in the intracellular levels of miRNA-30a. The expression of beclin-1 was 4-fold higher in Hep G2.2.1.5 cells compared to Hep G2 cells. miRNA-30a over-expression in Hep G2 and Hep G2.2.1.5 cells resulted in a significant decrease in the expression of beclin-1 protein levels (8-fold and 4-fold respectively; *n*=3; *p*\<0.05). Hep G2 cells were transfected with pSG5-HBx plasmid or empty vector. It was found there was a significant increase in beclin-1 expression (6-fold increase in HBx transfected cells). There was no effect of HBx on miRNA-30a. Over-expression of miRNA-30a significantly increased cleaved caspase-3 protein levels, suggesting that over-expression of miRNA-30a induces apoptosis.

*Conclusion*: These data demonstrate that HBx induces beclin-1 expression and over-expression of miRNA-30a could successfully inhibit the autophagy induced by HBx.
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### Etiological pattern of acute viral hepatitis in Sikkim (North Eastern State) {#Sec322}

***O P Dhakal*** *, Mona Dhakal*

Sikkim-Manipal Institute of Medical Sciences (SMIMS) and Central Referral Hospital (CRH), 5th Mile Tadong, Gangtok, Sikkim 737 102, India

*Introduction*: Hepatitis is an inflammation of the liver, commonly caused by a viral infection, alcohol, drugs and other systemic causes. The five main hepatitis viruses are A, B, C, D and E. These are of greatest concern because of the burden of illness and potential for outbreaks and epidemic spread. Types B and C leads to chronic disease and are the most common cause of liver cirrhosis and cancer. Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of blood or fluid contact. Acute infection may occur with limited or no symptoms, or may include symptoms such as jaundice, dark urine, extreme fatigue, nausea, vomiting and abdominal pain.

*Aim of Study*: To see the etiological pattern of acute viral hepatitis.

*Method*: One hundred cases of acute hepatitis over a period of two years were taken for study and collected blood sample was tested for HBsAg, anti-HCV, IgM HAV and IgM HEV.

*Result*: Out of 100 cases 54 cases were males and 46 were females. Two percent of total were positive for HBsAg, one percent were positive for anti-HCV, 80 % were positive for IgM HAV and 6 % were positive for IgM HEV and 11 % tested for none.

*Conclusion*: Majority of patients tested positive for hepatitis A infection and few tested for hepatitis E infection. Those who tested positive for hepatitis E infection were all females.
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### Maternal anthropometric and biochemical factor in hepatitis E virus infection during pregnancy {#Sec324}

***Sheetal Sharma*** *, Ashok Kumar, P Kar, Sarita Aggarwal*

Departments of Obstetrics and Gynecology, Department of Medicine, Department of Biochemistry

*Background*: Hepatitis E virus (HEV) infection during is fatal during pregnancy. Pregnant women in developing countries suffer from malnutrition which as a host factors is known to cause reduced immunocompetence leading to greater risk of multiple viral infections.

*Objective*: To evaluate the maternal nutritional status in viral hepatitis during pregnancy and correlate it with severity of hepatitis E in pregnancy.

*Method*: The study includes 45 HEV infected pregnant cases, 54 non-HEV pregnant cases and 45 control cases were recruited in the study during February 2012 to May 2013. Nutritional factors were evaluated by measuring the anthropometric parameters and biochemical factors. Liver function test was done.

*Results*: BMI, mid-arm circumference and tricep skin fold thickness were found to be significantly lower in ALF pregnant patients compared between AVH pregnant patients in the HEV group and control group (*p*\<0.01). Significant decrease in level of total protein, serum albumin and globulin in AVH and ALF cases of HEV group was observed when compared to control cases (*p*\<0.01). All the anthropometric parameters showed negative correlation with PT and TB and positive correlation with SGOT. Although only PT showed a significant correlation with BMI and TFT (r=0.297, *p*=0.05 and r=0.304, *p*=0.04 respectively).

*Conclusion*: Nutritional factors were low in ALF patients in HEV group which might be able to explain poor prognosis of disease during pregnancy.
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### Profile of hepatitis B screening in a tertiary hospital in Salem {#Sec326}

***T Rajkumar Solomon*** *, Caroline Selvi K, A Aravind*

Department of Medical Gastroenterology, Government Mohan Kumaramangalam Medical College Hospital, Salem 636 001, India

*Aim*: To present the profile of hepatitis B screening programme at the Department of Medical Gastroenterology at a tertiary referral centre.

*Methods*: This is a prospective study. One thousand five hundred and eleven persons were screened for HBsAg between July 2012 and June 2013. Subsequently liver function tests, HBeAg, HBV DNA quantification and abdominal ultrasound were done for HBsAg positive persons.

*Results*: Of these 1,511 persons, eighty one patients tested positive (5.36 %). Males outnumbered females (62 males vs. 19 females) M:F ratio was 3.26. Those who tested positive for HBsAg were from ages 12 to 70 years. The HBsAg positive persons were evaluated with liver function tests, abdominal ultrasound, HBeAg and HBV DNA quantification by PCR method. Family screening was done for persons positive for HBsAg. Hepatitis B vaccine was advised for those negative for HBsAg. Nine patients who were HBeAg positive had viral DNA more than 20000 IU/mL and 21 patients who were HBeAg negative had HBV DNA more than 2000 IU/mL. The rest (61 persons) were HBeAg negative, HBV DNA negative with normal transaminases. ALT and AST were significantly elevated in those with significant viral load in both HBeAg positive and HBeAg negative subjects. These patients were inducted for anti-viral therapy and they were (and are) reviewed and monitored with liver function tests every 3 months and viral load every 6 months. One family of four is on anti-viral therapy.

*Conclusion*: Hepatitis B screening helps to identify HBV infection in this community and to assess those that require active treatment.
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### Hepatitis B virus and hepatitis C virus infection among chronic alcoholics in tertiary care hospital {#Sec328}

***A K Sharma*** *, A K Pannu, V Singh, U Debi, K Singh*

Departments of Super Speciality of Gastroenterology and Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Alcohol drinking and viral hepatitis are major cause of liver disease worldwide. The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among alcoholics with morbidity attending for medical care is not clearly known from this region.

*Objective*: To know the prevalence of HBV and HCV infection among chronic alcoholics attending tertiary care hospital.

*Methods*: One hundred and three consecutive alcoholic patients with various ailments attending Department of Gastroenterology and Hepatology, Nehru Hospital, PGIMER were included in the study. Questionnaire based information was collected on alcohol consumption and disease profile. Routine blood investigations and USG were done. All were also tested for HBsAg and anti-HCV by ELISA.

*Results*: Among chronic alcoholics 102 were males (99 %) and 01 female (1 %). Mean age of alcoholics was 44.11 yrs±10.69. The mean daily intake of alcohol was 108.35 g /day± 66.88. The mean duration of alcohol drinking was 17.27 yrs.±8.79. Overall 77.6 % (80/103) chronic alcoholics had liver disease based on clinical, biochemical and USG. Twenty percent (16/80) alcoholics had fatty liver disease while 6.2 % (5/80) had only hepatitis. 72.5 % (58/80) patients were having liver cirrhosis. Among these alcoholics 15 % (12/80) had acute on chronic liver disease while 57.5 % (46/80) had decompensated cirrhosis. 3.9 % (4/103) alcoholics were reactive for HBsAg while 9.7 % (10/103) were reactive for anti-HCV by ELISA.

*Conclusion*: Prevalence of HCV infection among chronic alcoholics was 9.7 %. HBV infection was found in 3.9 % chronic alcoholic patients attending tertiary hospital from this region.
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### Hepatitis B seroprevalence among pregnant women and its vertical transmission rate in Department of Digestive Health and Diseases, KMC, Chennai {#Sec330}

***M Tarakeshwari*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, SJeevan Kumar*

Department of Digestive Health and Diseases, Government Peripheral Hospital, Kilpauk Medical College, Chennai 600 010, India

*Background*: A teaching hospital based population study is a strong indicator of true HBV infection rate in the community as large number of patients from different backgrounds attend the hospital.

*Aim*: To determine the prevalence of HBV infection among pregnant women at Kilpauk Medical College Hospital.

*Methods*: A total of 5,463 pregnant females with 38 weeks of gestation constituted the target of the present study. Blood samples were drawn from all subjects and sera was tested for hepatitis B surface antigen by ELISA technique. Hepatitis B positive mothers were further tested for hepatitis B e antigen, liver function tests and HBV DNA titre. Infants of hepatitis B positive mothers were tested for surface antigen at nine months.

*Results*: Overall 53 (0.97 %) pregnant women were identified as positive for hepatitis B surface antigen. Women in the age group of 21-25 had the highest prevalence at 60.37 %. Of the seropositive mothers hepatitis B e antigen was positive in 13 patients with 2 having elevated DNA titres. Of the 40 patients who were hepatitis e antigen negative one had elevated DNA titre. All three patients with elevated DNA titre had elevated liver enzymes and were started on antivirals. One infant born of infected mothers tested positive for hepatitis B surface antigen.

*Conclusion*: The seroprevalence of hepatitis B among pregnant women in our study was found to be 0.97 % which was less than the national average of 2 % to 7 %. Most of the patients were asymptomatic. The vertical transmission rate was 6.25 %.
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### Maternal and fetal outcome in HEV and non-HEV infected pregnant patients with acute viral hepatitis {#Sec332}

***Jasmine Parihar*** *, Aparna Agrawal, Abha Singh, Manoj Jais*

University of Delhi

In this prospective observational study of 63 pregnant patients with acute viral hepatitis during pregnancy, 13 had hepatitis E virus (HEV) infection (group A) and 50 had non-HEV infection (group B). The mean age of study population was 24.4±2.8 years, majority being primigravida (38.9 %) and in 3rd trimester of pregnancy (60.32 %). The difference in the demographic profile, clinical presentation, hematological and biochemical parameters between 2 groups at presentation was statistically insignificant. Group A and B had comparable peak serum levels of biliuribin (7.6±4.7mg/dL vs. 9.3±4.9mg/dL; *p*=0.4), AST (1640±798IU/L vs. 1645±924IU/L; *p*=0.98) and ALT (1918±1085IU/L vs. 1585±899IU/L; *p*=2.6). Cerebral edema was more common in group A than B (23.1 % vs. 2.1 %; *p*=0.006). Fulminant hepatic failure developed in 23 % of group A patients and 12.5 % of group B patients (*p*\>0.05). The frequency of none of the other complications was significantly different between 2 groups. 46.2 % of HEV infected patients had preterm labor as compared to 18.7 % of non-HEV patients (*p*=0.044). Maternal mortality was similar in two groups (7.7 % vs. 4.2 %; *p*=0.581). Obstetric outcome was also comparable. Eleven HEV infected and 40 non-HEV infected patients delivered live babies. Among these 36.4 % of group A and 75 % of group B patients had term appropriate for gestational age (AGA) babies (*p*=0.043) whereas 54.5 % of group A patients had preterm AGA babies (vs. 17.5 % in group B; *p*=0.014). Neonatal deaths were more common babies of HEV infected mothers (18.2 % vs. 2.5 %; *p*=0.05).
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### Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality {#Sec334}

*Bhupesh K Prusty, Suresh Hedau, Ajay Singh,* ***Premashis Kar*** *, Bhudev C Das*

Division of Molecular Oncology, Institute of Cytology and Preventive Oncology, Noida, India, Department of Medicine, Maulana Azad Medical College, Bahadur Shah Zafar Marg, Delhi Gate, Delhi 110 002, India

Fulminant hepatitis in Asian pregnant women is generally caused by hepatitis E virus infection, and extremely high mortality is most common in them. Decreased cell-mediated immunity is considered a major cause of death in these cases, but what exactly influences decreased immunity and high mortality specifically during pregnancy is not known. We used electrophoretic mobility shift assays, immunoblotting, and immunohistochemical analysis to study the expression and DNA binding activity of NF-kB p50 and NF-kB p65 in pregnant fulminant hepatic failure (FHF) patients and compared them with their nonpregnant counterparts. In both PBMC and postmortem liver biopsy specimens the DNA-binding activity of NF-kB was very high in samples from pregnant FHF patients compared with those from nonpregnant women as well as pregnant women with acute viral hepatitis (AVH) without FHF. Further dissection of the NF-kB complex in supershift assays demonstrated complete absence of p65 in the NF-kB complex, which is formed by homodimerization of the p50 component in pregnant FHF patients. Western blotting and immunohistochemical analysis of the expression of p50 and p65 proteins both showed higher levels of p50 expression and a complete absence or a minimal expression of p65, indicating its nonparticipation in NF-kB dependent transactivation in pregnant FHF patients. We suggest that the exclusion of p65 from the NF-kB transactivation complex seems to be a crucial step that may cause deregulated immunity and severe liver damage, leading to the death of the patient. Our findings provide a molecular basis, for developing novel therapeutic approaches.
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### IL-8 serum levels and CXCR-2 gene polymorphisms in HBV and HCV related chronic hepatitis and cirrhosis {#Sec336}

***Shubham Vatsya*** *, Richa Dewan, P Kar*
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*Background and Aims*: Interleukin-8 is a potent chemo attractant for neutrophils and contributes to acute liver inflammation. Much less is known about IL-8 in chronic liver diseases (CLD). We investigated the regulation of IL-8, its receptors CXCR1 and CXCR2 in CLD patients.

*Methodology*: A total of 50 cases of chronic hepatitis, 50 cases of liver cirrhosis and 50 healthy age sex matched individuals as control were included in the study. Serum IL-8 and CXCL5 levels were estimated by using respective ELISA kit. The isolated total genomic DNA, SNPs in CXCR2 (rs2230054 \[C/T\]) and CXCL5 promoter (rs352046 \[C/G\]), were detected by PCR technique using type specific primers.

*Results*: Three genotypes of the same SNP rs2230054 of receptor CXCR-2 namely CC, TC and TT were analyzed to see the difference in serum levels of Interleukin-8 between the HBV and HCV group and amongst the three genotypes of this SNP. The difference in the serum levels of Interleukin-8 between the HBV and HCV group was statistically significant as far as the TC genotype was concerned *p*-value=0.001.

*Conclusions*: Serum Interleukin-8 levels were highest in the chronic hepatitis group followed by the cirrhotic group and lowest in the control group. In HBV infections the SNP rs2230054 TC genotype of receptor CXCR-2 influenced Interleukin-8 serum levels and significantly high levels were found in these cases, which mean association of rs2230054 TC genotype with HBV enhances progression of the disease.
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### Hepatitis B virus precore and basal core promoter mutation in HBeAg negative inactive carriers {#Sec340}

***Neha Gupta***, *Jitendra Kumar Choudhary, Manish Kumar Tripathi, Smita Verma, Arttrika Ranjan, Vinod Kumar Dixit, Ashok Kumar Jain*
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*Background*: Chronic hepatitis B virus (HBV) infection has high prevalence in our country accounting for almost 50 million subjects. Mostly chronic HBV infected subjects are asymptomatic. Many of these have inactive infection with HBeAntigen (HBeAg) negative and others have replicative infection with HBeAg positivity. However, these asymptomatic individuals need evaluation with particular reference to presence of mutations in precore (PC) and basal core promoter (BCP) region.

*Aim*: To study the relevance of HBV mutants in asymptomatic HBV infected subjects.

*Patients and Methods*: In this study 37 (34 HBeAg negative) asymptomatic subjects with normal liver function were enrolled. The determination and confirmation of precore and basal core promoter sequence and mutation of HBV was done by using PCR followed by RFLP and direct sequencing.

*Results*: Majority 34 (92 %) subjects were HBeAg negative and 3 (8 %) were HBeAg positive. HBeAg positive subjects might had immunotolerant infection without any clinical and biochemical abnormality. Mean viral load in immunotolerant 7.08±1.16 and in HBeAg negative subjects 1.64±1.21 was significant (*p*\<0.05). The prevalence of mutation was PC 3 (8.8 %), BCP 8 (23.5 %) and PC+BCP 12 (35.3 %) in HBeAg negative subjects ie. inactive chronic carriers.

Comparison of biochemical parameters in mutant and wild type in HBeAg negative subjectsVariableMutant (*n*=23)Wild type (*n*=11)*p*-valueALT (IU/L)31.00±9.8326.64±5.710.114Serum albumin (g/dL)4.65±0.484.64±0.580.937Prothrombin time (INR)1.11±0.151.22±0.190.112DNA (log10 copies/mL)1.81±1.031.27±0.860.146

*Conclusion:* BCP/PC mutation was noted in two third of HBeAg negative asymptomatic chronic infection (inactive carriers). Clinical and biochemical profile was similar irrespective of presence or absence of mutant strains.
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### Community prevalence of HBV in an urban industrial population in south India {#Sec344}

***Chintan Kansagra*** *, B Sukanya, Nayana Joshi, Sandip Shah, Nikhil Shirole, Kunal Vyawahare, Ajit Kumar*

Department of Medical Gastroenterology, Nizam's Institue of Medical Sciences, Punjagutta, Hyderabad 500 082, India

*Background*: India comes in the intermediate zone for the prevalence for HBV. There exist only few studies, which reflect the status in the general population as most studies come from the blood banks.

*Aim*: To study the prevalence of hepatitis-B infection in South Indian industrial population.

*Methods*: The study population comprised of 4,021 healthy industrial workers and their families who were screened for hepatitis-B surface antigen (HBsAg) spot test. Seroprevalence rate was calculated and stratified by age and sex. Appropriate statistics was applied.

*Results*: Out of 4,021 workers, 66 (1.64 %) were HBsAg positive. Higher prevalence of HBsAg was found amongst males 1.67 % (58/3453) than females 1.4 % (8/568) (*p*=NS). The age specific prevalence increased from 0.81 % (1/123) in workers aged 11-20 years to a maximum of 2.45 % (21/855) in workers aged 41-50 years and decreased in older age groups. The peaks were detected in male participants aged 41-50 years and in females aged 31-40 (2.20 %) years. HBeAg positivity was low (5/66) (7.56 %). Only one out of 66 patients required treatment based on HBV DNA, ALT and other criteria.

*Conclusion*: Prevalence of HBsAg was very low in our population. Majority were in non-replicative phase of HBV infection. Males and females had equal prevalence.
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### Role of serum Mannan-Binding lectin levels in chronic hepatitis C patients undergoing interferon plus ribavirin treatment {#Sec346}

***Rajesh Ruttala*** *, Phani Kumar Gumma, Vijay Kumar Karra, Soumya Jyoti Chowdhury, Sunil Kumar Polipalli, Premashis Kar*
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*Background*: Chronic hepatitis C virus (HCV) infection is a major worldwide public health problem affecting an estimated 180 million people worldwide and leads to chronic liver disease. Mannan-Binding lectin (MBL) is a liver-derived pluripotent serum lectin that plays a role in the innate immune system of the host. It is an acute-phase protein that is involved in the activation of the classical complement pathway. MBL may play a defensive role in HCV infection.

*Objectives*: To investigate the relationship between MBL concentration and HCV infection in North Indian patients suffering from chronic hepatitis C.

*Materials and Methods*: Serum samples obtained from 60 North Indian population visiting Lok Nayak Hospital, OPD who were diagnosed with hepatitis C and underwent conventional treatment with interferon+ribavirin. Sixty normal controls were assayed for MBL using commercial ELISA kit. MBL concentrations were correlated to disease characteristics and treatment response.

*Results*: Mean age±S.D of the patient group was 37.43±9.65. The mean+S.D. of MBL levels was significantly different in healthy controls and CHC patients (1325±492 ng/mL vs. 619±130 ng/mL \[*p*\<0.001, t=10.65\]). The MBL levels of responders (*n*=39, 1870±288 ng/mL) was significantly higher than non-responders (*n*=21, 1020±160 ng/mL) (*p*\<0.0001, t=11.26).

*Conclusions*: MBL levels were significantly higher in CHC patients when compared to healthy controls. The significant difference between the responder and non-responder in treatment group indicates MBL as an important factor influencing the outcome of CHC to treatment.
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### IL-28B genotype testing in chronic hepatitis C patients and healthy populations in India {#Sec350}

***Baibaswata Nayak*** *, Chandreswar Prasad, Jyotish Kumar Jha, Shyam Praksah, Shalimar, Subrat Kumar Acharya*
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The IL28B gene encodes protein that belongs to type III IFN family known as IFN 3. The expression of IL-28B gene can activate IFN-stimulated regulatory factor 3 and induce expression of other genes containing IFN-stimulated response elements through JAK/STAT pathway and exert antiviral response. Single nucleotide polymorphisms (SNPs) of IL-28b gene can affect its expression and its antiviral effect. Recent genome wide association study (GWAS) in chronic hepatitis C (CHC) patients indicate that IL28B gene SNPs can be used as a predictive marker for the success of PEG-IFN/RBV therapy. The IL28B gene SNP genotype testing will be useful for determining IFN responsiveness and the likelihood of achieving rapid virological response (RVR) and sustained virological response (SVR) in CHC patients. However, association of SVR to PEG-IFN/ribavirin therapy is shown for IL28b SNPs rs12979860 and rs8099917. We have developed test for IL28b genotype for SNPs rs12979860 and rs8099917 for mass genotyping in Indian populations. The genomic DNA from whole blood of CHC patient and healthy volunteer was isolated. For genotyping, three tests were standardized that includes Taqman probe based genotyping, Genome Lab SNP start primer extension kit for multiplexing and SYBR green detection based real time ARMs-PCR test and confirmed by sequencing. We have evaluated sixty CHC patients and sixty healthy volunteer for IL28b genotyping. Frequency and distribution of favorable phenotype (CC or C allele for rs12979860 and TT or T allele for rs8099917) in healthy and CHC patients has been evaluated and prospectively followed for virological response in CHC patients.
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### Prevalent of hepatitis B virus genotype D in a tertiary care hospital in Guwahati, Assam {#Sec352}

***Namrata Kumari***, *Snigdha Saikia, Parag Nath, Moumita Bose, Subhash Medhi, Bhavadev Goswami, Premashis Kar, Manab Deka*
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*Background and Aim*: The geographical distribution pattern of HBV genotypes have a distinct molecular epidemiology in the eastern part compared to other parts of India. This study is an effort to examine the prevalence of HBV genotypes diagnosed in HBV infection with respect to various spectrums of liver diseases in Assam.

*Method*: A total of 450 liver diseases cases attending the general OPD of Gauhati Medical College were screened for HBsAg positivity by ELISA. HBsAg positive cases were further examined for HBV DNA using primers specific for the core and precore region. HBV genotypes were determined by multiplex PCR (Krischberg et al. January 2004).

*Result*: Serological screening showed 109 samples to be HBsAg positive (24.2 %) which included acute viral hepatitis 43/109 (39.4 %), chronic hepatitis 62/109 (56.88 %), cirrhosis 3/109 (2.75 %), HCC 1/109 (0.91 %), with a mean age of 39.3±13 and Male: female::5:1. Out of the 109 HBsAg positive cases, HBV DNA were positive in 20 cases (18.3 %). Of which 17 were chronic and 3 were acute viral hepatitis. Genotype-D were found in all HBV positive cases.

*Conclusion*: HBV genotype D were most prevalent in Guwahati. HBV genotyping became a routine exercise in clinical medicine and molecular epidemiology.
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### Development of in-house method for quantification of HCV RNA by real time PCR {#Sec354}

***Shyam Prakash***, *Priyatma, Shalimar, S K Acharya*
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Quantitation of HCV RNA is important for monitoring of disease progression and assessment of viral response to antiviral therapy. Various in-house assays have been developed, but many of these have limitations of relatively low sensitivity and limited dynamic range. To develop a fluorogenic probe based detection of viral RNA by real time PCR. Two hundred and seventeen serum samples were collected from the liver clinic of the Department of Gastroenterology, AIIMS, New Delhi. Each of them was screened for anti-HCV, HBsAg, HBeAg and subsequently subgroups were made for HCV RNA quantitation. The range of age was 13-75 years (M/F ratio 1.8:1). Twenty healthy subjects were also included and screened for anti-HCV, HBsAg and HBeAg in the study. In the etiology of hepatitis clinical, biochemical and ultrasonographical investigations were done in patients. The real time PCR showed good intra-inter reproducibility over a wide dynamic range (1 x 100 to 1 x 1000000 copies/mL) and correlated well with those from commercial assay (r=0.99, (*p*,0.001). For assay calibration, the Acromatrix HCV international standard was used and procured from the Applied Biosciences. Statistical analysis was done and *p*-values \<0.05 were deemed statistically significant. This method is reliable, accurate and reproducible. HCV RNA quantification by real time PCR can be used to monitor the efficacy of HCV therapy and for studying the relationship between HCV viral load and stage of the disease.
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### Screening the influence of folate receptor alpha expression on hepatitis E related pregnancy outcome {#Sec356}

***Purabi Deka Bose*** *, Diptika Tiwari, Chandana Ray, M Bose, Tarun Basumatary, Manab Deka, Sujoy Bose*
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Folate transport from the mother to the fetus across the placenta involving folate transporters is critical for proper fetal growth and development. Possible associations between placental abruption, altered folate receptor expression requires additional attention with respect to HEV-infected-pregnancy-related complications like preterm birth, and both fetal and maternal mortality.

*Aim*: Study the role of differential expression of folate receptor-alpha (FR-α) in deciding the fate of pregnancy outcome or severity of Hep-E related pregnancy cases.

*Methods*: HEV-infected-pregnancy cases (AVH=16, FHF=09), preterm delivery cases (*n*=50) and healthy pregnant women from the same community (*n*=65) were included in the present study and followed till delivery or outcome. HEV genotyping was performed by PCR-sequencing analysis. Differential mRNA profile of FR-α expression was studied by RT-PCR using β-actin as internal control. Statistical analysis was performed by SPSSv13 software.

*Results*: Preterm delivery was observed in Hep-E related HFH cases (100 %) and high number of AVH cases (4/10=40 %). Fetal death (*p*=0.009) and maternal death (0.012) was significantly higher in FHF cases compared to AVH. FR-α expression was found to be down-regulated multiple folds in preterm delivery, AVH and FHF cases; the lowest expression observed in FHF cases showing more than 20 fold down-regulation of FR-α compared to controls. FR-α expression was significantly lower in FHF cases compared to AVH (*p*=0.05) and preterm delivery cases (*p*\<0.001); and significantly lower in AVH compared to healthy preterm delivery cases (*p*\<0.001).

*Conclusion*: Down-regulation of FRα expression especially in Hep-E related FHF cases can lead to reduced folate transfer to the fetus which may critically effect pregnancy complications and outcome like fetal and maternal mortality.

LVH-22 {#Sec357}
------

### Clinical significance of serum HBV DNA viral load levels in patients of chronic hepatitis B {#Sec358}

***Shilpa Arora***, *Rajesh Ruttala, Premashis Kar*
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*Background/Aims*: Serum levels of hepatitis B virus (HBV) DNA are direct measures of viral replication in hepatocytes. We investigated the correlations between HBV viral load and the clinical implications in chronic hepatitis B (CHB) infected patients.

*Methods*: Three hundred CHB \[103 inactive HBsAg carriers, 55 asymptomatic replicative carriers, 111 CHB patients and 31 patients with liver cirrhosis\] were enrolled. Study group included subjects with detectable serum HBsAg, HBeAg or anti-HBc in serum at the time of screening and for at least six months before study entry. Quantitation of HBV DNA was performed by real-time PCR.

*Results*: One hundred and eight (36 %) were HBeAg positive and 192 were (64 %) HBeAg negative. HBV DNA levels of the replicative carriers, chronic hepatitis, and cirrhosis were expressed as geometric mean±SD, 1.65×103±0.97 copies/mL, 3.83 × 106±1.28 copies/mL and 5.93 × 105±1.34 copies/mL, respectively. The mean ALT levels in patients with high viral content (66.3±1.4 mg/dL) were significantly higher than in patients with lower viral content (54.7±0.89 mg/dL; *p*\<0.001). HBV DNA levels in HBeAg positive group were significantly higher than those in HBeAg negative group (*p* \<0.0001). The correlation coefficient between HBV DNA level and HBeAg was only 0.351.

*Conclusions*: There is significant correlation between HBV DNA levels and HBeAg status as well as HBV DNA levels and ALT levels.
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### Association of serum HBsAg levels with liver histology in HBeAg positive chronic hepatitis B patients {#Sec360}

***Sundeep Goyal*** *, A K Jain, V K Dixit, S Shukla, J Ghosh, M Behra, V B Abhilash*
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*Background*: There is preliminary data suggesting lower hepatitis B surface antigen (HBsAgl) serum levels is associated with more severe liver fibrosis in HBeAg-positive patients. We studied whether single point HBsAg quantification may contribute to diagnosis of moderate to advance liver fibrosis in untreated hepatitis B e antigen-positive Indian patients.

*Methods*: HBsAgsl were measured at baseline in 374 carriers followed up prospectively (median, 12; range, 12-24 months). HBV phases were defined after 1-year monthly monitoring of HBV-DNA and transaminases. Liver histology was scored using the METAVIR system.

*Results*: HBeAg (+) patients showed significantly higher HBsAgl compared with HBeAg (-) patients: median, 29785.77 (range, 240--9,00,987) vs. median, 5475 (range, 0.07--65,105) IU/mL; *p*\<.001. Among HBeAg (-) patients HBsAgsl were significantly lower in 107 inactive carriers (IC) than 166 active carriers (AC): median, 1,018 (range, 0.07--7725) vs. median, 12,673 (range, 135--65,105) IU/mL; *p*\<.001. Serum HBsAg and HBV DNA levels in HBeAg (+) patients showed moderate correlation (r=0.32, *p*\<0.01), as did serum HBsAg levels and fibrosis severity (r=-0.61, *p*\<0.01). HBeAg (+) patients with fibrosis score ≥2 exhibited significantly lower serum HBsAg levels compared with patients with minimal or no fibrosis. In HBeAg (+) patients only factor independently associated with fibrosis ≥2 on multivariate analysis was the level of serum HBsAg.

*Conclusion*: Lower baseline levels of HBsAg might reflect the status of advanced liver fibrosis in HBeAg positive chronic hepatitis B patients.
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### Expression of Th1/Th2 cytokines in hepatitis B and C related chronic liver disease from Assam {#Sec362}

***Kangkana Kataki*** *, Subhash Medhi, Sujoy Bose, Priyanka Kashyap, Namrata Kumari, B B Borthakur, Anupam Sarma, Amal Chandra Kataki, Manab Deka*
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*Background and Aim*: Hepatitis B and C are the main causes of chronic liver disease and HCC worldwide. This study was targeted to correlate HBV and HCV associated chronic liver disease with Th1/Th2 cytokines (IL-2, IL-4, IL-6, IL-10, TNF-α± and INF-γ).

*Method*: A total of 37 chronic liver diseases cases were included in the study which include HBV related chronic hepatitis *N*=12, cirrhosis *N*=2, hepatocellular carcinoma (HCC) *N*=10. HCV related chronic hepatitis *N*=9, cirrhosis *N*=3 and HCC *N*=1 and healthy control *N*=5. Cytokine profiles of the samples were analyzed using BD cytometric bead array (CBA) human Th1/Th2 cytokine Kit II.

*Result*: In all the samples IL6 showed highest expression. Irrespective of the etiology among HCC and chronic cases expression IL-6 is statistically significant (*p*-value 0.0250). The highest concentration of IL-6 was shown in HBV mediated HCC samples with an average of 1732.89 pg/μL and the lowest concentration of IL-6 was shown in HCV mediated cirrhosis samples with an average of 10.96 pg/μL.

*Conclusion*: From the above study conducted it can be concluded that there is a significant increase in the expression of IL-6 in HBV and HCV mediated chronic liver disease compared to normal control where there is no expression and may be a prognostic marker. The small sample size is a limiting factor in this study which need further evaluation.
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### Molecular epidemiology of hepatitis C virus from India {#Sec364}

***Syed Rahamathulla*** *, Raju Nagarapu, A Anusha, Aejaz Habeeb Mohammed, V V Ramachandra Rao, Madhavi Chandra, Aleem Ahmed Khan, Vishnupriya Satti, Khaja Mohammed Nanne*
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Hepatitis C virus (HCV) infection is becoming a major menace and is evolving as a public health problem globally. Studies on the prevalence of HCV in different countries suggest that more than 300 million people worldwide got infected, out of which at least 20 million people reside in India. The population size in the present investigation is 3,168 which include 194 (6.12 %) individuals positive for HCV infection as detected by RT-PCR method, but the third generation ELISA detected only 126 (3.97 %) positive individuals. Among the 586 patients who attended the gastroenterology outpatient unit, 5 (0.85 %), 6 (1.02 %) individuals were positive for HCV by ELISA and RT-PCR methods respectively. Out of 1,698 voluntary blood donors screened, 23 (1.35 %) were positive in ELISA, while 28 (1.64 %) were positive by RT-PCR method. In the risk group category total number of patients screened were 877, out of which 98 (11.17 %) and 160 (18.24 %) were positive by ELISA and RT-PCR methods respectively. Genotypic distribution of 194 HCV patients in various categories of population. Among 6 patients attended gastroenterology camps, genotype 1a was found in 1 patient, genotype 1b in 1, genotype 3a in 1, genotype 3b in 1 patient, mixed genotypes in 2 patients. Among 28 blood donors genotype 1a was found in 2, genotype 1b in 13, genotype 3a in 2, genotype 3b in 10, and one new genotype 5a was reported. Genotyping in risk groups revealed that genotype 1b with 45.36 % is predominant followed by genotype 3b with 24.74 %.
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### Development of in vitro model for hepatitis c virus infection in human hepatocyte progenitors {#Sec366}

***Aleem Ahmed Khan*** *, Raju Nagarapu, Sandeep Kumar Viswakarma, Rahamathulla Syed, Avinash Bardia, Anusha Aggi, Ganga Bhavani, Aejaz Habeeb Mohammed*
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Hepatitis C virus (HCV) is a major health concern causing chronic liver disease in humans. Understanding the pathogenesis of HCV infection in vivo presents several hurdles for the development of more appropriate treatment modalities. In vitro culture model of HCV infection in primary hepatocytes may provide a significant tool to study the mechanism of pathogenesis of HCV in acute and chronic liver diseases. In present study EpCAM positive human hepatic progenitor cells were cultured in vitro and transfected with different genotypes of HCV serum and RNA samples. In vitro proliferation and survival of cells was determined using MTT assay, changes in cell morphology was identified using phase contrast microscopy. The transfection efficiency of HCV infection was determined by identification of viral RNA amplification using RT-PCR. The study provides a better understanding about the pathogenesis, viral replication, and in vitro susceptibility of HCV. Characterization of HCV/serum infected in vitro model will give a clear image for the study of HCV infection. It also demonstrates the response of hepatocytes with different genotypes and HCV infected serum samples.
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### Reduction in CD4+ T cells and altered monocytes/macrophages is associated with fatal acute liver failure hepatitis E virus infected pregnant patients {#Sec368}

***Rashi Sehgal*** *, Paul David, Ashish Vyas, Preeti Rawal, Syed Hissar, Gouri Nath Samudrala, Sharda Patra, Shubha Sagar Trivedi, Shiv Kumar Sarin, Nirupma Trehanpati*
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*Aim*: To investigate the innate and adaptive immune responses in pregnant women with or without fatal HEV infection.

*Methods*: We investigated the difference in innate and adaptive immune cells in HEV infected fatal acute liver failure in pregnant patients (Group A, *n*=5), pregnant females with acute viral hepatitis (Group. B, *n*=35), HEV infected non-pregnant females (Group C, *n*=10), healthy pregnant (Group D, *n*=20). Using six color flow cytometry, expression of TLR3, TLR7 and TLR9 on peripheral monocytes/macrophages, B cells was done. Memory cells in CD4+/CD8+ T cells, CCR1, CCR5, CCR6, CCR9, CXCR3 and CXCR5 were analyzed. Frequency of CD4+/CD8+cytokine-secreting cells were compared in all groups after stimulation of PBMCs with HEV ORF2, ORF3 and PMA/Ionomycin.

*Results*: Significantly increased CD14 monocytes and CD11b+CD163 macrophages (28 % and 32 % *p*=0.001, 0.002) and TLR3, TLR7 expression (*p*=0.01, *p*=0.002,) observed in Group A, B than C, D. Frequency of monocytes were significantly increased in patients with low viral load than high viral load. In Group A, reduced frequencies of CD4 T cells (*p*=0.05) and expression of CXCR5 on CD4 T cells (*p*=0.04) were observed than Group B. PBMCs stimulated with HEV ORF2 and HEV ORF3 showed decreased IL-10, IL-2 and IL-6 and increased TNF alpha, IFN- in Group A than Group B.

*Conclusion*: In fatal HEV related ALF in pregnant females, significantly reduced frequency of T cells, reduced expression of CXCR5 on CD4 T cells and consecutive increased monocytes macrophages suggests a major role of monocytes in regulating CD4 T cells.
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### Interferon induced reactivation of tuberculosis: An ignored reality! {#Sec370}
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Departments of Hepatology and Pulmonology, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India

*Background and Aims*: Interferon treatment induces immunomodulation. There have been some cases of patient developing reactivation of tuberculosis as a consequence of interferon therapy but overall data is limited. The study was done to study the profile of patients developing tuberculosis during/after interferon treatment for chronic HCV or HBV infection.

*Methods*: A prospective analysis of data involving IFN treatment in HCV or HBV infection (2009-2013) was done.

*Results*: Two hundred and thirty-three patients were administered IFN for chronic HCV infection and 35 patients for chronic HBV infection. Twelve patients developed tuberculosis as a consequence of interferon treatment for HCV or HBV related infection. Mean age was around 50 years (42-67) (Male:Female 6:6). Four patients developed tuberculosis during interferon therapy, 3 developed tuberculosis within 6 months after stopping interferon therapy and 5 patients developed tuberculosis more than 1 year after completion of interferon therapy. Three patients had diabetes and 1 also had HIV infection. Four patients had liver decompensation as presentation of development of tuberculosis. Two patients had prior tuberculosis. Focus was pulmonary in 7 patients. After treatment 11 were declared cured and 1 patient died.

*Conclusion*: Interferon treatment for chronic HCV or HBV infection increases chances of reactivation of tuberculosis infection possibly through immunomodulation. Presentation of tuberculosis could be as liver decompensation and can be delayed also. High percentage of tuberculosis occurrence site after interferon treatment was pulmonary. Routine Monteux testing and exclusion of TB infection is recommended before starting IFN therapy in chronic liver disease patients.
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### HCV genotype 3a core polymorphism in Indian patients is not associated with hepatic steatosis {#Sec372}
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*Background*: Hepatic steatosis is a common histological feature of hepatitis C infection (HCV). HCV genotype (GT) 3a core protein is associated with marked accumulation of neutral lipids contained in large lipid droplets compared to GT1b core protein. However, there is still no consensus on association of HCV core sequence polymorphism and steatosis in HCV GT3a patients. We aimed at investigating specific polymorphism in HCV GT3a core protein and its association with increased lipid accumulation in these patients.

*Method*: The study group included patients who were treatment naive, nonalcoholic, HCV genotype 3a infected with fibrosis score F=0-2 on liver biopsy. Patients were grouped into nonsteatotic (*n*=17) and steatotic (*n*=14); moderate to severe steatosis, grade 2; 33 % to 67 % cells with fat, mild steatosis, grade 1; 5 % to 32 % cells with fat and no steatosis, grade 0; 0 % to 5 % cells with fat. HCV core gene was PCR amplified, cloned and sequenced. Translated HCV core sequences were aligned using ClustalW program in Bioedit, v7.2.0 to identify candidate polymorphisms associated with increased intracellular lipid levels. Phylogenetic and molecular evolutionary analyzes were conducted with MEGA5 software by maximum likelihood method. For in vitro assessment of lipid accumulation, full length HCV core gene were subcloned in pEGFP-C3 vector and transfected in Huh7 cells and lipid accumulation was assessed by Nile Red staining.

*Result*: We observed 2 polymorphisms at amino acid position 106; domain1; S to N/T (*p*=0.45) and 162; domain 2; I to V (*p*=0.47), however, no significant association was found between particular amino-acid residues or motifs in the full genome core region (domains 1, 2 and 3) and steatosis. Residues specific to genotype 3a strain, such as F164 were found in all patients irrespective of steatosis severity, as opposed to previous report implicating it with steatosis in vitro. Similarly, phenylalanine-valine (FV) at positions 182 and 186 (as opposed to FI) were not found in our study, albeit leucine- isoleucine (LI) was found more frequently in both the study groups. Phylogenetic analysis of the core sequences from steatosis and non-steatosis patients revealed that sequences were found to be equally distributed throughout the phylogenetic tree. Further, we did not observe a difference in intracellular lipid accumulation in GT3a core transfected Huh7 cells compared to vector transfected cells.

*Conclusion*: Thus, we conclude that polymorphisms observed in GT3a core sequence do not associate with steatosis in Indian patients, suggesting the involvement of other HCV proteins or individual host factors in mediating hepatic steatosis.
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### Etiolology and prognostic factors in patients of acute liver failure {#Sec374}

***M K Behera*** *, A K Jain, V K Dixit, V B Abhilash, S Goel, J K Ghosh, M P Tripathy*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Introduction*: Acute hepatic failure is characterized by the rapid deterioration of liver function resulting in altered mental status and coagulopathy in patients with previous normal liver or at least well compensated liver disease. The etiology of fulminant hepatic failure refers to a wide variety of causes, of which viral hepatitis or toxin-induced are most common.

*Material and Method:* This was a retrospective study done between January 2008 to March 2013. A total of 61 patients were included in the study based on retrospective collection of data of acute liver failure patients. Multiple parameters were compared between survivors and nonsurvivors in a univariate analysis. All significant factors on univariate analysis were analyzed further into stepwise logistic regression analysis to identify independent variables of prognosis.

*Results*: Out of 61 patients, there was 35 female and 26 male patients and the sex ratio was 1.34:1. Acute hepatitis B was causative agent in 22 (36.06 %) patients, and acute hepatitis E, alcoholic hepatitis, acute hepatitis A, antitubercular drugs, acute Budd-Chairi syndrome acoounts for 6 (9.83 %), 5 (8.19), 3 (4.91), 2 (3.27 %) patients. There was overall mortality rate of 81.9 % (50 patients) and survival rate was 19.1 % (11 patients). On multivariate analysis, non-hepatitis A etiology, prothrombin time \>30 s, grade of coma \>2 predicted poor outcome.

*Conclusions:* Most common cause of acute liver failure in our instution was acute hepatitis B and early predictors of mortality were non-hepatitis A etiology, prothrombin time\>30 s, Grade of coma \>2.
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### Prevalence and trends of hepatitis C virus seropositivity among blood donors in Punjab: A 5 year analysis {#Sec376}

*Sonia Gupta,* ***Omesh Goyal*** *, Rajesh, Amarjeet Kaur*

Dayanand Medical College and Hospital, D M C Road, Tagore Nagar, Ludhiana 141 001, India

*Background*: Hepatitis C virus (HCV) is a major cause of post-transfusion hepatitis. Seropositivity of HCV among blood donors varies from 0.34 % to 5.1 % in different parts of India. We aimed to study the prevalence of anti-HCV antibodies among healthy blood donors in Punjab.

*Material and Methods*: This retrospective analysis included blood donor screening data from January 2007 to December 2011 (5 years). Screening for anti-HCV antibodies was done using 3rd generation ELISA kits.

*Results*: Of the total 1,50,752 blood units screened, 1.62 % (*n*=2453) were found to be reactive for anti-HCV antibodies. The seropositivity of HCV varied from 1.14 % to 1.89 % in the last 5 years, with an overall decline in year 2011 (1.44 %). Out of the total blood donors positive for anti-HCV antibody, 89.9 % were replacement donors while 10.1 % were voluntary blood donors.

*Conclusion*: Mean seropositivity rate of HCV in blood donors in Punjab during 5 years (2007-2011) was 1.62 %, with a gradual decline in the last 2 years. Of the total donors positive, 89.9 % were replacement donors while 10.1% were voluntary donors.
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### Role of dietary supplement for management of end-stage HCC {#Sec379}

***Mamun Al-Mahtab*** *, Fazle Akbar, Helal Uddin, Lovely Begum, Nasrin Zahan, Salimur Rahman*

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, Department of Medical Sciences, Toshiba General Hospital, Tokyo, Japan, Clinical Research Organization, Dhaka, Bangladesh, and Catalysis South Asia Operations, Dh

*Introduction*: Management of end-stage HCC represents challenge in developing countries. Most patients here come with end-stage HCC. This study assesses utility of dietary supplement for management of end-stage HCC.

*Methods*: Thirty-six patients with end-stage HCC were enrolled. Twenty received Oncoxin (50 mL syrup plus 3 capsules, Catalysis, Madrid, Spain), a dietary supplement, for 3 months containing glycine 2000 mg, glucosamine 2000 mg, malic acid 1200 mg, arginine 640 mg, cystine 204 mg, zinc, green-tea extract and folic acid. Another 16 did not consent and were managed conservatively (control group). General well-being of both groups was similar (30 % to 40 % according to Karnofsky Performance Scale Index). All were followed until death.

*Results*: 2/16 (12.5 %) in control group survived \>2 months. 9/20 (45 %) receiving oncoxin survived \>2 months (p6 months. Karnofsky Performance Scale Index decreased in all in control group (50 % from at 1 month compared to that at study commencement of 100 %), but increased in patients receiving oncoxin (150 % at 1 month compared to 100 % at study commencement).

*Conclusion*: This study inspires optimism about safety and efficacy of a food supplement for management of end-stage HCC, some of whom may become subject to molecular targeted therapy, like sorafenib.
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### Interesting case of jaundice {#Sec381}

***T S Ramesh Kumar*** *, A R Venkateswaran, Revathy*

Medical Gastroenterology Department, Stanley Medical College Hospital, Chennai 600 001, India

Hepatotoxicity following acute poisoning with rodenticides has been infrequently reported in literature. To emphasize the fact that this form of clinical presentation is not unusual. We are reporting one case of rodenticide poisoning masquerading as severe hepatic dysfunction and patient recovered from fulminant hepatic failure.
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### Wilson\'s disease associated with pancreatitis {#Sec383}

***T S Ramesh Kumar*** *, Sathiamoorthy Preethi, Hariprasad, Azimudeen, Manoj, Chitra, Manimaran, Murali, A R Venkateswaran*

Medical Gastroenterology Department, Stanley Medical College Hospital, Chennai 600 001, India

A 14-year-old girl presented with a 1-month history of abdominal pain and distention. A diagnosis of Wilson\'s disease was established, and zinc acetate therapy was initiated. An associated pancreatitis was diagnosed on presentation, based on elevated serum amylase and an enlarged pancreas ultrasonically. Subsequently, regular follow up disclosed no abdominal pain, with repeatedly normal serum amylase level and a normal pancreas on ultrasonography. Since abdominal pain is a common symptom in Wilson\'s disease on presentation, this possibility should be considered in untreated patients. It is concluded that pancreatitis may be associated with Wilson\'s disease, possibly because of copper deposition in the pancreas, and is probably responsive to copper chelation therapy.
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### De novo autoimmune hepatitis following liver transplantation: A case report {#Sec385}

***T S Ramesh Kumar*** *, A R Venkateswaran, Revathy*

Medical Gastroenterology Department, Stanley Medical College Hospital, Chennai 600 001, India

De novo autoimmune hepatitis (AIH), a rare disorder first described in 1998, appears in patients with liver transplants due to autoimmune and nonautoimmune etiologies. De novo AIH occurs in 2.5 % to 3.4 % of allografts; children seem to have a predilection for this syndrome. We have present herein a case of a liver allograft recipient who developed chronic hepatitis associated with autoimmune features outlining the clinical course, liver histology, and response to treatment.
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### Association between minimal hepatic encephalopathy and ***H. pylori*** infection in cirrhotics {#Sec387}

***S Mukundan*** *, R Vinoth Kumar, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai 600 010, India

*Introduction*: *Helicobacter pylori* bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. The role of *H. pylori* infection in causation of minimal hepatic encephalopathy (MHE) has not been well studied. This is a prospective study on the relationship of *H. pylori* infection with MHE in 50 patients with liver cirrhosis from August 2012 to January 2013 in the Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai.

*Aim*: To study the prevalence of *H. pylori* in asymptomatic cirrhotics with MHE.

*Materials and Methodology*: A total of 50 patients with liver cirrhosis underwent psychometric testing for MHE after ruling out overt HE. Rapid urease test was done to diagnose *H. pylori* infection.

*Results*: A total of 50 patients were included in the study. Thirty-five (70 %) had MHE based on psychometric testing. *H. pylori* was positive in 30 (60 %) of patients. Among patients with MHE, *H. pylori* was seen in 26 (74 %) and in patients without MHE it was seen only in 4 (26 %).

*Conclusion*: This study concludes there is a high incidence of *H. pylori* infection in patients with minimal hepatic encephalopathy, thereby suggesting a probable cause effect relationship. Further large scale studies are required to assess *H. pylori* prevalence and outcome of treatment in patients with MHE.
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### Predictors of mortality in severe alcoholic hepatitis treated with pentoxifylline {#Sec389}

***P Maya*** *, P Augustine, M J Chooracken, P G Mathew, J V Francis, A P Chettupuzha, R J Mukkada, A Koshy*

Digestive Diseases Centre, Lakeshore Hospital and Research Centre, Kochi 682 304, India

*Background*: A stoppage rule for severe alcoholic hepatitis (SAH) not responding to pentoxifylline does not exist, although Lille model is used to stop steroids.

*Aim*: To identify factors which predict non-response to pentoxifylline in SAH.

*Methods*: Retrospective comparison of survivor (*n*=36) and nonsurvivor (*n*=21) SAH patients on pentoxifylline (2008-2012). SAH was defined as patients with alcohol consumption in last 3 weeks, AST\>ALT with AST \>2 ULN, and Maddrey's discriminant function (MDF) 32. Patients who received pentoxifylline for \<7 days, aged 60 y, received corticosteroids or hepatotoxic drug, had viral hepatitis or hepatocellular carcinoma were excluded. Parameters on day of starting pentoxifylline and day 7 (D7) were used. Primary outcome: 30 day mortality.

*Results*: Baseline parameters survivors vs. non-survivors: Age, s.bilirubin, AST, ALT, s.albumin and presence of ascites were similar. INR (1.9±0.6 vs. 2.9±0.9, *p*\<0.001), s.creatinine (1.5±0.9 vs. 0.9±0.3, *p*=0.01), encephalopathy (7/36 vs. 13/21, *p*=0.002), MDF (113±41 vs. 66±32, *p*\<0.001) and MELD (27±7 vs. 32±7, *p*=0.03) were significantly different. D7 parameters, s.bilirubin (15±7 vs. 22±10, *p*=0.01), INR (2.1±1.2 vs. 2.8±0.7, *p*=0.006), s.creatinine (0.8±0.2 vs. 1.5±0.9, *p*=0.004), encephalopathy (0/36 vs. 16/21, *p*\<0.001), ascites (9/36 vs. 18/21, *p*\<0.001), MDF (64±34 vs. 116±39, *p*\<0.001) and MELD (26±7 vs. 33±7, *p*=0.001) were significantly different. In multivariate analysis, D7ascites and D7MELD predicted mortality, ROC 0.92. Survival (cut-off 0.54)=8.182 - 0.192 (D7MELD) - 3.584 (D7 ascites), sensitivity: 89 %, specificity: 85 %.

*Conclusion*: In pentoxifylline treated SAH, D7ascites and D7MELD predicted non-response and mortality. These patients may be considered for liver transplantation.
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### Incidence of duodenal ulcers in patients with cirrhosis of liver presenting with upper gastrointestinal bleeding {#Sec391}

***A Santhi Selvi*** *, G Ramkumar, G Muthukumaran, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Diseases, Kilpauk Medical College, Chennai 600 010, India

*Aim*: To determine the incidence of duodenal ulcers in patients with liver cirrhosis presenting with upper gastrointestinal bleeding.

*Study*: *Prospective Place*: Department of Digestive Health and Diseases, Government Peripheral Hospital, Annanagar, KMC, Chennai.

*Period*: January 2012 to December 2012.

*Methodology*: Total 132 patients who were established cases of liver cirrhosis, presenting with upper gastrointestinal bleed were included in the study. All patients were subjected to endoscopic examination after hemodynamic stabilization.

*Results*: Twenty-four (18.18 %) patients had duodenal ulcers on OGD. Age ranged from 30-55 years. Among 24 patients, 22 (91.66 %) were males, 2 (8.33 %) were females. Almost all duodenal ulcers were Forrest-III. Three (12.5 %) patients had stigmata of recent bleed. Twenty-one (87.5 %) patients had esophageal varices along with DU. Sixteen (66.66 %) patients had grade I-II varices, 3 (12.5 %) had grade III varices. Four (16.66 %) patients had esophageal varices with red signs. Three (12.5 %) patients had isolated fundic varices. Eleven (45.83 %) patients had associated mild portal hypertensive gastropathy and 4 (16.66 %) had severe PHG. Five (20.83 %) patients had associated prepyloric ulcer and 2 (8.33 %) patients had antral ulcer.

*Conclusion*: This study showed that duodenal ulcer was present in 18.8 % patients of liver cirrhosis. Its application will help in identifying the cause of bleeding in cirrhotic patients while performing upper gastrointestinal endoscopy and will help in appropriate management of such patients.
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### Lipid profile in patients with nonalcoholic fatty liver disease diagnosed on ultrasound basis in Sikkimese populations (North-Eastern State) {#Sec393}

***O P Dhakal*** *, Mona Dhakal*

Sikkim-Manipal Institute of Medical Sciences (SMIMS) and Central Referral Hospital (CRH), 5th Mile Tadong, Gangtok, Sikkim 737 102, India

*Introduction*: Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of hepatic pathology that resembles alcohol induced liver disease but develops in individuals who are not alcohol abuser.

*Aim of Study*: To analyze lipid profile in patients with nonalcoholic fatty liver disease.

*Method*: Blood sample was collected from 100 cases of fatty liver diagnosed on ultrasound and serum lipid profile was analyzed in fasting state.

*Result*: Out of 100 patient 56 were males and 44 were females. Nineteen percent fatty liver was seen in age group 21 to 40 years, 54 % in age group 41 % to 60 % and 27% in age group more than 60 years. Total cholesterol less than 200 mg/dL was seen in 22 %, 201 to 300 mg/dL in 64 % and more than 300 mg/dL was seen in 14 %. Triglycerides less than 150 mg/dL was seen 30 %, 151 to 300 mg/dL in 65 % and more than 300 mg/dL in 5 %. HDL and LDL was normal in all patient.

*Conclusion*: Majority of persons were males. Fatty liver was seen more in middle aged people and more in males. Total cholesterol and triglycerides was seen significantly elevated in more than 60 %.
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### Comparison of acoustic radiation force impulse imaging with transient elastography (Fibro Scan®) in the noninvasive assessment of cirrhosis {#Sec395}

***Sandeep Patil*** *, B Ravi Shankar*

Yashoda Hospitals, Behind HariHara, Kala Bhavan, S P Road, Secunderabad 500 003, India

*Background*: In certain situations the diagnosis of cirrhosis would not be obvious by routinely available methods. A liver biopsy may be needed for diagnosis. Three noninvasive alternate methods are MRI, TE and radiation force impulse imaging (ARFI). The present study was carried out to assess the sensitivity of ARFI and TE in confirmed cases of cirrhosis (F4).

*Material and Methods*: A total of 72 confirmed cirrhotic patients were included in the study. Both ARFI imaging and TE were performed in 25 patients, 27 underwent only TE and rest of the 20 underwent only ARFI. A median of 15 successful measurements were obtained for each patient using ARFI and TE.

*Results*: Age of patients included was 26-80 yrs, 17 (23.6 %) were male and 55 (76.4 %) female. Etiology of cirrhosis was HBV (15), NAFLD (03), HCV (08), alcohol (30), others (16). We found a mean LSM value of 40.77 kPa (range of 8.1-75 kPa) with TE and mean SWV measurement of 2.38 m/sec (range of 1.26-4.40 m/s) with ARFI. A sensitivity of 94 % was observed in determining the F4 stage (cirrhosis) using TE considering a cuto-ff of \>12 kPa; and a sensitivity was found to be 69 % using ARFI , considering a cut-off of 2.38 m/sec; 80 % with 2.25 m/sec; 93 % with 2.00 m/sec.

*Conclusion*: ARFI score of \>2.25 m/sec and a fibroscore of \>12 kPa is suggestive of cirrhosis. TE scores over ARFI in correctly identifying cirrhosis. However, in view of wide range of measurement values, follow up assessment could be appropriate with TE, rather than with ARFI.
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### Alcoholic hepatitis: MELD versus ABIC scoring in predicting 28 day mortality {#Sec397}

***S Pratibha*** *, P Shravan Kumar, M Umadevi, M Ramanna, I Bhrani*

Department of Gastroenterology, 5th floor, Gandhi Hospital, Secunderabad 500 025, India

*Aim*: To compare the MELD with ABIC score in predicting the 28 day mortality in patients with alcoholic hepatitis.

*Materials and Methods*: In this prospective study. All patients with features of alcoholic hepatitis were included. The patient history and clinical examination were recorded. Laboratory data was taken the scores and the 28 day mortality calculated.

*Results*: A total of 50 males were included. Seventy-eight percent of patients were in the age group of 30-49 years. One hundred percent presented with jaundice followed by anorexia (74 %) and pain abdomen (56 %). On examination icterus was seen in 100 %, ascites (84 %), encephalopathy (66 %) and hepatomegaly (58 %). Average s. bilirubin was 15.98 mg %. AST was elevated in all and average was 179 U/L. AST/ALT ratio was more than 2 in 48 (96 %) patients. Twenty-three (46 %) patients had high serum creatinine. The ΔPT was \>3 seconds in 45 (90 %) patients. Forty (80 %) had an INR \> 1.5. Forty-four percent expired. MELD score was \>21 in thirty-four (68 %) patients. All expired patients had with ABIC score \>8.81.

*Conclusions*: Many scoring systems have been proposed to assess the severity of the disease. On comparing MELD score with ABIC score to predict the 28 day mortality. AIBC score was a better predictor of 28 day mortality. Also in our study we noticed the AST/ALT ratio was above in 96 % of patients which is a surrogate marker of underlying cirrhosis.
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### An interesting case of vanishing bile duct syndrome caused by native medicine {#Sec401}

***H Azimudin*** *, Manoj, Sathiamoorthy, Ramesh Kumar, Venketeswaran, Revathy, Chitra, Manimaran, Murali, Malarvizhi*

Departmernt of Medical Gastroenterology, Government Stanley Hospital and Medical College, Chennai 600 001, India

*Background*: Vanishing bile duct syndrome (VBS) is a term loosely applied to a group of disorders associated with progressive destruction of mainly intrahepatic bile ducts and ultimately cholestasis. Among various causes postulated like immunological, congenital, genetic, fibrocystic, Hodgkin's lymphoma are xenobiotics like antibiotics (amox-clavulanic acid), tri-cyclic anti-depressants and native drugs

*Case Report*: We hereby report a case of an unmarried young female with no significant past medical or family history who presented to us with a 8 months duration of progressive jaundice, severe fatigue, itching, weight loss around 20 kgs allegedly following an episode of exanthemous illness (? chicken pox) for which she took native treatment for 4 months. Her LFT pattern showed predominantly conjugated type of hyperbilirubenemia with elevated alkaline phosphatase. An extensive work up including viral markers, exhaustive autoimmune markers and Wilson's work up (serum ceruloplasmin and screening for KF ring) were negative. A trial of steroids was tried and failed to yield any response. A liver biopsy was done which showed majority of portal tracts \> 50 % having absence of intralobular bile ducts and remaining showing markedly degenerating bile ducts with loss of polarity, cytoplasm vacuolization and nuclear pyknosis. Also seen were chronic cholestasis, portal and pericellular fibrosis suggestive of VBS for which various differential diagnosis were given like idiopathic adult onset ductopenia, AMA negative PBC, small duct PSC, late onset nonspecific paucity of intrahepatic bile-ducts, MDR-3 deficiency and drug induced liver injury.

*Conclusion*: We present a case of vanishing bile duct syndrome in a young female presenting as intrahepatic cholestasis probably caused due to ingestion of native medications.
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### Role of miRNA-21, miRNA-22 and miRNA-451 in modulating gluconeogenesis, and the role of high glucose and free fatty acids in regulating the expression of these miRNAs in hepatic cells {#Sec403}

***Parul Gupta*** *, Sweta Khanal, Aashirwad Shahi, Satendra Kumar, Preeti Damania, Senthil Kumar Venugopal*

South Asian University, Akbar Bhawan, Chanakyapuri, New Delhi 110 021, India

*Background*: Nonalcoholic fatty liver disease (NAFLD) is associated with obesity and insulin resistance, fat deposition in liver, and altered gluconeogenesis pathway. miRNAs are small non-coding RNAs that regulate cell functions. We hypothesized that dysregulation of miRNAs might modulate gluconeogenesis, thereby allowing NAFLD progression towards NASH.

*Methods*: miRNA-21, miRNA-22 and miRNA-451 were over-expressed in Huh7 cells and their effect on modulating gluconeogenesis was evaluated. After 72 hours, total RNA enriched with miRNAs, was isolated and real time PCR for miRNAs was performed. Western blots were performed for SIRT-1, PGC-1α, PEPCK and β-actin. Effect of high glucose (HG, 25 mM), palmitic acid (PA, 200 μM), oleic acid (OA, 150 μM) or combination with HG was evaluated on the expression of these miRNAs and gluconeogenesis by Western blots.

*Results*: Over-expression of these miRNAs led to increased intracellular levels of each miRNA in hepatic cells. miRNA-21 increased SIRT-1 levels to 4-fold in Huh7 cells, while miRNA-22 and miRNA-451 inhibited SIRT-1 to 3-fold and 2-fold respectively. Only miRNA-451 inhibited PGC-1α significantly (*n*=3; *p*\<0.01). Expression of PEPCK was increased by miRNA-21 (10-fold; *n*=3; *p*\<0.01), and inhibited by miRNA-22 and miRNA-451 (5-fold and 15-fold respectively; *n*=3; *p*\<0.01). OA and OA plus HG had increased expression of miRNA-21. PA increased SIRT-1 expression to 4-fold compared to control cells.

*Conclusion*: These data demonstrate that over-expression of miRNA-21 increased gluconeogenesis while miRNA-22 and miRNA-451 inhibited gluconeogenesis. Some of the free fatty acids alone or in combination with HG modulated the expression of these miRNAs and regulate gluconeogenesis in hepatic cells.

LO-14 {#Sec404}
-----

### Utility of liver biopsy in clinical practice {#Sec405}

***Kaivan Shah*** *, Dhaval Gupta, Nilesh Pandav, Meghraj Ingle, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To study utility of liver biopsy in clinical practice in patients with persistent abnormal liver function test.

*Methods and Material*: Patients from age 18 to 60 with persistently abnormal liver function test in form of altered ALT, AST and/or ALP underwent percutaneous liver biopsy. Patients with history of significant alcohol intake, focal liver lesions on imaging and positive viral markers (HIV, HbsAg, anti-HCV antibody) were excluded from study. Patients with autoimmune markers positivity were included in study. All liver biopsies were done after prior written consent with prior sonography guided marking of biopsy site.

*Results*: Out of 72 patients 40 were male. 51.3 % were diagnosed as NASH, 13.8 % found to be autoimmune hepatitis, 5.5 % had autoimmune hepatitis with overlap syndrome, 5.5 % had drug induced liver injury, 5.5 % had cryptogenic cirrhosis, 2.7 % had features of biliary injury, 2.7 % had no specific changes, 1.3 % had features of extramedullary hemopoiesis, 1.3 % had small duct primary sclerosing cholangitis and 8.3 % had normal liver biopsies. In 55.5 % patients diagnosis were confirmed in form of NASH, autoimmune hepatitis and DILI. New diagnosis were found in 33.3 % patients for autoimmune hepatitis, autoimmune hepatitis with overlap syndrome, small duct PSC, cryptogenic cirrhosis and biliary injury, 8.3 % biopsies were found normal and 2.7 % were nonspecific for any etiology.

*Conclusion*: Liver biopsy is thereby useful for confirming suspected diagnosis as well as in evaluating diagnostic dilemma cases in patients with persistently abnormal liver function test.
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### Nonalcoholic fatty liver disease and hypothyroidism {#Sec407}

***Pathik Parikh*** *, Sandeep Patil, Prasad Bhate, Mukesh Nasa, Aniruddha Phadke, Prabha Sawant*

Department of Gastroenterology, Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai 400 022, India

*Aim*: To confirm the correlation between hypothyroidism and nonalcoholic fatty liver disease (NAFLD).

*Methods*: Patients visiting Gastroenterology OPD between September 2011 and September 2012 at our tertiary care center were stratified into NAFLD and controls on the basis of ultrasound examination. All patients above 18 years were included. All patients with alcohol intake greater than 20 g/d, HBsAg or anti-HCV positivity and history of liver disease were excluded. Full thyroid profile was carried out in all patients and they were classified as having subclinical (TSH\>5.5 IU/mL but 10 mIU/L).

*Results*: Four hundred (250 NAFLD and 150 controls) patients were studied. The mean age and female: male ratio of NAFLD patients was 44.3±3.2 and 1.8:1 and of controls was 41.6±3.89 and 1.94:1 respectively (*p*\>0.05). Hypothyroidism was seen in 16.8 % and 1.3 % of NAFLD and controls respectively (*p*\<0.001). Twenty-six percent of these NAFLD patients had subclinical hypothyroidism. None of the controls had overt hypothyroidism. ALT, AST and BMI in hypothyroid NAFLD was 53 IU/L, 44 IU/L and 29.17±0.56 kg/m2 and in hypothyroid controls was 21 IU/L, 18 IU/L and 25.14±0.14 kg/m2 respectively (*p*\<0.05). Multivariate regression analysis showed that NAFLD was statistically significantly associated with hypothyroidism (odds ratio (OR) 14.94, 95 % confidence interval (CI), 3.5 to 62.6)

*Conclusion*: The prevalence of hypothyroidism in NAFLD is 16.8 %. Hypothyroidism is closely associated with NAFLD independently of known metabolic risk factors, confirming a significant clinical relationship between these two diseases.
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### Clinical profile of patients with alcoholic hepatitis {#Sec409}

***I Bhrani*** *, P Shravan Kumar, M Umadevi, M Ramanna, S Pratibha*

Department of Gastroenterology, 5th Floor, Gandhi Hospital, Secunderabad 500 025, India

*Aim*: To study the clinical profile of patients with alcoholic hepatitis.

*Materials and Methods*: This is a prospective study of 50 patients. All data was collected from the patients and the mortality at 28 days was recorded. The MELD score and the 28 day mortality risk were calculated.

*Results*: Total patients were 50. All were males. Forty-four percent were in the age group of 30-39 years followed by 34 % in the age group of 40-49 years. Majority of the patients (40 %) were consuming alcohol of 81-120 g/day, 34 % consumed between 121-200 g/day. Mean alcohol consumption by the patients in our study was 120.96±59.35 g/day. Most common symptom was jaundice (100 %) followed by anorexia (74 %), pain abdomen (56 %), nausea or vomiting (52 %). Most common sign is jaundice (100 %). Among the 50 patients who were followed up for 28 days, 56 % of them survived. The mean admission serum bilirubin, serum creatinine, difference of PT, INR and scores were significantly higher in the death group compared to survival group.

*Conclusion*: All the patients in this study group were males with the most common age group of presentation being between 30-39 years. Most of the patients consumed a significant amount of alcohol ie. more than 80 g/day. The mortality at 28 days was high and predictors of mortality being serum bilirubin, serum creatinine, ΔPT, INR, high mDF and high MELD.

LO-17 {#Sec410}
-----

### Awareness and opinion of nonalcoholic fatty liver disease patients about obesity and its consequences {#Sec411}

*Shivaram Prasad Singh,* ***Bijay Misra*** *, Debasis Misra, Girish Kumar Pati, Ayaskanta Singh, Sanjib Kumar Kar, Manas Kumar Panigrahi, Chudamani Meher, Omprakash Agrawal*

Department of Gastroenterology, S C B Medical College, Cuttack 753 007, and Department of Radiology, Beam Diagnostics, Cuttack, India

*Background and Aim*: The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising globally. The aim of this study is to know the opinion of NAFLD patients regarding NAFLD and obesity and its consequences.

*Material and Methods*: This prospective study was conducted in 326 incidentally detected NAFLD patients using a face-to-face questionnaire.

*Results*: Of 326 patients, 68 (20.86 %) had normal weight (BMI23). 23.93 % didn't have knowledge about harmful effects of obesity. About half didn't know that consumption of fast food and pre-packed meals promoted obesity. Two-thirds (64.42 %) had not been advised by their doctors to reduce weight. Besides, 38.76 % (100/258) of the obese presumed that they had normal body weight in comparison to lean NAFLD (46/68) \[38.76 % vs. 67.65 %; *p*\<0.0002\]. 61.24 % of patients who considered themselves obese attributed it to inactivity, overeating, familial and combined causes in 55.06 %, 28.48 %, 3.8 % and 12.03 % cases respectively. One-third of obese NAFLD \[50/158(31.65 %)\] didn't have guilt of being overweight and 9.49 % (15/158) didn't want to lose weight.

*Conclusion*: Despite high prevalence of NAFLD, awareness among NAFLD patients regarding obesity is grossly inadequate. A third of NAFLD patients are ignorant about harmful effects of obesity. Two fifths of obese NAFLD felt that they were non-obese. Two thirds of NAFLD patients were neither educated by their physicians about effects of obesity nor advised to shed weight. There is a gross lack of awareness regarding NAFLD and obesity in patients and physicians.
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### Utility of liver stiffness measurement using Fibroscan in differentiating acute severe viral hepatitis and acute on chronic liver failure at admission {#Sec413}

***Rinkesh Kumar Bansal*** *, Praveen Sharma, Vinit Shah, Varun Gupta, Abdul Rauf, Pankaj Tyagi, Ashish Kumar, Vikas Singla, Naresh Bansal, Anil Arora*

Gastroenterology and Hepatology, Sir Ganga Ram Hospital, Old Rajinder Nagar, Delhi 110 060, India

*Introduction*: Liver stiffness (LS) measurement using FibroScan is a reproducible and accurate technique for assessment of fibrosis. Often it is difficult to differentiate severe acute viral hepatitis (AVH) from patients with acute on chronic liver failure (ACLF) at admission. Aim is to determine utility of LS measurement in differentiating patients from severe AVH and ACLF at admission.

*Aims and Methods*: Ninety patients with severe AVH (serum bilirubin \>5 and INR \>1.5) and ACLF as per APASL guidelines were recruited prospectively. LS and biochemical tests performed at admission.

*Results*: The mean age 37.7±14.9 years and (M:F:78:12). The etiology of acute hepatitis (*n*=45) included (HAV, *n*=12, HEV, *n*=18, drug induced, *n*=3, HBV, *n*=3 and unknown, *n*=9). Similarly etiology of ACLF (*n*=45) were HBV with severe reactivation, *n*=10, alcoholic with alcoholic hepatitis, *n*=24, acute viral hepatitis on cryptogenic cirrhosis, *n*=11. There was no significant difference at baseline between ACLF and AVH in platelet count (202±88 vs. 212±78 thousand/cumm), serum bilirubin (15±8 vs. 13±8.5 mg/dL) and INR (1.8±0.4 vs. 1.8±0.3). However there was significant difference in ACLF and AVH in median AST (123, 33-1049 vs. 230, 54-3721 IU/L, *p*=0.01) and ALT (118, 24-751 vs. 246, 66-6349 IU/L, *p*=0.001). Mean LS (53.3±21.5 vs. 16.1±9 kPa, *p*=0.001) were significant more in ACLF compared to AVH. Multivariate analysis showed only LS at admission could differentiate severe AVH versus ACLF (*p*=0.0001). Taking a cut-off for LS as 28.2kPa sensitivity and specificity for diagnosing ACLF was 84 % and 85 % respectively.

*Conclusion*: Baseline liver stiffness measurement by fibroscan can differentiate severe acute viral hepatitis from acute on chronic liver failure at admission.
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### Predictors of mortality in patients with acute on chronic liver failure: Do we need sub classification? {#Sec415}

***Vinit Sanjay Shah*** *, Praveen Sharma, Rinkesh K Bansal, Pankaj Tyagi, Ashish Kumar, Naresh Bansal, Vikas Singla, Anil Arora, Abdul Rauf, Varun Gupta*

Department of Gastroenterology and Hepatology, Sir Gangaram Hospital, Old Rajender Nagar, New Delhi 110 060, India

*Background*: We describe clinical, biochemical profile of acute on chronic liver failure (ACLF), effect of acute insult and organ failures on mortality.

*Methods*: Patients classified as ACLF-1 when no organ failure except liver, ACLF-2 (one organ failure along with liver), ACLF-3 ( two organ failures along with liver) and ACLF-4 with (3 organ failures along with liver).

*Results*: Three hundred and eighteen patients (mean age 44.4±11.5 years; M/F 292:26), median serum bilirubin 15.4 (5-64 mg %), CTP score (11±1.9), MELD score (26.7±7.9) and hospital stay 8 (1-82 days) were prospectively enrolled. Acute insults were alcoholic hepatitis (*n*=185, 58 %), HBV reactivation (*n*=32, 10 %) and acute hepatitis E (*n*=23, 7 %). Etiology of chronic liver disease were alcohol (*n*=204, 64 %), HBV (*n*=35, 11 %), cryptogenic (*n*=67, 21 %) and others (12, 4 %). Ascites present in 284 (89 %), hepatic encephalopathy (HE) 152 (48 %), septicemia 41 (13 %), chest infection 62 (20 %), spontaneous bacterial peritonitis 30 (9 %), acute kidney injury (AKI) in 143 (45 %) at the time of admission. ACLF-1 were 155 (49 %); ACLF-2, 87 (27 %); ACLF-3, 39 (12 %) and ACLF-4, 37 (12 %). Mortality was 50 (32 %) in ACLF-1, 47 (54 %) in ACLF-2, 28 (71 %) in ACLF-3 and 36 (97 %) in ACLF-4. On multivariate analysis total leukocyte count (TLC) and loss of 2 organ failures either at presentation or during hospital stay were predictors of mortality. Combination of AKI and HE were associated with highest mortality.

*Conclusions*: Loss of 2 organ functions either at presentation or during hospital stay and high TLC at baseline are independent predictors of mortality in ACLF.
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### Translation and validation of Hindi version of quality of life questionnaire for liver cirrhosis patients {#Sec417}

***Manisha Kakaji***, *Gourdas Choudhuri, Sushil Gupta, U C Ghoshal, Rachna Mishra, Uttam Singh*

Departments of Endocrinology and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

The chronic liver disease questionnaire (CLDQ) is disease specific questionnaire, developed to evaluate the impact of liver cirrhosis (LC) on QoL. But till date it has not been validated in Hindi. This study attempted to translate original CLDQ into Hindi, validated it for assessment of QoL in LC patients.

*Methods*: Translation permission was taken from author, The CLDQ was translated from the original version to the Hindi version. Total 124 subjects were recruited, 62 LC patients and 62 normal subjects. The Hindi version of CLDQ was administered. The diagnosis of LC was based on abdominal ultrasound, and esophageal varices. Grading of LC was assessed according to Child-Pugh scoring into class A, B and C. All of the participants were subjected to history taking, disease duration, clinical examination, abdominal ultrasonography. The data was analyzed using the SPSS 16.0.

*Results*: Forty-three (69.4 %) patients, forty-six (74.2 %) were men in both the groups, the mean age of the patients was almost similar (*p*\>0.05) among cases (47.56±9.25) and controls (57.16±9.88). Twenty-one (33.8 %), thirty-two (51.6 %) and nine (14.5 %) were categorizes into CTP score A, B, C. The reliability of Hindi CLDQ was determined from the Cronbach's alpha was overall scores 0.61. However, among the cases, the Cronbach's alpha for individual domains was 0.90, the lowest being 0.89 and highest 0.91. The test-retest correlation coefficient for average CLDQ among the cases was 0.78 (*p*\<0.0001). The test-retest correlation coefficient among the cases was above 0.62

*Conclusion*: Our study confirmed the validity of Hindi CLDQ version in assessing the QoL among patients with liver cirrhosis.
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### Poor quality of life and predictors of health related quality of life (HRQoL) in cirrhosis at a tertiary care hospital India {#Sec419}

***Manisha Kakaji*** *, Gourdas Choudhuri, Sushil Gupta, U C Ghoshal, Rachna Mishra, Uttam Singh*

Departments of Endocrinology and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Cirrhosis produces variety of symptoms which eventually lead to a negative impact on health related quality of life (HRQoL). The general aim of this study was to evaluate the magnitude of poor HRQoL and to assess factors related with HRQoL in patients with cirrhosis in India.

*Findings*: This was a cross sectional study conducted in Gastroenterology Outpatient Clinics of Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow on adult patients with cirrhosis. In this study chronic liver disease questionnaire (CLDQ) was used to assess HRQoL of these patients and CLDQ score was used as an outcome measure to determine factors related with HRQoL. Two hundred and twenty-two participants were recruited in the study 166 (74.75 %) were males. Mean age of participants was 45.99 ±8.71. The most common cause for cirrhosis was cryptogenic 98 (44.15 %). Mean model for end-stage liver disease (MELD) score was 13.36±4.07 and more than half of patients 144 (64.86 %) had advanced cirrhosis in Child-Turcot-Pugh (CTP) B or C stage. Mean CLDQ score was 3.65±0.58, 3.06±0.68, 2.04±0.36 respectively in Child class A, B, C. Amongst all of the domains, fatigue and activity domain prior history of decompensation were significant factors associated with HRQoL in patients with liver cirrhosis.

*Conclusion*: Frequency of poor HRQoL determined by CLDQ score is high in patients with liver cirrhosis. Hemoglobin, serum albumen, prior history of decompensation (like encephalopathy and upper gastrointestinal bleed), are associated with health related quality of life.
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### Epidemiology, disease characterization and management of alcoholic liver disease in India {#Sec421}

*Deepak Kumar Agarwal, Lucknow; G N Ramesh, Cochin; K Narayanaswamy, Chennai; Dharmesh Kapoor, Hyderabad; Deepak N Amarapurkar, Mumbai; Ajit Sood, Ludhiana; G Badari Narayanan, Tirunelveli; Anil Arora, Delhi; S Mukewar, Nagpur; Sanjay Kumar, Bhopal;* ***V G Mohan Prasad***

Alcoholic Liver Disease Evidence Development Program (ALD EDP) Group.

*Background*: A steady rise in alcoholic liver disease (ALD) in India has brought forth a need for understanding the characterization and management of the disease. This program aimed at establishing a repository of epidemiology, clinical presentation and management outcomes of ALD in Indian population.

*Methods*: This national, multicenter, one point non-interventional, evidence development program collected data on ALD patients who sought medical care at 64 non-governmental hospitals/clinics across India, between May 2011 and May 2012.

*Results*: Of the 1,486 patients with ALD, 51.6 % patients were recruited from Tamil Nadu, Uttar Pradesh, Madhya Pradesh and Andhra Pradesh. Majority of the patients were male (99.5 %), married (89 %), literate (83 %), employed (82 %), Hindu (80 %), in the age group 30-60 years (80 %) and belonging to upper-middle class (41.79 %). Whisky (44.05 %) was the most common alcoholic beverage consumed, followed by beer (17 %). The mean duration of alcohol intake was 15.6±8.98 years with the mean quantity of alcohol consumed per day estimated at 69.2±71.63 gm. Abdominal pain (51 %), lack of appetite (34 %) and nausea (25 %) were the common complaints noted. The withdrawal symptoms included insomnia (52 %), tremor (20 %), drowsiness and anxiety (6 % each). The main treatments included nutritional hepatoprotectives and supportive therapy.

*Conclusion*: Patients in this cohort were found to be between 30-60 years of age and belonged to the upper-middle socioeconomic class, consumed spirits (distilled beverages), had a long and heavy drinking pattern. Hepatoprotective therapy and supportive care formed the primary line of therapy.

*Disclaimer*: Program supported by grants from Abbott India Ltd, Mumbai.
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### Assessment of health related quality of life (HRQoL) in patients with cirrhosis at a tertiary care hospital India {#Sec423}

***Manisha Kakaji*** *, Gourdas Choudhuri, Sushil Gupta, U C Ghoshal, Rachna Mishra, Uttam Singh*

Departments of Endocrinology and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Cirrhosis has negative impact on health related quality of life (HRQoL). However, there is limited information about HRQoL in Indian subjects with cirrhosis. We studied HRQoL in north Indian subjects based on a newly developed Hindi questionnaire.

*Setting*: Cross sectional study at a tertiary academic medical Institute in North India.

*Methods and Results*: Adult subjects with cirrhosis (*n*=222, age 45.99±8.7 yrs, males: 74 %) in various stages of chronic liver disease (CTP and MELD scores) were enrolled. HRQoL was evaluated by a newly developed questionnaire in Hindi. The etiology of cirrhosis was: cryptogenic (44.15 %), alcoholic (36.03 %), post-hepatitis (18.47 %) and autoimmune hepatitis (1.35 %). Advanced cirrhosis (CTP score B and C) was present in 65 % of subjects. Mean CLDQ score were 3.65±0.58, 3.06±0.68, and 2.04±0.36 in Child class A, B and C respectively. The domains, fatigue and activity were significantly impaired in Child class B and C.CTP statusANOVA*p*-valueA (*n*=21)B (*n*=32)C (*n*=9)Average CLDQ3.65±0.583.06±0.682.04±0.360.0001AB3.88±0.813.20±0.812.07±0.540.0001FA3.95±0.632.78±0.912.02±0.550.0001SY3.88±0.813.20±0.812.07±0.540.0001AC3.29±1.142.87±1.151.84±0.670.001EM3.31±0.773.06±0.942.10±0.690.001WO3.48±0.973.11±1.132.22±0.690.001

*Conclusion*: The poor HRQoL was determined by CLDQ score is in patients with liver cirrhosis. The CLDQ showed significant worsening of QoL in parallel with increase of the clinical severity of diseased measured by CTP score
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### Development and validation of Hindi version of quality of life questionnaire for liver cirrhosis patients {#Sec425}

***Manisha Kakaji*** *, Gourdas Choudhuri, U C Ghoshal, Rachna Mishra, Uttam Singh, Sushil Gupta*

Departments of Endocrinology and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Quality of life (QoL) is a subjective measurement of health perception. The QoL questionnaire is available in Bengali. We developed the Hindi based questionnaire based on original English questionnaire and validated it in Hindi speaking population.

*Methods:* The CLDQ was translated, after permission, from the original English version (Younossi et al.1999) to the Hindi version using standard translation process. Sixty-two subjects with liver cirrhosis and 62 control subjects were enrolled. The diagnosis and severity of LC was based on standard criteria (biochemistry, abdominal USG, UGI endoscopy) and Child-Pugh scoring. Patients with malignancy, TIPS, renal impairment or on glucocorticoids were excluded. The Hindi version of CLDQ was administered to patients and controls. The data used was analyzed using the SPSS 16.0.

*Results*: Forty-three (69.4 %) patients, forty-six (74.2 %) were men in both the groups, the mean age of the patients was almost similar (*p*\>0.05) among cases (47.56±9.25) and controls (57.16±9.88). Among the patients twenty-one (33 %), thirty-two (51.6 %) and nine (14.5 %) were categorizes into CTP score A, B, C respectively. The reliability of Hindi CLDQ was determined from the Cronbach's alpha was overall scores 0.61. However, among the cases, the Cronbach's alpha for individual domains was nearly 0.90, the lowest being 0.89 and highest 0.91. The test-retest correlation coefficient for average CLDQ among the cases was 0.78 (*p*\<0.0001) which was above 0.62.

*Conclusion*: Our study confirmed the validity of Hindi CLDQ version in assessing the QoL among patients with LC.
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### Serum apoptosis markers \[CK 18 {M30 andAND M 65}\] in acute liver failure {#Sec427}

***Chetanya Malik*** *, Anita Chakravarti, Suresh Kumar, Premashis Kar*

Departments of Medicine and Microbiology, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, India

*Introduction*: Several clinical studies of acute liver failure (ALF) patients have demonstrated significantly increased levels of circulating apoptosis markers. Interest has recently focused upon the measurement of cell death markers such as caspase-cleaved and total cytokeratin \[CK 18 {M30 and M 65}\] as a means of identifying the extent and relative proportions of apoptotic and necrotic cell death in ALF patients. Very few studies have been performed on patients with ALF. This study was aimed to assess whether the circulating apoptotic markers \[CK 18 {M30 and M 65}\] are altered in ALF and to correlate it with the prognosis.

*Methods*: Thirty cases of ALF (sample collected at day of admission and day 3), 30 cases of acute viral hepatitis and 30 healthy controls were included in the study. The serum levels of M30 and M65 were measured using commercially available ELISA kits.

*Results and Conclusion*: The levels of M30 in ALF cases on the day of admission were 497.04±115.93 mIU/mL and 451.24±369 mIU/mL at day 3. The levels of M65 in ALF cases on the day of admission were 138.02±120.62 mIU/mL and 109.40±77.23 mIU/mL at day 3. The ALF patients with M30 and M65 levels had grave prognosis as assessed by Kings' College criteria. Serum levels of apoptotic biomarkers \[CK 18 {M30 and M 65}\] were significantly (*p*\>0.05) elevated in ALF cases compared to AVH and control groups.
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### Serum cholinesterase: A useful marker for liver synthetic function {#Sec429}

***Kunal Vyawahare*** *, Ajit Kumar, Nayana Joshi, B Sukanya, Chintan Kansagra, Sandip Shah, Nikhil Shirole*

Department of Gastroenterology, Nizam's Institue of Medical Sciences, Punjagutta, Hyderabad 500 082, India

*Background*: Serum cholinesterase or pseudocholinesterase is an enzyme synthesized by liver and its levels decrease with decreased synthetic function of liver as in cirrhosis. It is also found to decrease further with the degree of liver decompensation.

*Aims*: To compare the levels of enzyme in cirrhotic and noncirrhotic patients and to determine whether fall in the levels correlate with the degree of decompensation.

*Methods and Results*: This is a cross sectional analytical study conducted at the Department of Gastroenterology at our hospital. Thirty-four patients were studied. Sixteen were cirrhotics and 18 were noncirrhotics. The median levels of serum cholinesterase in cirrhotic group was 135 U/L (Range:5-520) whereas it was 645 U/L (Range: 230-1300) in the noncirrhotic group (*p*-value \<0.0001). Cirrhotic patients were further classified on the basis of Child-Pugh\`s criteria in to classes A, B and C which included 2, 8 and 6 patients respectively. The median levels of serum cholinesterase in these three classes were 515 U/L, 135 U/L and 123 U/L respectively (*p*-value: 0.016).

*Conclusion*: Thus serum cholinesterase is an important liver synthetic function test that can be used to identify cirrhotic patients and its levels decrease further with the degree of decompensation.
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### Renal resistive index and its utility in cirrhotic patients {#Sec431}

***Harshad Vinay Joshi*** *, Pradeep Kakkadasam Ramaswami, Nilesh Toke, Sunil K Mathai, Charles Panackl, Rony Thomas*

Medical Trust Hospital, M G Road, Kochi 682 016, India

*Background*: Renal failure in patients with end-stage liver disease is associated with significant morbidity and mortality. In patients with cirrhosis activated renin angiotensis system (RAS) is responsible for maintaining effective systemic volume with its attendant complication in form of renal hypoperfusion due to renal arterial vasoconstriction. Renal hemodynamic changes are evident even before changes in serum creatinine occur. Renal resistive index (RI) is a direct measure of renal vasoconstriction and can be a good tool in identifying patients who have high renal vasoconstriction hence are at risk of HRS. The purpose of this study is to evaluate the usefulness of RI in cirrhotic patients. So far not many studies have assessed correlation between Child's class, MELD scores and RI.

*Objectives of Study*: A prospective study to compare resistive index in cirrhotic patients with controls, and to assess relation of RI with Child--Pugh's class and MELD score.

*Materials and Methods*: Adult in-patients with cirrhosis from May 2011 to April 2013 in our tertiary care hospital were included in the study after exclusion using predetermined facts. These patients were grouped into 3 according to Child's class as A, B and C. Forth group consisted of controls. Each group consisted of 25 patients. Renal resistive index (RI) was calculated in each patient using duplex ultrasound with color doppler by two radiologists. A value of less than 0.7 was taken as normal based on several past studies in literature.

*Results*: Amongst the study population of 100 patients, 80 were males (80 %) while 20 were female. Overall amongst all Child's class alcohol topped the list of etiology, followed by cryptogenic, HBV, HCV and NASH in descending order. Majority of patients were in 40-60 years age group (\~ 42 %). Mean RI value in patients with Child's A cirrhosis was 0.69 (+/-0.015), in Child's B cirrhosis was 0.71 (+/-0.08) and in Child's C cirrhosis was 0.89 (+/-0.026) whereas mean RI amongst controls was 0.622 (+/-0.053). Compared to controls the RI was higher amongst all Child's classes. There was no significant difference within individual Child's classes. RI showed statistically significant correlation with MELD. With higher MELD score the RI value increased with a correlation coefficient of 0.78. This correlation was even stronger for value of MELD \>25. RI was found to increase in linear with age and BUN. Inverse correlation was seen between serum albumin, sodium and RI. These correlations although were statistically not very significant. RI did not vary in different etiologies of cirrhosis.

*Conclusion*: Our study showed that resistive index significantly increases with a higher MELD score. Higher RI show positive correlation with cirrhosis compared to controls. RI is independent of etiology of cirrhosis. Higher RI is associated with higher TBIL, BUN, INR and lower albumin and sodium levels, although statistically less significant. RI could be a good tool to detect patients who are likely to develop HRS early in clinical course even before worsening of creatinine. Long-term follow up studies are needed to study how many of patients with high RI develop overt renal failure on follow up, which could help in establishing predictive value of RI amongst cirrhotics.
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### Hepatocellular carcinoma: An unusual case presenting with right heart failure {#Sec433}

***Arvind Namdeo*** *, Pankaj Manoria, Rajesh Mehra*

Shivalaya Gastroenterology and Liver Clinic, 6 Deepak Housing Society Doodh Dairy Bus Stop, Chuna Bhatti, Bhopal, India

Hepatocellular carcinoma (HCC) is most common primary liver tumor. Most commonly presents as asymptomatic on screening, or with deterioration of symptoms of cirrhosis like jaundice and ascites, weight loss, weakness, anorexia, palpable liver. The case of a 59-year-old man presented with progressive breathlessness on exertion for 3 months with marked swelling in lower limbs and abdominal distension for 1 month. On examination patient had raised JVP, palpable liver with marked pedel edema. Echo showed a large mass in right atrium, lab showed HBsAg positive, USG showed large mass in liver infiltrating in IVC and right atrium. AFP was \>30000. CECT showed typical HCC with increased arterial uptake in segment VII and VIII with invasion in hepatic part of proximal IVC and complete extension into right atrium. To conclude its an unusual case of large HCC presented with symptoms of right sided heart failure with infiltration in IVC and heart.
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### Histopathological features of liver in patients with chronic hypertransaminaesaemia of unknown etiology {#Sec435}

***Rajesh Bathini*** *, Praveen Kumar, Praveen Mathew, Somasekhar, Md Dawood*

Vydehi Institute of Medical Sciences, Whitefield, Nallurahalli, Bangalore 560 066, India

*Objective*: Asymptomatic persistent transaminaesemia is a common finding and may alter treatment plan if correct diagnosis is made.

*Aim*: The aim of the study is to determine the spectrum of histopathological features of liver and probable etiology in these patients.

*Methods*: From August 2012 to June 2013, 14 patients with persistent hypertransaminaesemia of more than 6 months with no clear diagnosis on clinical, sonological and serological evaluation were included. Liver biopsies were done and fibrosis was staged by Ishak method.

*Results*: Total 14 patients, 8 (58 %) were male. Mean age was 33 yrs. Histopathological features of liver biopsies showed bland fibrosis in 3 (21.5 %), fibrosis with chronic hepatitis in 1 (7.5 %), steatohepatitis in 5 (35.5 %), cirrhosis in 1 (7.5 %), Dubin-Johnson syndrome in 2 (14 %) and nonspecific changes in 2 (14 %). In patients with bland fibrosis, one patient had noncirrhotic portal fibrosis and another patient was found to have occult hepatitis B. In patient with fibrosis with chronic hepatitis, patient had interface hepatitis with fibrosis who later turned out to be ASMA positive. In steatohepatitis patients, 2 had 3/6 fibrosis. In cirrhotic patient, no cause was found.

*Conclusion*: Liver biopsy is a useful investigation in patients with persistent hypertransaminaesemia based on which further evaluation could pick up underlying etiology. In this study common histopathological findings were steatohepatitis, bland fibrosis.
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### Transaminase levels are better than platelet count as predictors of adverse outcome in dengue virus infection {#Sec437}

***C S Thyagaraj*** *, M Narendranathan*

Department of Gastroenterology, Kerala Institute of Medical Sciences, Vinod Nagar Road, Post Anayara, Anamukham, Thiruvananthapuram 695 029, India

*Background*: Hepatic involvement has been recognized as a complication of dengue fever. Traditionally platelet counts have been used to assess the severity of dengue fever. One of the objectives of this study was to develop a score to predict adverse outcome in these cases.

*Methods*: Admissions with serologically proved dengue infection were included in the study. The lab data of the cases were analyzed to identify the predictors of mortality. Mortality was the independent variable. The independent variables studied are age, platelet count, AST, ALT and alkaline phosphatase.

*Results*: Ninety-one cases of dengue were included in the study. Eleven patients from this group died. Ninety-two percent had platelet count below 100,000. Platelet count was not significantly different in the two groups (53.7 x 103 in the survivors compared to 42.9 x 103 in the fatal cases; *p*=0.922). Transaminase levels were significantly higher (*p*\<0.001) in the mortality group (ALT: 2211 vs. 182; AST: 1579 vs. 131). From the data a score was developed (ALT/100)+age) - Add 60 to this score in case of infants. A score above 70 could predict mortality with a sensitivity of 100 % and a specificity of 94.8 %.

*Conclusions*: The study was done in a select group of severe cases of dengue virus infection admitted to the hospital. In this group of cases transaminase levels were better predictors of mortality than platelet count. The score incorporating age and ALT could predict mortality with an accuracy of 95.5 %. This score has to be validated in a prospective study.
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### Kidney biopsy changes in patients with ethanol related cirrhosis and severe alcoholic hepatitis {#Sec439}

***S K Ravikiran***, *C K Adarsh, G K Prashanth, Mallikarjun Patil, Keyur A Seth, H Aradya Venu, T R Vijay Kumar, Harshad Devarbhavi*

Department of Gastroenterology, St Johns Medical College, Bangalore 560 034, India

*Background*: In cirrhotics, the renal pathological changes are not easily available as renal biopsy has high rate of complications and often renal diagnosis is based on clinical scenario, urine examination, and renal imaging. Our objective is to analyze the spectrum of renal lesions in patients who die of ethanol related cirrhosis and alcoholic hepatitis.

*Methods*: Ultrasonography guided, percutaneous renal and liver biopsies were performed in 25 consecutive patients immediately after death (within 10 minutes) due to ethanol related liver disease. Urine analysis and serum biochemical tests were available during hospitalization at the same sitting.

*Results*: Patients had advanced liver disease as reflected in a MELD score of 30 and a Maddrey's discriminant score of 87. Fifteen of 25 patients (60 %) had serum creatinine \> 1.5 mg/dL. Five (20 %) patients had urinary tract infection, 8 (32 %) had spontaneous bacterial peritonitis and 4 (16 %) had comorbidities. Renal biopsies were normal in 8 (28 %) patients. Most patients (48 %) had ATN. Bile casts were seen in 2 (8 %) patients. Patients who had ATN also had higher creatinine and it correlated positively. Nonspecific mesangial matrix expansion was seen in 3 and proliferation in 2 patients.

*Conclusions*: Contrary to the popular belief that cirrhotic patients with renal dysfunction have hepatorenal syndrome (HRS) where renal histology is normal, we found a significant number of ATN. AKI due to ATN is preventable with appropriate attention to hemodynamics, infections and diuretics. This study lays emphasis on ruling out reversible causes of AKI before making a label of HRS.
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### Clinical spectrum and the role of non-surgical intervention in Budd-Chiari syndrome: Experience at a tertiary care center {#Sec441}

***Manoj Kumar*** *, Manu Tandan, Rajesh Gupta, R Jagadeesh, Piyal Nag, D Nageshwar Reddy*

Departments of Gastroenterology and Intervention Radiology, Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Aims and Objectives*: To evaluate the clinical spectrum, pattern of vascular obstruction and role of nonsurgical treatment in Budd-Chiari syndrome (BCS).

*Methods*: Seventy cases of primary BCS were prospectively evaluated for clinical spectrum and pattern of vascular obstruction. Patients with refractory ascites and/or deteriorating liver function, depending on obstruction of inferior-vena-cava (IVC) and/or hepatic vein (HV), were triaged for radiological intervention (RI). Patients with diuretic-responsive ascites or stable liver function were managed conservatively. Follow up was done at the end of the 1st, 3rd, 6th and 12th month. Repeat RI were preformed as and when required during follow up.

*Results*: HV obstruction was most common (55.7 %) followed by IVC obstruction (31.4 %). An underlying coagulation disorder was defined in 54 % cases with polycythemia-vera being the commonest (11.4 %) and 36 % patients showed multiple coagulation disorders. RI were performed in 50 patients, IVC stenting being the commonest (38 %) followed by HV stenting (32 %). TIPS was performed in 11 patients. Technical success achieved in all patients. Re-occlusion of HV and IVC stent was observed in 12.5 % and 19 % respectively. Among TIPS patients primary patency rate at 1 year was 90.9 % and mortality was 9 %. Of the 20 patients managed conservatively, four required RI due to progressive ascites during follow up. Overall mortality was 7.6 %.

*Conclusions*: Hypercoagulability is important etiological factor and the work up should not be stopped after detecting single cause. Pattern of vascular obstruction is changing. Medical therapy is indicated for asymptomatic patients. RI is preferred in patients with refractory ascites or deteriorating liver functions.
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### BCLC staging of patients with HCC presenting for first time in a tertiary care centre {#Sec443}

***Anil P John*** *, Yamuna R Pillai, Siljo Jose, K R V Kumar*

Medical Gastroenterology Department, Trivandrum Medical College, Thiruvananthapuram 695 011, India

*Background*: The clinical profile of HCC patients in detail will help us to optimize the surveillance of at risk patients and hence the timely therapeutic intervention of affected patients.

*Aim*: BCLC staging of patients with HCC presenting for first time in a tertiary care centre.

*Methods*: Retrospective analysis of clinical data of patients diagnosed with HCC between 2008 and 2012 in Medical Gastroenterology Department, Government Medical College, Thiruvananthapuram, was done.

*Results*: One hundred and fourteen patients, male *n*=90 (78.9 %), female *n*=24 (21.1 %) were included into the analysis. The mean age at diagnosis was 62 years, range of 30 to 88. HBV related chronic liver disease was 32 %, followed by alcoholic liver disease (25 %), NASH (19 %), HCV (6 %), alcohol with HBV (15 %) and alcohol with HCV (3 %). Sixty percent of patients had AFP \>200. Forty percent of patients with liver cirrhosis had no impaired liver function (Child A) at diagnosis of HCC, 18 % were in Child B and 42 % in Child C. Vast majority of patients presenting in advanced and end-stage of the disease (BCLC B 7.2 %, BCLC C 47.8 %, BCLC D 45 %).

*Conclusions*: HBV related liver cirrhosis is the most important risk factor for HCC in our tertiary centre. Majority of patients presents with advance stage or end-stage disease at diagnosis.
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### Autoimmune liver disease: Impact on etiology of chronic liver disease and its disease spectrum: Experience from North-Western India {#Sec445}

***Paras Shah*** *, Vivek Agarwal, Sandeep Nijhawan, Amit Mathur, Gaurav Gupta*

Department of Gastroenterology, Sawai Man Singh Medical College, J L N Marg, Jaipur 302 004, India

*Background and Aim*: Autoimmune liver disease (AILD) is considered rare cause of chronic liver disease (CLD) in India with few studies till date. We aim to study the impact of AILD as etiology in our patients of CLD and to evaluate the disease spectrum of AILD patients.

*Methods*: We prospectively analyzed 936 consecutive patients of CLD admitted to Gastroenterology Department, S M S Medical College, Jaipur, between July 2011 till June 2013, for presence of AILD and analyzed their clinical, biochemical and histological characteristics. Patients in whom etiological work up could not be completed were excluded.

*Results*: Out of 936 CLD patients (612 males-65.38 % and 324 females-34.62 %), AILD was found in 58 (6.19 %). Females outnumbered males (49 females, 09 males, M:F=1:5.4). Prevalence of AILD was 1.47 % in males and 15.12 % in females. Mean age of presentation was 32±14 years. In females AILD was major cause of non-ethanol, non-B, non-C related CLD, with adjusted prevalence of 45.37 %. Presenting complains in majority of AILD patients was jaundice (72.41 %) and ascites (53.44 %), while GI bleed and HE being uncommon. Out of AILD-AIH was seen in 47 (35-definite, 12-probable), PBC in 6, PBC/AIH overlap in 2, PSC in 3. Associated autoimmune disorders were seen in 27.58 %.

*Conclusion*: Autoimmune liver disease is not uncommon cause of CLD in Northwestern India with prevalence being 6.19 %. Majority of our AILD patients were females, presented late with advanced liver disease and associated other autoimmune disease were not commonly seen.
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### Evaluation of blood sample for the diagnosis of amebic liver abscess {#Sec447}

***Ujjala Ghoshal*** *, Virendra Jaiswal, Sanjay S Baijal, Tapan N Dhole, Uday C Ghoshal*

Departments of Microbiology, Radiodiagnostic and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226 014, India

*Background*: Diagnosis of amebic liver abscess (ALA) is challenging, as sensitivity of microscopy is very low (0 % to 15 %). Serum IgG antibody may not distinguish past from current infection, especially in endemic regions and is positive in a proportion of healthy population. Although, liver aspirate is the most suitable for diagnosis but this facility is not widely available.

*Objective*: We evaluated utility of blood sample for diagnosis of ALA using PCR.

*Method*: Twenty-eight patients with ALA and 10 patients with pyogenic liver abscess (PLA) were included. Diagnosis of liver abscess was based, I. Clinical symptoms (fever, pain in the right hypochondrium, lower chest, shoulder. II. Enlarged and/or tender liver without jaundice. III. Space occupying lesion in the liver diagnosed by ultra sound IV. For ALA- presence of amebic DNA in liver aspirate and for PLA-aspirate culture showing growth of a pyogenic organism. Liver aspirate and whole blood were collected from each patient. DNA was extracted from liver aspirate and blood samples. *E. histolytica* DNA was amplified using species specific primer.

*Results*: 25/28 patients with liver abscess had amebic DNA in their blood sample. 22/25 (88 %) of these patients ALA patients had already received prior amoebic treatment. Sensitivity, specificity of PCR for the diagnosis of ALA in blood samples were 89 % and 100 % respectively. PCR was remained negative in blood samples of all PLA patients. *Conclusion*: Detection of *E. histolytica* DNA in blood sample could be used for diagnosis of ALA patients where aspiration of pus is not feasible.
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### Study of non-alcoholic fatty liver disease in higher-socioeconomic population of western India {#Sec449}

*S Patwari, Nikhil Lala, Bhavesh Panchal*

Sterling Hospital, Sterling Hospital Road, Memnagar, Ahmedabad 380 052, India

*Aim and Background*: The prevalence of non-alcoholic fatty liver disease (NAFLD) has doubled during last 20 years, whereas the prevalence of other chronic liver diseases has remained stable or even decreased. progression of NAFLD to nonalcoholic steatohepatitis (NASH) increases risks of liver cirrhosis, liver failure, and hepatocellular carcinoma (HCC). Cirrhosis due to NASH is an increasingly frequent reason for liver transplantation. Available data of NAFLD prevalence in India is scanty.

*Objectives and Method*: Four hundred and thirty-seven objectives were screened by basic ultrasonography of abdomen to diagnose fatty liver. All the objectives were screened by age, gender, body mass index (BMI), w/h ratio (for central obesity), medical examination, primary lfts, history of chronic diseases (dislipidemia, diabetes, hypothyroidism, etc.) and alcohol consumption. Two different views have been taken to study. First NAFLD and suspected NASH (altered lfts with fatty liver) objectives were screened with different factors like age, gender, BMI, w/h ratio etc. Prevalence of these factors among NAFLD pool were noted. Secondly, different groups of population like overweight, diabetics etc were screened by proportion of NAFLD/suspected NASH to study NAFLD proportions among chronic diseases.

*Result*: Among 437 (266 males, 171 females) objectives, 165 (37.7 %) had NAFLD. Thirty-one of 165 (18.7 %) had altered lfts (suspected NASH). It accounts 7.3 % of total objectives. Out of 165 NAFLD, 126 (76.4 %) were males and 39 (23.6 %) were females. Among NAFLD, 149 (90.3 %) dislipidemic, 145 (87.8 %) overweight (BMI \>25), 67 (41%) obese (BMI \>30), 125 (75.5 %) centrally obese (w/h \>0.85), 52 (31.5 %) diabetics, 16 (10 %) hypothyroids, were found. One hundred and thirty-one (79.3 %) of NAFLD objectives were both overweight (BMI \>25) and dislipidemic. 87.9 % (131/149) of dislipidemic NAFLD and 88.4 % (46/52) of diabetic NAFLD have BMI \> 25. 84.3 % of dislipidemic and 76.9 % diabetic NAFLD have w/h ratio \>0.85. Averge BMI and w/h ratio of NAFLD group are 30.01 kg/m2 and 0.93 respectively. NAFLD proportions in males and females are 47.3 % (126 of 266) and 22.8 % (39 of 171) respectively. NAFLD proportion in 51 to 60 yrs age group is 40.3 % (23 of 57). NAFLD among dislipidemic 47.3 % (164 of 346), overweight 43.8 % (145 of 331), obese 51.9 % (66 of 127), centrally obese 46 % (123 of 267), diabetics 55.3 % (52 of 94) were found. 51.6 % (16 of 31) of suspected NASH group have been found to have globulin level greater than 3.5 g/dL.

*Conclusion*. Proportion of NAFLD is more in higher socioeconomic population in western region of India. NAFLD is more prevalent in males than females. With increase in age, NAFLD proportion increases (highest among 51-60 yrs). There is significant drop in NAFLD proportion on removal of any form of obesity. Average NAFLD individual is centrally obese/obese. Diabetics and dislipidemics have higher NAFLD proportions, if their BMI is \>25. Majority of NAFLD is in combination of dislipidemia and BMI \>25. Higher globulins levels in suspected NASH objectives were found, which requires further study of immunological phenomena.
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### Radiofrequency ablation of hepatocellular carcinoma: Recurrence, satellite lesions and needle seed tracking {#Sec451}

***Antony Raphel Joy*** *, R N Harikumar, S Ismail, M Sreekanth, K P Sreekumar, P K Nazar*

Amrita Institute of Medical Sciences and Research Centre, AIMS Ponekkara PO, Kochi 682 041, India

*Background*: Radiofrequency ablation (RFA) has emerged in clinical practice, as a simple and effective technique for treatment of hepatocellular carcinoma (HCC). It is not associated with major side effects and can be performed with ease, safety and reasonable cost. RFA as a modality has been used with curative intent, palliative intent and as a bridge to liver transplantation.

*Aim*: The aim of this study is to assess the response rate of RFA in the form of recurrence, satellite lesions and needle track seeding with a follow up of up to 1 year.

*Methods*: A retrospective descriptive study of 108 patients with 115 HCC (mean diameter 3.23, 1.4 SD) were submitted to RFA between May 2004 and December 2011. In all cases RFA was performed with percutaneous approach under ultrasound guidance using Covidien\'s Cool Tip RF ablation needle, size depending on the lesion size. Treatment efficacy was estimated with MDCT abdomen and AFP levels.

*Results*: Complete ablation after treatment was 66 %, 56.3 % and 28.5 % in HCC smaller than 3 cm, between 3 and 5 cm and larger than 5 cm respectively. Eighteen (26.4 %) lesions out of 68 developed local recurrence after complete ablation during a mean follow up of 3 months. Twenty-two (20.3 %) patients out of the total developed new satellite lesions during a follow up of 1 year. There were no needle tracking seen during a follow up period of 1 year after RFA. There were no treatment related deaths.

*Conclusion*: RFA is an effective treatment for HCC smaller than 5cm with complete ablation in more than 60 % of lesions. Patients with elevated AFP had a worse prognosis with development of recurrence and satellite lesions.
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### Association of dendritic cell SIGN polymorphism in hepatocellular carcinoma patients from India {#Sec453}

***Dipu Bharali*** *, Manash P Sarma, Premashis Kar*

Department of Medicine, Maulana Azad Medical College, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, India

*Objective*: To investigate the association of mutation in dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC SIGN) promoter region in hepatocellular carcinoma (HCC) patients and healthy control without any history of liver diseases and also to analyze the mutation as a risk factor for HCC.

*Methods*: A total of 40 cases of HCC and 40 healthy controls without any liver abnormalities were included in the study. Total 5 mL peripheral blood samples were collected and genomic DNA was isolated followed by PCR amplification and direct sequencing (Macrogen, Korea) along with comparing those sequences with the published database.

*Results*: The characteristic mutation within DC SIGN promoter region in HBV infected HCC individuals was observed. There was 2 hot spot mutation located in positions -139, -142 which were observed in HCC patients. Only 1 spot mutation located in position -139 was observed in healthy controls. The -142 which was absent in the healthy control was observed in 17 HCC (42.5 %). The -139T was far more frequent in the healthy control (98 %) than in the HCC patients (35 %).

*Conclusion*: In the DC SIGN promoter region, -142 may be associated as a genetic factor for developing HBV associated HCC but -139 may be associated with protection against.
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### Assessment of HRQOL in patients with cirrhosis using CLDQ (chronic liver disease questionnaire): A pilot study from north costal Andhra Pradesh {#Sec455}

***P S Chakravarthy*** *, Vidya Viswanath, L R S Girinath, P Murali Krishna*

Andhra Medical College, Jagadamba Junction, Visakhapatnam Part, Andhra Pradesh 530 002, India

*Aim*: To validate a liver specific questionnaire CLDQ in correlation to CTP scoring in patients with cirrhosis in the region of north costal Andhra Pradesh.

*Methods*: Subjects with chronic liver disease who are willing to participative and CTP scoring=5+(except those with complications of cirrhosis such as malignancy, SBP, renal failure, pulmonary failure and unwilling patients) were enquired CLDQ in local language (Telugu). Each patient's responses were assessed according to 1 to 7 scale in CLDQ in 6 health related domains prescribed in CLDQ scoring system. Each patient's CTP score was calculated. Data was analyzed using chi-square testing and *p*-value \<0.05 was taken as significant.

*Results*: A total of 32 patients were included in the study. In CTP A group (*n*=3) of patients, the score was moderate (4-5) in all domains. In CTP-B group (*n*=16), score was severe (1-3) in abdominal domain and moderate in other domains. In CTP C group (*n*=13), score was severe in abdominal and fatigue domain and moderate in other domains.

*Conclusion*: The administered CLDQ thus showed the abdomen domain and fatigue domain as areas with most distressing symptoms, followed by systemic domain. The severity of the CLDQ scoring is matching with severity of the disease according to standard CTP scoring for liver disease.
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### Spontaneous intracranial hemorrhage in patients of cirrhosis {#Sec457}

***A K Choudhury*** *, Anand Lovkesh, S K Taneja, C Vasistha, S K Sarin*

Department of Hepatology, Institute of Liver and Biliary Sciences. D-1 Vasant Kunj, New Delhi 110 070, India

*Introduction*: Spontaneous intracranial hemorrhage (SICH) is though rare it often mimics hepatic encephalopathy. There is a paucity of data on SICH in cirrhotic patients presenting with encephalopathy.

*Aims and Objectives*: To determine the incidence, clinical profile and outcome of SICH in cirrhotic patients with HE.

*Materials and Methods*: A retrospective analysis of 3,170 cirrhotic patients out of which 1,243 admitted to the intensive liver coma unit of a tertiary referral hospital over a period of 4 years from 2009 to 2013 taken.

*Results*: Hepatic encephalopathy is seen in 682 patients and abnormal neuroimaging seen in 26 patients (12.75 %). Which include hemorrhage in 20 (9.8 %) and infarct in 6 (2.9 %). Of these 20 patients with SICH, 16 were males and 4 females with a median age of 55.5 (IQR 50-61.5). The etiology of liver disease was alcohol in 9, hepatitis C in 3, hepatitis B and NASH in 2 each and cryptogenic in 4 patients. The commonest presentation was progressive deep coma in 7, seizures in 6, persistent HE in 3, focal neurological deficit in 2 and headache in 1 patient. Of these 20 patients of SICH 9 patients were in Grade IV HE, 3 in Grade III and 8 in Grade II. The median platelet count was 70 x 103/mm3 (IQR 57-96) and INR was 1.7 (IQR 1.5- 2.3). The median bilirubin was 4.6 mg/dL (IQR 1.9-9.8), serum creatinine was 1.07 mg/dL (IQR 0.7-2.1) and serum sodium was 142.6 (IQR 135.5-150.8). According to CTP score 14 patients had Child C grade, 4 had Child B and 2 had Child A grade. The median MELD score was 24 (IQR 16-27). The median MELD Na was 26 (IQR 22-29). The commonest site of bleed was frontoparietal in 6, followed by subdural and basal ganglion in 3 patients each. None of the patient underwent surgical intervention due to coagulopathy and severe liver disease. The overall mortality was 80 %, with 4 patients (20 %) showing spontaneous recovery. There was no significant difference in age, sex, clinical presentation; biochemical parameters, MELD, MELD Na, INR and platelet count in the survivors as compared to those who died. Mannitol was used in 10 patients but was not found to significantly alter outcome.

*Conclusion*: Spontaneous intracranial hemorrhage is rare in cirrhotic patients but caries very high mortality. It is more common in male alcoholics with severe liver disease.
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### A new prognostic score for severe alcoholic hepatitis {#Sec459}

***Neeraj Nagaich*** *, Sandeep Nijhawan, Radha Sharma, Subhash Nepalia, Amit Mathur, Gaurav Gupta*

Department of Gastroenterology, Sawai Man Singh Medical College, J L N Marg, Jaipur 302 004, India

*Background*: Alcoholic hepatitis (AH) is a cause of considerable mortality and morbidity. Short-term prognosis of alcoholic hepatitis is worse than that of decompensated cirrhosis as agreed at the Baveno IV consensus conference. The stratification of patients with severe alcoholic hepatitis (SAH) have potential clinical implications. The modified Maddrey's discriminant factor (mDF) is most frequently used score. This study was aimed to determine role and validity of a new score for predicting short and long-term prognosis in patients with SAH.

*Methods*: In 151 patients admitted with SAH (DF -2). A score combining individual score assigned for each of these 5 variables \[age, bilirubin level, Delta PT (prothrombin time) (normal PT value - PT of patient), creatinine level and grade of encephalopathy\] was compared to DF in determining survival at 30 days, 90 days and 6 months.

*Results*: The predictive value of this SCORE was better than DF. By stepwise multivariate analysis, this SCORE was identified as independently associated with 6-month mortality. This new score value greater than 7 was associated with increased risk of mortality (18 % vs. 63 %) and showed higher predictability as compared to DF, particularly so for 6 month mortality, AUROC 0.84 (0.71-0.96) vs. 0.64 ( 0.44-0.84). *Conclusion*: This new SCORE includes parameters easily obtained at admission, which allows a rapid identification of the prognosis. In this study it compared well with the DF and rather performed better. It may help in early risk stratification and management of patients with SAH.
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### A study of spectrum of hepatic dysfunction in dengue fever {#Sec461}

***Vineet Behera*** *, Velu Nair, N Naithani, Pankaj Puri, V R Mujeeb, Juhi Varshney, B Saini*

Departments of Gastroenterology and Internal Medicine, Armed Forces Medical College, Pune 411 040, India

*Objective*: To study the clinical and laboratory spectrum of hepatic dysfunction in dengue and study the factors predisposing to hepatic dysfunction.

*Materials and Methods*: We designed a two year cross sectional study in a tertiary care hospital. The study population comprised of patients of dengue fever (as per revised WHO criteria). The clinical presentation especially gastrointestinal features were recorded. Hemogram, routine biochemistry, bilirubin, LFT, dengue serology and ultrasonography of abdomen was done for all. Other causes of hepatitis like viral markers, NASH, alcohol intake markers, drugs were excluded.

*Results*: 1.204 patients of dengue were included in the study. The gastrointestinal symptoms seen were nausea/vomiting in 52 % cases, anorexia in 42 %, pain abdomen in 17.6 %, jaundice in 12.2 % cases. 2. USG showed hepatomegaly in 23.5 %, splenomegaly in 15.1 %, ascites in 24 % and acalculous cholecystitis in 20 % cases. LFT revealed hyperbilirubinemia (\>1.5 mg/dL) in 13.2 %, elevated AST and ALT (\>50 IU/L) in 54.9 % and 47.05 % respectively (15.7 % \>3 ULN enzymes), hypoalbuminemia (\<3.5 g/dL) in 33.3 % cases (30.8 % of these \<50,000/cu mm, hemorrhagic manifestations and features of capillary leak were statistically significant.

*Discussion*: Dengue has clinical hepatic and gastrointestinal manifestations as given, hypoalbuminemia, transaminitis (\<3 times ULN) and rarely jaundice with acalculous cholecystitis and ascites on USG. It is more frequent and severe in patients with thrombocytopenia, hemorrhagic manifestations and capillary leak.

*Conclusion*: Hepatic manifestations are seen in patients of dengue and are a marker of severe disease.

LO-43 {#Sec462}
-----

### Clinical profile and factors associated with liver enzyme abnormalities among HIV-infected persons {#Sec463}

***Ashok Mohite*** *, Pravir Gambhire, Dharmesh Shah, Piyush Somani, Qais Contractor, Pravin Rathi*

Department of Gastroenterology, T N Medical College and B Y L Nair Hospital, Mumbai Central, Mumbai 400 008, India

*Background*: As HIV infected patients are experiencing longer life expectancies, liver disease has been recognized as a major issue but data is more limited and is mostly from western countries.

*Aims and Objectives*: To study the clinical spectrum of liver enzyme abnormalities in HIV infected patients. To study the potential cause(s) and identify factors associated with liver test elevations among HIV-infected patients.

*Materials and Methods*: Cross sectional, prospective study in tertiary care hospital. Thirty-three HIV infected patients with deranged liver enzymes are followed and evaluated for possible causes and outcome of deranged LFT.

*Results*: Mean age of patients was 39.3±9.46 with 9 (27 %) females and 24 (73 %) males. The most common diagnosis was alcoholic liver disease (21 %) and chronic hepatitis B infection (21 %) followed by ATT induced hepatitis (18 %). Three (9 %) patients had multiple causes and one had hepatic tuberculosis. Liver biopsy was done in 4 patients. Eleven patients (33 %) had cirrhosis at the time of presentation. Despite laboratory tests and ultrasound examination, abnormal liver test results was unexplained in 10 (30 %) patients of which 7 patients was on HAART. During mean follow up of 6 months two patients died, one worsened and others improved.

*Conclusions*: Liver test abnormalities are common among HIV patients during the HAART era. The most common diagnosis was alcoholic liver disease and chronic hepatitis B infection. Despite laboratory and radiologic investigations into the cause of liver dysfunction, 30 % were unexplained, but might be related to unrecognized fatty liver disease induced by HAART.

LO-44 {#Sec464}
-----

### Hepatocellular carcinoma in the era of newer treatments: A single center experience {#Sec465}

*Prachi S Patil, Shaesta Mehta,* ***Mahesh Mahadik***

Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Parel, Mumbai 400 012, India

*Introduction and Aims*: Hepatocellular carcinomas (HCC) are associated with poor prognosis. Newer treatment modalities like Sorafenib and Trans Arterial Radioembolisation (TARE) have been introduced recently. We present an audit of HCC patients seen at the Tata Memorial Hospital from 2012-2013.

*Methods*: Review of a prospective database of 183 consecutive patients with HCC to assess the etiology, stage, treatment and outcomes.

*Results*: The mean age was 57 years (range 18-80 years). Most patients were male (85.2 %). The mean alpha-fetoprotein (AFP) levels were 82,308 ng/mL (range 2.5-3376570 ng/mL). AFP levels more than 400 ng/mL were seen in 93 patients (52 %) while levels between 100-400 ng/mL were seen in 17 (9.4 %). The commonest etiological factors were HBV infection in 77 patients (42 %), HCV infection in 18 (9.8 %) and alcohol consumption in 72 (39.6 %). The BCLC stage was A in 5 %, B in 32 %, C in 30 % and D in 33 % patients. Most patients had an ECOG-PS of 2 (69 %) or 3 (24 %). Chronic liver disease was present in 131 (72 %). One hundred and twelve patients (62 %) were Child-B and 69 (38 %) Child-C. Sixty-eight patients (38 %) presented with decompensation. Eighteen patients (9.8 %) underwent surgical resection, 8 (4.4 %) underwent RFA and 54 (29.5 %) underwent TACE. Newer treatment modalities like TARE and Sorafenib were used in 19 (10.4 %) and 42 (23 %) patients respectively. Twenty-nine (15.8 %) were planned for best supportive care only.

*Conclusions*: Most HCC present in an advanced stage and with a suboptimal performance status. Newer treatment modalities are used in almost one third of all HCC patients.
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### A rare case of amebic liver abscess presenting as nephrotic syndrome {#Sec467}

***Vineet Behera*** *, Pankaj Puri, S Srivastava, N Naithani, A Sagar, R Yadav, P Kumar*

Departments of Gastroenterology and Internal Medicine, Armed Forces Medical College, Pune 411 040, India

*Background*: Amebic liver abscess presenting as nephrotic syndrome is very rare. Case Report: A 38-years-old-man presented with fever with pain right upper abdomen of 7 days and swelling of feet and had tender hepatomegaly. His investigations showed leukocytosis, creatinine 1.7 mg/dL and conjugated hyperbilirubinemia. USG and CT scan confirmed an 9.5 cm X 10.8 X 10 cm abscess in right lobe of liver impending rupture with evidence of IVC compression on doppler. His amebic serology was positive. He had 3+proteinuria with 24 hour urine protein of 3600 mg, serum albumin 2.4 mg/dL and hypertriglyceridemia confirming a nephrotic syndrome. A percutaneous drainage of the abscess was done and was given IV metronidazole and cefotaxime. His symptoms improved over 48 hours and had gradual resolution of abscess size, IVC compression, proteinuria and other parameters.

*Discussion*: Amebic liver abscess can cause thrombosis of the portal vein or IVC or can compress these veins causing bilateral pedal edema and ascites. But significant IVC compression causing renal vein congestion and leading to a picture like nephrotic syndrome is extremely rare. Huddle reported a case of ALA complicated with nephrotic syndrome due to external IVC compression which recovered after drainage of the abscess. Liver abscess in close proximity to the IVC or hepatic veins, \>5 cm in size or with pedal edema or anasarca should undergo CT or doppler USG to demonstrate compression or abnormal flow. It requires aggressive medical therapy, anticoagulation and urgent drainage of the abscess.
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### A rare case of storage cirrhosis --Niemann-Pick disease {#Sec469}

***V Saravanan***

Madras Medical College, Chennai 600 003, India

Niemann-Pick disease is a rare lysosomal storage disorder which manifest mainly in childhood. Here we present a case of Niemann-Pick disease who had presented during his adulthood. A 23-year-old male presented to our pod with pain abdomen, jaundice. On examination, he had short 4th metatarsal hand, hepatomegaly. He had thrombocytopenia, altered lipid profile and liver function tests. His liver biopsy showed gralumatous hepatitis with noncaseating granuloma with lymphocytic infiltrates. His bone marrow showed foamy cells. Diagnosis was made with decreased sphingomyelinase activity in blood. Since he did not have neurological involvement, he was diagnosed to have Niemann-Pick disease, type2. He was kept under follow up. Niemann-Pick disease as such a rare entity can very occasionally present in adulthood and can pose difficulty in diagnosis.
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### Chemokine ligand CXCL-8 mediated activation and neutrophil influx aggravates liver injury and correlates with clinical severity indices in acute-on-chronic liver failure {#Sec471}

***Arshi Khanam*** *, Peggy Reise, Nirupma Trehanpati, Chandan Kumar, Carlos Albert Guzman, Shiv Kumar Sarin*

Departments of Research and Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, and Department of Vaccinology and Applied Microbiology, Helmohltz Centre for Infection Research, Braunschweig, Germany

*Background*: Acute-on-chronic liver failure (ACLF) is a serious and often fatal condition, having very high incidence of infection and mortality. Impaired neutrophil and Th17cell function has been observed in ALF and served as a biomarker involved in organ dysfunction and sepsis. We investigated role of neutrophils and Th17cells associated with disease progression in ACLF.

*Methods*: Eighteen alcohol induced, 17HBV-related ACLF and 18 healthy controls (HC) were enrolled. TJLB was collected from patients. Peripheral blood was taken from patients and HC. Percentage of neutrophil, CD16 (activation marker), CXCR-1and 2 was observed. Absolute neutrophil, lymphocyte and TLC was compared in patients with and without sepsis. IL-6,IL-23,CCL-20 and GM-CSF level were detected. Circulating and intrahepatic Th17cells, IL-23 receptor and transcription factor ROR γT was investigated. CytokinesIL-17, IL-22, CXCL-8, and IFN γ were measured.

*Results*: Significant increase in percentage of neutrophils, CD16, CXCR-1/2 was observed in alcohol (*p*\>0.008, 0.00, 0.00, 0.003) and HBV-induced ACLF (*p*\>0.00, 0.00, 0.00, 0.00) than HC. No differences were seen in alcohol vs. HBV-induced ACLF. Absolute neutrophil and lymphocyte count was higher in patients with sepsis than without. Inflammatory cytokines (IL-6 *p*\>0.00, GM-CSF-0.00, IL-23-0.01) were high in both groups and positively correlated with INR (*p*\>0.008), MELD (*p*\>0.03) and CTP score. Th17cells (*p*\>0.003), IL-23 receptor (*p*\>0.04) and ROR γT was higher in peripheral blood of ACLF than HC and same was even higher in liver tissue with respect to peripheral blood in ACLF. Increased Th17cells positively correlated with ALT (*p*\>0.00), s bilirubin (*p*\>0.00) and INR value (*p*\>0.00). Circulating IL-17 (*p*\>0.002), IL-22 (*p*\>0.05), CXCL-8 (*p*\>0.03) and IFN γ produced by Th17cells was highly elevated in ACLF than HC and even higher in liver than peripheral blood in ACLF. High CXCL-8 showed strong correlation with increased neutrophil counts (*p*\>0.00).

*Conclusion*: Increased intrahepatic Th17cells produce CXCL-8 which recruits neutrophils to liver in CXCR-1/2 dependent manner. Hyper activated neutrophil produces abundant inflammatory cytokines; thus encourages hepatic inflammation and further disease progression.
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### Acquired hemophagocytic lymphohistiocytosis mimicking acute hepatic insult presenting as ACLF: Experience from a dedicated Liver Unit {#Sec473}

***Ankur Jindal*** *, Awinash Kumar, Ashok Kumar, Naveen Kumar, Manoj Kumar Sharma, Rakhi Maiwall, Hitendra Garg, S K Sarin*

Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi 110 070, India

*Background*: Hemophagocytic lymphohistiocytosis (HLH) is frequently fatal (overall mortality \>50 %) and often underdiagnosed. It involves a final common pathway of hypercytokinemia. A timely diagnosis is imperative to facilitate immunosuppressive therapy and decrease mortality. HLH presenting as severe acute viral hepatitis or acute-on-chronic liver failure is extremely rare. We present our experience with HLH in a dedicated liver ICU presenting mainly for severe acute hepatic insult.

*Methods*: Retrospective analysis of admitted patients with systemic inflammatory response (SIRS) fulfilling diagnostic HLH criteria (≥5/8).

*Results*: Seventeen patients \[Male:Female -14:3; Adults: Child- 14:3; median age- 26 years (range-1 month to 66 years\] were diagnosed with acquired HLH at our hospital from year 2010 to 2012. Twelve (70.6 %) patients presented clinically as ACLF (7) and AVH (5) at admission. Viral associated HLH (8 patients; 47.1 %) was most common (HAV-3, HEV-2, EBV-1, Dengue-1, Parvovirus-1). Although etiology remained undiagnosed in 7 (41.2 %) patients, few patients had lymphoma (1) and visceral leishmaniasis (1). While fever \[16 patients (94.2 %); median duration- 30 days (4-90 days)\] and jaundice \[14 patients; mean bilirubin-20.34±8.6 mg/dL\] were most common symptoms at presentation, clinical signs such as presence of enlarged liver (76.4 %), spleen (76.4 %) and ascites (58.8 %) were most frequent. Five patients also had AKI (serum creatinine \>1.5 mg/dL) at admission. Important biochemical parameters included hyperferritinemia \[all patients; mean-16064.7±7652 ng/dL\], hypertriglyceridemia (10 patients; mean-354.7±145.1 mg/dL), raised LDH (mean- 2952.66±726) and low fibrinogen (12 patients; mean-146.1± 32.4) levels. Bone marrow aspiration was done in 12 patients of which 11 shows presence of hemophagocytosed histiocytes. Ten patients (58.8 %) had in-hospital mortality and the main cause was eventual sepsis and multiorgan failure. Twelve patients (70.6 %) received specific immunosuppressive therapy (steroids-4, IV IG-4, plasmaphersis-4, cyclosporine-1) but it made no difference in clinical outcome (In hospital mortality- 66.67 % vs. 62.25 % respectively; *p*\>0.05).

*Conclusions*: HLH may masquerade as acute hepatic insult, it is important to suspect and recognize this entity early enough in patients with ACLF, as prognosis is poor despite immunosuppressive therapy.
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### Altered hepatic microenvironment governs the nature of hepatic regenerative response to acute hepatic insult {#Sec475}

***Smriti Shubham*** *, Jaswinder S Maras, Saira Hussain, Dhananjay Kumar, Chhagan Bihari, Hitendra K Garg, Rakhi Maiwall, Viniyendra Pamecha, Archana Rastogi, Anupam Kumar, Shiv K Sarin*

Departments of Research, Hepatology, Pathology, and HPB Surgery, Institute of Liver and Biliary Sciences, New Delhi 110 070, India

*Background*: Acute hepatic insult triggers hepatic regeneration in both normal and chronic liver. Hepatic microenvironment plays an important role in both hepatocyte and hepatic progenitor cell (HPC) mediated hepatic regeneration.

*Aim*: To understand the effect of altered hepatic microenvironment on hepatic regeneration in response to acute hepatic insult.

*Patients and Methods*: Hepatic vein plasma and liver sections of acute-on-chronic liver failure (ACLF, *n*=31; Gr. 1), acute liver failure (ALF, *n*=10; Gr. 2) decompensated liver disease (DLD, *n*=10; Gr. 3), were collected and subjected to immunohistochemical staining for Ki67 (hepatocyte self replication) and cytokeratin7 (HPC and intermediate hepatocytes) for characterization of nature of hepatic regeneration. Hepatic vein plasma of the same patients was subjected to cytokine bead array (Bio-Rad) and was correlated with hepatocyte self replication, HPC activation and maturation.

*Results*: Immunohistochemical analysis documented a significant decrease in Ki67+hepatocytes in Gr.1 as compared to Gr. 2 (*p*=0.003). Further the number of CK7+HPC and its maturational lineages was found to be significantly increased in Gr. 1 as compared to Gr. 2 (*p*=0.027). Cytokine array analysis showed that GCSF, GMCSF, TNFα, IL-2Rα, BNGF, HGF, IL-3, SCGFB, BFGF were all significantly down regulated in Gr.1 as compared to Gr. 2 (*p*\<0.05). On correlation we observed that BFGF, GCSF, GMCSF correlated directly to hepatocytes self replication \[Ki67 (*p*\<0.05, r2\>0.3)\]. While TNF-α, GCSF and GMCSF documented an inverse correlation with CK7+HPC and its maturational lineages (*p*\<0.05, r2\>-0.3). Multinomial logistic regression analysis documented BFGF independently correlates with hepatocytes self replication with a LR=6.3 and HR=26.4 CI (1.4-495). While GCSF and TNF-α are inversely associated with CK7+HPC activation and its maturational lineages \[HR=7.4 (0.9-58), 6.4 (0.9-43)\].

*Conclusion*: Overall the result suggest that acute insult in a healthy liver triggers hepatocytes self replication while acute insult in chronic liver triggers HPC mediated hepatic regeneration. Loss of BFGF in ACLF may be responsible for compromised hepatocytes self replication and loss of GCSF and TNF-α may be associated with increased HPC activation and its maturation.
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### Relative adrenal insufficiency in chronic liver disease is similar to sepsis {#Sec477}

***Faiz Ahmed***, *Sharad Malhotra, Ankush Bansal, R K Himthani*

Batra Hospital and Medical Research Centre, 1,Tughlakabad Institutional Area, Near Saket Metro Station, Mehrauli Badarpur Road, New Delhi 110 062, India

*Introduction*: Patients with severe sepsis and septic shock commonly have abnormalities in adrenal function and this is associated with decreased response to catecholamine therapy, hemodynamic instability and a high mortality. Similar findings have been observed in patients with chronic liver disease. This phenomenon has been termed relative adrenal insufficiency (RAI). We therefore decided to screen for relative adrenal insufficiency in severely stressed chronic liver disease patients and compare them with patients of sepsis.

*Methods*: We enrolled 20 patients with chronic liver disease and 20 patients with severe sepsis. Patients who had received steroids in last 6 weeks were excluded. Cortisol levels were measured by a radioimmune assay technology (Sourcerer RIA counter, Oakfield Health Care). The peak cortisol level was defined as the highest cortisol level obtained after synacthen administration at 60 minutes. The criteria for adrenal insufficiency were defined as follows: baseline value less than 15 mcg/dL (414 nmoL/litre), or cortisol response less than 9mcg/dL (less than 248 nmoL/litre) with a baseline value between 15 and 34 mcg/dL.

*Results*: Adrenal insufficiency is common in patients with both chronic liver disease and severe sepsis. In our study we found the incidence of adrenal insufficiency to be 60 % and 55 % in chronic liver disease and sepsis respectively, In our study mean arterial pressure, serum bilirubin, vasopressin dependency, renal dysfunction and bacteremia were independent factors predicting adrenal insufficiency in critically ill patients with chronic liver disease and severe sepsis.

*Conclusion*: Clinically relevant Adrenal insufficiency is seen in chronic liver disease similar to sepsis and may require similar management.
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### Prospective study of spontaneous bacterial peritonitis in a tertiary care center {#Sec479}

***A Bharath Kumar*** *, Jeyamani Ramachandran, Sajith, Ashish Goel, V Balaji*

Departments of Hepatology and Microbiology, Christian Medical College, Vellore 632 004, India

*Aim and Methods*: We assessed the microbiolgical profile, response to antibiotics and factors affecting outcome prospectively in cirrhotic patients with SBP from July 2012 to July. SBP was categorized based on mode of acquisition into-community acquired (CA), health care related (HCR) and nosocomial (NC). Protocol was to treat CA and HCR with piperacillin tazobactum; NC and SBP with shock and multiorgan dysfunction with meropenem. Antibiotic was escalated in nonresponders, defined as Ë‚ 25 % reduction in ascitic neutrophil count after 48 hours.

*Results*: Among 150 episodes (in 130 patients, 86 % male) 45 %, 42 % and 13 % were CA, HCR and NC. Predominant etiology of cirrhosis was ethanol (46 %). Ascitic fluid cultures were positive in 39 %. Commonest organism was *E. coli* in CA and HCR. Both *E. coli* and gram positive organisms were the culprits in NC. Antibiotic escalation was required in 32 %, 28 % and 26 % in CA, HCR and NC. Organ failure (acute kidney injury) at admission occurred in 57 %, 67 % and 80 % in CA, HCR and NC. Piperacillin resistance was 37 %, 40 % and 75 % in CA, HCR and NC. One case each in CA and HCR had carbapenemase resistance. In hospital mortality was 26 % in CA and HCR and 34 % in NC. Recurrent infections were seen in 15 patients (11 %).

*Conclusions*: A significant proportion of CA showed lack of response to piperacillin. Presence of organ dysfunction at admission, need to escalate antibiotic, NC type and resistance to piperacillin were associated with poor outcome.
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### Clinical profile of drug induced liver injury: A prospective single centre study in Eastern India {#Sec481}

*Abhijit Chowdhury, G K Dhali, Kaushik Das,* ***Amit Mishra***

Department of Gastroenterology and Hepatology, S S K M Hospital, Kolkata 700 020, Institute of Post Graduate Medical Education and Research, Kolkata 700 020, India

*Background*: Drug induced liver injury (DILI) is an increasingly recognized cause of morbidity and mortality in patients receiving prescription drugs and complementary medications. Spectrum of DILI ranges from asymptomatic derangement in liver function tests to chronic liver disease and outcomes vary from early resolution to death.

*Aims and Objectives*: Prospective assessment of causes, clinical features, pattern, severity, strength of causality and outcomes of DILI in Eastern India.

*Material and Methods*: All consecutive patients admitted as inpatients in SDLD, SSKM Hospital or attending Hepatology OPD from February 2012 to July 2013, fulfilling predefined inclusion and exclusion criteria were included in this study. Predefined clinical and laboratory assessment was done for all patients. Strength of causality was assessed using RUCAM criteria.

*Results*: Of 39 included patients, 21 were female. Anti-tubercular drugs were causative agent in 19 (49 %), oral contraceptive pills in 10 (26 %), methotrexate in 4 (10 %), Ayurvedic drugs in 4 (10 %) and antiepileptic drugs in 2 (5 %). Twelve (31 %) patients had hepatocellular pattern, 23 (59 %) had mixed pattern and 4 (10 %) had cholestatic pattern of injury. Twenty patients had possible association and 18 patients had probable association according to RUCAM criteria. Jaundice (62 %) was most common symptom at presentation. Twenty-two (56.4 %) patients had \>50 % improvement in ALT within 30 days of stopping the drug while 1 patient expired due to possible DILI event.

*Conclusions*: Antitubercular drugs are most common cause of DILI in our population followed by oral contraceptive pills. Ayurvedic medications may under-recognised cause of DILI. Most DILI events have early resolution after withdrawal of causative agent.
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### Effect of rifaximin, probiotics and L-ornithine L-aspartate on minimal hepatic rncephalopathy: A case control study {#Sec483}

*Sanjay Pant,* ***Kapil Sharma*** *, S P Misra, Manisha Dwivedi, Sushil Narang, Kailash Mishra, Ravikant Kumar*

Department of Gastroenterology and Hepatology, Moti Lal Nehru Medical College, Allahabad 211 001, India

*Background*: Minimal hepatic encephalopathy (MHE) implies subtle impairment of cognitive functions in absence of features of overt encephalopathy.

*Aims*: To determine the prevalence of MHE in patients with liver cirrhosis and find out effect of rifaximin, probiotics and LOLA individually in reversal of MHE by comparing it with no treatment group.

*Methods*: A total of 317 cirrhotics were screened for the study of which 111 were excluded due to various reasons. Remaining 206 patients were screened for MHE using neuropsychometric tests (NPTs) and/or critical flicker frequency (CFF). Of these 124 patients with MHE were randomized to receive LOLA (drug 1), rifaximin (drug 2), probiotics (drug 3), for two months and were compared to patients who were not given any treatment for MHE.

*Results*: Out of the 206 cirrhotics, 124 (60.19 %) had MHE. Amongst these 124 MHE patients, 87 (70.16 %) patients with MHE had CFF \<39Hz, 112 (90.32 %) patients with MHE had 2 or more abnormal psychometric tests and 75 (60.48 %) patients had abnormality on both the CFF values and more than two NPTs. Intention to treat analysis showed patients who improved after giving treatment were 21/31, 22/31, 16/32 and 9 /30 for LOLA, rifaximin, probiotic and no treatment groups respectively. CFF scores were statistically significant (*p*-value

*The abstract matter was not received in full at the time of sending to press, despite reminders to corresponding author.*
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### Etiologic and clinical spectrum of chronic liver disease in a tertiary referral hospital in India {#Sec485}

***S M Shasthry*** *, M Kumar, H Garg, R Maiwal, C Vashisht, V Bhatia, R Kumar, Y K Joshi, S K Sarin*

Institute of Liver and Biliary Sciences, Sector D1, Vasant Kunj New Delhi 110 070, India

*Aims*: To evaluate the etiological and clinical spectrum of chronic liver disease \[CLD\], in a tertiary care center in Northern India.

*Methods*: We evaluated 3,170 chronic liver disease patients admitted at ILBS from June 2009 to April 2013. The diagnosis of CLD was based on clinical, radiological or endoscopic features.

*Results*: Alcoholic liver disease was the cause in 1,507 \[47.5 %\] CLD patients followed by viral etiologies 805 \[25.4 %\]; 13.4 % of HCV related CLD and 12 % HBV related CLD. Cirrhosis was due to NASH+NAFLD in 425 \[13.3 %\], cryptogenic in 380 \[12 %\] and autoimmune in 113 \[3.6 %\] of the total CLD patients. The mean age at presentation was 51.76+/-12.45 yrs with males being predominant 2,627 \[82.7 %\]. The mean CTP, MELD and MELDNa scores at presentation were 9.06+/-2.42 and 17.92+/-8.23, and 21.17+/-8.12. Two third of patients \[1916; 66.6 %\] had ascites and 731 \[23.1 %\] had hepatic encephalopathy and 336 \[10.6 %\] had associated HCC at presentation. ALD patients had significantly lower age (mean 48.34+/-10.7 yrs) compared to other etiologies (*p*\<0.001); with higher CTP (10.1+/-2.1), MELD (21.1+/-8.2) MELDNa (24.5+/-7.6), liver stiffness (49+/-23 kPa) and HVPG (17.75+/-4.73 mmHg) in comparison with HBV, HCV, NAFLD, AIH and ALD+ liver diseases (*p*\<0.001 with each group). Higher mortality at first presentation was seen in ALD (9.6 %) compared with HBV (6.6 %), HCV (3.8 %) and NAFLD (3.8 %) (*p*\<0.05 with each groups)

*Conclusion*: ALD constitutes nearly half of chronic liver diseases requiring hospital admissions in tertiary care center in India with younger age at presentation, more severe disease and higher mortality compared to other causes of chronic liver diseases.
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### Autoimmune hepatitis/primary biliary cirrhosis overlap {#Sec487}

***Karthikeyan*** *, Premkumar, Ratnakar Kini, Kanisheik Mohammad, T Pugazhendhi, Mohammed Ali*

Department of Medical Gastroenterology, Madras Medical College, Chennai 600 003, India

Overlap syndrome is used to describe a form of autoimmune hepatitis (AIH) which present with characteristics of AIH and primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). Patients with overlap syndromes present with both hepatic and cholestatic serum liver tests and have histological features of AIH and PBC or PSC. AIH-PBC is the most common form of overlap syndrome, affecting almost 10 % of adults with AIH or PBC. Transitions from PBC to AIH-PBC overlap syndrome have also been reported. Overlap syndromes show a progressive course without treatment, and therapy is empirical. Anticholestatic therapy with ursodeoxycholic acid is usually combined with immunosuppressive therapy with corticosteroids and/or azathioprine in both AIH-PBC and overlap syndromes. In end-stage disease, liver transplantation is the treatment of choice. Here we report one such case of autoimmune hepatitis-primary biliary cirrhosis overlap. Our patient was a 45 yrs old female with features of decompensated liver disease, portal hypertension and cholestasis. She had grossly elevated IgG, positive AMA, ANA and strongly positive AMA- M2. Liver biopsy showed features of both PBC and AIH.
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### Etiology and prognosis of acute liver failure in a tertiary centre {#Sec489}

***Siljo Jose*** *, E H Rooby*

Medical Gastroentrology, S S B Medical College, Trivandrum 695 011, India

*Background*: Acute liver failure (ALF) is a rare condition in which rapid deterioration of liver function results in altered mentation and coagulopathy in previously normal individuals.

*Objective*: To study the etiology and prognosis of acute liver failure patients admitted in Medical Gastroenterology Department, Trivandrum Medical College from August 2010 to July 2011.

*Methods*: There were 24 patients, 8 males and 16 females. The most common etiology was Hep B, drug induced, pancreatits followed by others. Six patients survived without tansplantation, 18 patients expired. None of the patients underwent transplantation. Liver biopsy was done in one patient with SLE and ALF, etiology found to be HSV.

*Conclusion*: ALF has a mortality of 75 % and prognosis is poor. The etiology was wide range, the most common being Hep B, drug induced, and pancreatits.
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### Altered hepatic microenvironment governs the nature of hepatic regenerative response to acute hepatic insult {#Sec491}

***Smriti Shubham*** *, Jaswinder S Maras, Saira Hussain, Dhananjay Kumar, Chhagan Bihari, Hitendra K Garg, Rakhi Maiwall, Viniyendra Pamecha, Archana Rastogi, Anupam Kumar, Shiv K Sarin*

Departments of Research, Hepatology, Pathology, and HPB Surgery, Institute of Liver and Biliary Sciences, Vasant Kunj Marg, New Delhi 110 070, India

*Background*: Acute hepatic insult triggers hepatic regeneration in both normal and chronic liver. Hepatic microenvironment plays an important role in both hepatocyte and hepatic progenitor cell (HPC) mediated hepatic regeneration.

*Aim*: To understand the effect of hepatic microenvironment on nature of hepatic regeneration in response to acute hepatic insult.

*Patients and Methods*: Hepatic vein plasma and liver sections of acute-on-chronic liver failure (ACLF, *n*=31; Gr. 1), acute liver failure (ALF, *n*=10; Gr. 2) decompensated liver disease (DLD, *n*=10; Gr. 3), were collected and subjected to immunohistochemical staining for Ki67 (hepatocyte self replication) and cytokeratin 7 (HPC and intermediate hepatocytes) for characterization of the nature of hepatic regeneration. Hepatic vein plasma samples of the same patients was subjected to cytokine bead array (bioplex-47 cytokines array-Bio-Rad) and was correlated with hepatocyte self replication, hepatic progenitor cell activation and maturation.

*Results*: Immune-histochemical analysis documented a significant decrease in Ki67+hepatocytes in Gr.1 as compared to Gr. 2 (*p*=0.003). Further the number of CK7+HPC and its maturational lineages was found to be significantly increased in Gr.1 as compared to Gr. 2 (*p*=0.027). Cytokine bead array analysis showed that GCSF, GMCSF, TNF-alpha, IL-2R Alpha, BNGF, HGF, IL-3, SCGFB, BFGF were all significantly down regulated in Gr.1 as compared to Gr.2 (*p*\<0.05). On correlation we observed that BFGF, GCSF, GMCSF correlated directly to hepatocytes self replication \[Ki67(*p*\<0.05,r2\>0.3)\]. While TNF-alpha, GCSF and GMCSF documented an inverse correlation with CK7+HPC and its maturational lineages (*p*\<0.05,r2\>-0.3). Multinomial logistic regression analysis documented BFGF independently correlates with hepatocytes self replication with a LR=6.3 and HR= 26.4 CI (1.4-495). While GCSF and TNF-alpha are inversely associated with CK7+HPC activation and its maturational lineages \[HR=7.4 (0.9-58), 6.4 (0.9-43)\].

*Conclusion*: Overall the result suggest that acute insult in a healthy liver triggers hepatocytes self replication while acute insult in chronic liver triggers HPC mediated hepatic regeneration. Loss of BFGF in ACLF may be responsible for compromised hepatocytes self replication and loss of GCSF and TNF-alpha may be associated with increased HPC activation and its maturation.
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### Overlap syndrome: Autoimmune hepatitis with AMA negative primary biliary cirrhosis {#Sec493}

***T S Ramesh Kumar*** *, A R Venkateswaran, Revathy*

Department of Medical Gastroenterology, Government Stanley Medical Hospital, Chennai 600 001, India

"Overlap syndrome" is used to describe variant forms of autoimmune hepatitis (AIH) which present with characteristics of AIH and primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). Patients with overlap syndromes present with both hepatitic and cholestatic serum liver tests and have histological features of AIH and PBC or PSC. AIH-PBC is the most common form of overlap syndrome, affecting almost 10 % of adults with AIH or PBC. Transitions from PBC to AIH-PBC overlap syndrome have also been reported. Overlap syndromes show a progressive course without treatment, and therapy is empiric. Ursodeoxycholic acid is usually combined with immunosuppressive therapy but end-stage disease requires liver transplantation. We report a case of AIH/PBC overlap with relevant discussion of literature.
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### The comparison of bone mineral density between patients with chronic liver disease and the control group {#Sec495}

***Manisha Kakaji*** *, Gourdas Choudhuri, Sushil Gupta*

Departments of Endocrinology, and Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background and Aim*: Hepatic osteodystrophy is a complication of longstanding liver disease results in osteopenia and osteoporosis. It can significantly affect morbidity and quality of life of these patients. The aim of this study was to compare the rate of bone mineral density (BMD) between patients with chronic liver disease (CLD) and healthy control group.

*Materials and Methods*: One hundred and sixty-four patients with CLD and 222 individuals without CLD (control group) were enrolled in this study. The CLD group included alcoholic liver disease, idiopathic, C or B virus related, and autoimmune hepatitis patients. The CLD patients were divided to Child class - A, B and C by severity. Bone mineral density (BMD) was measured by dual energy X-ray absorptiometry (DEXA).

*Results*: Adult patients (46.38±8.96 M: F: 3:1) was enrolled. CTP score of A, B, and C was present in 31.10 %, 56.70 % and 12.20 % respectively. BMD were measures at three sites, patients with child A has 0.832±0.133, 0.848±0.135, 0.609±0.101, B 0.822±0.120, 0.843±0.160, 0.604±0.122 and C has 0.797±0.112, 0.773±0.274, 0.593±0.125 and normal were 0.921±0.105, 0.896±0.127, 0.627±0.122 respectively. Seventy-nine (48.18 % has osteoporosis 78 (47.56 %) had osteopenia and 7 (4.26 %) were normal according to T score. Significant correlations were found between BMD and CTP score. Although statistically not significant, the mean bone mass (mean Z. score) was lower and the frequency of osteoporosis was higher in CLD compared to those of the control group (*p*\>0.05). The mean bone mass was decreased from Child-A to Child-C (*p*\>0.05).

*Conclusion*: CLD could reduce BMD. The risk increases with severity of cirrhosis.
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### Risk factors associated with gallbladder cancer in coastal Odisha {#Sec498}

*Ankit Tiwari, S P Singh, Niranjan Rout,* ***Manjusha Dixit***

School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, Odisha 751 005, Department of Gastroenterology, S C B Medical College, Cuttack, Odisha 753 007, AHRCC, Cuttack, Odisha, and Kalinga Gastroenterology Foundation, Cuttack, Odisha, India

*Background and Aim*: Gallbladder carcinoma (GBC), the most common biliary tract cancer has highest incidence rate and is the commonest cancer in North Indian women (21.5/100,000). The distribution suggests a high-incidence region, popularly known as GBC belt, comprising Uttar Pradesh, Bihar, Orissa, West Bengal, and Assam. Epidemiologic studies suggest that GBC is multifactorial in nature. This study aims to identify risk factors associated with GBC in coastal Odisha.

*Patients and Methods*: We recruited 45 GBC patients and 524 controls from Beam Diagnostics Center, Cuttack, Odisha. A questionnaire was developed for this study to record various environmental risk factors including dietary habits, reproductive history, previous infections, family history for cancers, occupation, age, BMI and gender. The dietary evaluation was carried out by the dietary recall method. Data was analyzed using SPSS 17 software. Data analysis was done for known risk factors including use of impure water, mustard oil, and family history of cancer.

*Results*: Frequency of GBC was found to be much higher in females (2.27:1). Odds ratio for gender female to male was 2.198 (95 % CI 1.17-4.13). Consumption of impure water and mustard oil were strongly associated (*p*\<0.000) with increased risk (Odds ratio 11.32, 95 % CI 4.70-27.27 and 3.25, 95 % CI 1.69-6.27) of GBC. Family history of cancer was also found as highly significant (*p*\<0.000, Odds ratio 16.45, 95 % CI 7.49-36.16) risk factor for GBC.

*Conclusion*: This ongoing study shows that female gender, impure water, mustard oil and family history of cancer are risk factors for gallbladder cancer.
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### Clinical and etiological profile of obstructive jaundice in tertiary referral hospital {#Sec500}

***P Laksmana Chandra*** *, P Shravan Kumar, M Umadevi, M Ramanna*

Gandhi Medical College Hospital, Secunderabad 500 025, India

*Background/Aim*: Obstructive jaundice is one of the common refferal cases to gastroenterology. In this study, we aimed at identifying clinical and etiological profile of obstructive jaundice in patients referred for ERCP procedure.

*Patients and Methods*: Three hundred and twenty-three patients with obstructive jaundice referred for ERCP over a period of 4 years from 2009-2013 were studied retrospectively. Demographic, clinical, biochemical and ultrasonography, CT, MRCP, ERCP findings were analyzed and biopsy details were noted.

*Results*: Of all the 323 patients, 128 males (40 %); median age 42 years; range 17-67 years and females 195 (60 %); median age 38 range 19-64 years. The clinical profile of patients include jaundice 323 (100 %), abdominal pain 170 (55 %), vomiting 94 (29 %), anorexia 90 (29 %), loss of weight 80 (26 %), pruritus 50 (15 %), pale stools 58 (18 %). The spectrum of diseases diagnosed include choledocholithiasis 139 (43 %), periampullary carcinoma 47 (15 %), benign biliary stricture 44 (14 %), hilar cholangiocarcinoma 31 (10 %), distal cholangiocarcinoma 20 (6), carcinoma head of pancreas 16 (5 %), postoperative bile leak 15 (5 %), choledochal cyst 4 (1 %), carcinoma gallbladder 3 (0.9 %), hydatid cyst 2 (0.6 %), portal biliopathy 2 (0.6 %), PSC 2 (0.6 %). Gender wise analysis 128 males (40 %), 195 females (60%). Common etiology in males choledocholithiasis 53 (17 %), periampullary carcinoma 38 (12 %), hilar cholangiocarcinoma 20 (6 %) and females-choledocholithiasis 86 (27 %), benign biliary stricture 28 (9 %).

*Conclusion*: Choledocholithiasis found to be the commonest cause of obstructive jaundice followed by periampullary carcinoma in this study.
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### Double-guidewire-assisted technique for difficult biliary cannulation: A case series {#Sec502}

***Amit Bhasin*** *, Anoop Alva, Shanthi Vijayaraghavan, S Shanmuganathan*

Department of Medical Gastroenterology, Sri Ramachandra Medical College, Porur, Chennai 600 116, India

*Background*: A common problem with endoscopic retrograde cholangiopancreatography (ERCP) is difficulty reaching a deep biliary cannulation. An alternative method for difficult biliary cannulation is the double-guidewire technique (DGT). Our study aimed to assess the feasibility and safety of the double-guidewire-assisted biliary cannulation using this technique.

*Methods*: A total of 10 patients who were undergoing ERCP with intent to cannulate the CBD between January to June 2013 were included in the study. DGT was applied after three repeated pancreatic guidewire entry. The application of the DGT for deep biliary cannulation and the complications of ERCP procedure (pancreatitis, perforation, bleeding) using the DGT were determined. The overall success rate for biliary cannulation in these cases also was determined. Main outcome measurements CBD cannulation rate and ERCP-related complications.

*Results*: A total of seven female and three male patients with age range of 29-72 years were included in the study. Eight out of ten patients had underlying CBD stone. One patient was post cholecystectomy CBD leak and one had carcinoma head of pancreas. The DGT was applied in the above 10 cases after three attempts. CBD cannulation was achieved in 100 % (10/10). None of the patients (0 %) developed any post procedural complications.

*Conclusions*: The double-guidewire technique is a feasible and safe method for biliary cannulation in all patients with failed standard cannulation technique with low rate of complications.
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### Diagnostic and therapeutic role of ERCP in patients with post laparoscopic cholecystectomy bile leak {#Sec504}

***S Pratibha*** *, P Shravan Kumar, M Umadevi, M Ramanna, I Bharani*

Department of Gastroenterology, 5th Floor, Gandhi Hospital, Secunderabad 500 025, India

*Aim*: To study ERCP findings in post laparoscopic cholecystectomy bile leak.

*Materials and Methods*: This is a retrospective analysis of 17 patients. The details were recorded from the medical records. All patients who had a bile leak post cholecystectomy and underwent an ERCP were included.

*Results*: Total of 17 patients was analyzed. The age range was 25-65 years. There were 12 males and 5 females. Cannulation was successful in 13 patients. Cholangiogram revealed leak in 8 patients, 3 had leak at CBD level, 4 at cystic duct insertion level. A complete cut-off was seen in 4 patients. Two patients had stones in the CBD. All 17 patients underwent sphincterotomy and stenting was successful in 9 patients. Stone extraction was successful in one patient. Four patients in whom cannulation was unsuccessful were referred for CBD exploration. All the stented patients had shown a resolution of leak at 1 week follow up.

*Conclusions*: ERCP and stenting is an effective modality of treatment for bile leak. The common sites of leak were CBD and at cystic duct insertion. However stenting was successful in approximately half of the patients.
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### Outcome of emergency endoscopic biliary stenting without imaging guidance in patients with obstructive jaundice {#Sec506}

***S Sukumaran*** *, K Muthukumaran, G Ramkumar, R Balamurali, P Ganesh, S Jeevan Kumar*

Department of Digestive Health and Disease, Kilpauk Medical College, Chennai 600 010, India

*Introduction*: Endoscopic biliary stenting (EBS) is an effective method to achieve biliary drainage in patients with obstructive jaundice due to malignancy or benign conditions. In routine practice, ERCP and biliary stenting are performed with fluoroscopy. However, in emergency conditions, patients with an impaired general status who cannot be transported to the radiology units, emergency EBS stenting without imaging guidance may be applied.

*Aim*: To study outcome of emergency EBS without imaging guidance performed in patients with obstructive jaundice in our centre.

*Materials and Methods*: In this retrospective study, technical success and outcome of emergency EBS without imaging guidance that were performed in our centre in 45 patients with obstructive jaundice were analyzed. Patients were evaluated with imaging studies like MRCP and CECT abdomen. Patient under conscious sedation; SVS done and selective cannulation of CBD (bile aspiration in cannula)+/-sphincterotomy and stent placement were done. X-ray abdomen done for confirming stent position.

*Results*: In 45 patients, successful stenting was achieved in 39 patients (89 %) of which sphincterotomy done in 24 patients (61 %). In two patients stenting was done after choledochotomy and through choledochoduodenal fistula in one patient. Substantial reduction in bilirubin levels was achieved in all patients with successful stenting. There were no major immediate and late complications.

*Conclusion*: Technical success and outcome of EBS is very much similar to conventional ERCP. EBS is safe and efficacious method of biliary drainage in emergency conditions and patients with an impaired general status who cannot be transported to radiology units.
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### Single incision laparoscopic cholecystectomy and per operative ERCP as single stage treatment {#Sec508}

***P S Rajan*** *, Mohd. Juned Khan, P Karthikeyan, C Palanivelu*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Background/Aims*: Even though laparoscopic cholecystectomy and ERCP have revolutionized the management of common bile duct stones, the use of these modalities as a single stage procedure remains controversial. More over, with increasing application of single incision minimally invasive procedure, we carried out our study to determine the feasibility of single incision laparoscopic cholecystectomy and ERCP as a single procedure.

*Methods*: We involved all patients planned for management of both gallbladder and CBD stones excluding those with acute cholecystitis, empyema of gallbladder from August 2010. We submitted them for single incision laparoscopic cholecystectomy and per operative ERCP. Age group from 6 to 63 years. Total number of patients 55.

*Result*: CBD access and stone clearance was achieved in 100 % of patients. Out of 55, 11 patients required needle knife sphincterotomy because of failure to cannulate ampulla. Three patients required lithotripter to crush the larger size stones. With regard to gallbladder, cholecystectomy was performed with single incision multiport technique. Nine patients required converstion to standard laparoscopy in view of dense adhesions around Calot's triangle and the need for suturing infundibuluam where the cystic duct dissection and clipping not possible.

*Conclusion*: Single incision laparoscopic cholecystectomy and ERCP provides effective therapy for CBD and gallbladder stones with least morbidity and may be beneficial to selected patients as both are done under single anesthesia.
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### Laparoscopic assisted endoscopic retrograde cholangiography following Roux-En-Y reconstruction {#Sec510}

***P S Rajan*** *, Mohd. Juned Khan, P Karthikeyan, Amol Shinde, C Palanivelu*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Background/Aims*: Laparoscopy assisted endoscopic retrograde cholangiography (LAERC) allows the diagnosis and treatment of biliopancreatic conditions in patients with altered anatomy following any kind of Roux-En-Y reconstruction. However experience with this technique is limited and its results are still emerging.

*Methods*: To report on the experience with LAERC in consecutive patients from a tertiary centre with high-volume of bariatric surgeries and to evaluate success rates of ERC with the laparoscopy-assisted approach.

*Result*: Five patients underwent LAERC, three for choledocholithiasis after RYGB, one for recurrent stricture after hepaticojejunostomy for choledochal cyst and one for choledocholithiasis following subtotal gastrectomy. Endoscopic access was obtained through the gastric remnant (in three RYGB patients) or biliopancreatic limb (in other two patients). Biliary cannulation was successfully achieved in all the patients. Biliary sphincterotomy was performed in the three patients with intact sphincters. Average time taken to achieve laparoscopic assisted endoscopic cannulation was 40 min (range 20 min-55 min) and average time taken to complete the entire procedure was 140 minutes (range 110 min-160 min). All the four choledocholithiasis patients were treated by balloon sweep, and wide sphincterotomy. The patient with recurrent cholangitis following hepaticojejunostomy stricture for choledochal cyst managed with stenting. The median post-procedure hospital stay was 4 days.

*Conclusion*: LAERC is safe and successful for the treatment of biliopancreartic condition in patients with Roux-en-Y anatomy.
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### Single stage laparoscopic peritoneal lavage and ERCP in biliary peritonitis following cholecystectomy {#Sec512}

***P S Rajan*** *, Mohd. Juned Khan, P Karthikeyan, Sathyamurthy, Amol Shinde, C Palanivelu*

G E M Hospital and Research Centre, 45-A, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 005, India

*Background*: Post cholecystectomy with biliary peritonitis is a challenging clinical scenario where there is role of both surgery and endoscopy. Our objective of this study is to see the feasibility and advantages in aiding fast recovery by combining both laparoscopic peritoneal lavage and ERCP with stenting at single stage.

*Methods*: From September 2008 to January 2013, 43 patients with biliary injury presented with peritonitis in our Institute (30 M and 13 F). After preoperative work up, they were scheduled for combined laparoscopic peritoneal lavage and ERCP. Three patients were converted to open surgery in view of dense adhesions.

*Technique*: After general anesthesia, thorough peritoneal lavage done. Multiple intraabdominal drains placed in all compartments. Before completion, ERCP was performed in same supine position. Cannulation was successful in 32 patients and in 11 patients following pre-cut needle knife sphincterotomy, guide-wire could be taken into CBD and plastic stent deployed in 33 patients. In 10 patients, there was complete transaction of CBD seen and hence stenting could not be performed.

*Result*: Out of 43 cases, 10 patients had complete CBD transaction and were kept on with drains for 3 months before taken up for definitive hepaticojejunostomy procedure. In 33 cases, 24 patients had leak from cystic duct or infundibulam cut-end. Nine patients had lateral wall injury to CBD. All the patients settled well with endoscopic stenting following sphincterotomy. Two patients had mild postoperative pancreatitis treated conservatively.

*Conclusion*: Combined application of laparoscopy and ERCP aids in faster recovery in patients with biliary injury.
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### Prognostic significance of maspin mRNA expression in patients with resected gallbladder cancer {#Sec514}

***Kavita Baghel*** *, Hasan Raza Kazmi, Saloni Raj, Abhijit Chandra, Rajeshwar Nath Srivastava*

Departments of Surgical Gastroenterology, and Orthopedic Surgery, King George\'s Medical University, Lucknow 226 003, India

*Introduction*: In the present study, we investigated expression of maspin mRNA in normal, gallstones and gallbladder cancer (GBC) tissues and its prognostic significance for patients with GBC.

*Materials and Methods*: The study consists of 81 patients including 25 each of normal and gallstones and 31 of GBC (stage II: *n*=16, stage III: *n*=15). RNA was isolated from tissues followed by cDNA synthesis. Maspin mRNA expression was evaluated by reverse transcriptase PCR and real time PCR.

*Results*: Significant higher (*p*=0.043) expression of maspin mRNA was observed in GBC by reverse transcriptase PCR. Further, 36 % and 65 % increase (*P* 1.5 (median survival; 11 months) as compared with those patients in which R.Q. \<1.5 (median survival; 17.5 months) (HR=3.02, 95 % CI=2.304-11.53). Significant difference (*p*=0.02) in survival was observed for stage II patients however no significant difference (*p*=0.117) was observed for stage III disease. The HR for stage II and III disease was 8.9 (95 % CI=1.395-56.8) and 2.17 (9 5% CI=0.7907-8.477) respectively.

*Conclusion*: Increased maspin mRNA expression from gallstones to GBC indicates presence of gallstones may lead to malignant transformation and poor survival. Maspin mRNA may be used as a prognostic marker for resected stage II GBC.
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### Epidemiological factors in gallbladder carcinoma in northern India {#Sec516}

***Smita Verma*** *, Jitendra Kumar Choudhary, Neha Singh, Neha Gupta, Manish Kumar Tripathi, Sapna, Vinod Kumar Dixit, Ashok Kumar Jain*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Background*: Gallbladder cancer (GBC) is one of the most common gastrointestinal malignancies in northern India. It is a fatal and incurable disease and has reputation for being aggressive and incurable. The poor prognosis of gallbladder carcinoma is attributed to late diagnosis due to absence of specific clinical findings in early stage. However, the data regarding GBC are limited.

*Aim*: To evaluate role of epidemiological factors in gallbladder carcinoma in north-eastern region of India.

*Method*: Subjects presented with GBC were included in this prospective study. Study has been carried out in 45 patients, attending the Gastroenterological Unit of S S Hospital, BHU. A thorough evaluation was carried out on the basis of clinical history and physical examination. Diagnosis was made on the ultrasonography, computed tomography and/or MRI findings.

*Result*: Prospective study of 45 GBC subjects in our hospital over 16 months analyzing how the epidemiological factors are influencing the disease. Mean age of subjects was 55.8±12.10 (M/F-18/27). Majority were in lower socioeconomic status 44 (97.8 %), with non vegetarians 31 (68.9 %). Male smokers were significantly high (*p*=0.000). BMI value is non significant in male and female (*p*=0.361). Gallstones were present in 23 (51.1 %, *p*=0.000). Pain abdomen was present in 28 (62.2 %), followed by lump, nausea and vomiting and jaundice in 69.84 %, 86.7 %, 88.9 % patients respectively.

*Conclusions*: This study shows that GBC is more prone to female that belong from low socioeconomic status. Gallstone, nonvegetarian diet and smokers were significantly associated with GBC.
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### Vitamin D deficiency in patients with gallstones: Prevalence and effect of supplementation of parenteral vitamin D on gallbladder ejection fraction {#Sec518}

*G Petluri,* ***U Dutta*** *, A Bhattacharya, S K Bhadada, K Singh*

Departments of Gastroenterology, Nuclear Medicine, and Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Gallbladder stasis is a cofactor in the pathogenesis of gallstones (GS). Vitamin-D deficiency (VDD) if present in patients with GS, is likely to further promote GB stasis. Patients with GS are prone to VDD due poor fat absorption.

*Aims*: To study the vitamin-D profile in patients with GS and determine the effect of vitamin-D supplementation (VDS) on GBEF.

*Methods*: Prospective study at a tertiary center in North-India (2009 - 2011). Those with symptomatic GS were enrolled as cases (*n*=91). Sera were analyzed for 25-OH vitamin-D levels using chemiluminiscence assay. They were classified as vitamin-D deficient (30 ng/mL). GBEF was estimated using cholescintigraphy after a standard fatty meal and classified as nonfunctional (0 %), static (75 %). Those with suboptimal GBEF underwent repeat evaluation for GBEF, 2 weeks after VDS (single IM dose of 6,00,000 IU).

*Results*: Mean vitamin-D levels among cases \[*n*=91; mean age of 48 (13) years; 78 % F; 86 % multiple GS\] was 14 (7.5) ng/mL. Of them, 75 (82.4 %) were deficient, 12 (13.2 %) insufficient and 4 (4.4 %) had sufficient vitamin-D levels. Of them, 14.4 % had nonfunctional, 16.4 % had static, 47.2 % had suboptimal and 22 % had optimal GB function. After VDS in 19 of those with suboptimal GBEF, the mean GBEF increased from 52 (16.3) to 62.7 (13.8) \[*p*-value=0.001\]. Median increase in GBEF was by 17 % (IQR 9.6,44.4). In all the five patients with static GB, GBEF was restored to normal range after VDS.

*Conclusions*: Vitamin-D deficiency is highly prevalent among patients with GS. Vitamin-D supplementation resulted in significant improvement in GBEF and normalized GB function in those with static GB.
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### Comparison of EUS-CD, EUS-HG and EUS-AG as techniques of EUS guided biliary drainage (EUS-BD) {#Sec520}

***Nachiket Dubale*** *, Advay Aher, Amol Bapaye*

Department of Digestive Diseases and Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Erandawne, Pune 411 004, India

*Background*: ERCP fails in 5 % to 10 % due to various causes. EUS guided biliary drainage (EUSBD) is an alternative. EUSBD is possible by EUS-ERCP rendezvous (EUSRV); or by transmural choledochoduodenostomy (EUSCD) or hepaticogastrostomy (EUSHG); or antegrade transpapillary stenting (EUSAG).

*Aim and Methods*: To compare technical aspects, success rates, clinical outcomes and complications of EUSCD, EUSHG and EUSAG. Retrospective study. Included -EUSCD, EUSHG or EUSAG. Excluded - EUSRV. All EUSBD conducted by single endoscopist. Statistical analysis simple t-test and chi-square test. *P*-value \<0.05 considered significant.

*Results*: Thirty-one EUSBD procedures in 7 years (2005-12); EUSCD-13 (42 %), EUSH -9 (29 %), EUSAG-9 (29 %). Three groups comparable for baseline characteristics. EUSAG technically successful in 90 % vs. 77.7 % (EUSHG) and 84 % (EUSCD) (*p*\>0.05, NS). Clinical success similar in 3 groups. Failures converted to alternative EUSBD (1 each-EUSCD and EUSAG) or percutaneous drainage (EUSHG). Failed drainage-1 (EUSHG). Procedure time shortest-EUSCD, longest-EUSHG. Aggressive track dilatation (diathermy/balloon) most frequently required-EUSHG, never-EUSAG. Complications-5/14 - EUSCD (4 minor leaks), 2/9 - EUSHG (1 major biliary peritonitis and death) and 1/10-EUSAG (late stent occlusion).

*Conclusions*: The 3 EUSBD techniques are comparable for technical success and clinical efficacy. EUSCD had shortest procedure time. Aggressive track dilatation was not required in EUSAG. EUSHG was technically more difficult. Further randomized prospective studies comparing these 3 techniques are needed to confirm these findings.
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### Delineation of the critical molecular switches controlling the development of gallbladder diseases and its progression to carcinoma {#Sec522}

***Rajkumari Deblakshmi*** *, S Bose, M Bose, A Saikia, D Thanjam, B Thanjam, Bir Kumar Sharma, Manab Deka*

Departments of Biotechnology, and Biological Sciences, Gauhati University, Guwahati, Assam, Central Hospital, NF Railway, Guwahati 781 014, Assam, Babina Diagnostic Centre, Lamphelpat, Manipur, India RIMS, Lamph

Deregulation in the expression of proto-oncogenes, tumor suppressor genes and cell cycle regulators are critical for carcinogenesis.

*Aim*: To study the role of deregulation of proto-oncogene β-catenin, downstream cell cycle regulatory gene CyclinD1, and tumour suppressor gene p53 expression in the development and progression of gallbladder disease and carcinoma.

*Methods*: Surgically ressected tissuees of clinically and histopathologically proven cases of gallbladder disease patients {Cholelithiasis(CL, *n*=25), cholecystitis (CS, *n*=20) and CaGB (*n*=20) along with autopsy based controls (*n*=10)} were collected from Central Hospital, NF Railway, Guwahati; and RIMS, Manipur. β-catenin, CyclinD1 and p53 mRNA expression was studied by RT-PCR, using β-actin as internal control. Differential protein expression was studied by immunohistochemistry and/or western blotting. Statistical analysis was performed by SPSS software.

*Results*: β-catenin mRNA expression was up-regulated chronologically in the gallbladder diseases (control\<CL\<CS\<CaGB). CyclinD1 expression was significantly increased in CaGB cases (11.954±3.11 folds) and CL (5.03±3.61 folds, *p*=0.036) but not in CS compared to controls; and correlated significantly with increased β-catenin (*p*=0.015) expression. p53 expression was found to be significantly down-regulated in CL (*p*=0.002) and CaGB (*p*=0.004) compared to controls. β-catenin levels negatively co-related with p53 expression significan-tly (*p*=0.049). The protein expression data was in accordance with the mRNA expression profile. Protein expression study by western blot also shows up-regulated expression of β-catenin and CyclinD1 in CaGB and CL cases compared to controls while downregulation of p53 was observed in the same cases. IHC based analysis showed increased membranous and cytoplasmic expression β-catenin in CaGB cases comp-ared to controls and CL.

*Conclusion*: Deregulation of β-catenin, CyclinD1 and p53 is pivotal for the development of gallbladder disease and carcinogenesis.
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### Direct peroral cholangioscopy using standard pediatric gastroscope: A pilot study {#Sec524}

***A S Puri*** *, N Gupta, S Sachdeva, A Sanghi*

Department of Gastroenterology, G B Pant Hospital, J L Nehru Marg, New Delhi 110 002, India

*Background*: Direct peroral cholangioscopy (POCS) is an emerging technique with several diagnostic and therapeutic indications.

*Aims*: To study the feasibility and safety of direct peroral cholangioscopy using standard pediatric gastroscope.

*Study Design*: Retrospective analysis of prospectively collected data.

*Material and Methods*: Patients referred for ERCP for various indications and found to have CBD dilated (\>1 cm) till lower end were included in the study. Initial procedure of biliary cannulation and papillotomy was done using standard adult therapeutic duodenoscope. Then POCS was performed using standard pediatric gastroscope in the same sitting. Success and complication rate were analyzed.

*Results*: Nine patients (median age 37 yrs, seven females) were enrolled in the study. Indication for ERCP was choledocholithiasis in 8 and lower end CBD stricture in one patient. Successful intubation of CBD was possible in 8 of the 9 patients giving a technical success rate of 89 %. Median procedural time was 4 minutes (35 sec to 12 minutes). One patient developed retroperitoneal perforation which was managed conservatively with hospital stay of 3 days. No other complications were observed. One patient underwent biopsy of choledochal mucosa which changed the diagnosis and management plan.

*Conclusion*: Direct peroral cholangioscopy using standard pediatric gastroscope is feasible without significant complication rate with several diagnostic and therapeutic implications.
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### Spectrum of pancreaticobiliary pathologies in a tertiary care centre in northern India {#Sec526}

***V B Abhilash*** *, Lovekesh, M K Behera, V K Dixit, A K Jain*

Departments of Gastroenterology and Radiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Objectives*: The objective was to study the spectrum of congenital, obstructive and neoplastic pancreaticobiliary conditions found in patients of northern India using MRCP. The incidence of anomalous pancreaticobiliary junction (APBJ) in hepatobiliary disease was also identified.

*Methods*: The study was conducted in Sir Sunderlal Hospital, BHU, Varanasi during the period from August 2011 to June 2013. Fifty patients who presented with symptoms and investigations suggestive of pancreaticobiliary disease were subjected to MRCP. MRCP images were analyzed for the morphology of ductal system, ductal calculi, pancreaticobiliary junction, length of common channel and accessory duct.

*Results*: The majority of patients were females (33). Choledochal cysts were more common in females (62.5 %). Eighty-seven percent of the choledochal cysts were of type I. Three cases of choledochal cysts were complicated by choledocholithiasis. 87.5 % of choledochal cysts were associated with APBJ. Most common cause of biliary obstruction was choledocholithiasis (43 %) followed by benign stricture (33 %) and malignant stricture (14 %). All cases of chronic pancreatitis showed a dilated pancreatic duct all through the pancreas.

*Conclusion*: APBJ was found in 15 cases and was associated mainly with choledochal cyst. Ten cases (67 %) of APBJ were right angled type and 5 (33 %) were of acute angled type. Post-surgical biliary conditions identified were biliary strictures in 62.5 % followed by biliary stones (25 %) and biliary leakage (12.5 %). MRCP is currently the imaging modality that best demonstrates the biliary and pancreatic duct with simultaneous visualization of the ducts proximal and distal to the site of pathology.
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### Role of altered modulation β-catenin and hTERT in the development and progression of gall bladder diseases and carcinoma {#Sec528}

*Sujoy Bose,* ***Rajkumari Deblakshmi,*** *Anjan Saikia, Manab Deka, Dhabali Thanjam, Bipin Thanjam*

Department of Biotechnology, Gauhati University, Guwahati, Assam, Department of Biological Sciences, Gauhati University, Guwahati, Assam, Central Hospital, NF Railway, Guwahati, Assam, Babina Diagnostic Centre, Lamphelpat, Manipur, India

*Background*: Activation and reactivation of proto-oncogene *β-catenin* and telomerase respectively are critical in the development of cancers of various cellular etiologies. Limited data is available on the role of these key signal transducers in the development of gallbladder diseases and progression to gallbladder carcinoma (CaGB).

*Aim*: To study the modulation of β-catenin and hTERT (human telomerase RT component) in the development and progression of gallbladder diseases and carcinoma.

*Methods*: Surgically ressected tissues of clinically and histopatho-logically proven cases of gallbladder disease patients {cholelithiasis (CL, *n*=25), cholecystitis (CS, *n*=20) and CaGB (*n*=20) along with autopsy based controls (*n*=10)} were collected from Central Hospital, NF Railway, Guwahati; and RIMS, Manipur. *β-catenin*, and *hTERT* mRNA expression by real time-PCR, using *β-actin* as internal control. Mutation analysis of *β-catenin* exon3 region was performed by PCR-sequencing based analysis. *β-catenin* protein expression was studied on 5μm formalin fixed paraffin embedded sections by immunohistochemistry and/or western blotting, while *hTERT* expression was studied by western blot analysis. Statistical analysis was performed by SPSSv13.0 software.

*Results*: *β-catenin* mRNA expression was up-regulated chronologically in the gallbladder diseases (control \<cholelithiasis \<cholecystitis \<CaGB). Mutation analysis for the exon3 region of *β*-catenin showed presence of mutation in 2/20 (10 %) of CaGB cases only. The up-regulation of *β*-catenin co-related statistically significantly with upstream HGF mRNA expression and down-stream cyclin D1 expression at mRNA and protein level. hTERT expression was up-regulated in gallbladder diseases, highest being in CL (1.999±0.0282), followed by CS (1.479±0.5656) and CaGB (1.0065±0.009) cases compared to controls. The protein based expression analysis by IHC showed increased expression of membranous and cytoplasmic *β-catenin* in CaGB cases compared to controls and CL. Protein expression study by western blot also shows up-regulated expression of *β-catenin* and *hTERT* in CaGB and CL cases compared to controls.

*Conclusion*: Deregulation of Wnt/*β*-catenin and telomerase signalling promotes gallbladder disease development and progression to carcinogenesis. Reactivation of *hTERT* is an early event in gallbladder disease development and may be used as a selective biomarker to access disease predisposition. *β*-catenin may be a used as a therapeutic target to control disease development and progression.
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### Snare ampullectomy for ampullary tumors - Single centre retrospective study {#Sec530}

***Nachiket Dubale*** *, Amol Balpaye*

Department of Digestive Diseases and Endoscopy, Deenanath Mangeshkar Hospital, Erandawne, Pune 411 004, India

*Background*: Tumors of duodenal papillae may be malignant or premalignant. Endoscopic snare papillectomy (ESP) may be a minimally invasive solution to treat these lesions.

*Methods*: Included-patients with ampullary tumors treated with ESP during 6-years (February 2007 to January 2013). All underwent pre-ESP imaging confirming suitability for the procedure. ESP was performed using a diathermy snare by fulcrum technique followed by biliary and pancreatic stenting. Patients with adenocarcinoma were counseled for surgery or follow up. Follow up done at 1, 3, 6, 12, 18, and 24 months and yearly thereafter.

*Results*: N-36 mean age 63 (33-83), 23-males. Mean tumor diameter 18 mm (7-37). Complications-2 minor bleeds, one biliary stenosis, one fatal pancreatitis. Histopathology: adenocarcinoma 20 (56 %), adenoma 15 (41 %), NET-1. Mean follow up 13.6 months (1-58). Four (11 %) lost to follow up, adenoma - no recurrence-10 (67 %), recurrence-3 (treated by APC), NET 3-month no recurrence. Adenocarcinoma-8 (40 %) surgery, seven (58 %) - no recurrence at mean 26-month (14- 58), recurrence -2, fatal pancreatitis-1, lost to follow up-2.

*Conclusions*: ESP for ampullary tumors is effective and safe. It can be curative for most ampullary adenomas. ESP for localized adenocarcinoma may be potentially curative in \>50 % patients.
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### Endoscopic management of post-cholecystectomy benign biliary strictures: The SGPGI experience {#Sec532}

*Vivek A Saraswat, Praveer Rai, Samir Mohindra,* ***Sachin S Shetty*** *, Sreejith Venugopal*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Endoscopic management of post-cholecystectomy benign biliary strictures (BBS-PC) is first line therapy in many centers. Experience at SGPGIMS from January 2006 to June 2013 with this modality is reviewed.

*Methods*: BBS-PC was defined as biliary stricture after cholecystectomy, negative for malignancy, and was classified according to Bismuth. Technical success was the ability to dilate and stent the stricture. Stents were exchanged every 3-months and increasing numbers of stents were placed till the diameter in the stricture was same as downstream to it and without significant recoil 48 hours after removal of all stents.

*Results*: Total of 147 procedures were performed in 38 patients (mean age 41.9±12 years, 65 % women). Strictures were hilar in one-thirds \[Bismuth type 1 -5, type 2 -20, type 3 -5, type 4 - 8\]. Median treatment duration was 10 months (range 1 - 38 months) and median of 4 procedures were performed per patient (range 2 -10). The maximum number of stents placed per patient were 4.57 (range 3-6). Technical success was achieved in 95 % (36/38). Therapy is completed in 19 patients, who are asymptomatic on median follow up 16.8 months (range 1 month - 6 years) after stent removal, and is ongoing in 9 patients. Treatment failed in 2 patients, 1 died due to cardiac cause and 7 defaulted after 1-3 sessions.

*Conclusion*: An aggressive protocol is effective for BBS-PC, even for type 3 and 4 strictures. While early results are encouraging, longer follow up in more number of patients is needed.
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### Endoscopic management of post-operative bile leaks-A tertiary care experience {#Sec534}

***S Vadivel Kumaran***

Madras Medical College, Chennai 600 003, India

*Background*: Significant bile leak as an uncommon complication after biliary tract surgery may constitute a serious and difficult management problem. Surgical management of biliary fistulae is associated with high morbidity and mortality. Biliary endoscopic procedures have become the treatment of choice for management of biliary fistulae.

*Methods*: Twenty-five patients presented with bile leaks after cholecystectomy (open cholecystectomy in 1 patient, laparoscopic cholecystectomy in 24). The presence of bile leaks was confirmed by appearance of bile in percutaneous drainage of abdominal collections and ERCP. Of the 25 patients, 8 patients had complete transection of the common bile duct as demonstrated by ERCP and were subjected to bilioenteric anastomosis. In the remaining patients after cholangiography and localization of the site of bile leaks, therapeutic procedures like sphincterotomy, biliary stenting were performed. Stents of 7F size were placed according to the standard techniques. The stents were removed after an interval of 6-8 weeks.

*Results*: Sites of bile leaks were cystic duct - 8, common bile duct - 6, right hepatic duct-1, T-tube-1. Stenting was successful in 12 patients. Bile leaks stopped in all patients at a median interval of 3 days (range 3-16 days) after endoscopic interventions.

*Conclusions*: Post-cholecystectomy bile leaks occur most commonly in the cystic duct. Endoscopic therapy is safe and effective in the management of bile leaks and after surgery.
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### A rare case report of umbilical metastasis from gallbladder carcinoma {#Sec536}

***C Vijai Shankar***, *Mohammed Ali, T Pugazhendhi, K Prem Kumar, Kani Shaikh Muhammed, P Ratnakar Kini*

Department of Medical Gastroenterology, Madras Medical College, Chennai 600 003, India

Metastatic umbilical deposits from abdominal and pelvic malignancy is termed Sister Mary Joseph's nodule. Metastasis of gallbladder carcinoma to the umbilicus is extremely rare, even rarer is for this metastasis to be the initial presentation of gallbladder carcinoma. A 74-year-old male presented with hard umbilical swelling with foul smelling discharge for 1 month duration and jaundice for 1 week. Physical examination revealed a hard globular mass in right hypochondrial region.

*Investigations*: Work up revealed raised bilirubin and alkaline phosphatase. Fine needle aspiration of umbilical swelling was suggestive of metastatic adenocarcinoma. CT abdomen revealed a heterogeneous enhancing mass lesion in distal body and neck of gallbladder suggestive of gallbladder carcinoma with liver infiltration and transverse colon involvement, mild intrahepatic biliary radicles dilatation and periportal nodes. *Treatment and Course*: Patient was referred for palliative chemotherapy after relief of obstructive jaundice by endoscopic retrograde cholangiographic stenting of right biliary system.

*Conclusion*: Umbilical metastasis from gallbladder primary is very rarely reported though common after seedling in umbilical port site following laparoscopic cholecystectomy and its presence indicates worse prognosis.
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### Reverse transcription polymerase chain reaction is sensitive method for lymph node micrometastasis in gallbladder cancer, cholangiocarcinoma and pancreas cancer {#Sec538}

*Pranjal Deka,* ***Ritu Khosla*** *, Nirupma Trehanpati, Archana Rastogi, Shiv K Sarin, Tushar K Chattopadhyay*

Hepato-Pancreato-Biliary, Institute of Liver and Biliary Sciences, D-1 Vasant Kunj, New Delhi 1100 70, India

*Background*: Gallbladder, bile-duct and pancreas cancer are significant clinical problems. Cancer recurrence occurs in regional lymph nodes (LNs) in substantial number of patients. Routine histopathological examination of resected LNs is unable to diagnose micrometastasis and hence immunohistochemical analysis was initiated. Recently, RT-PCR is being considered more sensitive method.

*Aim*: To study the prevalence of micrometastasis in biliary and pancreatic cancer using RT-PCR and Immunohistochemistry

*Patients and Methods*: Total 71 LNs (68 from cancers and three from non-cancer) were dissected along the hepatoduodenal ligament, common hepatic-artery, celiac-axis, peripancreatic, suprapyloric and infrapyloric region from cholangio, gallbladder and pancreatic carcinoma. Histological examination was made by H&E staining and immunohistochemistry was performed on serial sections of paraffin-embedded tissues using CAM5. Two and K-Ras monoclonal antibodies. Total RNA was isolated and 1μg was used to prepare cDNA. Quantitative RT-PCR was performed in triplicate using syber green and specific primers for K-Ras, MAGE3, CK20 and CEA. 18S RNA was used as the control for normalization. Relative expression of each gene was analyzed by calculating the LogRQ of Ct value.

*Results*: Out of 68 LNs, 23 were positive for malignancy on histopathological examination. Of these positive LNs, 17 showed more than two fold up-regulation of K-Ras, MAGE3, CK20 or CEA gene expression. Most of the nodes were positive for dual expression of K-Ras, MAGE3 or CK20 by RT-PCR. Eighteen HE negative LNs also showed upregulated expression of either one of these genes. However, these nodes did not reveal CAM5.2 and K-Ras staining by IHC.

*Conclusion*: RT-PCR appears to be a more sensitive technique for detecting micro-metastasis than IHC. Long-term follow up for recurrence of micro-metastasis in these patients will further strengthen the importance of RT-PCR in prognostic work up.
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### Incidence of gallbladder cancer in rural and semi-urban population of South Indian population {#Sec540}

***T S Ramesh Kumar*** *, A R Venkateswaran, Revathy*

Department of Medical Gastroenterology, Stanley Medical College, Chennai 600 001, India

There is marked increase in the incidence of gallbladder cancer (GBC) in Indian subcontinent in recent times. No hospital based data or registry is available for this important cancer from south of India. The present study aims to make a first insight into the pattern of GBC in southern region of India during the year (2011-2013). A retrospective study was carried out at the Stanley Hospital, Chennai, South India, to identify the pattern of GBC in different districts of south India. The data obtained were analyzed for statistical significance by calculating the average value of the parameters followed by sample *t*-test using Graph Pad Prism 5. Most of the patients were from rural background with poor economic status (55.07 %) with low body mass index (BMI - 18.5) and were either uneducated or educated up to primary level only. The crude incidence rate of GBC was 15.5/1,00,000 in females and 5.9/1,00,000 in males. The female/male ratio was 2.3 for gallbladder diseases.
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### A rare cause of recurrent acute pancreatitis: Case report {#Sec543}

***Lokesh Jain*** *, Praveen Gupta, Dilip Dubey, Praveen Manglunia*

Saket Hospital and Research Center, Sector 10, Meera Marg, Mansarovar, Jaipur 302 020, India

A 45-year-old male presented to us with history of epigastric pain and vomiting of three days duration. Investigations revealed Hb 12.5 mg/dL, TLC 11900, b.sugar 88 mg/dL, bil.0.9, SGOT 45, SGPT 35, alkaline phosphatase 111, amylase 445, lipase 599, Cr. 0.9. USG abdomen and total lipid profile was within normal limits. He had similar attacks of pancreatitis three times in last one year. Each episode was mild in severity and lasted for three to five days. CECT abdomen showed bulky pancreas with fat stranding. MRCP showed normal CBD and MPD. ERCP was planned and biliary and pancreatic sphincterotomy done. He was discharged in a stable condition but admitted again after six weeks with attack of acute pancreatitis. Serum Ca and PTH were sent as a part of work up for recurrent acute pancreatitis. Serum Ca was 12.7 mg/dL and PTH was 325 pg/mL. USG scan of neck showed a well defined solid hypoechoic heterogenous mass measuring 1.8 x1.1 x 1.0 cm with cystic areas and vascularity within it noted behind the upper pole of right lobe of thyroid. Tc SestaMIBI parathyroid scan was suggestive of parathyroid adenoma in right upper lobe. He underwent right upper lobe parathyroidadenoidectomy. After 24 hrs of surgery, serum Ca was 9.2 mg /dL and PTH was 75 pg/mL. He is symptom free at six months of follow up. PHPT has been associated with different types of pancreatitis, such as acute, subacute, or chronic calcifying pancreatitis. It is important to estimate serum calcium after an episode of unexplained pancreatitis. This will minimize the delay before the diagnosis of PHPT is made.
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### Risk factors for development of secondary diabetes in chronic pancreatitis and impact of ductal decompression {#Sec545}

***Rupjyoti Talukdar*** *, G Venkat Rao, D Nageshwar Reddy*

Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Pancreatic calcification has been shown to be a risk factor for diabetes (DM) chronic pancreatitis (CP). It was unclear whether ductal calculi or parenchymal calcification attributes to the risk. We prospectively re-explored the disease-related risk factors for DM in CP and studied the impact of ductal decompression on DM.

*Patient and Methods*: Six hundred and forty-five patients with CP were followed for a mean (range) duration of 3.5 (1.3-10.1) yrs. Data on clinical/radiological characteristics of CP, diabetic status, and ductal decompression were recorded. CP related data from evaluation performed elsewhere were also recorded. Univariate analysis was performed to evaluate the association of etiology, clinical characteristics (steatorrhea/acute exacerbation), morphology (ductal diameter/ductal calculi/parenchymal calcification/ductal/biliary stricture) with DM. Variables with significant difference were put to multivariate analysis. Impact of ductal decompression on diabetes was evaluated using logistic regression.

*Results*: One hundred and thirty-eight patients did not have complete data and were excluded and 507 analyzed. Mean age (IQR) of CP onset was 26 (18-32) yrs; 385 (76.1 %) patients were males. One hundred and ninety (38 %) patients had DM, of which 107 (56.3 %) developed DM after onset of CP. Mean (95 % CI) duration between onset of CP and DM diagnosis was 2.2 (0.9-3.5) yrs. Univariate analysis identified following significantly associated parameters (OR\[95 % CI\]; p): steatorrhea (2.1\[1.03-4.16\];0.04), ductal calculi (6.4\[1.8-22.3\];0.0001) and biliary stricture (5.7\[1.71-18.71\];0.0034). Multivariate analysis identified ductal calculi (*p*=0.005) as the single independent risk-factor for DM. There was no association of ductal decompression on development of DM (OR 0.88; *p*=0.54).

*Conclusions*: Presence of ductal calculi is the single important risk factor for the development of DM in patients with CP. Impact of ductal decompression on DM warrants further study.
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### Validation of the revised Atlanta definitions of severity of acute pancreatitis: Have all loose ends being tied? {#Sec547}

***Rupjyoti Talukdar*** *, Abhik Bhattacharrya, Bhavana Rao, Mithun Sharma, G Venkat Rao, D Nageshwar Reddy*

Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Revision of the Atlanta criteria for acute pancreatitis (AP) was long awaited. Though the revised Atlanta criteria has been recently proposed, this has not been prospectively validated. We validate the new definitions in a prospective cohort.

*Patient and Methods*: One hundred and sixty-three consecutively admitted patients with AP were followed for 6 months after discharge. AP was categorized as mild (MAP) (no local complication \[LC\] and organ failure \[OF\]), moderate (MSAP) (transient OF or local/systemic complication but no persistent OF) and severe (SAP) AP (persistent OF). LC included acute peripancreatic fluid collections, pseudocyst, acute necrotic collection and walled-off necrosis. Baseline characteristics (age/gender/hematocrit/BUN/SIRS/BISAP) and outcomes (total hospital stay/need for ICU care/ICU days/infected pancreatic necrosis \[IPN\] in-hospital death) were compared.

*Results*: Eighty-seven (53.4 %) patients had MAP, 58 (35.6 %) MSAP and 18 (11.04 %) SAP. Among the baseline characteristics, BISAP was significantly higher in MSAP compared to MAP \[1.2(1.9-2.4) vs. 1.6 (1.5-2.01); *p*=0.002\]; and BUN was significantly higher in SAP compared to MSAP \[64.9(50.7-79.1) vs. 24.9 (20.7-29.1); *p*\<0.0001\]. All outcomes except mortality were significantly higher in MSAP compared to MAP. Need for ICU care (83.3 % vs. 43.1 %; *p*=0.01), total ICU days (7.9(4.8-10.9) vs. 3.5 (0.5-2.5); *p*=0.04) and mortality (38.9 % vs. 1.7 %; *p*=0.0002) was significantly more in SAP compared to MSAP; while total hospital stay and frequency of IPN were similar in both. Four (4.6 %) patients with MAP required ICU care due to pneumonia and sepsis, and had similar hospital stay as MSAP. Patients with MSAP who had primary IPN (*n*=10) had similar outcomes as patients with SAP.

*Conclusions*: This study validates the utility of the Revised Atlanta definitions of AP. MSAP patients with primary infected necrosis needs further elaborate evaluation.
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### An elusive cause of acute pancreatitis from intraluminal hardware {#Sec549}

***Yousef Reda***

State University of New York at Upstate, 620 Jefferson Avenue, Suite 17 Winnipeg, Manitoba Canada R2V0P2

*Introduction*: Percutaneous endoscopic gastrostojejunostomy tubes (PEG-J) are devices to bypass oral obstruction, gastroparesis, and any hinderance of food or medication to be orally taken. They still carry the risk of aspiration, and host of problems at the insertion site.

*Case*: A 20-year-old male with cerebral palsy required long-term tracheostomy and PEG-J tube feeding developed a cellulitis at the site of PEG-J tube insertion, requiring replacement.

The patient returned to have PEG/J tube malfunction with severe abdominal pain. CT showed that the J-Limb of the PEG-J-tube extended through the duodenum and into the proximal jejunum. There was a small bowel intussusception within the jejunum surrounding the J-limb and acute pancreatitis.

A PEG/J tube contrast study which confirmed the malpositioned PEG-J-tube. The patient underwent surgical repositioning followed by repeat contrast studies for confirmation. Postoperatively patient's symptoms had resolved with tolerable feeding.

*Discussion:* Acute pancreatits as a result of duodenal papillary obstruction from a migrated PEG-J is a rare but serious complication. PEG/J-tubes, as opposed to PEG-tubes, offer patients the benefit of possible small decreased aspiration risk, however puts the patient at increased risk of iatrogenic pancreatitis. Four cases in literature involved a Foley catheter and two were from a loosened external bumper. Mechanism of migration is due to gut peristalisis in the setting of loosened external bumper. This patient developed a small bowel intussusception in addition to pancreatitis which is life threatening if prompt recognition to remove the tube is not completed.
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### Clinical profile of early onset and late onset idiopathic chronic pancreatitis in South India {#Sec551}

***G Rajesh*** *, A B Veena, M Saumya, V Balakrishnan*

Department of Gastroenterology, Amrita Institute of Medical Sciences, AIMS Ponekkara PO, Kochi 682 041, India

*Background and Aim*: Idiopathic chronic pancreatitis (ICP) is the most common form of chronic pancreatitis reported in India. There is paucity of literature on the prevalence and profiles of early onset- and late onset forms of ICP in India.

*Patients and Methods*: We compared the profile of early- and late onset ICP in a patient population attending a tertiary care hospital in South India. We also tried to correlate clinical features with amount of alcohol abuse in male patients with early onset CP.

*Results*: Pain appears to be the characteristic feature as more than 90 % of both early onset- and late onset ICP had pain as the most significant symptom. Onset of pain was at 14.97±7.7 years in early onset and at 38.12±9.9 in late onset ICP (*p*\<0.001). Diabetes was seen in 41.4 % in early onset- as compared to 69.1 % in late onset ICP (*p*\<0.001). Pancreatic exocrine insufficiency was seen in 34.4 % in early onset- as compared to 53.2 % in late onset ICP (*p*\<0.001). Risk of diabetes in patients with early onset chronic pancreatitis is increased among those who use alcohol and is correlated with the quantity of alcohol used. This risk is further increased by smoking along with alcohol consumption.

*Conclusions*: There are differences between early onset- and late onset ICP in south Indian patients. Smoking and consumption of small amounts of alcohol influences the clinical presentation and course of disease in ICP.
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### Factors associated with acute exacerbations in patients with chronic pancreatitis {#Sec553}

***Rupjyoti Talukdar*** *, G Venkat Rao, D Nageshwar Reddy*

Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Chronic pancreatitis (CP) is associated with significant comorbidity. Acute on CP adds to the comorbidities. In this study we evaluate factors associated with acute on CP.

*Patient and Methods*: Six hundred and forty-five patients with CP were followed for a mean (range) of 3.5 (1.3-10.1) yrs. Data on clinical/radiological characteristics of CP and acute exacerbations were recorded. Acute exacerbation was defined as (increased) abdominal pain along with an elevation of serum amylase/lipase to greater than three times the upper limit of normal, with or without imaging features of AP. Univariate analysis was performed to evaluate association of etiology, gender, disease duration, steatorrhea, ductal diameter, ductal calculi, parenchymal calcification, ductal and biliary stricture with acute exacerbations. Variables with significant association were put to multivariate analysis.

*Results*: One hundred and thirty-eight patients did not have complete data; therefore 507 were analyzed. Mean age (IQR) of CP onset 26 (18-32) yrs; 385 (76.1 %) patients were males. One hundred and forty-one (27.8 %) patients had acute exacerbations after the diagnosis of CP. Mean (95 % CI) number of acute exacerbations was 1.6 (1.39-1.75). Univariate analysis showed following significantly associated (OR\[95 % CI\]; p) factors with a higher frequency of acute exacerbation: male gender (1.77\[1.07-2.90\];0.03); intake of alcohol+smoking (2.59\[1.65-4.08\];

*The abstract matter was not received in full at the time of sending to press, despite reminders to corresponding author.*
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### An interesting case of acute pancreatitis {#Sec555}

***H Azimudin*** *, Manoj, Sathiamoorthy, Ramesh Kumar, Venketeswaran, Revathy, Chitra, Manimaran, Murali, Malarvizhi*

Department of Medical Gastroenterology, Government Stanley Hospital and Medical College, Chennai 600 001, India

*Background*: Ascariasis being highly motile migrates via ampulla Vater into biliary tree or pancreatic duct and cause a variety of manifestations ranging from biliary colic, ascending cholangitis, acalculous cholecystitis or acute pancreatitis.

*Case Report*: We hereby report a case of a 34-year-old male nonalcoholic nonsmoker who presented to us with 3 days duration pain abdomen radiating to back suggestive of acute pancreatitis which was further supported by lab investigations which showed elevated serum amylase (963 u/L) and lipase (557 u/L). USG abdomen showed GB wall to be thickened 0.4 mm, edematous filled with sludge features suggestive of acalculous cholecystitis and 2 obstructing calculi in a dilated distal CBD measuring 7 mm. Upper GI endoscopy showed ascariasis worms which were removed via forceps. SVS was done which showed a diverticulum above ampulla. As cannulation of bile duct via ampulla failed it was attempted via the diverticulum successfully which showed a linear filling defect in mid CBD at cystic duct insertion probably due to worms. The patient was subsequently put on albendazole managed conservatively and was discharged on follow up.

*Conclusion*: Ascariasis as a cause of acute pancreatitis must be always be kept in one's mind as a differential diagnosis especially in a developing country like ours. Also CBD stone disease was concurrently found in our case. A choledochodeodenal fistula type II was incidentally detected via which a novel ERCP was performed. This case is being presented to highlight ascariasis causing pancreatitis and also incidental interesting finding of a choledochodeodenal fistula and novel ERCP attempted.
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### Protection of chronic pancreatitis in animal model of rats with wheatgrass {#Sec557}

***Surendra Sharma*** *, Satya Vati Rana, Deepak Kumar Bhasin, Surinder Rana, Ritambhra Nada, Samir Malhotra*

Departments of Super Speciality Gastroenterology, Histopathology, and Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: Wheatgrass (Triticum aestivum), has been found effective in preventing various diseases in human as well as animals. However it's role in chronic pancreatitis has not yet been studied.

*Methods*: Twenty-four Wistar rats of either sex were divided into 4 groups. Group 1 (control): Rats were given IP injections of normal saline on day 1,4,7,10,13,16 and 19 as well as intragastrically water daily 2 days before starting. Group 2: L-arginine hydrochloride (250 mg/100 g bw/day) IP in 2 repeated doses of 1 hr interval on day 1, then single dose on day 4,7,10,13,16 and 19. Group 3: Rats in this group received orally wheatgrass dissolved in water at a dose of 0.8 gm/kg b.wt daily 2 days before starting of L-arginine. Group 4: Animals in this group received wheatgrass alone at a highest dose of 1.2 gm/kg b.wt. Levels of serum amylase, lipase and pancreatic glutathione (GSH) and lipid peroxidation (LPO) were studied on day 21. H&E and Masson's trichrome stain were used for histopathology.

*Results*: Levels of serum amylase and lipase were significantly higher in arginine group. Supplementation of wheatgrass reduce activity of amylase, lipase. Also, it was found that level of LPO in pancreatic tissue were significantly higher whereas GSH levels were significantly lower in arginine group and wheatgrass supplementation significantly increased GSH level and decrease LPO levels. Histologically, inflammation, fibrosis, fat infiltration and edema scores were significantly higher in arginine group as compared to wheatgrass given along with arginine.

*Conclusion*: Wheatgrass supplementation significantly reduced severity of chronic pancreatitis in experimental model of rats.
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### ERCP as a diagnostic and therapeutic modality in cases of chronic pancreatitis with pancreatic ascites {#Sec559}

***I Bhrani*** *, P Shravan Kumar, M Umadevi, M Ramanna, S Pratibha*

Department of Gastroenterology, Gandhi Hospital, Secunderabad 500 025, India

*Background/Aim*: Chronic pancreatitis is one of commonest referral to Gastroenterology. In this study, we identified patients with chronic pancreatitis who presented with ascites as a complication and who were evaluated and treated with ERCP.

One hundred and four patients with chronic pancreatitis over a period of 7 years from August 2007- July 2013 were studied retrospectively. Demographic characteristics, clinical presentations, ERCP findings and the procedures done and response were analyzed. Out of those 11 (10 %) patients presented with ascites all of which showed increased ascitic fluid amylase (5000-45000 U/L). Out of the 11 patients 1 (10 %) was female and 10 (90 %) were males. One (10 %) patient had jaundice along with ascites and 3 (27 %) patients had pseudocyst. On ERCP leak was seen in 9 (82 %) patients (head/body-4 patients (36 %); body/tail-2 patients (18 %); head-2 (18 %) patients; tail- 1 (10 %) patient). Stenting was possible in 7 (63.6 %) patients. All patients showed resolution of ascites in follow up of 15 days. And there were no recurrences in a 3 month follow up.

*Conclusion*: ERCP is an effective modality of diagnosis and treatment in cases of chronic pancreatitis with ascites.
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### Pleural effusion as a presenting symptom in chronic pancreatitis: Role of therapeutic ERCP {#Sec561}

***I Bhrani*** *, P Shravan Kumar, M Umadevi, M Ramanna, S Pratibha*

Department of Gastroenterology, Gandhi Hospital, Secunderabad 500 025, India

*Background/Aim*: Chronic pancreatitis is a common referral to Gastroenterology. In this study, we identified patients with chronic pancreatitis who presented with pleural effusion as a complication and underwent therapeutic ERCP

*Materials and Methods*: One hundred and four patients from August 2007- July 2013 were studied retrospectively. Demographic characteristics, clinical presentations, ERCP findings and the procedures done were analyzed.

*Results*: Thirty-six (34.6 %) patients presented with shortness of breath at admission, 14 (39 %) had moderate to severe pleural effusion (8-left 4-bilateral; 2-right) pancreatic effusion was confirmed with pleural fluid amylase (400 to 2400 units/L). Four (28 %) were females and 10 (72 %) were males. Of the 14 patients who underwent ERCP 8 (57 %) patients showed a leak in PD. Four (28 %) had leak in body and tail region, 3 (22 %) at the junction of head and body, 1 (7 %) in the region of head. Four (28.5 %) patients showed ductal dilation with proximal stricture with effacement of side branches; two (14.2 %) patients PD could not be cannulated. Five (35.2 %) patients underwent sphincterotomy alone, while stenting was possible in 9 (64.2 %) patients. All patients (100 %) showed resolution of effusion in a span of 7 to 10 days. There was no recurrence of effusion in a three month follow up in any of the patients (100 %).

*Conclusion:* ERCP is an effective modality of diagnosis and treatment in cases of pancreatic pleural effusions.
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### A case series of pancreatic pseudocysts {#Sec563}

***Vishnu Abishek*** *, Balaji, Babu vinish, Jeevan Kumar, P Ganesh*

Kilpauk Medical College, Chennai 600 010, India

*Aim*: To study the presentation of pancreatitis with complication and treatment experience at a tertiary care centre.

*Methods and Materials*: A prospective analysis of a series of cases of acute pancreatitis with local complication was done between January and March 2013, at Kilpauk Medical College Hospital. Specific cases of pancreatic pseudocyst were isolated. The course of the illness and treatment outcome studied in this cohort.

*Results*: A total of 9 cases of pancreatitis developed complication of pseudocyst. Male/female (*n*=8/1). The presentation was acute severe pancreatitis in 4 cases, recurrent pancreatitis in 2 cases, acute on chronic pancreatitis 3 cases. Etiology was post traumatic (*n*=1), idiopathic chronic calcific pancreatitis (*n*=1), alcohol induced (*n*=7). Pancreatic ascites was present in 3 cases. Average cyst fluid amylase was 5,600 IU/mL. The average size of the pseudocyst is 6.5 cm. Among the 3 types of pseudocyst, 3 cases were type 1, 6 cases were type 2. Pancreatic duct calculus was seen in 3 patients. Mortality was 22 % (2/9) due to sepsis and both had ascites. One patient of acute on chronic pancreatitis underwent percutaneous drainage of cyst, 1 case underwent laparoscopic cystogastrostomy, 2 cases had spontaneous resolution of cyst in 8 weeks.

*Conclusion*: Pseudocyst was more common with acute on chronic pancreatitis and type 2 communicating pseudocyst was more common in this series. Intervention was required in multiloculated cyst, giant cyst (\>10 cm) and cyst with abnormal radiological morphology. Sepsis was seen more commonly with pancreatic ascites.
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### Taurolithocholic acid induced acinar injury: A model of human acute biliary pancreatitis {#Sec565}

***Aparna Jakkampudi*** *, Ramaiah Jangala, C Ramji, M Sasikala, G Venkat Rao, D Nageshwar Reddy, Rupjyoti Talukdar*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Acute pancreatitis (AP) is a potentially life-threatening illness. AP begins as a local inflammation of the pancreas resulting from acinar cell injury, which eventually mounts a systemic inflammatory response syndrome. Even though several mechanisms of AP have been suggested by experimental studies in murine models, the precise mechanisms are not clear in humans.

*Aim*: The aim of the present work was to elucidate the response of human pancreatic acini to bile acids, a known causative factor for AP.

*Methods*: Human pancreatic tissue was collected from the patients who underwent pancreatic surgery for indications other than malignancy/chronic pancreatitis. Harvested pancreata were cut into small blocks, which were then sliced into thin sections of 140 μm. Trypsin activity was measured at 37oC fluorimetrically using Kawabata's method while cathepsin B activity was assayed by McDonald and Ellis method after exposing the tissue to 300 and 500 μM taurolithocolic acid (TCLS) for different time points. H&E stain was performed on paraffin--embedded tissue blocks to evaluate histological changes of tissue injury.

*Result*: Functionality of the pancreatic tissue slices was established by the secretion of amylase into the medium in response to secretagogues. There were 15 and 20 folds increase in the trypsin and cathepsin B activities respectively when exposed to 500μM for 2 hrs. H&E staining showed patchy degeneration of acinar tissue. The acinar cell cytoplasm in these areas appeared pale and edematous; and there were several pyknotic nuclei indicating necrosis.

*Conclusion*: TLCS can cause necrosis of acinar tissue of human pancreas.
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### Acinar cell regeneration in chronic pancreatitis: Preliminary studies {#Sec567}

*Madhavi Meduri,* ***Aparna Jakkampudi*** *, Ramaiah Jangala, P Pavan Kumar, M Sasikala, D Nageshwar Reddy, G Venkat Rao, Rupjyoti Talukdar*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Chronic pancreatitis (CP) is characterized by irreversible pancreatic damage resulting in exocrine/endocrine dysfunction. Currently no curative treatment exists for CP. It is not known if there is acinar regeneration in CP, unlike in acute pancreatitis. Demonstration of acinar regeneration in CP could lead to development of curative treatment. We evaluated if there is acinar cells regeneration in CP in this preliminary study.

*Methods*: Experiments were performed on pancreatic tissues obtained from specimens of CP patients undergoing pancreatic resection/drainage for pain. Healthy pancreatic tissue from resected specimens of patients undergoing surgery for periampullary adenomas/pancreatic cystic lesions (nonmalignant) constituted controls. Immunofluorescence (IF) was performed to assess beta-catenin (a transcription factor required for maturation and maintenance of acinar cells; and acinar regeneration after acute pancreatitis). Ki-67, (marker of cell proliferation) was also evaluated. In order to localize the beta-catenin positive cells, concomitant immunostaining for insulin was performed.

*Results*: Studies were conducted on 4 CP and 3 control samples. Mean (+/-SD) duration after diagnosis of CP was 18+/-3.5 mths. All patients were male; mean (+/-SD) age was 22.3 (3.4) yrs. Compared to 2 (+/-0.6) % in control tissue, CP tissue showed 17.8 (+/-4.9) % beta-catenin positive cells. Beta-catenin was observed in cells outside the islets (on merged images), implying them to be acinar cells. There was no difference in Ki-67 positive cell fraction (2.3 % vs. 2.8 %) between control and CP, implying absence of proliferation.

*Conclusion*: Our preliminary results suggest that there is acinar cell regeneration in CP, which occur via nonproliferative mechanisms. Further studies are required to confirm the findings and elucidate the regenerative mechanisms.
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### IFN-γ expression is regulated by miR-29c in chronic pancreatitis {#Sec569}

***A Maheshwari*** *, K Murali Manohar, P Pavan Kumar, K Uma Mahesh, M Sasikala, G V Rao, D Nageshwar Reddy*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Background and Aim*: IFN-γ was shown to be the predominant intra pancreatic cytokine responsible among all other inflammatory cytokines and it was shown to correlate with glycemic status in chronic pancreatitis. It was reported that miRNA-29 controls immune responses by targeting interferon-Î^3^. The 3-UTR of IFN-γ mRNA bears the miR-29c binding sites and thus, IFN-γ is a direct target of miR-29c. In this study, we evaluated the miR-29c and correlated with pancreatic Interferon gamma levels in chronic pancreatitis patients.

*Materials and Methods*: Pancreatic tissues were obtained from CP patients undergoing partial pancreatectomy (study group, *n*=6) and patients undergoing Whipple's pancreaticoduodenectomy (control group, *n*=10). MicroRNA profiling in CP and controls was done using Genechip miRNA microarray (Affymetrix, California, USA). Differentially expressed miRNAs of CP were identified using the significance analysis of microarrays (SAM) version 4.0 with a threshold difference in expression set to 2. Pancreatic tissue IFN-γ levels were estimated by flow cytometer.

*Results*: In comparison to controls, miRNA profiles showed differential expression of 16 miRNA in CP. SAM analysis indicated miR-29c to be down regulated with a fold change of 2.0. Expression levels of IFN-γ in pancreatic tissues were found to be 4 times higher in CP patients when compared to controls.

*Conclusion*: This result demonstrates that miR-29c regulates IFN-γ expression and contributes to inflammatory milieu in chronic pancreatitis.
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### Involvement of Notch 3 and Notch 4 genes in pancreatic ductal adenocarcinoma {#Sec573}

***Jayanta Borkakoti*** *, Ranjana Gondal, Anil Aggarwal, Syed Akhtar Hussain, Premashis Kar*

Department of Medicine, Maulana Azad Medical College, Bahadur Shah Zafar Marg, Delhi Gate, Delhi 110 002, Department of Pathology and Gastrointestinal Surgery, G B Pant Hospital, J L Nehru Marg, New Delhi 110 002, and Department of Biotechnology, Jamia Millia Islamia, Jamia Nagar, New Delhi, Delhi 110 025

*Background and Objectives:* Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis due to late presentation and aggressive metastatic potential. The study was targeted to analyze the expression level of Notch-3 and Notch-4 proteins in pancreatic carcinoma tissues using immunohistochemistry.

*Methods*: A total of 47 cases of pancreatic ductal adenocarcinoma and 28 cases of chronic pancreatitis were collected during the years 2011-2013. Standard immunohistochemistry staining protocol ABC method was used to analyze the expression levels of Notch-3 and Notch-4 proteins in paraffin-embedded sections of pancreatic carcinoma tissue.

*Results*: The mean age of the cases were 53.88±11.84 years with age range of 26-69 years. Out of total 47 tissues, 16 (34.04 %) showed well-differentiation, 18 (38.29 %) showed moderate differentiation and the remaining 13 (27.65 %) showed poor differentiation. Among well differentiated tumor cases, 3 (18.75 %) showed moderate notch-3 expression, whereas 13 (81.25 %) showed no expression for notch -3 in comparison to 8 (50 %) cases which showed high expression of notch-4, 2 showed (12.5 %) moderate notch-4 expression, 4 (25 %) cases presented with mild notch-4 expression and 2 (12.5 %) showed no expression for notch-4. Among moderately differentiated cases, three (16.67 %) showed mild expression of notch-3, whereas 15 (83.33 %) showed no expression for notch-3. The cases of pancreatic carcinoma showed predominantly positive staining in the malignant glands for Notch-4 while the Notch-3 stained slides did not show significant positivity.

*Conclusion*: The study suggests that the notch pathways up regulation can be related to the human pancreatic carcinoma. Notch 4 is a key regulator in human PDAC.
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### Neutrophil gelatinase associated lipocalin: A novel marker of acute lung injury in patients with acute pancreatitis {#Sec575}

***Pradeep Kumar Siddappa*** *, Jahangeer Basha, Manish Manrai, Sreekanth Appasani, N Kalra, S K Sinha, K Singh, R Kochhar*

Departments of Gastroenterology, and Radiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Aim*: To study the role of neutrophil gelatinase associated lipocalin (NGAL) in serum and urine in patients of acute pancreatitis with acute lung injury (ALI).

*Methods*: Fifty consecutive patients with acute pancreatitis (AP) within 3 days of symptom onset and 31 age and sex matched healthy controls were studied. Patients were tested for urinary and serum NGAL levels (ELISA), (within 24 hours of admission) and once in controls.

*Results*: Pancreatitis patients were aged 13-85 yrs (males 60 %), with 31 age and sex matched controls. ALI was seen in 28 patients (56 %), with 19 (67.85 %) having persistent and 9 (32.15 %) having transient ALI. The mean serum and urine NGAL levels (587.66±251.5 ng/mL and 252.84±165.89 ng/mL) were significantly higher in patients with AP than in controls (15.10±6.29 and 4.26±4.57 ng/mL respectively). After excluding patients with ALI on day 1{13 patients (46.42 %)}, patients who developed ALI had significantly higher serum and urine NGAL levels compared to those who did not (*p*=0.014 and 0.006 respectively). Both serum and urine NGAL (cut-off 690.19 ng/mL, AUC-0.72 and 258.38 ng/mL, AUC 0.74) predicted ALI with good sensitivity and specificity (73 % to 73 % vs. 67 % to 71 % respectively). Similarly urine NGAL was able to predict persistent ALI at a cutoff of 258.38 ng/mL with a sensitivity and specificity of 72 % and 70 % respectively (AUC-0.713, sig. 0.032).

*Conclusion*: ALI is the most common organ failure seen in AP with \>50 % presenting at onset. Persistent ALI has high mortality (32 %). Serum and urine NGAL levels are higher in patients of ALI compared to controls. Urine NGAL (day 1) is a novel biomarker which predicts ALI with good accuracy.
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### Natural history of acute kidney injury in patients with acute pancreatitis {#Sec577}

***Pradeep K Siddappa*** *, Jahangeer Basha, Manish Manrai, Sreekanth Appasani, N Kalra, S K Sinha, K Singh, R Kochhar*

Departments of Gastroenterology, and Radiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Aim*: To study the natural history of acute kidney injury (AKI) in patients of acute pancreatitis (AP).

*Methods*: Fifty consecutive patients with AP within 3 days of symptom onset were followed, fate of AKI patients recorded. AKI was defined according to Atlanta classification.

*Results*: Patients were aged 13-85 yrs (males 60 %) and were followed till discharge or death. AKI developed in 21 (42 %) of which 11 (52.38 %) had persistent and 10 (47.62 %) had transient AKI. Of the 11 persistent AKI, AKI resolved in 5 (45.45 %) and 6 (54.54 %) patients died. Four (36.6 %) of these required dialysis (3HD+1PD) of whom 3 died. None of the patients with transient AKI required dialysis, but 4 died in this group (mostly to other organ failure and sepsis). Ten (47.6 %) patients had AKI on day 1, 7 (70 %) persistent and 3 (30 %) transient AKI. Of the remaining 5 with persistent AKI, 3 had onset on day 2 and 1 each on day 6 and 9. Of the remaining 7 with transient AKI, 5 had onset on day 2 and 1 had onset on day 14. Fever requiring antibiotics was seen in all patients who developed AKI beyond first 2 days. Thirteen had both ALI and AKI at the same time, with 6 of these having hypotension, none survived.

*Conclusion*: AKI is a common complication of AP, half of them presenting at onset. Persistent AKI have high mortality (\>50 %). Half of patients with AKI also have associated ALI and those with triple organ failure have 100 % mortality. Patients who develop AKI later than first 2 days have associated sepsis.
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### Does aggressive fluid resuscitation alter the clinical course of acute pancreatitis? {#Sec579}

*P Vasudevan, G R Verma, Ashish Bhalla, Naveen Kalra, Jahangeer Basha,* ***Manish Manrai*** *, Sreekanth Appasani, Puneet Chhabra, Pradeep Siddappa, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Surgery, Internal Medicine, and Radiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Aim*: To evaluate whether aggressive fluid resuscitation in the first 24 hours alter the clinical course of acute pancreatitis.

*Methods*: Fifty consecutive patients (mean age-41.64 yrs, 33 males) of acute pancreatitis \>18 yrs of age presenting within 5 days of onset of pain between January 2012 and June 2013 were subjected to complete demographic profile, clinical and laboratory evaluation. Intravenous fluid was infused as 20 mL/kg bolus till a base line CVP of 8 cm of normal saline and at a rate of 3-5 mL/kg/hr to maintain a CVP of 8-12 cm of NS and urine output of 0.5 mL/kg/hr. Patients were divided into aggressive group (*n*=19, 38 %) and nonaggressive group (*n*=31, 62 %) based on fluids received either \>33 % or 2 weeks (58.06 % vs. 47.36 %, *p*=0.461). However, in patients who received \>10 liters of fluid at the end of day 5, had more frequent presence of pancreatic necrosis, infective complication, organ failure, need for mechanical ventilation, dialysis, increased hospital, ICU stay with increased mortality.

*Conclusion*: Aggressive fluid resuscitation in the 0-24 hours is associated with decreased frequency of pancreatic necrosis, decreased need for mechanical ventilation and overall decreased need for ICU stay and subsequent mortality.

P-20 {#Sec580}
----

### Does the type of fluid used in resuscitation matter in the clinical course of acute pancreatitis? {#Sec581}

*P Vasudevan, G R Verma, Ashish Bhalla, Naveen Kalra, Jahangeer Basha, Sreekanth Appasani, Puneet Chhabra,* ***Manish Manrai*** *, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Surgery, Internal Medicine and Radiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Aim*: To evaluate whether the type of fluid, Ringer lactate or normal saline used in resuscitation matter in the clinical course of acute pancreatitis.

*Methods*: Fifty consecutive patients (mean age: 41.64, *n*=33 males) of acute pancreatitis \>18 yrs of age presenting within 5 days of onset of pain between January 2012 and June 2013 were subjected to complete demographic profile, clinical and laboratory evaluation. Hemodynamic parameters were assessed along with a central venous pressure and an hourly urine output intravenous fluid was infused as 20 mL/kg bolus till a base line CVP of 8 cm of normal saline and at a rate of 3-5 mL/kg/hr to maintain a CVP of 8-12 cm of NS and urine output of 0.5 mL/kg/hr. Patients were randomized into 2 groups to receive either 0.9 % normal saline or ringer lactate for resuscitation and were compared for outcome parameters.

*Results*: Alcohol was the most common etiology (*n*=30, 60 %) followed by gallstone disease (*n*=19, 38 %). Patients in the ringer lactate subgroup had lower percentage of pancreatic necrosis (20 % vs. 32 %, *p*=0.33), less incidence of organ failure (68 % vs. 80 %, *p*=0.33), less duration of hospital stay \>2 weeks (44 % vs. 64 %, *p*=0.15), less need for ICU stay (32 % vs. 52 %, *p*=0.152), less development of infective complications (28 % vs. 40 %, *p*=0.37) and less need for intervention (32 % vs. 24 %, *p*=0.529) though the difference did not reach statistical significance.

*Conclusion*: Patients who received ringer lactate showed a trend towards less incidence of morbidity than those who were resuscitated with normal saline.
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### Natural history of gastrointestinal fistulae in acute pancreatitis {#Sec583}

***Jahangeer Basha*** *, Vikas Gupta, G R Verma, Thakur Deen Yadav, Naveen Kalra, Puneet Chhabra, Sreekanth Appasani, Manish Manrai, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Surgery and Radiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Objective*: To evaluate the prevalence, clinical course and outcome of gastrointestinal (GI) fistulization in acute pancreatitis (AP).

*Methods*: All patients of AP with GI fistulae detected both in retrospective (2006-2009) and prospective (2010-2013) analysis were studied for demographic characteristics, clinical presentation, etiology of pancreatitis, interval between onset of pancreatitis and stulization, diagnostic studies, treatment (including surgery), and outcome.

*Results*: GI fistulization occurred in 38 patients (mean age 39.03±12.2 years; 35 males). The interval between onset of AP and detection of fistulae was 5.84±5.2 weeks. The commonest feature was persistent fever (68.4 %), followed by GI bleed (50 %) and pain abdomen (34.2 %). Fistulae developed spontaneously 73.7 % the rest had history of surgical or percutaneous intervention. The commonest site of fistulae was duodenum (44.7 %), followed by colon (39.5 %), stomach (7.9 %), small bowel (2.6 %) and both colon+duodenum (5.3 %). CECT raised suspicion of fistulae by presence of air within the necrosis in 50 % and by inflammatory involvement of the bowel in 16 %. Of 21 patients, who underwent endoscopy, 17 (44.7 %) had direct visualization of fistulae. Majority of patients underwent treatment including surgery (55.3 %) followed by conservative management (21.1 %), endoscopic (15.8 %) and percutaneous intervention (7.9 %). Overall mortality was 31.6 %. Patients who had GI bleed had significantly higher chance of colonic fistulae (*p*=0.05) and worse outcome (*p*=0.036). The need for surgical intervention and mortality were significantly higher in colonic than upper GI fistulae (*p*=0.008 and 0.003).

*Conclusion*: Development of GI fistulae in patients with AP is an ominous and uncommon complication requiring high index of suspicion. GI bleed as a presenting feature and colonic location are adverse prognostic factors requiring surgical intervention and higher mortality.
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### Non relief of pain by endoscopic therapy in chronic calcific pancreatitis is a predictor of poor response to surgical treatment {#Sec585}

***Chitta Ranjan Panda*** *, Haribhakti Seba Das, Bijay Misra, Debasish Misra, Shivaram Prasad Singh*

Department of Gastroenterology, S C B Medical College, Cuttack 753 007, India

*Background*: Duct decompression by pancreatic sphincterotomy and stent placement in chronic calcific pancreatitis with dilated MPD is a good short-term method of relief of pain, as an alternative to surgical treatment.

*Aim*: To determine whether surgical procedure helps in those patients where endoscopic procedure failed to relieve pain.

*Methods*: Fifteen patients of chronic calcific pancreatitis who presented with intractable pain not responding to medical line of treatment and underwent pancreatic endotherapy, were included in the study from January 2010 to March 2013. Patients who did not respond to endoscopic therapy underwent surgery.

*Results*: Twelve patients were male and 3 were female. Mean patient age was 35.5years (18 yrs - 44 yrs). Six patients had alcoholic pancreatitis and 9 had idiopathic chronic pancreatitis. All patients had dilated main pancreatic ducts with calculi and/or stricture. Pancreatic sphincterotomy with stenting done in all patients, with dilatation of stricture whenever indicated. Stent exchanges were carried out on demand. Over a mean follow up period of 18 months (8-24 months) significant pain relief was achieved in 12 out of 15 patients. Three patients who did not respond at all to pancreatic stenting underwent surgical lateral pancreatojejonostomy procedure. Pain recurred in all the three cases within three months following surgery.

*Conclusion*: Non relief of pain after pancreatic endotherapy in chronic calcific pancreatitis is predictor of poor response to surgery in those cases.
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### Complications of chronic pancreatitis: A 3 year experience {#Sec587}

*Bijay Misra,* ***Haribhakti Seba Das*** *, C R Panda, S P Singh, Debasish Misra, Sanjib Kumar Kar, Manas Kumar Panigrahi*

Department of Gastroenterology, S C B Medical College, Cuttack 753 007, India

*Background and Aim*: Chronic pancreatitis and its complications has significant morbidity and mortality. The aim of this study was to analyze the complications seen in patients with chronic pancreatitis.

*Material and Methods*: All patients of chronic pancreatitis seen during last 3 years were included in the study with special reference to its complications. They underwent routine biochemical examination, USG, X-ray chest and abdomen, CT scan, upper GI endoscopy, Doppler study, MRCP, ERCP and angiography as and when required for diagnosis of the disease and its different complications.

*Results*: Total 104 patients of chronic pancreatitis with M: F ratio of 78:26, age range of 9-75 years and mean age of 39.16+13.12 were studied for complication. Etiology was alcoholic in 51, idiopathic in 50, sickle cell disease in one, familial in 2 cases. Complications seen were pseudocyst in 24, ascites in 19, splenic artery aneurysm in 2, pancreatico pleural fistula in 2, portal vein thrombosis in 3 and duodenal obstruction in 3, paniculitis with skin nodules were seen in one case. Benign head mass was present in 4 patients, malignancy in 3 and IPMN in 2 cases. Splenic vein thrombosis leading to fundic varices was observed in two cases. Diabetes was seen in 15 cases. Exocrine deficiency leading to steatorrhea was noted in 4 patients. Acute exacerbation with pancreatic necrosis was seen in 4 cases.

*Conclusion*: Pseudocyst and pancreatic ascites are the commonest complication. Alcoholic and idiopathic pancreatitic do not show much difference in terms of complication.
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### Small intestinal bacterial overgrowth in patients with chronic pancreatitis {#Sec589}

***Kundan Kumar*** *, Uday C Ghoshal, Deepakshi Srivastava, Asha Misra, Samir Mohindra*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raibareily Road, Lucknow226 014, India

*Introduction*: Patients with chronic pancreatitis can develop small intestinal bacterial overgrowth (SIBO) due to steatorrhea leading to gut stasis, reduced gut defence (failed conversion of prodefensin to defensin) and loss of pancreatic juice. Previous reports describe 30 % to 40 % frequency of SIBO in chronic alcoholic pancreatitis with scanty data on frequency of SIBO in patients with chronic idiopathic pancreatitis. We therefore studied the frequency of SIBO in patients with alcoholic and idiopathic chronic pancreatitis.

*Material and Methods*: Sixty-eight patients with chronic pancreatitis and 74 age and sex matched healthy controls were evaluated for SIBO using glucose hydrogen breath test (GHBT). Persistent rise in breath hydrogen 12 ppm above basal (at least two readings) was considered diagnostic of SIBO.

*Result*: SIBO was found in 10/68 patients (14.7 %) as compared to 1/74 healthy controls (1.3 %) (*p*=0.003). 3/22 (13.6 %) patients with alcoholic pancreatitis had bacterial overgrowth compared to 7/46 (15.2 %) patients with idiopathic chronic pancreatitis (*p*=0.86). Age, sex, body mass index (BMI), presence of steatorrhea, presence of pain, pancreatic calcifications and use of pancreatic enzyme supplements had no relationship with the presence of SIBO.

*Conclusion*: SIBO was found to be significantly more common in patients with chronic pancreatitis of any etiology compared to healthy controls but frequency of SIBO was not significantly different between alcoholic and idiopathic etiologies. Presence of SIBO did not correlate with steatorrhea or other parameters of exocrine and endocrine insufficiency. Appropriate diagnosis and treatment for SIBO can alleviate symptoms and improve quality of life in these patients.
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### Indications for ERCP in patients with chronic pancreatitis {#Sec591}

***K Jayachandran*** *, S Pratibha, P Shravan Kumar, M Umadevi, M Ramanna, I Bharani*

Department of Gastroenterology, 5th Floor, Gandhi Hospital, Secunderabad 500 025, India

*Background/Aim*: Chronic pancreatitis is one of commonest diagnosis in gastroenterology. In this study, we identified patients with chronic pancreatitis who underwent ERCP for various indications.

*Materials and Methods*: One hundred and one patients with definite chronic pancreatitis on imaging from August 2007- July 2013 were studied retrospectively. Patients with persistent pain, features of cholestatic jaundice, pleural effusion, ascites and pseudocyst with complications who underwent ERCP were included.

*Results*: Forty-one (40 %) patients presented with persistent pain 36 (35.6 %) presented with jaundice, 5 (4.9 %) had pleural effusion, 10 (9.9 %) had ascites, 9 (8.9 %) had complicated pseudocyst. ERCP showed dilated PD in 37 (36.6 %), stricture PD in 3 (2.9 %) each, leak in 12 (11.8 %) normal in 10 (9.9 %), not cannulated in 36 (35.6 %). CBD was dilated in 15 (14.8 %) patients of whom 3 had stones also. Normal in 25 (24.7 %), CBD stricture was seen in 31 (30.6 %), not cannulated in 30 (29.7 %). One hundred percent patients with ascites, pleural effusion responded to stenting. 5/9 (55 %) of complicated pseudocyst with a leak improved with stenting. LFTs after 1 week of stenting jaundiced patient showed improvement. 10/40 (25 %) with persistent pain showed improvement in pain score by 1 week.

*Conclusion*: Among the various patients who underwent ERCP in chronic pancreatitis with most common indication was persistent pain. In our study the response was seen best in patients with ascites, pleural effusion, jaundice and complicated pseudocyst with leak.
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### Does the site of fluid collection alter the clinical course of acute pancreatitis? {#Sec593}

***Manish Manrai*** *, Thakur Deen Yadav, Niranjan Khandelwal, Jahangeer Basha, Sreekanth Appasani, Pradeep Siddappa Naveen Kalra, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Surgery and Radiology, Postgraduate Institute of Medical Educationand Research, Chandigarh 160 012, India

*Aim*: To evaluate whether the site of fluid collections alters the clinical course of acute pancreatitis.

*Methods*: One hundred and eighty-nine consecutive patients (mean age-38.85 years, 70 % males) of acute pancreatitis \>12 yrs of age between July 2011 and December 2012 were subjected to complete demographic profile, clinical and laboratory evaluation. Details of acute fluid collections based on CECT findings were noted and patients were categorized according to site of collection into pancreatic alone, peripancreatic alone, distant alone, peripancreatic with distant and pancreatic with peripancreatic/distant collections. Outcome parameters compared between different groups were organ failure, need for organ support, need for intervention, hospital and ICU stay and mortalty.

*Results*: Overall, 151 (79.9 %) patients had fluid collections and 38 (20.1 %) had no collections. Location of collections were pancreas only in 5 (3.31 %), peripancreatic only in 52 (34.43 %), distant only in 5 (3.31 %), peripancreatic+distant in 52 (34.43 %), and pancreatic with peripancreatic/distant in 38 (25.1 %). Patients with peripancreatic with distant collections had more incidence of organ failure (3 organ failures with Marshall score \>2 vs. 2 organ failures; 56 % vs. 31 %), more morbidity with increased ventilator and dialysis requirements, increased infections (if pancreatic site is also included; 37 % vs. 8 %), increased need for intervention (both percutaneous as well as surgery), prolonged hospital stay (22 days vs. 17 days), and increased mortality (47 % vs. 34 %).

*Conclusion*: Presence of collections in peripancreatic area along with distant collections increased the morbidity and mortality along with need for intervention suggesting a different protocol for management of collections as per the location.
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### Pancreatic stellate cells contribute to intra islet inflammatory milieu in chronic pancreatitis {#Sec595}

***Ratnakar Reddy*** *, R Talukdar, M Sasikala, P Pavan Kumar, A Maheshwari, G V Rao, R Pradeep, D Nageshwar Reddy*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Pancreatic stellate cell (PSCs) activation leading to fibrosis, increased pancreatic IFN-γ causing early β-cell dysfunction and apoptosis manifesting into clinical diabetes in chronic pancreatitis (CP) are reported. It was demonstrated that early β-cell dysfunction in CP results from increased IFNγ secreting T helper (Th) cell mediated inflammation. This study evaluates the association of PSCs, Th cells and βcell dysfunction.

*Methods*: Pancreatic tissues obtained from surgical specimens of CP patients without (*n*=16) and with (*n*=15) diabetes mellitus (DM) and controls (*n*=16) were evaluated for morphology and fibrosis by hematoxylin and eosin (H&E), and Masson's trichrome (MT) staining. Presence of α-smooth muscle actin (SMA) and glial fibrillary acidic protein (GFAP) for identifying activated PSCs within the islets was assessed by immunohistochemistry (IHC) and immufluorescence (IF). Quantification of α-SMA was performed on flow cytometry. Transforming growth factor (TGF)β expression within isolated islets was evaluated by RT-PCR.

*Results*: Duration of symptoms was 1-2 yrs in non-diabetics and 3-10 yrs in diabetic CP patients. Fibrosis was dense in the peri islet area as opposed to minimal intra-islet fibrosis. Intra-islet α-SMA positive cells in CP patients without and with DM indicated presence of activated PSCs. FACS analysis of non β cell islet suspension showed 0.1 % and 1.1 % α-SMA positive cells in non-diabetic and diabetic CP respectively. Presence of intra-islet α-SMA and GFAP double positive cells confirmed intra-islet activated PSCs. TGF-β mRNA was evident within the islets.

*Conclusion*: TGFβ secreted by intra-islet activated PSCs may aid in differentiation of naïve and Th17 cells to IFN-γ secreting Th1 cells, thereby contributing to inflammatory milieu and βcell dysfunction in CP.
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### Natural history of fluid collections in acute pancreatitis classified as per Atlanta 2012 revision {#Sec597}

***Manish Manrai*** *, Thakur Deen Yadav, Niranjan Khandelwal, Jahangeer Basha, Sreekanth Appasani, Pradeep Siddappa, Naveen Kalra, Saroj Kant Sinha, Kartar Singh, Rakesh Kochhar*

Departments of Gastroenterology, Surgery, and Radiology, Postgraduate Institute of Medical Educationand Research, Chandigarh 160 012, India

*Aim*: To study the course and outcome of pancreatic-extra pancreatic acute fluid collections in patients of acute pancreatitis (AP).

*Methods*: One hundred and eighty-nine consecutive patients (mean age-38.85 years, 70 % males) of AP between July 2011 and December 2012 were subjected to complete clinical and laboratory evaluation. Details of acute fluid collections ie. acute peripancreatic fluid collections (APFCs) and acute necrotic collections (ANCs) based on CECT findings were noted. Patients were followed up for short-term (up to 3 months) and long-term (\>3 months) for sequelae.

*Results*: Alcohol was the major cause (*n*=80 (42.3 %). Necrotizing pancreatitis seen in 153 (80.9 %) with ANC in 143, interstitial edematous pancreatitis in 36 with APFC in 8 and no fluid collections in 38 (20.1 %). Collections were located in pancreas in 5 (3.31 %), peripancreatic in 52 (34.43 %), distant in 5 (3.31 %), peripancreatic+distant in 52 (34.43 %), and pancreatic+peripancreatic/distant in 38 (25.1 %). One hundred and forty-two (75.13 %) patients were followed up for 3 months and 64 beyond 3 months. Of 105 ANCs, 21 (20 %) resolved and 83 (79 %) developed walled-off-necrosis (WON) and 1had WON+pseudocyst. All APFCs resolved except one, evolved into pseudocyst. Infections were seen in 56.7 % of ANCs and none of APFCs. Fify-four patients required percutaneous drainage (30-resolved, 16-resolving WON and 8-persistent WON, expired). Endoscopic drainage was done in 16 patients (2-resolved, 11-resolving WON and 2-persistent WON. Twenty-four patients required surgery and 12 expired.

*Conclusion*: Fluid collections developed in 80 % of AP and most were peripancreatic or distant or combination. ANCs occurred in 93.4 % of patients with necrotizing pancreatitis, of whom, 20 % resolved and rest developed WON. APFCs developed in 22.2 % of interstitial pancreatitis and all of them resolved except 1, developed a pseudocyst.
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### CFTR mutations are not associated with chronic pancreatitis in Indian subjects {#Sec599}

***Urmila Steffie Avanthi*** *, V V Ravi Kanth, Rupjyoti Talukdar, M Sasikala, D Nageshwar Reddy*

Asian Healthcare Foundation, and Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, India

*Introduction*: Chronic pancreatitis (CP) is characterized by irreversible destruction of pancreatic tissue resulting in exocrine and endocrine dysfunction. The prevalence of CP is high in India (114-200/100,000 population). N43S in the Spink1 gene is significantly associated with Indian CP, however SPINK1 polymorphism is only a disease modifier and additional polymorphisms interacting/modifying the Spink1 gene have to be identified. CFTR is an important gene in this context. The objective of this study was to genotype individuals with and without CP for 4 mutations in CFTR gene, N34S in Spink1 gene and N29I; R122H in the PRSS1 gene.

*Methods*: One hundred and twenty-five individuals with CP and 50 healthy controls were recruited. ARMS-multiplex PCR was employed to genotype individuals for 4 CFTR mutations namely ï, F508, G551D, G542X and 621+1G\>T. Primers flanking the polymorphisms in SPINK1 and PRSS1 genes were designed and genotyped by direct DNA sequencing.

*Results*: Only 1 individual from CP and none from control group had ï, F508 mutation in the CFTR gene. None of the other mutations of the CFTR or PRSS1 gene were seen either in the CP or control group. Of the 125 from the CP group, 58.54 % were wild type, 29.27 % were heterozygous and 12.20 % were homozygous for the SPINK1 polymorphism. SPINK1 polymorphism in the control group was seen to be 2.76 % from our earlier study.

*Conclusions*: Mutations in the CFTR gene were not significantly associated with CP in the present study in Indian subjects.
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### Pancreatic calculus causing biliary obstruction at the ampulla - Endoscopic therapy {#Sec601}

***Anurag J Shetty*** *, C Ganesh Pai, Ganesh Bhat, Sumit Bhatia*

Department of Gastroenterology and Hepatology, Kasturba Medical College, Manipal 576 104, India

*Introduction*: Biliary obstruction in chronic calcific pancreatitis (CCP) is often caused by inflammatory or fibrotic strictures of the bile duct, carcinoma of head of pancreas or less commonly by compression from pseudocysts. Pancreatic calculi causing ampullary obstruction and leading to obstructive jaundice is extremely rare.

*Methods*: A hospital based retrospective study was done. The medical records of all patients with CCP or biliary obstruction who underwent ERCP over 3 years between 2010-2013 in Kasturba Medical College, Manipal were analyzed.

*Results*: Three cases of CCP with impacted pancreatic calculi at the ampulla identified. All 3 patients presented with biliary obstruction and 2 of these patients had features of cholangitis. All 3 patients were incidentally detected to have chronic calcific pancreatitis when evaluated for biliary obstruction. Imaging- CT/ERCP showed biliary dilatation down to the ampulla with a pancreatic calculus at the ampulla. There were no intrapancreatic biliary stricture/neoplasm/pseudocyst causing biliary obstruction. All the patients were managed successfully with endoscopic papillotomy and extraction of pancreatic calculi from the ampulla. All patients had complete resolution of biliary obstruction with a single endoscopic procedure.

*Conclusion*: Pancreatic calculus causing ampullary obstruction though very rare should be considered as a possibility in patients with chronic calcific pancreatitis presenting with biliary obstruction. Endoscopic therapy is effective in extraction of pancreatic calculi impacted in ampulla and resolution of biliary obstruction.
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### Effects of vitamin D deficiency in patients with acute pancreatitis {#Sec603}

*Deepak K Bhasin, Chalapathi Rao, Surinder S Rana,* ***Ravi Kumar Sharma*** *, Vishal Sharma, Naresh Sachdeva, Anil Bhansali*

Departments of Gastroenterology, and Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Background*: The association between hypovitaminosis D and acute pancreatitis (AP) has not been studied.

*Aim*: Study incidence of vitamin D deficiency in patients with AP and assess the correlation, if any, between hypovitaminosis D and severity, complications and its outcome.

*Methods*: Ninety-four patients (56M; age 38±13.34 years) with AP who were admitted between January 2011 and October 2012 were retrospectively analyzed. The clinical, laboratory, radiological parameters, need for intervention and final outcome were retrieved.

*Results*: The most common etiology of AP was alcohol intake (*n*=39; 41.4 %) followed by gallstone disease (*n*=32; 34 %). Eighty (86.2 %) patients had severe disease (Atlanta criteria) and 76 (80.9 %) patients had necrotizing pancreatitis. Persistent organ failure was noted in 48 (51 %) patients of which respiratory failure was the most common (*n*=39; 41.5 %). Mean CTSI was 6.65±2.70 and 7 (7.4 %) patients succumbed to their illness. The mean vitamin D levels in the patients studied were 21.4±23.7 ng/mL. The mean corrected calcium and phosphate levels were 7.7±72 mg/dL and 3.0±1.49 mg/dL. Seventy-three (77.7 %) patients were found to be vitamin D deficient (vitamin D levels \<30 ng/mL). Persistent organ failure was seen more commonly in patients with vitamin D deficiency compared to patients with normal levels (56.2 % vs. 33.3 %; *p*=0.04. However, compared to deficient group, those with normal levels had similar incidence of pancreatic necrosis (*p*=0.52), acute fluid collections (*p*=0.38), severity (*p*=0.94), sepsis (*p*=0.17), intervention {percutaneous catheter drainage (*p*=0.42)/surgery (*p*=0.80)} and mortality (*p*=0.68).

*Conclusions*: Patients of AP with vitamin D deficiency have increased incidence of persistent organ failure.

P-32 {#Sec604}
----

### EUS study of fluid collections in acute necrotizing pancreatitis: Are they pseudocysts, walled off pancreatic necrosis or need a new name? {#Sec605}

***Surinder S Rana*** *, Deepak K Bhasin, Yalaka Rami Reddy, Chalapathi Rao, Ravi K Sharma, K Jeyashree, Rajesh Gupta*

Department of Gastroenterology, School of Public Health and Surgery, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160 012, India

*Background*: There have been attempts to develop universally applicable nomenclature for pancreatic fluid collections (PFC's) in acute pancreatitis. But PFC's following acute necrotizing pancreatitis (ANP) has not been studied by sensitive imaging techniques like EUS.

*Aims*: Prospectively study PFC's occurring following ANP by serial endoscopic ultrasound (EUS).

*Patients*: Over last 14 months, 47 patients (34 males; mean age 36.7±11.6 years) of ANP with PFC were followed up with EUS at 6 weeks, 3 months and 6 months respectively.

*Results*: On EUS at 6 weeks, 41/47 (87 %) patients had fluid collection with solid debris. Follow up EUS at 3 and 6 months revealed progressively decreasing solid content (52 % and 44 % patients had solid content respectively). During this period, 11 (23.4 %) patients needed intervention for symptomatic PFC and two of these patients had no solid debris. Addition of retrospective data of endoscopic drainage of WOPN done over last 3 years identified 43 patients and 40 % solid debris was present in 6, 33 and 4 patients respectively. Patients with \<10 % necrotic debris needed only single session of endoscopic drainage whereas patients with 10 % to 40 % solid debris needed 2 or more sessions. Patients with \>40 % solid debris either needed direct endoscopic debridement or surgical necrosectomy.

*Conclusions*: All PFC following ANP may not have solid necrotic content and over period of time necrotic content tends to liquefy. This may have therapeutic implications.
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### Comparative study of combined EUS and ERCP with CT scan for evaluation of patients with suspected periampullary carcinoma and obstructive jaundice {#Sec607}

***Mohd. Juned Khan*** *, C Palanivelu, P S Rajan, P Kartikeyan, P Senthilnathan, B Tarannum*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Objective*: (1) To determine feasibility and outcome of EUS and therapeutic ERCP into single session and compare with CT scan findings. (2) To determine inoperability of patients who were operable on CT scan.

*Material and Methods*: \>Total of 30 patients between age group of 40-75 years, with suspected malignant obstructing lesion in periampullary region. Combined EUS and ERCP was done by our team in single sitting. By using linear array endoscope with or without radial echoendoscope (Olympus) an EUS evaluation of ampulla, pancrease, bileduct and duodenum was done.

*Results*: Out of 30 patients, CT scan of 22 showed mass with dilated IHBR and CBD and remaining 8 patients (26.66) showed only dilated IHBR and CBD on CT scan. EUS was done in these 22 cases. Out of these 22 EUS; 14 (63.6 %) cases are operable, while EUS of 8 (36.4 %) showed that patients are inoperable due to involvement of vessels and lymphnodes. CT scan of 8 patients showed only dilated IHBR and CBD. EUS study of these 8 patients showed that 3 (37.5 %) cases has early small mass in head of pancreas. Two patients were found to have stricture, one proved to be malignant and one proved to be benign on biopsy. Last one patient have small CBD stone and sludge in terminal CBD.

*Conclusion*: 1. Combined EUS and ERCP done in same sitting is cost effective and time saving. 2. EUS is superior modality to CT scan abdomen in redeciding the operability of periampularry malignancy
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### Prevailing factors and prognosis in post ERCP pancreatitis {#Sec609}

*I Naresh Md, P Muralikrishna,* ***K Jayaram*** *, L R S Girinadh*

Department of Gastroenterology, Andhra Medical College, King George Hospital, Vishakhapatnam, India

*Introduction*: Acute pancreatitis is the most common and serious complication of ERCP procedure. Serum amylase elevation is common after ERCP, seen up to 75 % of the patients. Fortunately, acute pancreatitis requiring hospitalization is less common.

*Aim of the Study*: 1.To estimate the frequency, severity and outcome of post ERCP pancreatitis. 2. To identify the risk factors associated with post ERCP pancreatitis. 3. To predict the onset of post ERCP pancreatitis.

*Materials and Methods*: Patients undergoing ERCP in Endoscopy Unit, Department of Gastroenterology, King George Hospital, Vishakhapatnam, during the period from January 2011 to February 2013 were included in the study. Serum amylase estimation was done with in 4 hours after ERCP. In patients with elevated serum amylase at 4 hours post ERCP, repeat serum amylase estimation was done at 24 hours after ERCP.

*Results*: 1. Overall incidence of post ERCP pancreatitis is about 8.7 % (16 of 198). Asymptomatic hyperamylesemia is about 42.4 %. 2. On univariate analysis patient related factors like age 24.9 kg/m2 are found to be significant. 3. Procedure related factors like involvement of trainee/junior consultant and difficult cannulation are found to be associated with post-ERCP pancreatitis.

*Conclusions*: 1.The incidence of post-ERCP pancreatitis is about 8.7 %. Asymptomatic rise in serum amylase is about 42.2 % in our study. 2. Post-ERCP pancreatitis runs a benign course and has good outcome. 3. The level of serum amylase measured at 4 hours after ERCP is the most reliable predictor of post-ERCP pancreatitis.
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### Hemorrhage complicating the course of severe acute pancreatitis {#Sec611}

***R V Pradeep Krishna*** *, Vikas Gupta, Yadav, D Thakur, Bhalla, Asheesh; J D Wig, Rakesh Kochhar*

Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

*Introduction*: The course of severe acute pancreatitis (SAP) can be complicated by hemorrhage, which is associated with poor outcome.

*Objectives*: To evaluate the factors associated with hemorrhagic complications in SAP and their effect on outcome.

*Results*: Twenty-four (13.1 %) patients had hemorrhagic complications; 12 intraabdominal and 12 intraluminal. Thirteen had a major and 11 had minor bleed. Sixteen patients bleed before and 8 after intervention (radiological 3, surgical 5). The mean duration of pancreatitis prior to bleed was 27+27.2 days. Predictors of bleed on univariate analysis were male sex (*p*=0.014), organ failure (*p*=0.008), venous thrombosis (*p*=0.033), infective necrosis (0.001) and systemic sepsis (0.037). On multivariate analysis infected necrosis (*p*=0.015) was a significant factor. Radiological drainage was associated with decreased risk of bleeding (45.8 % vs. 54.4 %; *p*=0.000). Need for surgery (50 % vs. 12.6 %, *p*=0.003), intensive care stay (7.4+7.9 vs. 5.4+5.2 days; *p*=0.001) and mortality (41.7 % vs. 10.7 %; *p*=0.000) were significantly higher in bleeders. 7/13 of major bleeders had pseudoaneurysms - 4 were embolized, 4 needed surgery including 1 embolization failure. 7/12 intraabdominal bleeders required surgical intervention, 3 had successful embolization and 2 had expectant management. Of the 12 with luminal bleed, 8 had gastroduodenal ulcers and 4 had evidence of hollow viscus erosion, all of which required surgery. CT severity index (*p*=0.046) and surgical intervention (*p*= 0.041), were significantly associated with intraabdominal bleed. Organ failure (*p*=0.043), presence of pseudoaneurysm (53.8 % vs. 9.1 %; *p*=0.041) and surgical intervention (69.2 % vs. 27.3 %; *p*=0.020) were associated with major bleed. No significant factor could be identified for post-intervention bleed.

*Conclusions*: Hemorrhage in SAP indicates severe disease. Infection causes local events which predispose to hemorrhage. Luminal bleed may be indicative of erosion into the adjacent viscera. Pseudoaneurysms were associated with major bleeding. Bleeding occurring after intervention have similar course as those without.
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### Endoscopic drainage of pancreatic pseudocysts at a tertiary care center in Northern India {#Sec613}

***Sandeep Kumar*** *, Samir Mohindra, Praveer Rai, Vivek A Saraswat*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background*: Endoscopic drainage is an effective non-surgical treatment for pancreatic pseudocysts. Experience with this modality was reviewed at a tertiary care centre.

*Methods*: Records of consecutive patients from 2000 to 2013 undergoing endoscopic drainage of pancreatic pseudocysts were analyzed. Cyst were drained after dilating the cyst puncture track with a controlled radial expansion balloon (CRE, Boston Scientific Corp; 12-18 mm) and placing plastic double pigtail stents with or without a nasocystic drain. Stents and drain were removed after resolution of pseudocyst on imaging.

*Results*: Seventy-seven patients \[age 37 years (15-73); 81 % men\] underwent cystogastrostomy (81 %), cystoduodenostomy (14 %) or transpapillary drainage (5 %). An endoscopic nasocystic drain (ENCD) was placed in 39 patients (50 %). Pseudocysts developed most often in acute pancreatitis (86 %), were located in the lesser sac (93 %) and were large \[median volume 677 mL (80-2706 mL)\]. Median duration of symptoms was 15.7 wks (4-68 wks). Drainage was successful in 98 %. There was 1 death (1.3 %) due to sepsis. Complications occurred in 19 others (25 %) \[pancreatic abscess (12), bleeding (5), perforation (2)\]. 68 patients (88 %) were followed for a median period of 26 months (1-120 months). Endoscopic drainage was definitive treatment in 60 (88 %) patients while 4 (5.8 %) had recurrence of pseudocyst. A second endoscopic procedure was done in 13 patients (19 %; sepsis 12, recurrent PPC 1), surgery was needed in three (3.8 %; bleed 1, recurrence 2) and angiography with embolization in 1 patient (1.3 %).

*Conclusions*: Endoscopic drainage is effective and safe for pancreatic pseudocysts in the setting of acute pancreatitis.
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### Pancreas divisum in Lucknow: Clinical presentation and long-term results of endoscopic therapy {#Sec615}

*Vivek A Saraswat, Praveer Rai, Samir Mohindra,* ***Sachin Munjal*** *, Manoharlal Sharma*

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Aim*: To evaluate clinical presentation and long-term results of endoscopic therapy in patients with pancreas divisum.

*Patients and Methods*: Database of patients undergoing endotherapy for pancreas divisum from January 2002 to July 2013 was analyzed for clinical presentation and results of therapy. Technical success was completion of minor papilla endotherapy while clinical success was resolution of symptoms with unhindered pancreatic drainage after endotherapy. Patients with CP were treated with clearance of PD calculi, dilatation and stenting of strictures in the dorsal duct and repeated stent exchanges till resolution of strictures.

*Results*: Forty-three procedures were done in 21 patients with pancreas divisum \[mean age 24 years (8 to 54), 12 male\] presenting with recurrent pain for 47 months (6 to 274). Recurrent acute pancreatitis (RAP) was present in 5 while 16 had chronic pancreatitis (CP; 10 calcific, 6 non-calcific). Minor papilla sphincterotomy with PD stent (4) provided pain relief in RAP for clinical success of 100 %. Technical success was 90.5 %; minor papilla canulation failed in 2 patients with CP, who underwent surgery. Dorsal duct CP was treated with dilatation and stenting (8) or by dilatation alone (6). Pain was relieved completely in 10, persisted in 1, while 3 are still on treatment. Mean duration of follow up after endotherapy was 17.6 months. Clinical success was achieved in 77 % (10/13) completing therapy. Complications occurred in 5 patients (20 %; mild pancreatitis 4, stent migration 1).

*Conclusion*: Endoscopic therapy was successful in patients with pancreas divisum, providing long-lasting relief in both CP and RAP.
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### Cysto enteric fistula of pancreatic pseudocyst {#Sec617}

***S John*** *, Kani Sheik, Rathnakar Kini, Premkumar, Pugazhendhi, Mohammed Ali*

Department of Medical Gastroenterology, Madras Medical College, Chennai 600 003, India

Cysto enteric fistula of pancreatic pseudocyst has been rarely reported. It can be attributed as one of the natural course of pseudocyst resolution as well as a complication.

This is a case report of 18-year-old male who presented with abdominal pain of pancreatic type and abdominal distension. Physical examination revealed a vague mass palpable in the epigastrium and ascites.

*Investigation and Course*: He had raised serum amylase and lipase. He had high SAAG ascitic fluid and ascitic fluid amylase of 3946 IU/L. CECT abdomen revealed a pancreatic pseudocyst 18\*12 cm in lesser sac compressing the stomach. Patient developed large volume diarrhea following which he was relieved of the abdominal pain and distension and amylase level was raised (3456 IU/L) in the loose stool sample. Repeat imaging showed significant reduction in the size of pseudocyst to 5\*4.5 cm even though imaging could not demonstrate the site of fistula.

*Conclusion*: Cysto enteric fistula of pancreatic pseudocyst is a rare mode of resolution of pseudocyst and rarely associated with complication due to intrinsic healing capacity of bowel wall.
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### Exocrine insufficiency in chronic pancreatitis {#Sec619}

***Namrata Singh*** *, Vikas Sachdev, Indu Arora, Ashish Datt Upadhyay, Anoop Saraya.*

Departments of Gastroenterology and Human Nutrition, and Biostatistics, All India Institute of Medical Sciences, New Delhi 110 029, India

*Aim*: To see the association between pancreatic exocrine insufficiency and clinical parameters in patients with chronic pancreatitis (CP).

*Methods*: Fecal elastase, fecal fat and fecal chymotrypsin were measured in patients with CP. Association of these three parameters with pain, steatorhea, diabetes, disease duration, BMI and USG findings (Atrophy, ductal dilatation and calcification) were examined.

*Results*: Out of 153 patients (mean age 33.26±12 years, males 118), 140 presented with pain. Diabetes and steatorhea was present in 21 % and 32.03 %, respectively. Fecal elastase (85(1-520) μg/gm) was normal (\>200 μg/gm) in 36 (23.52 %), fecal fat (4.6 (0.24-48.87) gm/24 hours) was normal (7 units/gm) in 53 (34.64 %) patients. Diabetes was more prevalent in CP patients with high fecal fat (*p*=0.001) and low chymotrypsin (*p*=0.001) levels. Duration of disease had no effect on the three studied parameters. Three methods did not correlate with ductal dilatation, pancreatic atrophy and calcification. Chymotrypsin levels had a positive correlation with elastase (r=0.6238, *p*\<0.001) and BMI (r=0.2047, *p*=0.0200). Fecal fat had a weak negative correlation with elastase (r=-0.2538, *p*=0.0032) and chymotrypsin (r=-0.2058, *p*=0.0175).

*Conclusion*: Fecal chymotrypsin levels correlated with fecal fat excretion and BMI. Fecal chymotrypsin estimation may be helpful in early detection of malabsorption in chronic pancreatitis.
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### Tumor necrosis factor alpha gene polymorphisms and hospital outcomes in patients with acute pancreatitis {#Sec621}

***V A Jiffy Rasak*** *, Ebby George Simon, S Pugazhendhi, B S Ramakrishna*

Department of Gastroenterolgy, Wellcome Research Laboratory, Christian Medical College, Vellore 632 004, India

*Background*: Acute pancreatitis is an inflammation of the pancreas which can be precipitated by multiple factors. The severity of illness can range from mild to life threatening. We hypothesized that the polymorphisms in TNF alpha can affect the severity of illness once a patient develops pancreatitis.

*Aims*: 1. To study the clinical profile of patients presenting with acute pancreatitis. 2. To study the effect of TNF alpha gene polymorphisms on the outcome of pancreatitis and severity of illness.

*Methods*: All patients presenting with acute pancreatitis to CMC were recruited. Their clinical and laboratory profiles were studied and the in-hospital outcomes and severity of illness were assessed. Venous blood was collected from all patients for DNA analysis. The polymorphisms being studied were TNF 308 G/A, TNF 857 C/T, TNF 863C.

*Results*: One hundred and ten patients have been recruited for the study till date - 93 males and 17 females. Eighty-eight patients presented with the first episode whereas 22 had recurrent attacks. Alcohol was the commonest etiology. Fifty-one patients had mild attack and 59 of them had a severe attack. Eleven patients required ICU admission and there were seven deaths. The most common complication requiring ICU admission was ARDS/ALI. The genetic analysis of these patients is under way.

*Conclusion*: More than 50 % of the patients in our study had severe acute pancreatitis. We expect to find a positive correlation to the severity of illness and the TNF polymorphisms.
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### Evaluation of hydrogen sulfide as a prognostic marker in patients with acute pancreatitis {#Sec623}

***Iqbal N Qureshi*** *, A J Joseph, Kavitha Reuben, K A Balasubramanian, Anup Ramachandran*

Department of Gastrointestinal Sciences, Christian Medical College, Vellore 632 004, India

*Background*: Hydrogen sulphide (H2S) is a vasoactive molecule with varied function. The study was aimed to evaluate the role of H2S in acute pancreatitis.

*Materials and Methods*: All patients of acute pancreatitis admitted between June 2012 and May 2013 were included in the study. Severity of acute pancreatitis was defined as per Atlanta classification. Plasma H2S was measured (spectrophotometry) at admission, at 48 hours and at discharge. H2S was also measured in 13 healthy volunteers.

*Results*: Thirty-eight patients (male:30; age: 39.5, 13-72 years; median, range) were included. Alcohol (18) and biliary (9) were common etiology of pancreatitis. Eleven (29 %) had severe pancreatitis; 10 had acute lung injury and 2 had acute kidney injury. Admission plasma H2S levels in patients with acute pancreatitis (*n*=34) was similar to those of healthy volunteers (16.4, 7-81 μmol/L vs. 16.4, 11-26 μmol/L; median, range; *p*-value: 0.8). Admission plasma H2S levels in patients with mild pancreatitis (*n*=24) was similar to patients with severe pancreatitis (15.7, 7-81 μmol/L vs. 36, 10-54 μmol/L; *p*-value: 0.5). Plasma H2S levels at 48 hours after admission (*n*=34; 15, 3.6-76 μmol/L vs. 22, 10-59 μmol/L; *p*-value: 0.6) and at discharge (*n*=23) was also similar in patients with mild and severe pancreatitis. Admission plasma H2S levels did not predict acute lung injury in the study patients. Plasma H2S levels at admission in the single patient who expired of multi-organ failure was 10 μmol/L.

*Conclusion*: Plasma H2S levels at admission or at 48 hours after do not predict severity in patients with acute pancreatitis.
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### Utility of the "Harmless Acute Pancreatitis Score" in predicting a non-severe course of acute pancreatitis: A pilot study in an Indian cohort {#Sec625}

***Rupjyoti Talukdar*** *, Mithun Sharma, Amal Dev Goswami, Arunima Goswami, Anup Baro*

Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad 500 082, and NEMCARE Hospital, Guwahati, Assam, India

*Introduction*: Harmless Acute Pancreatitis Score (HAPS) is a newly developed system that predicts a mild course of AP. HAPS includes absence of rebound abdominal tenderness, normal hematocrit and serum creatinine \<0.0001). Significantly higher proportions (%, *p*) of non-HAPS patients needed ICU care (84.6 %; 0.001), had local complications (81.3 %; 0.0004), POF (87.5 %; 0.007) and infections (68.8 %; 0.021). The ROC AUC of HAPS in predicting mild disease was 84.8 (95 % CI 74.8-93.2), with sensitivity, specificity, positive and negative predictive values of 76.3 (95 % CI 63.4-86.4), 85.7 (95 % CI 73.6-96.8), 93.8 (95 % CI 82.8-98.6) and 56.3 (95 % CI 37.7-73.6) respectively.

*Conclusion*: HAPS can be useful in severity assessment of AP in Indian patients.
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### An interesting case of trichobezoar {#Sec628}

***M G Manoj*** *, Azimudin, Ramesh Kumar, Sathiamoorthy, Venketeswaran, Revathy, Chitra, Manimaran, Murali, Malarvizhi*

Department of Medical Gastroenterology, Government Stanley Hospital and Medical College, Chennai 600 001, India

*Background*: Trichobezoars (hair ball) are usually located in the stomach, but may extend through the pylorus into the duodenum and small bowel (Rapunzel syndrome). It is a rare condition almost exclusively seen in young females usually with psychiatric disturbances. Human hair is resistant to digestion as well as peristalsis due to its smooth surface leading it to accumulate between the mucosal folds of the stomach. The impaction of hair together with mucus and food resulting in the formation of a trichobezoar.

*Case Report*: We hereby report a case of 7-year-old female child admitted in Pediatric Surgery referred to us for evaluation of abdominal mass, decreased food intake and abdominal pain on and off. Patient was taken up for upper gastrointestinal endoscopy which showed balls of hair mixed with food in stomach and duodenum assuming the shape of the stomach and extending in to the duodenum. Patient was taken up for surgery by the pediatric surgeons and the trichobezoar was removed with no postoperative complications and subsequently the child was discharged.

*Conclusion*: Trichobezoar is to be entertained as one of the differential diagnosis in young females and children presenting with nonspecific abdominal complaints and should be subsequently investigated with aids such as upper GI endoscopy which helps in planning management as in our case. This case is presented to highlight the diagnosis of trichobezoar in any cases of vague pain abdomen especially in younger age group and whose diagnosis requires a high index of alertness and suspicion by clinician.
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### Whipple's disease: A case report {#Sec630}

***Amit Sitapara*** *, Arvind Vikani, Neema Sitapara*

Laxmi Children Hospital, 2nd floor, Opal Plaza, Akshar Marg, Amin Marg Corner, Rajkot 360 004, India

The present article reports the clinical case of a 12-year-old male child presented with complain of diarrhea, blood in stool, weight loss, anorexia and abdominal pain. General appearance of patient was cachexic. The abdomen was soft, flat and there was palpable tender mass in hypogastrium on per abdomen examination. Per rectal examination showed mucosal thickening with hard extraluminal fixed mass. Blood report showed decreased hemoglobin level, increased WBC count and ESR. Peripheral smear examination of blood showed neutrophilic leukocytosis and hypochromic microcytic anemia. USG abdomen revealed thickening of sigmoid and descending colon with surrounding thick mysentry with enlarged nodes. CT scan of abdomen with pelvis showed diffuse circumferential mildly enhancing wall thickening involving the sigmoid colon, rectum, hepatic flexure and proximal descending colon with surrounding fat infiltration and multiple enlarged lymphnodes in the mesentry and ischiorectal fossa. Colonoscopy showed multiple thick nodular lesions with ulcer more in rectosigmoid region. Histopathological examination of specimen of colon revealed benign colonic mucosa, lumina is crowded by large macrophages, glands are mildly distorted, severe infiltration of lymphocytes and neutrophil with occasional giant cells seen. Patient was treated by combination of trimethoprim with sulphamethoxazole for one year and followed up every three months. On follow up, patient's general condition was good, decrease frequency of stools, increase appetite, weight gained and colonoscopy showed all lesions were healed.
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### Prevalence of hepatopulmonary syndrome in children with extrahepatic portal venous obstruction and cirrhosis {#Sec632}

***Vibhor Vinayak Borkar*** *, U Poddar, A Kapoor, S K Yachha, A Srivastava*

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Background/Aim*: Hepatopulmonary syndrome (HPS) has not so far been reported to occur among children with extrahepatic portal venous obstruction (EHPVO). We have prospectively studied the prevalence of HPS in children with portal hypertension.

*Methods*: Over a period of 18 months, children with portal hypertension due to cirrhosis and EHPVO between ages 1-18 years were studied and prevalence of HPS was compared in each group. HPS was diagnosed by the presence intrapulmonary shunt using transthorasic contrast echocardiography and hypoxia/orthodeoxia (in ABG).

*Result*: Of 121 children (35 cirrhotics and 86 EHPVO) studied, HPS was significantly more in children with cirrhosis than with EHPVO (37 %) vs. 14 %, *p*=0.007\]. Both the groups were comparable as per gender distribution (Male:74 % vs. 84 %) and age (10.8 ±3.7 vs. 10.9±3.9 years). Cirrhotics with HPS had increased frequency of clinical features (clubbing, dyspnea, cyanosis) and long standing disease duration (44±38 vs. 20±22 months, *p*=0.01) as compared to cirrhotics without HPS. Proportion of advanced liver disease (Child B and C) was similar in both the groups (70 % vs. 72 %). Among the EHPVO, clubbing was observed in children with HPS only (33 % vs. 3 %, *p*=0.003). There were no difference between children with HPS and without in terms of their gender, age, spleen size and hypersplenism.

*Conclusions*: This study shows occurrence of HPS among children with EHPVO and it occurs less often as compared to cirrhotic children. Long standing duration of disease with cirrhotics is more common with HPS.
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### Primary intestinal lymphangiectasia: A rare cause of chronic diarrhea in children {#Sec634}

***K S Prasanth*** *, S Anil Kumar, A B Suthanu, Tony Joseph, N Premaletha, A Santhosh Kumar, K R Vinaya Kumar*

Departments of Gastroenterology and Pediatrics, Government Medical College, Thiruvananthapuram 695 011, India

A 10-year-girl presented with recurrent small bowel diarrhea with features of malabsorption of fats and protein and growth retardation from the age of 3 years. This illness was not associated with fever, vomiting, abdominal pain, rash, arthralgia or urinary symptoms. She was second born to non-consanguineous parents, with a birth weight of 3.5 kg and was diagnosed to have congenital lymphedema right upper limb in the new born period. On examination she had gum hypertrophy, teeth overcrowding and prominent maxilla; lymphedema of right upper limb and bilateral pitting pedal edema. She had height 124 cm and weight 21 kg (both \<3rd centile) and BMI-13.65 kg/m^2^. She had hepatomegaly and shifting dullness. Other systems were normal. Hemoglobin 13 g/dL, WBC count - 8000 cells/cu.mm, differential count P83L14E3, ESR-10 mm/1st hour, platelet count 3.1 lakh/cu.mm.; 24 hour proteinuria-nil; stool fat 10/hpf; LFT:bilirubin-1/0.4, OT/PT-22/18 IU/L, ALP-160, total protein/serum albumin-3/1.4 g/dL, INR-1.02, blood urea-18 mg/dL, creatinine-0.5 mg/dL; fasting lipid profile: total cholesterol-75 mg/dL, triglyceride-60 mg/dL; HDL-14 mg/dL and LDL-47 mg/dL. Lymphoscintigraphy showed obstructive pattern of right upper limb lymphatic flow. USG abdomen showed ascites and edematous bowel loops. BMFT showed diffuse thickening of mucosal folds involving jejunum and ileum. The characteristic snow flake appearance of the duodenum was seen on upper gastrointestinal endoscopy. Duodenal biopsy showed dilated lymphatics which clinched the diagnosis of primary intestinal lymphangiectasia. She was given medium chain triglyceride based diet and albumin transfusions.
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### Endoscopic therapy of chronic pancreatitis in children: A 15-year experience {#Sec636}

*V A Saraswat,* ***R Malik*** *, P Rai, S K Yachha*

Departments of Gastroenterology and Pediatric Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226 014, India

*Objective*: To review indications and results of endoscopic management in children with chronic pancreatitis (CP).

*Methods*: Children (\<18 years) with CP undergoing ERCP at the Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow between January 1997 and May 2013 were studied. Patients were followed up in an outpatient clinic. Procedure outcomes and complications were evaluated.

*Results*: Twenty-three children (13 boys) underwent 63 procedures. Age at symptom onset was 9.4+4.4 years and at first ERCP 12.4+3.8 years. Indications were pain (*n*=21), pancreatic ascites with pain (*n*=1) and biliary stricture with pain (1). Eleven patients (48 %) had pancreatic calculi, 13 (52 %) had main pancreatic duct (PD) stricture while 3 (13 %) had stone with stricture. Pancreas divisum was seen in 6 patients (34.7 %). Therapeutic procedures included papillotomy of major papilla in 19 (82.6 %), of minor papilla in 3 (13 %), endoscopic stone extraction in 5 and stricture dilatation in 12. PD stents were placed in 13 patients (4 in dorsal duct-3 had pancreas divisum) with median 2 procedures/patient (range 1-3) and median 1 stent per procedure (range 1-3). Three patients underwent ESWL. Five cases had were referred surgical referral after initial ERCP (unsuitability for endoscopic therapy 2, technical failure 3). In remaining 18, median follow up was 24 months (1-144m). 77.77 % (*n*=14) had improvement of symptoms. Complication rate was 14 % (pancreatitis 5, anesthetic 4).

*Conclusions*: In the largest series of ERCP for children with CP from India we demonstrate that endotherapy offers significant long-term pain relief.
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### A case of Caroli syndrome with mental retardation and orofacial syndrome {#Sec638}

***M G Manoj*** *, Azimudin, Ramesh Kumar, Sathiamoorthy, Venketeswaran, Revathy, Chitra, Manimaran, Murali, Malarvizhi*

Department of Medical Gastroenterology, Government Stanley Hospital and Medical College, Chennai 600 001, India

*Background*: Caroli's disease and Caroli's syndrome are rare congenital disorders of the intrahepatic bile ducts. Caroli's syndrome is associated with autosomal recessive polycystic kidney disease. There is description of a patient with both OFD1 (oral-facial-digital syndrome) and Caroli\'s disease along with cystic renal disease occurring in 1:250,000 births it is rare. Most cases appear to be sporadic, but others are inherited in an X-linked dominant manner.

*Case Report*: We hereby report a case of a 18-year-old female born out of a second degree consanguineous marriage with history of delayed milestones, and past history of recurrent abdominal pain; fever and jaundice requiring multiple admissions since one and half years of age. She presented to us with decompensation in the form of abdominal distension and swelling of legs. Further work up revealed her to be in Child class B. USG abdomen and MRI was done which showed the characteristic bile duct dilatations with portal bundle of vessels passing through which was seen as a "central dot sign". Her previous biopsy report was reviewed which was also consistent with a picture of hepatic fibrosis dilated bile ducts and cholestasis leading to a final diagnosis of Carolis disease. She was subsequently counselled and put on a cadaveric deceased liver donor transplant wait list.

*Conclusion*: When one encounters a case of cholestatsis with recurrent cholangitis presenting in a younger age group as our patient among the various differential diagnosis one should keep in mind congenital disorders like Carolis disease. Literature shows that these patients may end up in decompensation ultimately needing liver transplantation as in our case. This case is presented for its rarity, the characteristic central dot sign which was well seen on imaging and to highlight on congenital diseases like Caroli's.
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### Miraculous role of wheatgrass in prevention of colorectal cancer in rats {#Sec641}

***J K Kamboj*** *, S V Rana, K K Prasad, K Vaiphei, D K Dhawan*

Departments of Gastroenterology, and Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, and Department of Biophysics, Panjab University, Sector 14, Chandigarh 160 014, India

Total sialic acid (TSA) level is sensitive marker for early detection of colorectal cancer (CRC). Wheatgrass, rich in chlorophyll and antioxidants may play important role CRC prevention.

*Aim*: To study wheatgrass effects on experimentally induced CRC in rats.

*Methodology*: Thirty-six Sprague Dawley rats were divided into 6 groups. Group1 (control): Rats received 1mM EDTA saline subcutaneously (SC)/week. Group 2: 1, 2 dimethylhydrazine (DMH) was administered SC at 30 mg/Kg b.wt dose once/week for 16 weeks. Group 3-5: Wheatgrass was given daily at doses ie. 80 mg, 100 mg and 120 mg/100 g b.wt respectively along with weekly DMH injection. Group 6: Alone wheatgrass given orally at dose of 120 mg/100 g b.wt. TSA levels were measured in serum at 8 and 16 weeks and histological studies were also conducted at end of study. *Results*: At 8 and 16 weeks, level of TSA in serum increased significantly to 49.2±4.9 and 65.2±8.9 mg/dL respectively in group 2 as compared to group 1 (35.6±5.4 mg/dL and 33.6±5.4 mg/dL). Wheatgrass treated groups showed significant decrease in serum TSA at 8 and 16 weeks although there was not much difference among group 4 and 5. Histologically, DMH group showed well differentiated adenocarcinoma, severe dysplasia and excessive mitosis. Improvement was seen with wheatgrass supplementation but there was not much difference in histology of groups 4 and 5.

*Conclusion*: Wheatgrass supplementation at dose of 100 mg/100 g b.wt showed similar protection as 120 mg/100 g b.wt both histologically and in TSA levels. Study also suggests that TSA can be boon in diagnosis of CRC as it is a cheaper and easier analysis than CEA.
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### Percutaneous endoscopic gastrostomy (PEG): A single centre experience {#Sec643}

***Harshad Vinay Joshi*** *, Pradeep Kakkadasam Ramaswami, Nilesh Toke, Sunil Mathai, Charles Panackel, Rony Thomas*

Department of Medical Gastroenterology, Medical Trust Hospital, M G Road, Kochi 682 016, Kerala, India

Percutaneous endoscopic gastrostomy (PEG) feeding is an important route for enteral feeding in patients deemed unfit for oral feeding due to various neurological and non-neurological causes. All patients who underwent PEG insertion from January 2011 to January 2013 were included in our study. Out of 105 patients 80 % were male with mean age of 56 years. Intracranial bleed due to road traffic topped the indication followed by stroke and degenerative neurologic diseases. Complication rate was mere 7 % with commonest being peg site infection. Buried bumper syndrome and bleeding were other complications although none necessitated removal of PEG tube. At mean of 100 days about 25 % patients had their tube removed due to clinical improvement. Twenty percent of our patients died due to non-PEG related complication. In conclusion, PEG feeding is an essential and safe feeding route in a set of patients with a minimal risk of complications and negligible mortality.
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### Nutritional and clinical abnormalities in cirrhotic patients: A comparison with different etiology of liver disease {#Sec645}

***Neha Singh*** *, Manish Kumar Tripathi, Smita Verma, Jitendra Kumar Choudhary, Ashok Kumar Jain, Vinod Kumar Dixit*

Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India

*Background*: Malnutrition is frequently occurs in patients with chronic liver disease. Multiple factors which are common to the underlying disease directly contribute to malnutrition, ie. anorexia, nausea, deficient food intake and absorption and catabolic state.

*Aim*: To analyze and compare the nutritional and clinical abnormalities in patients with different etiology of liver disease.

*Method and Materials*: A total of 294 consecutive patients (M/F-245/49) with Mean age were 39.86±11.51 years. Anthropometric evaluation was performed by the usual parameters: BMI, triceps skin fold (TSF) and mid arm circumference (MAC). The disease was diagnosed on the basis of blood profile and radiological imaging parameters. Food intake was retrospectively evaluated using 24-hour dietary recall method.

*Results*: Subject with virus related liver disease (VLD) (51 %), alcoholic liver disease (ALD) (23.8 %) and cryptogenic (25.2 %) were included in this study. BMI (p=0.004), TSF (p=0.000) and MAC (p=0.000) were significantly correlated in these patients. There were significant differences in serum albumin, hemoglobin, protein, calorie intake and CTP and MELD scores (Table 1).Table 1Comparison of nutritional and clinical status in patients with different etiologyParametersVLDALDCryptogenic*p*-valueSerum albumin (g/dL)3.09±0.252.90±.6662.86±.824Serum protein (g/dL)6.82±1.96.87±1.086.28±1.710.040Calorie intake (kcal/day)1503±3531126±2141130±228Protein intake (gm/day)37.8±8.5730.7±4.8132±5.900.004HB (g/dL)17.00±5.217.00±5.217.00±5.2CTP score7.85±1.78.73±1.848.41±1.880.000MELD score17.37±6.720.63±6.816.25±6.09

*Conclusion*: Differences in malnutrition between various etiologies of cirrhosis were explored in this study. The frequency of malnutrition in alcohol related cirrhosis was significantly higher.
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### Regulation of SirT1-a NAD dependent deacetylase as a molecular switch for liver disease development and its utility as novel therapeutic target {#Sec647}

***Manashree Sharma*** *, Nidhi Singh, Pinku Rajbongshi, Anupam Sarma, Manab Deka, Sujoy Bose*

Department of Biotechnology, and Biological Science, Gauhati University Guwahati 781 014, and Department of Pathology, Dr B Borooah Cancer Institute, Gopinath Nagar, Guwahati 781 016, Assam, India

SirT1 plays a critical role in the regulation of cell cycle, metabolism and stress response. We aimed to study the role of SirT1 in liver disease development and investigate if SirT1 may be used as therapeutic target.

*Methods*: Phase I: Experimental mice models (*n*=10) of liver fibrosis were developed using controlled doses of CCl4, and differential mRNA expression of SirT1 was studied by RT-PCR method. Phase II: Defined concentration of resveratrol (a potent Sirt1-activator) was supplemented along with requisite doses of CCl4 in mice models (*n*=5 each), to screen the therapeutic target value of the gene in controlling fibrosis development. Biochemical and histopathological examination was performed to confirm and access the liver fibrosis development/control. Phase III: Screening for the bioavailability of naturally derived resveratrol was performed by HPLC using selected fruits from N E India.

*Results*: Biochemical and histopathological results confirmed development of liver fibrosis after 4 weeks of regulated CCl4 administration. Sirt1 mRNA expression was significantly downregulated (0.199 folds) in fibrosis model compared to controls. In resveratrol treated mice, biochemical and histopathological examination showed minimal liver tissue damage compared to fibrosis model; and importantly these cases showed an increase in SirT1 expression, thereby confirming its therapeutic target value. HPLC based screening of resveratrol showed the presence of the compound in Embellica officialis, Elaeagnus pyriformis-(heiyai), Averrhoa carambola-(kordoi) etc. in adequate quantity.

*Conclusion*: Down regulation of Sirt1 is critical for liver diseases and may be effectively targeted for limiting liver disease development. Fruits containing high amount of resveratrol has potential neutralceutical values and can be used as alternative therapy against liver disease.
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### Approach to parenteral nutrition {#Sec649}

***Ankush Bansal*** *, Sharad Malhotra, Faiz Ahmed, R K Himthani*

Batra Hospital, 1, M B Road, New Delhi 110 064, India

Parenteral nutrition supplies all nutrients without use of intestinal tract and is indicated in patients who cannot tolerate or eat enteral feeds. It is indicated in severe malabsorption of nutrients as in cases of massive small bowel resection and in cases of complete bowel obstruction, massive gastrointestinal bleeding and fistulas. It can be given by central venous access when the expected length of therapy is long and peripheral venous access when the therapy is to be short. Total parentral nutrition (TPN) is a combination of amino acids, glucose and lipid solutions which can be given for a indefinite period. Subclavian vein the best access used and internal jugular vein is the next best. Main drawback is mechanical, catheter related, infectious and metabolic complications. Parenteral nutrition is delivered either through multiple bottles or all in one system. A typical parenteral nutrition solution is six times more concentrated than blood and consists of approximately 30 to 50 gram of protein and 1000 to 1200 calories/L. In clinical practice a mixture of glucose and long chain fatty acids is given in a ratio of 60 % to 70 % glucose to 30 % to 40 % of fat as non-protein calories. This system has many advantages as it keeps the osmolarity low and fluid balance is maintained. Some standard instructions are-infuse only through a new catheter, check vital signs 2 hourly, check X-ray chest, total asepsis, intake-output chart and daily dressing. Nutritional support may need expert adjustments in specific conditions in critically ill patients.
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### Etiology of nonvariceal upper GI bleed as diagnosed on endoscopy {#Sec652}

***S Pratibha*** *, P Shravan Kumar, M Umadevi, M Ramanna, I Bhrani*

Department of Gastroenterology, Gandhi Hospital, Secunderabad 500 025, India

*Aim*: To determine a source of upper GI bleed on first endoscopy.

*Materials and Methods*: A retrospective analysis of 169 cases from June 2012 to June 2013 with clinically suspected nonvariceal upper GI bleed. Data was collected from medical records.

*Inclusion Criteria:* All patients with either hematemesis or melena and referred for endoscopy.

*Exclusion Criteria*: History of recent corrosive ingestion.

*Results*: A total of 169 cases were analyzed. The number of males were 133 (78 %) and females were 36 (22 %). Adults were 157 (93 %) and children 12 (07 %). The clinical presentation was hematemesis in 80 (90 %) and melena in 9 (10 %) patients. Definite source was identified in 89 (53 %) and not clear in 80 (47 %). Gastritis, duodenal ulcer and gastric ulcer accounted for 17 (20 %), 15 (17 %) and 15 (17 %) respectively. Less common causes were esophagitis and Mallory-Weiss tear accounted for 10 (11 %) and 9 (10 %) respectively. Unsuspected varices and duodenitis in 7 % each. Carcinoma and esophageal ulcers accounted for 4 (4 %) each. Least common causes were Cameroon ulcer PHG and choledodudenal fistula which accounted for 1 % each.

*Conclusions*: In patients with upper GI bleed adult males patients predominated the females and children. A source was identified in just above half of the cases. The most common cause was gastritis followed by gastric and duodenal ulcers. Esophagitis and Mallory-Weiss tear accounted for a significant proportion of bleeds. The miscellaneous causes accounted for one fourth of the cases.
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### Design, development and feasibility of a novel fecal incontinence device consure 120 SMS {#Sec654}

***Govind Makharia*** *, Padma Vasantha, Balram Bhargava, Peush Sahni, Sandeep Singh, Sujoy Pal, Rohit Bhatia, Amit K Sharma, Nishith Chasmawala*

Departments of Gastroenterology and Human Nutrition, Neurology, Cardiology, and Gastrointestinal Surgery, All India Institute of Medical Sciences, New Delhi 110 029, India

*The abstract matter was not received in part or full at the time of sending to press, despite reminders to corresponding author*.
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### Rockall scoring system in acute upper gastrointestinal bleeding {#Sec658}

***Khus Raj Dewan*** *, B S Patowary, S Bhattarai*

Department of Gastroenterology, College of Medical Sciences, Teaching Hospital, Bharatpur 10, Chitwan, Nepal

*Introduction*: Acute upper GI bleeding is a common medical emergency with a hospital mortality of approximately 10 %. Higher mortality rate is associated with rebleeding. Rockall scoring system identifies patients at higher risk of rebleed and mortality.

*Methods*: This is a prospective, descriptive hospital based study conducted in Gastroenterology Unit of College of Medical Sciences and Teaching Hospital, Bharatpur, Nepal from January 2012 to January 2013. It included 120 patients at random presenting with manifestations of acute UGI bleed. Rockall scoring system was used to predict the prognosis and rebleeding by dividing the patients into two groups ie. Group I with Rockall score 6.

*Results*: Males were predominant (75 %). Age ranged from 14 to 88 years, mean being 48.76+17.19. At presentation shock was detected in 21.7 %, severe anemia and high blood urea were found in 34.2 % and 38.3 % respectively. UGI endoscopy revealed esophageal varices (47.5 %), peptic ulcer disease (33.3 %), erosive mucosal disease (11.6 %), Mallory-Weiss tear (4.1 %) and malignancy (3.3 %). Median hospital stay was 7.28+3.18 days. Comorbidities were present in 43.3 %. Eighty-six patients (71.7 %) had Rockall score \<5 and 34 (28.3 %) had \>6. Five patients (4.2 %) expired. Risk factors for death being massive rebleeeding, comorbidities and Rockall score \>7.

*Conclusion*: Mortality is associated with massive bleeding, comorbidities and Rockall score \>7. Rockall scoring system is an effective system for predicting outcome in patients with upper GI bleeding.
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### Extrahepatic replication of hepatitis E virus in human placenta:Its clinical implications {#Sec660}

*Purabi Deka, Bhudev Chandra Das,* ***Rajib Kishore Hazam***, *Ashok Kumar, Premashis Kar*

Departments of Medicine, and Obstetrics and Gynecology, Maulana Azad Medical College, University of Delhi, Bahadur Shah Zafar Marg, Delhi Gate, New Delhi, Delhi 110 002, and Dr B R Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110 007, India

*Background and Aims*: The incidence and severity of hepatitis E virus (HEV) infection in pregnant women is high in developing countries. Transplacental transmission of HEV in the third trimester of pregnancy has been found to be associated with a high fetal mortality. In humans, extrahepatic site(s) for HEV replication has not been reported to date, therefore this study was carried out to investigate if HEV replication occurs in the placenta of the infected mothers.

*Methods*: The study group included 68 acute viral hepatitis (AVH) and 22 acute liver failure (ALF) pregnant patients. Viral RNA was extracted from blood and placenta. HEV replication in placenta was confirmed by a replicative negative strand-specific rt-PCR. Viral load was estimated by real time PCR. Immunohistochemical studies using HEV antibody and electron microscopy (Tecnai G2, TEM) were also carried out for in situ detection of HEV in representative placental tissue sections.

*Results*: Replicative HEV RNA was detectable only in the placenta and not in the blood of the study group. Positive staining of placental tissue sections stained with hepatitis E virus antibody against the viral structural protein ORF3 was identified in all the representative cases. Hepatitis E virus particles were also observed by electron microscopy in placental tissue samples. HEV replication in placenta correlated with fetal and maternal mortality in ALF.

*Conclusion*: The extrahepatic replication of hepatitis E virus in human placenta is demonstrated for the first time by three methods. HEV replication in placenta is associated with the severity of disease in HEV infected pregnant women.
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### Endoscopic correlation of radiologic findings in the gastrointestinal tract {#Sec662}

*Krishnadas Devadas,* ***Anish Philip*** *, Mukunda Madhavan, Vinu P A Joseph, R Sobhanadevi*

Department of Gastroenterology Government Medical College, Kottayam 686 008, India

*Background and Aims*: Patients often come with radiological reports of bowel wall thickening on ultrasounds (USS) and CT scans done for even nonbowel related complaints. This results in invasive procedures like upper and lower GI endoscopies. We tried to look at the correlation between radiologic investigations and endoscopic findings and to see if presence of symptoms and signs could predict positive endoscopy. We also tried to see whether there was operator influence academic institutions vs. others.

*Materials and Methods*: Consecutive patients coming to the Medical Gastroenterology Department with radiologic (CT or USS) findings of bowel wall thickening underwent corresponding endoscopic examination.

*Results*: Fifty consecutive patients were included in the study. Thirty-seven patients (74 %) had findings on endoscopy. Patients with positive clinical findings had 91 % chance of positive endoscopy findings (*p* 0.047), but there was no correlation with symptoms. All subjects with a palpable mass had a positive endoscopy as against 63 % with no mass palpable. There was no difference between the sexes, across the different age groups, upper GI and lower GI involvement or with USS and CT findings. Reports from academic centres were more likely to have a positive endoscopic correlation (*p*=0.047, OR 5.8 (CI 1.13 to 29.9). Clinical findings in a patient with positive radiology from academic centre predict positive endoscopy in 100 %.

*Conclusions*: All patients with positive radiological findings will have to undergo invasive testing. Subjects with positive clinical findings and radiological testing in an academic institution have a very chance of having a positive endoscopy.
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### Associative role of MTHFR gene mutation and altered homocysteine levels in hepatitis E virus related preterm birth and pregnancy outcome {#Sec664}

***Diptika Tiwari***, *P D Bose, C Ray, A Saikia, M Bose, Rizwana Sultana, Manash Pratim Kalita, Devender Mittal, Bidisha Hazarika, S Bose*

Department of Biological Science, and Biotechnology, Gauhati University, Guwahati 781 014, Department of Biotechnology, Pandu College, Maligaon, Guwahati, 781 012, Guwahati, Assam, and Guwahati Medical College Hospital, Bhangagarh, Guwahati, 781 034, Assam, India

Possible associations between placental abruption, altered folate/homocysteine metabolism, and polymorphisms of folate pathway genes requires attention with respect to HEV infected pregnancy related complications like preterm birth, and both fetal and maternal mortality globally.

*Aim*: Study the association of MTHFRC→T genotypes and altered homocysteine level in preterm birth with special emphasis on HEV-related-preterm-cases.

*Methods*: *MTHFR677C→T* genotyping was performed using DNA extracted from whole blood of 171 preterm pregnancy cases {preterm with no pathological etiology (*n*=155); HEV associated preterm-\[AVH, *n*=10; FHF, *n*=6)}, and 65 term pregnancy cases enrolled from GMCH and Central Hospital, NF Rly, Guwahati; followed by PCR-RFLP based analysis. Plasma homocysteine levels were determined commercially. Statistical analysis was performed using SPSSv13 software.

*Results*: MTHFR mutant genotype was predominant in both preterm and HEV-related-preterm groups. Presence of mutant MTHFR genotype resulted in increased risk of preterm {OR=1.725(0.800-3.719), *p*=0.172} and HEV-related-preterm-birth {OR=9.167 (2.717-30.922), *p*\<0.001} compared to term pregnancy; and HEV-related-preterm-birth {OR=5.315(1.810-15.611), *p*=0.001} compared to healthy preterm cases. It also resulted in increased risk of fetal death in HEV-related FHF preterm cases compared to AVH cases. The average homocysteine levels was found to increase gradiently in the following order: Term-pregnancy (5.7±0.89) \<AVH (7.44±2.35) \<FHF (9.90±3.02) \<preterm cases (12.29±4.36). Homocysteine levels were significantly increased in AVH (*p*=0.023), FHF (*p*\<0.001) and preterm delivery cases (*p*=0.002) compared to term pregnancy cases; and in FHF (*p*=0.015) and preterm cases (*p*=0.003) compared to AVH cases. MTHFR mutation was associated with significantly higher homocysteine levels.

*Conclusion*: MTHFRC→T mutation and resulting higher homocysteine levels plays a critical role in preterm birth (both HEV and non-viral); and may be utilized as prognostic marker to evaluate preterm risk and inturn proper patient management.
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### Is 5 minutes of high level disinfection of GI endoscopes adequate to prevent transmission of hepatitis B or hepatitis C infection: Results from a tertiary care centre {#Sec666}

***Paras Shah*** *, Amit Soni, Amit Mathur, Sandeep Nijhawan, Gaurav Gupta*

Department of Gastroenterology, S M S Medical College, Jaipur 302 004, India

*Background and Aim*: For prevention of transmission of infection via GI endoscopy, the recommended soak time in high level disinfectant varies from 10 to 20 minutes as per various guidelines. Reducing the soak time to either 10 min or 5 min, can facilitate centers to reduce waiting time and ultimately cost. Current study aimed to determine whether reducing soak time to either 10 min or 5 min is adequate to prevent transmission of hepatitis-B or hepatitis-C infection.

*Methods*: Study was conducted at Gastroenterology Department, S M S Medical College, Jaipur, between July to December 2012. Study population consisted 240 patients (60 chronic hepatitis B, 60 chronic hepatitis C and 120 patients who were negative for B and C which comprised study group). Study group patients were negative for HBsAg, HBV-DNA, anti-HCV and HCV-RNA and were divided into four arms each of 30 patients, viz. B5, B10, C5 and C10. B5 and B10 arm constituted patients who underwent GI endoscopy after endoscopy of CHB patients with in between soak time of 5 min and 10 min respectively. Same was for C5 and C10 arm who underwent endoscopy after that of CHC patients.

*Results*: Study group subjects were followed at month 3 and 6 wherein their HBsAg, HBV-DNA, anti-HCV and HCV-RNA were tested. None of these subjects became positive for any above markers during follow up.

*Conclusion*: This suggests that soak time of 10 minutes and 5 minutes is adequate for prevention of transmission of hepatitis B or hepatitis C infection via endoscopy, provided all other steps of reprocessing are followed well.
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### Needle knife papillotomy is effective and safe method in failed CBD cannulation during ERCP {#Sec668}

*S Srivastava,* ***A Jindal*** *, P K Mishra, S Puri, S Sachdeva, N Gupta, B C Sharma, A S Puri*

Departments of Gastroenterology, GI Surgery, and Radiology, G B Pant Hospital, J L Nehru Marg, New Delhi 110 002, India

*Background and Study Aims*: Getting directly into common bile duct (CBD) is the most important step for successful therapeutic endoscopy. Needle-knife papillotomy (NKP) is the technique used in ERCP to facilitate access to CBD or PD when standard cannulation techniques have failed. Our aim was to examine the safety and efficacy of NKP to obtain selective cannulation of the CBD.

*Patients and Methods*: Retrospective analysis of prospectively kept data from January 2007 to June 2012. We assessed the safety and efficacy of NKP in 1,082 consecutive patients in whom attempts at standard common bile duct cannulation were unsuccessful. The data was obtained from complication register and ERCP report books.

*Results*: From January 2007 to July 2012, 1,082 (9.7 %) NKP were performed out of a total of 11,062 ERCP procedures. Of these 768 (70.9 %) were females and 470 (40.7 %) were in age group of 41-60 years. The indication for NKP was failed CBD cannulation in all except in patients with periampullary divericula (*n*=36; 3.3 %) and ectopic papilla (*n*=43; 3.9 %). Post NKP, CBD could be cannulated immediately in 765 (71 %) patients, 187 patients required second ERCP making total cannulation rate following NKP of 91 % (*n*=982). Post-NKP complications occurred in 7.9 % (*n*=86) as compared to 4.1 % (*n*=454) post-ERCP (without NKP).

*Conclusions*: NKP is effective in facilitating cannulation in patients with failed standard ERCP. The overall success rate was 91 % and it was associated with non-significant increase in complication rate.
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### Impact of completion of primary biliary procedure on management of post endoscopic retrograde cholangiopancreatographic perforation {#Sec670}

*S Srivastava,* ***A Jindal*** *, L Jain, P K Mishra, S Puri, S Sachdeva, N Gupta, B C Sharma, A S Puri*

Departments of Gastroenterology, GI Surgery, and Radiology, G B Pant Hospital, J L Nehru Marg, New Delhi 110 002, India

*Background*: Perforation is one of the most dreaded complications of therapeutic endoscopic retrograde cholangiopancreatography (ERCP). Retroduodenal perforation was reported in 0.5 to 2.1 percent of sphincterotomies in a number of large series. We planned to study incidence and epidemiology of post-ERCP perforation and risk factors for post-ERCP perforation.

*Methods*: From January 2007 to April 2012, 11,500 ERCPs were performed. Data was collected from complication register and ERCP report books maintained in department by 2 investigators independently. Case sheets of 171 (1.4 %) patients diagnosed as post-ERCP perforation with radiologic, endoscopic or surgical evidence were retrospectively reviewed. We analyzed epidemiology of perforation and risk factors associated with poor outcomes.

*Results*: 60.8 % (*n*=7000) of all patients undergoing ERCPs were females. One hundred thirty-nine (81.3 %) were females amongst patients who had post-ERCP perforation. Therapeutic ERCP was performed in all. Mean hospital stay was 14±6 days. Majority 129 (75.4 %) were related to use of needle knife precut. Female gender (1.9 % vs. 0.7 %, *p*\<0.001), age \>40 years (1.7 % vs. 1.1 %, *p*\<0.01), benign disease (1.7 % vs. 1.1 % *p*\<0.01) were independent risk factors for post-ERCP perforation. Most of the perforations (*n*=135, 79 %) were detected on table. Majority of patients were managed conservatively (*n*=164, 96 %). Although 159 patients recovered without poor outcomes, there was mortality in 13 patients (7 %). Of the 13 deaths, 8 patients died of ongoing cholangitis while only 5 died as a complication arising out of perforation. Completion of biliary procedure for primary disease was associated with low risk of mortality (2 % vs. 15.4 %, *p*\<0.001).

*Conclusions*: Post-ERCP perforation is uncommon, majority of patients can be managed conservatively. Mortality is rare and completion of biliary procedure for primary disease lowers the mortality significantly.
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### Corrosive injury-Tertiary care centre experience {#Sec672}

***A Sangameswaran***

Madras Medical College, Chennai 600 003, India

*Background*: The ingestion of corrosive substances induces a spectrum of injuries to the aero-digestive tract which includes extensive necrosis and perforation of the esophagus and stomach. The gold standard for safe assessment of the depth, extent of injury, and appropriate therapeutic regimen is upper GI scopy. The objective of this study is to report our clinical experience in adult patients diagnosed with corrosive ingestion and to evaluate the usage of a Zargar 6-point OGD classification system of injury.

*Methods*: The study was a retrospective medical chart review of patients admitted following corrosive ingestion in Rajiv Gandhi Government General Hospital. The patients underwent OGDscopy within 72 hours of admission and mucosal damage was graded using Zargar\'s modified endoscopic classification scheme.

*Results*: Total of 445 patients were included for analysis, out of which Grade 1 injury was the most common followed by grade 2b and grade 3a.

*Conclusion*: Endoscopy following corrosive ingestion to assess mucosal injury is useful to determine the severity of injury. This study shows the incidence of Grade 2b and above to be 37 %, as they are ones who are to kept under regular surveillance to prevent further complications.GradeEsophagusStomachTotal (*n*=445)%01899628564.04111122033174.382a40307015.732b42327416.623a32376915.503b148224.94

M-12 {#Sec673}
----

### Multidrug resistant diarrheagenic ***Escherichia coli*** as a cause of community acquired diarrhea in hospital based surveillance, India {#Sec674}

***Neelam Taneja***, *Sapna Pahil, Gagandeep Singh*

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160 012, India

Diarrheal illness is one of the most important causes of morbidity and mortality worldwide. A surveillance for diarrheagenic *E. coli* causing community acquired diarrhea at our centre was carried out. Stool samples were collected from children and adults with acute or chronic/persistent diarrheal illness and processed by conventional method to detect bacterial enteropathogens. Diarrheagenic *Escherichia coli* (DEC) pathotypes were identified by multiplex polymerase chain reaction (PCR). Out of 426 cases bacterial enteropathogens were identified in 38.26 % (163/426). Among DEC (24.41 %), EAEC (19.71 %) were the commonest, 77.38 % were classified as typical EAEC carrying the AggR regulon and 11.90 % as atypical EAEC lacking aggR regulon. EPEC was isolated in 2.58 % cases, typical EPEC in 72.72 % (8/11) cases and atypical EPEC in 27.27 % (3/11) cases. ETEC were isolated in 2.11 % cases. In this study more than 75 % isolates of EAEC were resistant to five antibiotics.

*Conclusion*: DEC are important etiological agents in acute as well as chronic/persistent diarrhea and should be routinely looked for by using molecular methods.
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### Prospective dohort study for incidence of post-endoscopic retrograde cholangiopancreatography adverse events {#Sec676}

***Vishal Khurana***, *Kshaunish Das, Gopal Krishna Dhali, Sanjay Banerjee, Rajib Sarkar, Souvik Ghosh, Mahinuddin Ahmed*

Department of Medical Gastroenterology, School of Digestive and Liver Disease (SDLD), Institute of Postgraduate Medical Education and Research, S S K M Hospital, Kolkata, West Bengal, and Department of Hepatology, School of Digestive and Live

*Background*: Endoscopic retrograde cholangiopancreatography (ERCP), commonly performed procedure for diagnosis and management of biliaropancreatic diseases, associated with a relatively high complication rate. There are various studies done on risk factors of various complications of ERCP but no studies from India. Demographic features of Indian population are different from western population. The relative contribution of risk factors to morbidity and mortality after ERCP, however, is unknown. Many studies have evaluated the risk factors of individual ERCP complication; few studies have evaluated all ERCP complication in one study.

*Aim*: Present study was done to identify incidence, risk factors and outcome of immediate, early and delayed post-ERCP adverse event in multivariable analysis.

*Study Design*: Single centre prospective cohort study,

*Method*: All consecutive patients undergoing ERCP, both diagnostic and therapeutic, in our institution were enrolled and followed up. Following ERCP, patient were kept in observation for -6 hours in our ward and if no symptom or sign at end of this period patient were discharged and further follow up was done by telephonic interview at 24 hours, 72 hours, 1 week and 30 days of ERCP procedure. If any adverse event occurred it was managed as per standard protocol. Adverse events and their severity were dened by established consensus criteria.

*Results and Conclusions*: Result and conclusion will be presented at the time of conference (as few patients are still in follow up and study will be over in few weeks).
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### Scientific yogic meditation ancient technique for de-stressing stress {#Sec678}

***M R Kotwal*** *, C Z Rinchen, Hsin-Li Sony Liu, R N, M S N*

Department of Home and Health, Shunyata, Tibet Road, Sikkim, India, Nursing Department, College of Nursing, Central Taiwan University of Science and Technology, Taichung, Taiwan

*Introduction*: We live in an era of constant information and almost infinite possibilities. Multitasking leaves us stressed. Daily meditation physically transforms the cerebral cortex. The most unexpected and comforting recent research confirm that the human brain retains an astonishing degree of plasticity and capacity for learning throughout life. Our mental performance, despite a few glitches with short-term memory, does not peak until mid life, when the white matter in the loftiest parts of the brain is thickest.

*Aim and Methods*: To evaluate efficacy of a self-learning de-stressing technique Swasthya Sukh Satyam Shivam Sundram in randomly assigned 60 students a meditation group from 114 students practiced meditation for 12 weeks and rest formed control group. Scientific technique is from ancient times. Five-step relaxation meditation practiced for 20 minutes 5 days weekly was taught to meditation group, while control group did not practice.

*Results*: A questionnaire analyzed confirmed validity, reliability and reproducibility. Three factors (Psyche, physical and life adjustment, happiness and moodiness) in the group that meditated two times a week for 12 weeks optimally showed statistically significant (*p*\< 0.0001) results.

*Conclusion*: Preliminary evaluation of an innovative relaxation meditation practiced twice a week for 12 weeks showed statistically significant results. The technique could be used in many medical situations which generate undue psychological stress and anxiety, to enhance well being. The technique could promote health and prevent stress disorders. DVD movie presentation of the technique would be made. The technique is fully explained and is most simple exercise.
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### Acid-fast bacilli culture positivity and drug resistance in primary abdominal tuberculosis {#Sec680}

***Hrishikesh Samant***, *Devendra Desai, Philip Abraham, Anand Joshi, Tarun Gupta, Sandeep Davavala, Rishikesh Kaleria, Camilla Rodrigues*

P D Hinduja National Hospital, Veer Savarkar Marg, Mahim, Mumbai 400 016, India

*Introduction:* Culture positivity for Mycobacterium tuberculosis complex (MTB) in abdominal tuberculosis (TB) varies from 25 % to 36 %. Data on the prevalence of drug resistance in primary abdominal TB is scant.

*Aim*: To study the AFB culture positivity rate in primary abdominal TB using Bactec MGIT and the prevalence of drug resistance in these patients.

*Patients and Methods*: Records of patients with abdominal TB (diagnosed on clinical features, endoscopy, histology, microbiology) seen during the period 2008-13 were retrieved from the Gastroenterology and Microbiology Departments. Patients with extraabdominal TB (5 pulmonary, 2 nodal, 1 adnexal) and HIV (1) were excluded from analysis.

*Results*: Of 61 patients, 31 (50.8 %) had AFB culture positive. In the 30 culture-negative patients, histology showed non-caseating granulomas in 25 patients. AFB smear was positive in 4 patients. Drug sensitivity pattern was analyzed in 18 patients; resistance was detected in 8 (44.4 %), including 3 (16.6 %) who were multi-drug resistant.

*Conclusion*: The rate of AFB culture positivity in primary abdominal TB was 50.8 % using Bactec MGIT. Drug resistance was seen in 44.4 % of those tested, of whom 16.6 % were multi-drug resistant.
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### Caustic ingestion in adults: The role of endoscopic classification in predicting the outcome at a tertiary centre {#Sec682}

***K Mansoor Ali***

Gandhi Medical College and Hospital, Hyderabad, India

*Background*: The ingestion of caustic substances induces an extensive spectrum of injuries to the Aero digestive tract which include extensive necrosis and perforation of the esophagus and stomach. The gold standard of safely assessing depth, extent of injury, and appropriate therapeutic regimen is esophagogastroduodenoscopy (EGD). The objective of this study was to report our clinical experience and to evaluate the role of a 6-point EGD classification system of injury in predicting outcomes in adult patients diagnosed with caustic agent ingestion.

*Methods*: The study was a retrospective medical chart review from 110 patients admitted to Gandhi Medical College, Secunderabad between June 2011-2013 for treatment of caustic ingestion. The patients underwent EGD within 24 hours of admission and mucosal damage was graded using Zagar\'s modified endoscopic classification scheme. After treatment, patients were followed in the outpatient clinic for a minimum of 6 months.

*Results*: A total of 110 patients were included for analysis. Grade 2b injury was the most common caustic injury (*n*=59, 53.6 %), followed by grade 3b injuries (*n*=20, 18.2 %). Stricture (both esophageal and antral) was the most common complication (*n*=21, 19.0%), followed by aspiration pneumonia (*n*=10, 9 %) and respiratory failure (*n*=2, 1.%). Compared to grade 3a mucosal injury, grade 3b mucosal injuries were at greater risk of prolonged hospital stay \>2 wks and gastrointestinal and systemic complications.

*Conclusion*: In patients with caustic ingestion, EGD should be performed within 12 to 24 hours and categorized according to a 6-point scale. Patients with grade 2b burns and beyond identified on endoscopy have high rates of morbidity. The 6-point scale is useful for predicting immediate and long-term complications and guiding appropriate therapy.
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### Abdominal tuberculosis: Paradigm shift in diagnostic approach {#Sec684}

***Pankaj Tyagi***, *A Arora, V Shingla, P Sharam, A Kumar, A Bansal*

Departments of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi, Delhi 110 060, India

*Background*: The abdomen is involved in 11 % of patients with extra-pulmonary tuberculosis. It is difficult to get the tissue in abdominal tuberculosis and WHO recommends to have tissue diagnosis before starting ATT. Endoscopic ultrasound (EUS) is being used more commonly in most of the endoscopic centres.

*Methods*: Prospectively 134 patients of abdominal tuberculosis were enrolled in tertiary care hospital in Delhi, and there clinical, diagnostic investigation and treatment was recorded.

*Results*: Out of 134 patients (Mean age 43±15 years) CECT abdomen in 130 patients showed lymphnode in 68 %, intestinal wall thicking was seen in 65 patients, mesentric thinking in 35 % of patients. CECT chest was available in sixty-eight patients which showed presence of mediastinal lymphadenopathy in 48 patients (70 %). Tissue diagnosis was obtained by EUS in 63 patients, surgically in 15 patients and endoscopic biopsy in 17 patients. EUS FNAC was done in 63 patients of which mediastinal EUS FNAC was done in 41 and abdominal EUS FNAC was done in 22. Histology present in 95 patients in whom granuloma present in 100 %, AFB was positive in 40 %.

*Conclusion*: Histological evidence can be achieved in 70 % of the patients of abdominal tuberculosis before starting ATT, EUS helped in getting histology in 66 % and mediastinal EUS FNAC was use full in 65 % of total EUS thus EUS should be included in the diagnostic algorithm of the abdominal tuberculosis.
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### Efficacy of Xpert MTB/RIF assay for diagnosis of peritoneal tuberculosis in patients with exudative ascites {#Sec686}

***Chinmay Bera1***, *Joy Sarojini Michael, Sridhar Gibikote, Ashish Goel, C E Eapen*

Departments of Hepatology, Microbiology and Radiology, Christian Medical College, Vellore 632 004, India

*Background*: Xpert MTB/Rif is a multiplex hemi-nested real-time PCR based assay to detect presence of M. tuberculosis within two hours of sample collection. The present study aimed at assessing efficacy of Xpert MTB/Rif assay for diagnosis of peritoneal tuberculosis.

*Methods*: Patients presenting to Liver Clinic with exudative ascites and negative Ziehl Nelsen (ZN) staining for acid fast bacilli (AFB) and unyielding cytology for malignant cells, were included after informed consent. Ultrasound guided omental biopsy sample were obtained in all. Besides histopathology and TB culture, Xpert was performed in all tissue samples. A composite reference standard for diagnosis was used as no single test is considered as gold standard in this setting.

*Results*: During January 2012 to July 2013, 18 patients (16 males; age: 42.5, 17-65 years; median, range, 3 with underlying cirrhosis) were recruited. All had high protein and low gradient ascites with negative result on ZN staining and cytology. Fourteen of the 18 study patients had peritoneal TB as diagnosed by composite reference standard- culture: 3; granulomatous inflammation of histology: 13 and response to 2 months of antituberculous therapy: 3 (unyielding culture/histology). Four patients were diagnosed as peritoneal carcinomatosis (adenocarcinoma: 2; mesothelioma: 1; metastatic carcinoma: 1). Xpert was positive in 3 of 14 patients with peritoneal TB and in none of the 4 patients with peritoneal carcinomatosis. The sensitivity, specificity, negative predictive value and positive predictive value for Xpert were 21 %, 100 %, 27 % and 100 % respectively.

*Conclusions*: Xpert MTB/Rif was not a sensitive test to diagnose peritoneal tuberculosis, however its positive predictive value was 100 %.
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### Step-by-step approach to NOTES - Our learning model {#Sec689}

***Mohd. Juned Khan***, *P S Rajan, P Karthikeyan, Amol Shinde, C Palanivelu*

G E M Hospital and Research Centre, 45, Pankaja Mill Road, Ramanathapuram, Coimbatore 641 045, India

*Background/Aims*: NOTES is a surgical procedure to be performed by endoscopic accessories via natural orifices like mouth, anal canal and vagina in females. With any transition from standard laparoscopy to newer approach, the results of the newer procedure should be with lesser morbidity. Hence we adopted step by step approach.

*Methods*: We progressed from porcine models to trans-umblical approach in human subjects followed by transvaginal to transgastric approach.

*Result*: Initially we performed transgastric endoscopic cholecystectomy in porcine models. Next we progressed to perform surgery with endoscopic accessories with endoscopy placed in the umbilicus, performed large human series of appendectomy and cholecystectomy. After gaining experience of performing transumbilical endoscopic appendectomy and cholecystectomy, we advanced to vaginal route and performed large series of appendectomy and cholecystectomy. During this process, if difficulty was encountered it was converted to standard laparoscopy without any added morbidity. Finally we proceeded to transgastric approach, at completion requires standard laparoscopic gastrotomy closure until we get a good tool to close the gastrostomy by endoscope.

*Transumbilical Access*: Number of cases=20 (12 appendectomies and 8 cholecystectomies). Age group=27-52 years. Duration of hospital stay=2-4 days. Operative time=30-110 minutes.

*Transvaginal Access*: Number of cases=80 (55 appendectomies and 25 cholecystectomies). Age group=32-58 years. Duration of hospital stay=2-4 days. Operative time=35-110 minutes.

*Transgstric Access*: Number of cases=5 (3 appendectomies and 2 cholecystectomies). Age group 27-44 years. Duration of hospital stay=4-6 days. Operative time=90-135 minutes.

*Conclusion*: NOTES being a complex procedure, this method of step-by-step learning approach in performing this endoscopic surgical procedures is safe without any morbidity associated with new techniques.
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### Efficacy, safety and tolerance of split dose sulphate solution versus split dose PEG versus single dose PEG for colonoscopy preparation: A prospective randomized trial {#Sec691}

***George Sarin Zacharia***, *A R Rajneesh, K Sandesh, K Sunilkumar, T M Ramachandran, Varghese Thomas*

Department of Gastroenterology, Government Medical College, Calicut 673 008, India

*Aims*: To assess the efficacy, safety and tolerance of three types of bowel preparation regimens for colonoscopy.

*Methods*: Prospective single blind randomized trial conducted in a tertiary care setting. Patients were randomized to receive any of the three bowel preparation regimens; (A) split dose sulphate solution or (B) split dose PEG solution or (C) same day single dose PEG solution. Efficacy of bowel cleansing was assessed by Boston Bowel Preparation Score (BBPS). Any adverse effects were noted.

*Results*: A total of 172 patients were considered for the study (A-56, B-61, C-55). Baseline variables were comparable across the groups. The mean BBPS scores amongst groups A, B and C were 8.02, 7.47 and 8.24 respectively (*p*=0.041). Bonferroni analysis revealed no significant difference between group A vs. groups B and C, where as the difference was significant between groups B and C; C with higher BBPS scores. Severe taste intolerance was reported in 41.1 % (*n*=23) of patients in group A compared to 19.7 % (*n*=12) and 7.3 % (*n*=4) amongst group B and C. Volume intolerance was seen in 14.6 % (*n*=6), 23 % (*n*=14), 38.2 % (*n*=21) in groups A, B and C respectively. Sleep disturbance was observed in groups A (14.3 %) and B (27.9 %).

*Conclusions*: All preparations provided satisfactory bowel cleansing. Same day single dose PEG provided superior bowel cleansing compared to split PEG regimen. Sulphate preparation was associated with more taste intolerance while single dose PEG was associated with more volume intolerance. Sleep disturbances were a problem for overnight bowel preparations.
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### Spectrum of gastrointestinal foreign bodies {#Sec693}

***G Balaji*** *, Muthukumar, G R M Kumar, R Balamurali, P Ganesh, S jeevankumars*

Department of Gastroenterology, Kilpauk Medical College and Hospital, Chennai 600 010, India

*Introduction*: Gastrointestinal foreign bodies (GIFBs) are comprised of food bolus impactions and intentionally and unintentionally ingested or inserted foreign objects. Most resolve without serious clinical sequelae. Regardless of imprecise morbidity and mortality rates, serious complications and deaths occur as a consequence of foreign body ingestions. It is important to understand which patients are at risk for GIFBs, know how to diagnose and treat GIFBs, and deal with their complications.

*Aim*: To study the spectrum of GI foreign bodies presented to our hospital with respect to the risk factors and its complications.

*Materials and Methods*: Total of 48 patients were enrolled in this study.

*Study Period*: March 2009 to April 2013, retrospective study.

*Results*: Of 48 patients 29 were pediatric group (60.4 %) and 19 were adults (39.6 %). Among pediatric group coin was the commonest foreign body (86.2 %) followed by safetypin (7.5 %) and stick (7.5 %). Among adults 9 patients had impacted food bolus (47.3 %), 6 had fishbone (31.5 %) and 4 were others. No risk factor was found in pediatric group where as in adults 10 had stricture. Of 48 patients 46 were treated endocopically and 2 underwent surgical intervention. One patient died in this study with mortality rate of 2 %.

*Conclusion*: Gastrointestinal foreign bodies are seen in both children and adults with increase prevalence in children. Endoscopic retrieval of foreign bodies is successful in most of cases. Surgical intervention was required in complicated cases where endoscopic therapy failed. Availability of endoscopic and surgical modalities of treatment in the same centre significantly decreases morbidity.
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### Diagnostic utility of EUS guided FNAC of mediastinal lymphadenopathy {#Sec695}

***K R Pradeep***, *V J Harshad, N T Nilesh, Rony Thomas, Charles Panackel, Sunil K Mathai*

Departments of Gastroenterology and Hepatology, Medical Trust Hospital, M G Road, Kochi 682 016, India

*Objective*: To analyze the diagnostic utility of EUS guided FNAC of mediastinal lymphadenopathy.

*Methods*: Retrospective chart review of all EUS guided FNAC of mediastinal lymphadenopathy from January 2010 to July 2013.

*Results*: A total of 86 EUS guided FNAC procedures were done on 85 patients. Fifty-six patients (65 %) were male, mean age was 55 years. Cough (76 %) and fever (64 %) were the most common presenting symptoms. Seventy-two patients (84.7 %) received a definitve diagnosis. Twenty-six (30 %) patients were diagnosed with granulomatous lymphadenitis, malignancy was diagnosed in 24 patients (29 %), of which 5 had lymphoma and 19 had metastases from different primaries (1 pancreatic, 1 HCC, 1 renal, 2 squamous cell carcinoma, 1 breast, 13 metastatic NSCLC). Interestingly 26 % of patients had reactive changes and EUS FNA was inconclusive in 13 cases (15 %). None of our patients developed any complications post the procedure.

*Conclusion*: EUS guided FNAC of mediastinal lymphadenopathy is safe and useful. It helps avoiding more invasive mediastinal sampling procedures and complex surgeries.
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### A study of cryptosporidial diarrhea in megaloblastic anemia {#Sec697}

***Vineet Behera*** **;** *Pankaj Puri, S Srivastava, Velu Nair, N Naithani, K D Kamal*

Departments of Gastroenterology, and Internal Medicine, Armed Forces Medical College, Pune 411 040, India

*Objective*: To study the incidence of cryptosporidiosis in megaloblastic anemia (MA) and compare with other anemias and general population.

*Materials and Methods*: The study population comprised of patient of and controls were patients of other anemias and asymptomatic individuals. A detailed clinicopathological record and etiological work up was done for MA. The stool samples of all patients was tested for cryptosporidiosis (light microscopy for oocysts and modified ZN staining) two times.

*Results*: 1. Study population -- MA (*n*=48); controls - 50 cases other anemias, 100 healthy controls. 2. The percentage number of patients with diarrheal symptoms and other stool examination abnormalities were 31 % and 12.5 % in MA, 18.7 % and 6.2 % in other anemia and 16 % and 6 % in healthy controls respectively (*p*\< 0.05). 3. Cryptosporidiosis was seen in 39 % of MA, 16 % of anemia and 14 % of controls (*p*\< 0.05). The presence of cryptosporidiosis in MA with (*n*=15) and without diarrheal symptoms (*n*=33) was compared and was statistically significant. Cryptosporidiosis was seen in 41.6 % of MA with known etiology (*n*=36) and about 30 % of MA with unknown etiology (*n*=12).

*Discussion*: Cryptosporidiosis is seen in 40 % of MA which is statistically significant when compared to other groups; therefore we can conclude that it is an etiological agent for MA. It was commoner in MA with diarrheal symptoms and can be co associated with other etiologies in MA.

*Conclusion*: Cryptosporidiosis is an etiological factor for MA and should be evaluated in all cases of MA with or without diarrhea.
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### Profile of upper gastrointestinal bleeding in a tertiary care hospital in Odisha {#Sec699}

***Haribhakti Seba Das*** *, M K Panigrahi, C R Panda, S K Kar, B Misra, S P Singh*

Department of Gastroenterology, S C B Medical College, Cuttack 753 007, India

*Background*: Upper GI bleeding is a potentially life threatening condition.

*Objective*: To study the profile of patient's presenting with upper GI bleeding in a tertiary care hospital in coastal Orissa.

*Materials and Methods*: The study population consists of 4,665 patients attending the Gastroenterology Outpatient Department of S C B Medical College and Hospital, Cuttack from June 2007 to July 2011 for upper GI bleeding. Patients underwent upper GI endoscopy, USG abdomen and Doppler USG, CT or MR angiography whenever required to diagnose the etiology of bleeding.

*Results*: Out of 4,665 patients 54 % were hospitalized. Mean age group was 28±14.27 years and 76.05 % were male. Patients presented with melena alone in 79.48 %, hematemesis only in 27.78 % and 44.99 % had both. Mean blood transfusions received was 2.06 units in hospitalized patients. Peptic ulcer was commonest cause (53 %) of upper GI bleed which includes duodenal ulcer (37 %), gastric ulcer (16 %). Variceal bleeding was found in 28 % of patients. Erosive gastritis was found in 13 % of bleeders. Carcinoma of stomach was found in 4 %. Other rare causes like Dieulafoy's lesion, Mallory-Weiss tear, duodenal carcinoid, tubercular ulcer and stromal tumor (GIST) accounted for 2 % of total cases. EHPVO accounted for 50 % of variceal bleeding. Surgery was done in 4.65 % of duodenal ulcer bleeding. Mortality rate of UGI bleeding was 7.5 %.

*Conclusion*: Peptic ulcer is the commonest cause of UGI bleeding referred to a tertiary care hospital in Odisha. Variceal bleeding and erosive gastritis are among the next common cause of upper GI bleeding.
